<?xml version="1.0" encoding="utf-8"?>
<documents>
  <document>
    <id>61206</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.fetalmedicine.com/fmf/online-education/01-11-136-week-scan/]]&gt;</url>
    <title>11-13 weeks scan</title>
    <publicationDate>2010-01-01T00:00:00</publicationDate>
    <publisher>Fetal Medicine Foundation</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),FETAL ANOMALY,PRE-ECLAMPSIA,11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM),18-20 WEEKS,28 WEEKS,36 WEEKS,PRE-ECLAMPSIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>An online education resource for patients and healthcare professionals covering all aspects of first trimester screening for chromosomal abnormalities, the diagnosis of major fetal effects and screening for preeclampsia.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This online education tool includes an internet based course in&amp;nbsp;20 different languages, a vidoe lecture, by Professor Kypros Nicolaides,&amp;nbsp;in English, French and Spanish, and an accompanying&amp;nbsp;booklet in 17 different languages.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>346225</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=11218]]&gt;</url>
    <title>18 0 to 20 6 weeks fetal anomaly scan national standards and guidance for England</title>
    <publicationDate>2010-01-28T00:00:00</publicationDate>
    <publisher>NHS Fetal Anomaly Screening Programme</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ 18-20 WEEKS,ANTENATAL,SCREENING,FETAL ANOMALY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;H3&gt;18+0 to 20+6 Weeks Fetal Anomaly Scan: National Standards and Guidance for England&lt;/H3&gt;
&lt;P&gt;The ’18&lt;SUP&gt;+0&lt;/SUP&gt; to 20&lt;SUP&gt;+6&lt;/SUP&gt; Weeks Fetal Anomaly Scan: National Standards and Guidance for England’ document, published by the NHS Fetal Anomaly Screening Programme (NHS FASP) was launched in January. It accompanies the &lt;A href="http://fetalanomaly.screening.nhs.uk/fetalanomalyresource/" target="_blank"&gt;online resource&lt;/A&gt; developed by the Cambridge-based partnership of Jill Rodgers Associates and Liberating Solutions.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Together the document and &lt;A href="http://fetalanomaly.screening.nhs.uk/fetalanomalyresource/" target="_blank"&gt;online resource&lt;/A&gt; provide a wealth of information for all those involved in anomaly screening to secure the national requirements for a homogenous and equitable scanning service. In particular, the &lt;A href="http://fetalanomaly.screening.nhs.uk/fetalanomalyresource/" target="_blank"&gt;online resource&lt;/A&gt; contains easily accessible information about the new standards, a range of practice-based activities, examples of best practice and resources to download and can be used by individuals or within teams to support personal and service development.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/fetalanomalyresource/" target="_blank"&gt;Link to the online resource here&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96101</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/7/5/151?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123063357544_119&amp;stored_search=&amp;FIRSTINDEX=30&amp;journalcode=ebmed]]&gt;</url>
    <title>A brief intervention reduced alcohol drinking for up to 48 months in problem drinkers</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ PRIMARY CARE,NOT ROUTINELY OFFERED,MANAGEMENT,ECONOMICS,ADULT,SCREENING,ALCOHOL PROBLEMS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A brief intervention reduced alcohol drinking for up to 48 months in problem drinkers. Evidence-Based Medicine 2002; 7:151.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Fleming MF, Mundt MP, French MT, et al.Brief physician advice for problem drinkers: long-term efficacy and benefit-cost analysis.Alcohol Clin Exp Res 2002 Jan;26:36–43.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Please not that this summary and the original research are &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95758</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/7/4/127?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122644461937_306&amp;stored_search=&amp;FIRSTINDEX=10&amp;journalcode=ebmed]]&gt;</url>
    <title>A comprehensive annotated reminder tool increased appropriate screening in primary care</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ INFORMED DECISION-MAKING,MANAGEMENT,PRIMARY CARE,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A comprehensive annotated reminder tool increased appropriate screening in primary care. Evidence-Based Medicine 2002; 7:127.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Shannon KC, Sinacore JM, Bennett SG, et al. Improving delivery of preventive health care with the comprehensive annotated reminder tool (CART).J Fam Pract 2001 Sep;50:767–71.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Please note this summary and the original research are &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69862</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/er0403.pdf]]&gt;</url>
    <title>A cost comparison of full field digital mammography with film-screen mammography in breast cancer screening</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BREAST CANCER,ADULT,SCREENING,ECONOMICS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study for the NHS Breast Screening Programme estimates and compares the cost of full field digital mammography systems (FFDM) with conventional mammography for use in breast cancer screening and assessment. 
&lt;P&gt;The report states that "&lt;FONT color=#211d1e&gt;FFDM could potentially reduce the need to recall women for repeat screening, hence generating cost savings and reducing staff workloads.....a&lt;FONT color=#211d1e&gt;s yet, the full costs and effects of FFDM are unknown. Further research is required to assess both the clinical and economic impact of FFDM compared with conventional mammography"&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>391946</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.jvascsurg.org/article/S0741-5214(10)00668-3/abstract]]&gt;</url>
    <title>A further meta-analysis of population-based screening for abdominal aortic anerysm</title>
    <publicationDate>2010-06-11T00:00:00</publicationDate>
    <publisher>Journal of Vascular Surgery, Elsevier</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Compared with controls, screening for abdominal aortic aneurysm (AAA) reduces AAA-related long-term mortality by 4 per 1000 in men aged 65 years or older. Although screening for AA shows a strong trend for reduction in all cause mortality, by 5 per 1000, this is not statistically significant.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, Embase and the Cochrane Central Register of Controlled Trials were searched up until June 2009. Data on AAA-related all cause mortality were abstracted from the four randomized controlled trials of population-based AA screening with long-term follow-up in men aged 65 years and older.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Pooled analysis demonstrated significant reduction in AAA-related mortality and a statistically non-significant reduction in all-cause mortality, compared to controls.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Takagi H, Goto SN, Matsui M et al. A further meta-analysis of population-based screening for abdominal aortic anerysm. Journal of Vascular Surgery 2010; 52(4):1103-8&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.jvascsurg.org/article/S0741-5214(10)00668-3/abstract" target="_blank"&gt;Abstract available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69872</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp14.pdf]]&gt;</url>
    <title>A Guide for Laboratories Participating in the NHS Cervical Screening Programme</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,QUALITY ASSURANCE,IMPLEMENTATION,ADULT,SCREENING,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This NHS Cervical Screening Programme publication&amp;nbsp;aims to assist the managers of laboratories to make the best use of the resources at their disposal. It brings together existing guidance and makes new recommendations for laboratories working in the cervical screening programme.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>301000</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10994]]&gt;</url>
    <title>A laboratory guide to newborn screening in the UK for medium chain acyl coA dehydrogenase deficiency (MCADD)</title>
    <publicationDate>2008-07-01T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MCADD,SCREENING,NEWBORN,BLOODSPOT (&lt;1WK)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Handbook for newborn screening laboratories</description>
    <body>&lt;![CDATA[ This handbook is provided for newborn screening laboratories as a guide for the implementation of newborn screening for MCADD in the UK. It is published by the UK Newborn Screening Programme Centre.]]&gt;</body>
  </document>
  <document>
    <id>61407</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61407]]&gt;</url>
    <title>A map of England showing the distribution of antenatal and newborn screening programmes</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,SCREENING,CHILD HEALTH,ANTENATAL,IMPLEMENTATION,SPECIALTIES,NEONATAL,QUALITY ASSURANCE,MANAGEMENT,NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A map of England showing the distribution of antenatal and newborn screening programmes across Strategic Health Authorities and NHS Trusts</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;A map of England showing the distribution of antenatal and newborn screening programmes&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;This &lt;A href="http://www.screening.nhs.uk/cms.php?folder=2445" target="_blank"&gt;map&lt;/A&gt; outlines &lt;A href="http://www.screening.nhs.uk/cms.php?folder=2445" target="_blank"&gt;regional teams of&amp;nbsp;the antenatal and newborn screening programmes&amp;nbsp;across England&lt;/A&gt; and provides further information on their role. 
&lt;P align=left&gt;&amp;nbsp; 
&lt;P align=left&gt;&lt;STRONG&gt;Regional teams (Antenatal and Newborn)&lt;/STRONG&gt; 
&lt;P align=left&gt;East of England 
&lt;P align=left&gt;East Midlands 
&lt;P align=left&gt;London 
&lt;P align=left&gt;North East 
&lt;P align=left&gt;North West 
&lt;P align=left&gt;South East 
&lt;P align=left&gt;South West 
&lt;P align=left&gt;West Midlands 
&lt;P align=left&gt;Yorkshire&amp;nbsp;&amp;amp; the Humber&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384930</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/20393399]]&gt;</url>
    <title>A meta-analysis of the clinical effectiveness of school scoliosis screening</title>
    <publicationDate>2010-05-01T00:00:00</publicationDate>
    <publisher>Spine, Lippincott Williams &amp; Wilkins</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,SCOLIOSIS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conslusions&lt;/STRONG&gt;: The forward bending test alone&amp;nbsp;was not sufficient in school scoliosis screening. Further research (large, retrospective cohort studies and follw-up) are needed to assess effectiveness of screening properly.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: PubMed, Google Scholar and Cinahl were among the databases&amp;nbsp;searched. References from identified reviews were also searched. Studies were included according to specific criteria and excluded if they were reviews, comments, case studies or editorials. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 775 studies were identified, of which 36 were included.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Fong DY, Lee CF, Cheung KM, et al. A meta-analysis of the clinical effectiveness of school scoliosis screening. &lt;EM&gt;Spine&lt;/EM&gt; 2010; 35(10):1061-71&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20393399" target="_blank"&gt;PubMed abstract freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63599</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63599]]&gt;</url>
    <title>A multidisciplinary approach to group B streptococcus disease prevention in neonates</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>Health Protection Agency</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD HEALTH,ANTENATAL,SCREENING,STREPTOCOCCUS B,NEONATAL,SPECIALTIES,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B screening from a NSC workshop
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;A multidisciplinary approach to group B streptococcus disease prevention in neonates&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;looks at different approaches to prevent group B streptococcus disease in neonates.
&lt;P&gt;&amp;nbsp;
&lt;P&gt;The UK NSC policy on &lt;A href="nelh:59860:0" name=internalLink&gt;screening for&amp;nbsp;streptococcus B&lt;/A&gt; has since been reviewed in November 2008.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>95764</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/6/1/32?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122645637319_411&amp;stored_search=&amp;FIRSTINDEX=20&amp;journalcode=ebmed]]&gt;</url>
    <title>A simple clinical tool that included age, weight, and oestrogen use helped to select women for bone densitometry</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ OLD AGE,NOT ROUTINELY OFFERED,ADULT,SCREENING,OSTEOPOROSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A simple clinical tool that included age, weight, and oestrogen use helped to select women for bone densitometry. Evidence-Based Medicine 2001; 6:32.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Cadarette SM, Jaglal SB, Kreiger N, et al.Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.CMAJ 2000 May 2;162:1289–94.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Please note that this summary, and the evidence on which it is based,&amp;nbsp;is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>345779</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/9793900]]&gt;</url>
    <title>A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism</title>
    <publicationDate>1998-09-01T00:00:00</publicationDate>
    <publisher>Journal of Public Health Medicine, Oxford Journals</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CONGENITAL ADRENAL HYPERPLASIA,BIOTINIDASE DEFICIENCY,MCADD,PHENYLKETONURIA,NOT ROUTINELY OFFERED,NEWBORN,BLOODSPOT (&lt;1WK)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: The published evidence confirms that phenylketonuria should be screened for. There was insufficient evidence to assess the cost-effectiveness of screening for any other inborn error of metabolism. There was reasonable evidence to extend neonatal screening for biotinidase deficiency, congenital adrenal hyperplasia, medium-chain acyl coA dehydrogenase and glutaric aciduris type 1.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic review of the literature. Pairs ofreviewers selected papers for critical appraisal based on exclusion and inclusion criteria.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 407 of 1,866 papers were identified for appraisal.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Thomason MJ, Lord J, Bain MD, et al. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. &lt;EM&gt;Journal of Public Health Medicine&lt;/EM&gt; 1998; 20(3):331-43&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full text available with NHS Athens login.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This systematic&amp;nbsp;review has not been critically appraised.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>239456</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?orig_db=PubMed&amp;db=PubMed&amp;cmd=Search&amp;term=19%5Bvolume%5D+AND+11%5Bissue%5D+AND+1074%5Bpage%5D+AND+2004%5Bpdat%5D]]&gt;</url>
    <title>A systematic review of the utility of self-report alcohol screening instruments in the elderly</title>
    <publicationDate>2004-11-01T00:00:00</publicationDate>
    <publisher>John Wiley &amp; Sons, Ltd</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,ALCOHOL PROBLEMS,MANAGEMENT,OLD AGE,PRIMARY CARE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in International J of Geriatric Psychiatry</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="International journal of geriatric psychiatry"&gt;Int J Geriatr Psychiatry.&lt;/SPAN&gt; 2004 Nov;19(11):1074-86.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE:&amp;nbsp;&amp;nbsp;to describe the&amp;nbsp;different self-report alcohol screening instruments that have been studied in the elderly, and their effectiveness as screening instruments&lt;/P&gt;
&lt;P&gt;CONCLUSION: Ease of use, patient acceptability, sensitivity and specificity must all be considered when selecting a self-report alcohol screening instrument for use in the elderly&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>386855</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://aaa.screening.nhs.uk/bibliography]]&gt;</url>
    <title>AAA bibliography</title>
    <publicationDate>2010-09-01T00:00:00</publicationDate>
    <publisher>NHS Abdominal Aortic Aneurysm Screening Programme</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ECONOMICS,BENEFITS &amp; HARMS,MANAGEMENT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This bibliography, prepared by the NHS Abdominal Aortic Aneurysm Screening Programme covers all aspects of screening, including costs, as well as other related subjects of interest, such as treatment, epidemiology and associated conditions.]]&gt;</body>
  </document>
  <document>
    <id>95766</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/6/1/24?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122649534225_630&amp;stored_search=&amp;FIRSTINDEX=20&amp;journalcode=ebmed]]&gt;</url>
    <title>Abdominal palpation had moderate sensitivity and specificity for detecting abdominal aortic aneurysm</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Abdominal palpation had moderate sensitivity and specificity for detecting abdominal aortic aneurysm. Evidence-Based Medicine 2001; 6:24.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Fink HA, Lederle FA, Roth CS, et al.The accuracy of physical examination to detect abdominal aortic aneurysm.Arch Intern Med 2000 Mar 27;160:833–6&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Please note that this summary, and the evidence on which it is based,&amp;nbsp;is &amp;gt; 5 years old.&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87730</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.nhs.uk/fullmono/mon1142.pdf]]&gt;</url>
    <title>Acceptability, benefit and costs of early screening for hearing disability: a study of potential screening tests and models</title>
    <publicationDate>2007-10-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ECONOMICS,OLD AGE,DEAFNESS,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Health Technology Assessment report on adult hearing screening</description>
    <body>&lt;![CDATA[ &lt;P&gt;The objectives of this study were to show that hearing loss has a high enough prevalence in the older population to justify screening, if effective and acceptable methods are available, and that take-up and benefit can make a measurable outcome difference in quality of life.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>239458</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://alcalc.oxfordjournals.org/cgi/content/full/39/2/75]]&gt;</url>
    <title>Accuracy of carbohydrate-deficient transferrin in the detection of excessive alcohol consumption: a systematic review.</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Oxford University Press</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ALCOHOL PROBLEMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Alcohol and Alcoholism</description>
    <body>&lt;![CDATA[ &lt;P&gt;Alcohol &amp;amp; Alcoholism Vol. 39, No. 2, pp. 75-85, 2004.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE:&amp;nbsp;to evaluate the diagnostic accuracy of carbohydrate-deficient&lt;SUP&gt; &lt;/SUP&gt;transferrin (CDT) in the detection of excessive alcohol consumption&lt;/P&gt;
&lt;P&gt;CONCLUSION: The&lt;SUP&gt; &lt;/SUP&gt;validity of CDT as a diagnostic tool is still questionable.&lt;SUP&gt; &lt;/SUP&gt;If the higher values for sensitivity that some studies report&lt;SUP&gt; &lt;/SUP&gt;can be confirmed by others it is a useful diagnostic tool in&lt;SUP&gt; &lt;/SUP&gt;unselected populations&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Please not that this review is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392240</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fn.bmj.com/content/92/3/F176.abstract]]&gt;</url>
    <title>Accuracy of pulse oximetry in screening for congenital heart disease in asymtomatic newborns: a systematic review</title>
    <publicationDate>2007-05-01T00:00:00</publicationDate>
    <publisher>Archives of Disease in Childhood Fetal &amp; Neonatal Edition</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,HEART,NEWBORN,PHYSICAL (&lt;72HRS)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Pulse oximetry is a highly specific tool with low false positive rates to detect congenital heart disease. Large, well conducted prospective studies are needed to assess sensitivity with higher precision.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic review of relevant studies identified through search of Medline, Embase, Cochrane Library, Medion and the bibliographies of retrieved primary and review articles. Two reviewers independently extracted data from eight included studies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Eight studies included 35,960 newborns. In all studies, pulse oximetry was performed on asymtomatic newborns. Functional or fractional oxygen saturation was measured. Oxygen saturation below 95% was the cut-off level. Sensitivity and specificity were estimated at 63% and 99.8% respectively, with a false positive rate of 0.2%.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Thangaratinam S, Daniels J, Ewer AK et al. Accuracy of pulse oximetry in screening for congenital heart disease in asymtomatic newborns: a systematic review. Archives of Disease in Childhood Fetal &amp;amp; Neonatal Edition 2007; 92(3):F176-80&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full text available with NHS Athens account&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69870</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/csp01.pdf]]&gt;</url>
    <title>Achievable Standards, Benchmarks for Reporting &amp; Criteria for Evaluating Cervical Cytopathology</title>
    <publicationDate>2000-05-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,QUALITY ASSURANCE,SCREENING,IMPLEMENTATION,ADULT,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P class=highlight1&gt;This NHS Cervical Screening Programme document sets achievable targets and standards for laboratories engaged in cervical screening. It supercedes the first edition (1995) which should no longer be used.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>250823</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.mhra.gov.uk/Howweregulate/Medicines/Availabilityprescribingsellingandsupplyingofmedicines/Frequentlyraisedissues/Retinalscreening/CON024106]]&gt;</url>
    <title>Advice on adminstering eye drops in retinal screening programmes</title>
    <publicationDate>2007-07-13T00:00:00</publicationDate>
    <publisher>Medicines and Healthcare Products Regulatory Agency</publisher>
    <publicationType>PROTOCOL</publicationType>
    <topics>&lt;![CDATA[ DIABETIC RETINOPATHY,RETINOPATHY,RETINA,CONDITIONS,DIABETES,SCREENING,ADULT,CAUSES,RETINOPATHY,DIABETIC RETINOPATHY,EYES AND VISION,CHRONIC COMPLICATIONS,EYE DISEASES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>National Screening Programme for Diabetic Retinopathy guidance</description>
    <body>&lt;![CDATA[ &lt;P&gt;National Screening Programme for Diabetic Retinopathy guidance on administering eye drops for retinal screeners.&lt;/P&gt;
&lt;P&gt;Originally published in 2006, updated in 2007.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>300842</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=10851]]&gt;</url>
    <title>Amniocentesis and chorionic villus sampling. Policy, standards and protocols</title>
    <publicationDate>2008-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>UK National Screening Committee standards document about amniocentesis and chorionic villus sampling</description>
    <body>&lt;![CDATA[ This document has been produced for the UK National Screening Committee, and is about amniocentesis and chorionic villus sampling. It considers counselling, information for women, the procedure, clinical standards, record keeping, sample labelling and results handling.]]&gt;</body>
  </document>
  <document>
    <id>383899</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=1181]]&gt;</url>
    <title>An audit of antenatal ultrasound scans from 22 hospitals in England and Wales during 2007</title>
    <publicationDate>2009-07-31T00:00:00</publicationDate>
    <publisher>NHS Fetal Anomaly Screening Programme</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,IMPLEMENTATION,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),FETAL ANOMALY,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,ULTRASOUND,QUALITY ASSURANCE,MANAGEMENT,11-14 WEEKS,BEFORE 16 WEEKS,18-20 WEEKS,DOWN'S SYNDROME]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This&amp;nbsp;2007 audit of antenatal ultrasound scans across England and Wales aims to identify whether the the patterns of antenatal ultrasound referrals differ between a selected sample of 22 hospitals.]]&gt;</body>
  </document>
  <document>
    <id>61002</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61002]]&gt;</url>
    <title>An Evaluation of Open Angle Glaucoma against the NSC Criteria for Screening Viability, Effectiveness and Appropriateness</title>
    <publicationDate>2001-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,VISION,EYES AND VISION,GLAUCOMA,ADULT,SCREENING,CONDITIONS,GLAUCOMA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Assessment of glaucoma screening against the NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;An Evaluation of Open Angle Glaucoma against the NSC Criteria for Screening Viability, Effectiveness and Appropriateness&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This&amp;nbsp; report reviews published literature to identify evidence on whether chronic open angle glaucoma (OAG)&amp;nbsp;meets the NSC criteria that are ideally required prior to initiation of a screening program. 
&lt;P&gt;The report concludes that "as a major cause of visual loss, OAG deserves consideration for screening despite the need to use more than one test".&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>95310</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/intervention-to-increase-breast-screening-uptake.pdf]]&gt;</url>
    <title>An intervention to increase breast screening uptake</title>
    <publicationDate>2002-03-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER,INFORMED DECISION-MAKING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This report was produced for the NHS Breast Screening Programme. The aim of this&amp;nbsp;randomised controlled trial&amp;nbsp;was to test whether a cost-effective intervention to increase the uptake of screening in the&amp;nbsp;NHSBSP could be set up.&lt;/P&gt;
&lt;P align=left&gt;The recommendations were: " (1) An intervention based on implementation intentions is a cost-effective means of increasing uptake, and could readily be incorporated in the invitation for screening. (2) The NHSBSP should consider a “field trial” of the procedure, probably in a sample of areas for which uptake is low. (3) The key group to approach will be those invited to their first round of screening. Attendance in the second and subsequent rounds is very high in women who attend their first round, and encouraging women to plan for their first round will maximise their attendance thereafter. (4) The NHS should consider similar trials for other forms of screening."&lt;/P&gt;
&lt;P align=left&gt;&lt;EM&gt;Note that this research is &amp;gt;5 years old.&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95006</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.npc.co.uk/ebt/merec/other_non_clinical/resources/merec_bulletin_vol15_no2.pdf]]&gt;</url>
    <title>An introduction to genetics and genetic tests: MeReC Bulletin</title>
    <publicationDate>2004-10-01T00:00:00</publicationDate>
    <publisher>National Prescribing Centre</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,CHILD,SCREENING,ADULT,PRIMARY CARE,NEWBORN,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;MeReC bulletins provide concise, evidence-based information about medicines and prescribing-related issues. This bulletin looks at genetic testing (MeReC Bulletin Volume 15, Number 2).&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325643</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=9432]]&gt;</url>
    <title>Analyses of inequality in national screening programmes using existing data systems: a supplementary report for the UK National Screening Commitee</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHILD,ADULT,MANAGEMENT,NEWBORN,PUBLIC HEALTH,DETERMINANTS,SOCIAL DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,ANALYSIS &amp; RESEARCH,METHODS,ANALYSIS,SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,MONTHLY ADDITIONS,NOVEMBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This report is a supplement to the &lt;A href="nelh:325640:0" name=internalLink&gt;'Interventions to reduce inequity and&amp;nbsp;inequality in accessing national screening programmes&lt;/A&gt;' report. Its purpose&amp;nbsp;is to describe which screening equity&amp;nbsp;analyses are possible using existing datasets for the antenatal, neonatal, child&amp;nbsp;health, diabetic retinopathy, breast cancer, cervical cancer and colorectal cancer&amp;nbsp;screening programmes.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>333436</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://cpd.screening.nhs.uk/timeline]]&gt;</url>
    <title>Animated screening timeline</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Animated version of the screening timeline showing the optimum times for antenatal and newborn screening tests to take place. It is just over 3 minutes long and can be used as a training and educational resource.]]&gt;</body>
  </document>
  <document>
    <id>325106</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325106]]&gt;</url>
    <title>Annual Evidence Update for Antenatal Screening 28th September - 4th October 2009</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>Screening specialist collection</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual Evidence Update for Antenatal Screening 28th September - 4th October 2009&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=center&gt;&lt;IMG id=nelh_tempImage1 border=1 name=nelh_tempImage1 alt="optimum testing times" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269344/nelhImp_0004_timeline.jpg" width=212 height=137&gt;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P align=center&gt;Click here for the &lt;A href="http://cpd.screening.nhs.uk/timeline" target="_blank"&gt;animated version of the screening timeline&lt;/A&gt;&lt;/P&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Contents&lt;/H2&gt;
&lt;P&gt;&lt;A href="nelh:325080:0" name=internalLink&gt;Screening for Down's syndrome&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325082:0" name=internalLink&gt;Screening for fetal anomalies &lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325048:0" name=internalLink&gt;Screening for infectious diseases in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325085:0" name=internalLink&gt;Screening for sickle cell and thalassaemia&lt;/A&gt;&lt;A href="nelh:325085:0" name=internalLink&gt;&lt;/P&gt;
&lt;P&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/womenshealth/ViewResource.aspx?resID=324315&amp;amp;tabID=289&amp;amp;catID=5713" target="_blank"&gt;Antenatal care&lt;/A&gt; (produced by the women's health specialist collection)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Thank you to: &lt;/H2&gt;
&lt;P&gt;Pat Ward (Programme Director), Fiona McInnes (National Projects Officer), Donna Kirwan (National Projects Officer), Alissa Delbarre (Programme Associate) and Fran Kennedy (Information and Communication Support Officer)&amp;nbsp;from the NHS Fetal Anomaly Screening Programme &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Dr Allison Streetly (Programme director),&amp;nbsp;Dr Elizabeth Dormandy (Quality Improvement Lead)&amp;nbsp;and Dr Sandra Anglin (former Programme Implementation Manager) from the Sickle Cell and Thalassaemia Screening Programme &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;John Marshall (Pojects and Programmes&amp;nbsp;Manager)&amp;nbsp;from the NHS Infectious Disease in Pregnancy Screening Programme&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>187226</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=187226]]&gt;</url>
    <title>Annual evidence update for neonatal cystic fibrosis screening 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ STAFF USE,GENETIC CONDITIONS,CHILD HEALTH,RESPIRATORY,SCREENING,CYSTIC FIBROSIS,SCREENING,CYSTIC FIBROSIS,SPECIALTIES,NEONATAL,GENETIC CONDITIONS A-Z,SYSTEMS &amp; SYMPTOMS,GENETICS - PRACTICE &amp; ISSUES,CYSTIC FIBROSIS (CF),BLOODSPOT (&lt;1WK),GENETIC SCREENING (FOR CONDITIONS),NEWBORN,KNOWLEDGE UPDATES,CONDITIONS C,PREGNANCY,BLOOD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on the topic of cystic fibrosis screening in neonates</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update for neonatal cystic fibrosis screening 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on&amp;nbsp;newborn screening for&amp;nbsp;cystic fibrosis&amp;nbsp;published between May 2006 and&amp;nbsp;Aug 2007.&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260735</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260735]]&gt;</url>
    <title>Annual evidence update for phenylketonuria (PKU) screening 2006/2007</title>
    <publicationDate>2007-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,STAFF USE,SCREENING,PHENYLKETONURIA,AMINO ACID METABOLISM DISORDERS,NEONATAL,SPECIALTIES,SCREENING,METABOLIC DISEASE,GENETICS &amp; DYSMORPHOLOGY,CHILD HEALTH,SYSTEMS &amp; SYMPTOMS,CONDITIONS N-R,GENETICS - PRACTICE &amp; ISSUES,KNOWLEDGE UPDATES,GENETIC SCREENING (FOR CONDITIONS),NEWBORN,BLOODSPOT (&lt;1WK),PHENYLKETONURIA (PKU),PREGNANCY,SKIN &amp; BONE DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines the annual evidence update on newborn screening for phenylketonuria 2006/2007</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update for phenylketonuria (PKU) screening 2006/2007&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on newborn screening for&amp;nbsp;PKU published between May 2006 and&amp;nbsp;July 2007.&lt;/P&gt;
&lt;P class=MsoNormal style="MARGIN: 0cm 0cm 0pt; LINE-HEIGHT: 150%; TEXT-ALIGN: justify"&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>155538</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=155538]]&gt;</url>
    <title>Annual evidence update on antenatal screening for hepatitis B 2006/07</title>
    <publicationDate>2007-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,HEPATITIS B,BEFORE 16 WEEKS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,VIRAL,HEPATITIS B,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A literature search on antenatal hepatitis B screening</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on antenatal screening for hepatitis B 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on antenatal screening for hepatitis B published between May 2006 and May 2007.&amp;nbsp; &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269136</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269136]]&gt;</url>
    <title>Annual evidence update on antenatal screening for HIV 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,HIV,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on antenatal screening for HIV 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on antenatal screening for&amp;nbsp;HIV published between May 2006 and&amp;nbsp;July 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269134</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269134]]&gt;</url>
    <title>Annual evidence update on antenatal screening for rubella 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,RUBELLA,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on antenatal screening for rubella 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on antenatal screening for&amp;nbsp;rubella published between May 2006 and&amp;nbsp;July 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>212461</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=212461]]&gt;</url>
    <title>Annual evidence update on antenatal screening for sickle cell and thalassaemia, and newborn screening for sickle cell disease 2006/07</title>
    <publicationDate>2007-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,SICKLE CELL,SICKLE CELL DISEASE,SPECIALTIES,NEONATAL,SCREENING,ANTENATAL,CHILD HEALTH,HAEMATOLOGY,SCREENING,STAFF USE,GENETIC CONDITIONS,CONDITIONS N-R,GENETICS - PRACTICE &amp; ISSUES,SYSTEMS &amp; SYMPTOMS,NEWBORN,BLOODSPOT (&lt;1WK),SICKLE CELL (SC) (SCD),THALASSAEMIA,GENETIC SCREENING (FOR CONDITIONS),8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA,KNOWLEDGE UPDATES,PREGNANCY,CONDITIONS S-Z,BLOOD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of sickle cell and thalassaemia screening</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on antenatal screening for sickle cell and thalassaemia, and newborn screening for sickle cell disease 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on antenatal screening for sickle cell and thalassaemia, and newborn screening for sickle cell disease&amp;nbsp;published between May 2006 and&amp;nbsp;June 2007.&lt;/P&gt;
&lt;P&gt;A more recent &lt;A href="http://www.library.nhs.uk/screening/viewResource.aspx?resid=325707&amp;amp;code=4003a45fc9686c1b973a69a4570a35f3" target="_blank"&gt;evidence update&lt;/A&gt;&amp;nbsp;was completed in September 2009.&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269135</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269135]]&gt;</url>
    <title>Annual evidence update on antenatal screening for syphilis 2006/07</title>
    <publicationDate>2007-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,SYPHILIS,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on antenatal screening for syphilis 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on antenatal screening for&amp;nbsp;syphilis published between May 2006 and&amp;nbsp;June 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269259</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269259]]&gt;</url>
    <title>Annual evidence update on newborn screening for cataract 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEONATOLOGY,SCREENING,OPHTHALMOLOGY,CHILD HEALTH,SCREENING,CATARACT,NEONATAL,SPECIALTIES,EYES,STAFF USE,OPHTHALMOLOGY,PHYSICAL (&lt;72HRS),NEWBORN,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on newborn screening for cataract 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on&amp;nbsp;newborn screening for&amp;nbsp;cataract published between May 2006 and&amp;nbsp;Aug 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269175</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269175]]&gt;</url>
    <title>Annual evidence update on newborn screening for congenital heart disease 2006/07</title>
    <publicationDate>2007-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEONATOLOGY,SCREENING,CARDIOLOGY,CHILD HEALTH,HEART,CONGENITAL HEART DISEASE,NEONATAL,SPECIALTIES,STAFF USE,NEWBORN,PHYSICAL (&lt;72HRS),KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on newborn screening for congenital heart disease 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on newborn screening for&amp;nbsp;congenital heart disease&amp;nbsp;published between May 2006 and&amp;nbsp;July 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269280</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269280]]&gt;</url>
    <title>Annual evidence update on newborn screening for congenital hypothyroidism 2006/07</title>
    <publicationDate>2007-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,BLOODSPOT (&lt;1WK),STAFF USE,SPECIALTIES,NEONATAL,HYPOTHYROIDISM,CONGENITAL HYPOTHYROIDISM,SCREENING,CHILD HEALTH,ENDOCRINOLOGY,SCREENING,NEONATOLOGY,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on newborn screening for congenital hypothyroidism 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on&amp;nbsp;newborn screening for&amp;nbsp;congenital hypothyroidism&amp;nbsp;published between May 2006 and&amp;nbsp;July 2007.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269182</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269182]]&gt;</url>
    <title>Annual evidence update on newborn screening for developmental dysplasia of the hip 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ PHYSICAL (&lt;72HRS),NEWBORN,HIPS,STAFF USE,SPECIALTIES,NEONATAL,CONGENITAL ABNORMALITIES,CHILD HEALTH,SCREENING,NEONATOLOGY,MUSCULOSKELETAL,SCREENING,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on newborn screening for developmental dysplasia of the hip 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on newborn screening for&amp;nbsp;hip dysplasia&amp;nbsp;published between Jan 2006 and&amp;nbsp;Aug 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269283</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269283]]&gt;</url>
    <title>Annual evidence update on newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) 2006/07</title>
    <publicationDate>2007-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ STAFF USE,CHILD HEALTH,METABOLIC DISEASE,NEONATOLOGY,GENETICS &amp; DYSMORPHOLOGY,SCREENING,SPECIALTIES,NEONATAL,AMINO ACID METABOLISM DISORDERS,HYPOGLYCAEMIA,MULTIFACTORIAL INHERITANCE,MCADD,SCREENING,GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,GENETICS - PRACTICE &amp; ISSUES,PREGNANCY,FATTY ACID OXIDATION DISORDERS (FOD) (MCAD),BLOODSPOT (&lt;1WK),GENETIC SCREENING (FOR CONDITIONS),NEWBORN,KNOWLEDGE UPDATES,CONDITIONS D-F]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on newborn screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on&amp;nbsp;newborn screening for&amp;nbsp;MCADD&amp;nbsp;published between May 2006 and&amp;nbsp;July 2007.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269331</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269331]]&gt;</url>
    <title>Annual evidence update on preconception care 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on preconception care 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on&amp;nbsp;preconception care&amp;nbsp;published between&amp;nbsp;Jan 2006 and&amp;nbsp;July 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269194</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269194]]&gt;</url>
    <title>Annual evidence update on screening for cryptochidism (undescended testes) in newborn boys 2006/07</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEONATOLOGY,SCREENING,CHILD HEALTH,NEONATAL,SPECIALTIES,TESTES,STAFF USE,NEWBORN,PHYSICAL (&lt;72HRS),KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on screening for cryptochidism (undescended testes) in newborn boys 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on screening for&amp;nbsp;cryptorchidism on newborn boys&amp;nbsp;published between Jan 2006 and&amp;nbsp;Aug 2007.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>201751</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=201751]]&gt;</url>
    <title>Annual evidence update on screening for Down's Syndrome 2006/07</title>
    <publicationDate>2007-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual literature search on the topic of screening for Down's Syndrome</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update on screening for Down's Syndrome 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;As part of a National Knowledge Week on Antenatal Care, the Screening Specialist library performed a&amp;nbsp;literature search to find citations on antenatal screening for&amp;nbsp;Down's Syndrome&amp;nbsp;published between May 2006 and&amp;nbsp;June 2007.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A more recent &lt;A href="http://www.library.nhs.uk/screening/viewResource.aspx?resid=325073&amp;amp;code=946096a29f3fe2148fbc69e516b32a7a" target="_blank"&gt;evidence update&lt;/A&gt; was completed in September 2009.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>325073</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325073]]&gt;</url>
    <title>Annual evidence update: antenatal screening for Down's syndrome (September 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),ULTRASOUND,11-14 WEEKS,BEFORE 16 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update: antenatal screening for Down's syndrome (September 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the 2009 National Knowledge Week on Antenatal Care, the Screening specialist collection performed a literature search to find citations on antenatal screening for Down's syndrome published between January 2007 and August 2009.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>325076</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325076]]&gt;</url>
    <title>Annual evidence update: antenatal screening for neural tube defects (September 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEURAL TUBE DEFECTS,BEFORE 16 WEEKS,18-20 WEEKS,ULTRASOUND]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update: antenatal screening for neural tube defects (September 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the 2009 National Knowledge Week on Antenatal Care, the Screening specialist collection performed a literature search to find citations on antenatal screening for&amp;nbsp;nueral tube defects&amp;nbsp;published between January 2007 and August 2009.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>325075</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325075]]&gt;</url>
    <title>Annual evidence update: antenatal ultrasound screening for fetal anomalies (September 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ ULTRASOUND,18-20 WEEKS,BEFORE 16 WEEKS,FETAL ANOMALY,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update: antenatal ultrasound screening for fetal anomalies (September 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the 2009 National Knowledge Week on Antenatal Care, the Screening specialist collection performed a literature search to find citations on antenatal ultrasound&amp;nbsp;screening for fetal anomalies published between January 2007 and August 2009.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>325707</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325707]]&gt;</url>
    <title>Annual evidence update: screening for sickle cell and thalassaemia (September 2009)</title>
    <publicationDate>2009-09-24T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>ANNUAL EVIDENCE UPDATE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,SICKLE CELL DISEASE,NEWBORN,BLOODSPOT (&lt;1WK),8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual evidence update: screening for sickle cell and thalassaemia (September 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the 2009 National Knowledge Week on Antenatal Care, the Screening specialist collection performed a literature search to find citations on screening for sickle cell and thalassaemia published between September 2008 and August 2009.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>250499</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=250499]]&gt;</url>
    <title>Annual knowledge update for vision screening in newborns &amp; preschool children 2006</title>
    <publicationDate>2007-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ EYES,NEONATAL,SPECIALTIES,EYES,STAFF USE,EYES AND VISION,VISUAL IMPAIRMENT,CHILD,SCREENING,CHILD HEALTH,OPHTHALMOLOGY,SCREENING,NEWBORN,PHYSICAL (&lt;72HRS),PHYSICAL (6-8 WKS),SCHOOL ENTRY,VISION,CONDITIONS,LENS,CATARACT,OCULAR MOTILITY,LOW VISION,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of screening for vision defects in newborns and children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update for vision screening in newborns &amp; preschool children 2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;February 2007]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;The systematic review that has been commissioned&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;by the Health Technology Assessment (HTA) programme to look at screening for amblyopia and strabismus in children, (see: &lt;A href="http://www.ncchta.org/ProjectData/1_project_record_notpublished.asp?PjtId=1467" target="_blank"&gt;What is the clinical and cost effectiveness of screening programmes for amblyopia and squint in children up to the ages of 4-5 years&lt;/A&gt;), is not due for publication until April 2008.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0pt" class=MsoNormal&gt;In the interim, a literature search was performed to find citations on screening for vision defects (e.g. amblyopia, cataract, strabismus) in newborns and pre-school children published since the document &lt;SPAN style="mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.library.nhs.uk/screening/viewResource.aspx?catID=8656&amp;amp;dg=107&amp;amp;resID=121465" target="_blank"&gt;Knowledge update for vision screening in newborns and pre-school entry children&lt;/A&gt; (Feb 2006). The last search date for this document was Dec 2005.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library, National Library for Health&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2006 to Jan 2007&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;46 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;vision defects in newborns and children.&amp;nbsp;These&amp;nbsp;46 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID250499/nelhImp_0002_KU2.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and links to&amp;nbsp;abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>259215</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=259215]]&gt;</url>
    <title>Annual knowledge update on neural tube defect screening 2006/07</title>
    <publicationDate>2007-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEURAL TUBE DEFECTS,SCREENING,ANTENATAL,18-20 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines the annual knowledge update on neural tube defect screening for 2006/2007</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on neural tube defect screening 2006/07&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;April 2007]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on&amp;nbsp;neural tube defect screening in pregnancy published since&amp;nbsp;the previous "Knowledge update on neural tube defect screening"&amp;nbsp;(Feb 2006). The last search date for this publication was&amp;nbsp;Jan 2006.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Feb 2006 to Feb 2007&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;43 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for neural tube defects in pregnancy.&amp;nbsp;These&amp;nbsp;43 citations were classified in a way that health professionals involved in screening would recognise.&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID259215/nelhImp_0000_KUtree_ntd.jpg"&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;A more recent &lt;A href="http://www.library.nhs.uk/screening/viewResource.aspx?resid=325076&amp;amp;code=de39199965da8fdbff2e4e5cc5693b6e" target="_blank"&gt;evidence update&lt;/A&gt; was completed in September 2009.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>235352</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=235352]]&gt;</url>
    <title>Annual knowledge update on screening for anal cancer 2006</title>
    <publicationDate>2007-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,CANCER,ANAL,ADULT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines an annual literature search on screening for anal cancer</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for anal cancer 2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;January 2007]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black"&gt;&lt;FONT color=#000066&gt;T&lt;/FONT&gt;he systematic review on anal cancer screening that has been commissioned by the Health Technology Assessment (HTA) programme, (see &lt;/SPAN&gt;&lt;U&gt;&lt;SPAN style="COLOR: blue"&gt;&lt;A href="http://www.ncchta.org/ProjectData/1_project_record_notpublished.asp?PjtId=1489" target="_blank"&gt;What are the pros and cons of screening high risk populations for anal cancer&lt;/A&gt;&lt;/SPAN&gt;&lt;/U&gt;&lt;SPAN style="COLOR: black"&gt;), is not due for publication until late 2007. In the interim, a literature search was performed to find citations on anal cancer screening published since the document “&lt;SPAN style="mso-bidi-font-weight: bold"&gt;&lt;A href="nelh:113106:0" name=internalLink&gt;&lt;SPAN style="mso-bidi-font-weight: bold"&gt;Knowledge update on screening for anal cancer&lt;/SPAN&gt;&lt;/A&gt;” (Jan 2006).&lt;/SPAN&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2006 to&amp;nbsp;Dec 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;19 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;anal cancer.&amp;nbsp;These&amp;nbsp;19 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID235352/nelhImp_0000_ac_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>235702</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=235702]]&gt;</url>
    <title>Annual knowledge update on screening for Chlamydia in pregnancy 2006</title>
    <publicationDate>2007-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHLAMYDIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual literature search on the topic of chlamydia screening in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for Chlamydia in pregnancy 2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;January 2007]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;The NICE guideline “&lt;A href="http://www.nice.org.uk/guidance/CG6/niceguidance/pdf/English/download.dspx" target="_blank"&gt;Antenatal care: routine care for the healthy pregnant woman&lt;/A&gt;” (Oct 2003) is not due to be updated until October 2007. In the interim, a literature search was performed to find citations on chlamydia screening in pregnancy published since the document “&lt;A href="nelh:112657:0" name=internalLink&gt;knowledge update on &lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;screening for Chlamydia in pregnancy&lt;/SPAN&gt;&lt;/A&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;” (Jan 2006).&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2006 to&amp;nbsp;Dec 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;19 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for chlamydia&amp;nbsp;in pregnancy.&amp;nbsp;These&amp;nbsp;19 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID235702/nelhImp_0001_chlamydia_tree2.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>197194</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=197194]]&gt;</url>
    <title>Annual knowledge update on screening for domestic violence in pregnancy 2005/06</title>
    <publicationDate>2006-11-07T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,DOMESTIC VIOLENCE,OUTCOMES,DETERMINANTS,PREGNANCY &amp; CHILDBIRTH DISORDERS,SCREENING,ANTENATAL,PUBLIC HEALTH,SOCIAL DETERMINANTS,MONTHLY ADDITIONS,2009 SEPTEMBER,DOMESTIC VIOLENCE,ABUSE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual literature search on the topic of antenatal screening for domestic violence</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for domestic violence in pregnancy 2005/06&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;November 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on domestic violence screening in pregnancy published since the document "&lt;U&gt;&lt;A href="nelh:112023:0" name=internalLink&gt;&lt;U&gt;Knowledge update on screening for domestic violence in pregnancy&lt;/U&gt;&lt;/A&gt;&lt;/U&gt;" was published (November 2005). The last search date for this publication was October 2005. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library, National Library for Health&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt;&amp;nbsp;Nov 2005&amp;nbsp;to end&amp;nbsp;Oct 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;46 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;domestic violence&amp;nbsp;in pregnancy.&amp;nbsp;These&amp;nbsp;46 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID197194/nelhImp_0001_dv_tree2.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>212588</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=212588]]&gt;</url>
    <title>Annual knowledge update on screening for genital herpes in pregnancy 2005/06</title>
    <publicationDate>2006-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,GENITAL HERPES,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual literature search on the topic of antenatal screening for genital herpes</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for genital herpes in pregnancy 2005/06&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;November 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;BACKGROUND:&lt;/STRONG&gt;&amp;nbsp; A literature search was performed to find citations on genital herpes screening published since the document "&lt;U&gt;&lt;FONT color=#0000ff&gt;&lt;A href="nelh:112025:0" name=internalLink&gt;&lt;U&gt;&lt;FONT color=#0000ff&gt;Knowledge update on screening for genital herpes in pregnancy&lt;/FONT&gt;&lt;/U&gt;&lt;/A&gt;&lt;/U&gt;&lt;/FONT&gt;" was published (Nov 2005). The last search date for this publication was October 2005. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt;&amp;nbsp;Nov 2005&amp;nbsp;to&amp;nbsp;Oct 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;52 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for genital herpes&amp;nbsp;in pregnancy.&amp;nbsp;These&amp;nbsp;52 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID212588/nelhImp_0000_herpesKU_tree.jpg"&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>186977</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=186977]]&gt;</url>
    <title>Annual knowledge update on screening for group B streptococcus 2005/2006</title>
    <publicationDate>2006-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual knowledge update on the topic of group B streptococcus screening</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for group B streptococcus 2005/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;October 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on group B streptococcus screening since the document "&lt;A href="nelh:103304:0" name=internalLink&gt;Knowledge update on screening for group B streptococcus&lt;/A&gt;" was published (August 2005). The last search date for this publication was August 2005. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt;&amp;nbsp;Aug 2005&amp;nbsp;to&amp;nbsp;Sep 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;82 citations were deemed to be relevant to&amp;nbsp;screening for&amp;nbsp;group B streptococcus.&amp;nbsp;These&amp;nbsp;82 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID186977/nelhImp_0000_groupb_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>156793</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=156793]]&gt;</url>
    <title>Annual knowledge update on screening for neuroblastoma 2005/06</title>
    <publicationDate>2006-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD HEALTH,ONCOLOGY,SCREENING,NEUROBLASTOMA,SPECIALTIES,NEONATAL,NEUROBLASTOMA,STAFF USE,NEWBORN,NOT ROUTINELY OFFERED,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines an annual knowledge update on screening for neuroblastoma in babies and children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for neuroblastoma 2005/06&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;Aug 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on screening for neuroblastoma in babies and young children&amp;nbsp;published since the document "&lt;A href="nelh:112049:0" name=internalLink&gt;knowledge update on screening for neuroblastoma&lt;/A&gt;" (July 2005)&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; July 2005&amp;nbsp;to&amp;nbsp;July (week 4)&amp;nbsp;2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;17 citations were deemed to be relevant to&amp;nbsp;neuroblastoma screening.&amp;nbsp;These&amp;nbsp;17 relevant citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal align=center&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID156793/nelhImp_0001_neuro_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>223693</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=223693]]&gt;</url>
    <title>Annual knowledge update on screening for pre-eclampsia 2005/2006</title>
    <publicationDate>2006-12-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ 28 WEEKS,36 WEEKS,PRE-ECLAMPSIA,PRE-ECLAMPSIA,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual literature search on the topic of antenatal screening for pre-eclampsia</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Annual knowledge update on screening for pre-eclampsia 2005/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;December 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on pre-eclampsia screening published since the previous "&lt;A href="nelh:112055:0" name=internalLink&gt;Knowledge update on screening for pre-eclampsia&lt;/A&gt;" was published (Nov 2005). The last search date for this publication was October 2005. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Nov 2005 to Nov 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;176 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;pre-eclampsia in pregnancy.&amp;nbsp;These&amp;nbsp;176 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID223693/nelhImp_0000_preeclampsia_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>95751</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/2/44?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122644461937_306&amp;stored_search=&amp;FIRSTINDEX=10&amp;journalcode=ebmed]]&gt;</url>
    <title>Annual screening with mammography and breast examination did not reduce breast cancer mortality in women 40–49 years of age</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Annual screening with mammography and breast examination did not reduce breast cancer mortality in women 40–49 years of age. Evidence-Based Medicine 2003; 8:44.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Miller AB, To T, Baines CJ, et al.The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years.Ann Intern Med 2002;137:305–12.&lt;!-- HIGHWIRE ID="8:2:44:1" --&gt;&lt;!-- /HIGHWIRE --&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Please note this summary is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>35574</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35574]]&gt;</url>
    <title>Antenatal and Newborn Screening for Cytomegalovirus</title>
    <publicationDate>2000-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CYTOMEGALOVIRUS,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Working paper on screening for cytomegalovirus.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal and Newborn Screening for Cytomegalovirus&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2 align=left&gt;Antenatal and Newborn Screening for Cytomegalovirus. Report of the working party --September 2000.&lt;/H2&gt;&lt;FONT face=TimesNewRoman&gt;
&lt;P align=left&gt;This working paper was submitted to the Antenatal Screening Subgroup in April 2001. T&lt;FONT face=TimesNewRoman&gt;hey concluded that: 
&lt;P align=left&gt;"At present it would not be appropriate to introduce routine antenatal screening for CMV infection in pregnancy".&lt;/P&gt;
&lt;P align=left&gt;&lt;EM&gt;A more recent review of screening for cytomegalovirus was included in the NICE &lt;/EM&gt;&lt;A href="http://www.nice.org.uk/Guidance/CG62/Guidance/pdf/English" target="_blank"&gt;&lt;EM&gt;Antenatal care: routine care for the healthy pregnant woman. CG62: full guidance&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;&amp;nbsp;and also concludes that screening for cytomegalovirus should not be offered.&lt;/EM&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56186</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56186]]&gt;</url>
    <title>Antenatal and Newborn Screening for Toxoplasmosis</title>
    <publicationDate>2001-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,TOXOPLASMOSIS,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report of the Working Group on antenatal and newborn screening for toxoplasmosis</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal and Newborn Screening for Toxoplasmosis&lt;/pageTitle&gt;&lt;pageBody&gt;A&amp;nbsp;National Screening Committee working group reviewed the literature and produced this report on antenatal and newborn toxoplasmosis screening.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>126383</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/extract/10/2/47]]&gt;</url>
    <title>Antenatal infection screening reduced preterm delivery</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,NOT ROUTINELY OFFERED,BACTERIAL VAGINOSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Informative abstract and expert commentary about antenatal infection screening</description>
    <body>&lt;![CDATA[ &lt;P&gt;Antenatal infection screening reduced preterm delivery. Evidence-Based Medicine 2005; 10:47&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Kiss H, Petricevic L, Husslein P. Prospective randomised controlled trial of an infection screening programme to reduce the rate of preterm delivery. &lt;I&gt;BMJ&lt;/I&gt; 2004;329:371&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>300852</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=10849]]&gt;</url>
    <title>Antenatal screening - working standards for Down's Syndrome screening 2007</title>
    <publicationDate>2007-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,MANAGEMENT,14-20 WEEKS,DOWN'S SYNDROME (SERUM),11-14 WEEKS,ANTENATAL,IMPLEMENTATION,SCREENING,WOMEN'S HEALTH,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,DOWN'S SYNDROME]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Standards to improve the quality of the Down's Syndrome screening process</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN style="10pt: "&gt;These standards are intended to improve the quality of the screening process and enable women to exercise informed choice along the Down's syndrome screening pathway. It was agreed that &lt;SPAN style="mso-bidi-font-style: italic"&gt;all women would be offered screening for Down's syndrome as part of new initiatives to modernise neonatal and antenatal screening. &lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="10pt: "&gt;&lt;SPAN style="mso-bidi-font-style: italic"&gt;The 2007 working standards have evolved from those originally published in 2004&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>52185</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=52185]]&gt;</url>
    <title>Antenatal Screening for Cystic Fibrosis: a workshop</title>
    <publicationDate>2002-12-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CYSTIC FIBROSIS,NEWBORN,BLOODSPOT (&lt;1WK),NOT ROUTINELY OFFERED,CYSTIC FIBROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report on a workshop looking at antenatal screening for cystic fibrosis</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal Screening for Cystic Fibrosis: a workshop&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;This is a report from an Antenatal SubGroup&amp;nbsp;workshop, looking at methods of antenatal screening, and possible difficulties arising from offering both antenatal and neonatal screening for cystic fibrosis.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32288</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32288]]&gt;</url>
    <title>Antenatal Screening for Fetomaternal Alloimmune Thrombocytopenia: Should we be doing it?</title>
    <publicationDate>2002-07-01T00:00:00</publicationDate>
    <publisher>Vox Sanguinis</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,THROMBOCYTOPENIA,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This review considers the case for antenatal screening for Fetomaternal Alloimmune Thrombocytopenia against the criteria for screening programmes set by the UK National Screening Committee.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal Screening for Fetomaternal Alloimmune Thrombocytopenia: Should we be doing it?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;M.F. Murphy, L.M. Williamson &amp;amp; S.J. Urbaniak. Antenatal Screening&amp;nbsp;for Fetomaternal Alloimmune Thrombocytopenia: Should we be doing it? Vox Sanguinis 2002; 83, (Suppl. I): 409-416.&amp;nbsp; 
&lt;P align=left&gt;This review was used to inform the &lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=32280&amp;amp;tabID=288&amp;amp;catID=1990" target="_blank"&gt;National Screening Committee's policy on screening for Fetomaternal Alloimmune Thrombocytopenia&lt;/A&gt;.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51536</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51536]]&gt;</url>
    <title>Antenatal screening for genital herpes</title>
    <publicationDate>2001-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENITAL HERPES,SCREENING,ANTENATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report sets out the advantages and disadvantages of antenatal screening for genital herpes.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal screening for genital herpes&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;B&gt;
&lt;P align=left&gt;Antenatal screening for genital herpes &lt;/B&gt;
&lt;P align=left&gt;This short paper sets out the advantages and disadvantages of antenatal screening for genital herpes. Genital herpes is assessed against the National Screening Committee's criteria for appraising the viability, effectiveness and appropriateness of a screening programme.
&lt;P align=left&gt;A &lt;A href="nelh:325441:0" name=internalLink&gt;more recent review&lt;/A&gt; was produced in 2005.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35761</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35761]]&gt;</url>
    <title>Antenatal Screening For Hepatitis C</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,HEPATITIS C,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Working party report on screening for hepatitis C in the UK</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal Screening For Hepatitis C&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;Working party report on screening for hepatitis C in the UK 
&lt;P align=left&gt;This report concludes that: 
&lt;P align=left&gt;"At the present time no case can be made for an HCV screening programme which specifically targets the antenatal period". 
&lt;P align=left&gt;&amp;nbsp;A more recent review of screening for&amp;nbsp;hepatitis C&amp;nbsp;was included in the &lt;A href="http://www.nice.org.uk/Guidance/CG62/Guidance/pdf/English" target="_blank"&gt;&lt;EM&gt;NICE Antenatal care: routine care for the healthy pregnant woman. CG62: full guidance&lt;/EM&gt;&lt;/A&gt; and also concludes that screening for hepatitis C should not be offered.&lt;BR&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61045</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.gov.au/internet/msac/publishing.nsf/Content/8FD1D98FE64C8A2FCA2575AD0082FD8F/$File/Ref%2009b%20-%20Antenatal%20screening%20Summary.pdf]]&gt;</url>
    <title>Antenatal screening for heritable thrombophilia</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>Medical Services Advisory Committee</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,THROMBOPHILIA,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Summary of a systematic review assessing effectiveness of antenatal thrombophilia screening</description>
    <body>&lt;![CDATA[ &lt;P&gt;Antenatal screening for heritable thrombophilia. &lt;BR&gt;Medicare Services Advisory Committee 2002 
&lt;P&gt;The Medical Services Advisory Committee (MSAC) advises the Australian Minister for Health and Ageing on evidence relating to the safety, effectiveness and cost-effectiveness of new medical technologies and procedures. 
&lt;P&gt;This is a summary of a&amp;nbsp;systematic literature review assessing safety, effectiveness and cost effectiveness of antenatal thrombophilia screening.&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;This report recommended that "on the strength of evidence pertaining to antenatal screening for heritable thrombophilia, public funding should not be supported for systematic screening of all pregnant women. Since there is currently insufficient evidence pertaining to high-risk women with obstetric indications, selective antenatal screening should not receive public funding at this time".&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This recommendation is&amp;nbsp;more than five years old. However,&amp;nbsp;it is still current.&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>59830</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=59830]]&gt;</url>
    <title>Antenatal Screening Service for Down's Syndrome in England: 2001</title>
    <publicationDate>2002-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,IMPLEMENTATION,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),MANAGEMENT,11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This National Screening Committee report presents findings of a survey about Down's syndrome screening within NHS maternity units in England</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal Screening Service for Down's Syndrome in England: 2001&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This National Screening Committee report&amp;nbsp;presents selected findings of a survey undertaken in 2001 to establish service provision, and the underlying infrastructure, for Down's syndrome screening within NHS maternity units in England. 
&lt;P&gt;The report is divided into two parts: 
&lt;UL&gt;
&lt;LI&gt;an introduction to antenatal screening for Down's syndrome and its historical background &lt;/LI&gt;
&lt;LI&gt;key findings from the 2001 Survey&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>103161</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=10856]]&gt;</url>
    <title>Antenatal ultrasound screening - ultrasound survey of England 2002</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ WOMEN'S HEALTH,FETAL ANOMALY,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,SCREENING,ANTENATAL,ULTRASOUND,BEFORE 16 WEEKS,18-20 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This document presents the data obtained from a survey of routine second trimester ultrasound screening programmes in England.]]&gt;</body>
  </document>
  <document>
    <id>260775</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260775]]&gt;</url>
    <title>Antenatal ultrasound screening: 2002 Ultrasound Survey: an evaluation of service provision in the South West of England</title>
    <publicationDate>2004-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ULTRASOUND,BEFORE 16 WEEKS,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal ultrasound screening: 2002 Ultrasound Survey: an evaluation of service provision in the South West of England&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;FONT color=#231f20 size=2 face=GillSansStd-Light&gt;
&lt;P align=left&gt;This report aims to identify the current service provision of ultrasound services offered as part of antenatal care by maternity units in the three Strategic Health Authorities in the South West region.&lt;/P&gt;&lt;/FONT&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260771</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260771]]&gt;</url>
    <title>Antenatal ultrasound screening: evaluation of service provision in North East of England</title>
    <publicationDate>2004-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ULTRASOUND,BEFORE 16 WEEKS,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report on antenatal ultrasound provision in North East England</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal ultrasound screening: evaluation of service provision in North East of England&lt;/pageTitle&gt;&lt;pageBody&gt;This report was commissioned by the Antenatal subgroup of the National Screening Committee in order to assess the current state of obstetric ultrasound provision across England.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260767</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260767]]&gt;</url>
    <title>Antenatal ultrasound screening: report of ultrasound service provision in the East of England</title>
    <publicationDate>2005-12-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,BEFORE 16 WEEKS,ULTRASOUND]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal ultrasound screening: report of ultrasound service provision in the East of England&lt;/pageTitle&gt;&lt;pageBody&gt;This report was commissioned by the Antenatal sub group of the National Screening Committee in order to assess the current state of pregnancy ultrasound provision across England.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260773</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260773]]&gt;</url>
    <title>Antenatal ultrasound screening: report of ultrasound service provision in the South East region</title>
    <publicationDate>2004-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,BEFORE 16 WEEKS,ULTRASOUND]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal ultrasound screening: report of ultrasound service provision in the South East region&lt;/pageTitle&gt;&lt;pageBody&gt;This report was commissioned by the Antenatal sub group of the National Screening Committee in order to assess the current state of pregnancy ultrasound provision across England.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260769</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260769]]&gt;</url>
    <title>Antenatal ultrasound screening: ultrasound survey of London: 2002</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,BEFORE 16 WEEKS,ULTRASOUND]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report describing antenatal ultrasound practice in London</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Antenatal ultrasound screening: ultrasound survey of London: 2002&lt;/pageTitle&gt;&lt;pageBody&gt;This report describes antenatal ultrasound practice in the 30 maternity units and two private hospitals in London in 2002 covering approximately 100,000 births. &lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386786</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=52]]&gt;</url>
    <title>Appraisal for screening for Alzheimer's Disease</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED,ALZHEIMER'S DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses Alzheimer's disease against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>392402</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=94]]&gt;</url>
    <title>Appraisal for screening for glomerulonephritis</title>
    <publicationDate>2010-09-01T00:00:00</publicationDate>
    <publisher>Solutions for Public Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses glomerulonephritis against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>60992</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60992]]&gt;</url>
    <title>Appraisal of Evidence about Screening Women for Domestic Violence</title>
    <publicationDate>2001-10-01T00:00:00</publicationDate>
    <publisher>Royal London and Bart's Medical School</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,DOMESTIC VIOLENCE,SCREENING,ANTENATAL,ADULT,DOMESTIC VIOLENCE,DETERMINANTS,PUBLIC HEALTH,SOCIAL DETERMINANTS,MONTHLY ADDITIONS,DOMESTIC VIOLENCE,2009 SEPTEMBER,ABUSE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report examining the evidence for domestic violence screening.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Appraisal of Evidence about Screening Women for Domestic Violence&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report for the NSC examines the evidence for domestic violence screening in women. 
&lt;P align=justify&gt;The report concludes that "a health service based screening programme for domestic violence is not justified. We need good quality evidence of the benefit of intervention and lack of harm from routine questioning of women about domestic violence. If this evidence is forthcoming we need a strategy for changing the views of clinicians about the role of screening and its implementation. The weakness of evidence for screening is not an argument for health services to ignore the problem of domestic violence".&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>70892</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/cervic_tr_e.pdf]]&gt;</url>
    <title>Assessment of techniques for cervical cancer screening</title>
    <publicationDate>1997-05-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA) Technology Reports are critical appraisals or systematic reviews of the literature&amp;nbsp;to provide a clear picture of the clinical effectiveness, cost-effectiveness and impact of health technologies in Canada. 
&lt;P&gt;This report** concludes that "barriers that prevent women from participating in screening may put them at a higher risk for cervical cancer. Opportunistic screening leads to over screening of younger, affluent, lower-risk women and underscreening of older, less affluent and minority group women. The targeted recruitment of women in coordination with an information system that would allow regular follow-up and recall of women could significantly reduce the number of cervical cancer cases". 
&lt;P&gt;**Please note that this report is &amp;gt;10 years old.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212844</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16440876&amp;query_hl=30&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Attitudes towards carrier testing in minors: a systematic review</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Edition Medecine Et Hygiene</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Genet Couns.</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="Genetic counseling (Geneva, Switzerland)"&gt;Genet Couns.&lt;/SPAN&gt; 2005;16(4):341-52&lt;/P&gt;
&lt;P&gt;OBJECTIVE: to review the attitudes of the different stakeholders (minors, healthcare professionals, parents and relatives of affected individuals) towards carrier testing in minors&lt;/P&gt;
&lt;P&gt;CONCLUSION: the studies retrieved suggest that most parents are interested in the carrier status of their children and want their children to be tested before they reach legal majority (and some even in childhood). &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69765</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/226_No18_bonemineral_preassess_e.pdf]]&gt;</url>
    <title>Bone mineral density screening</title>
    <publicationDate>2003-02-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,OSTEOPOROSIS,LATER LIFE,SCREENING AND SURVEILLANCE,TRAUMA,INVESTIGATION,OSTEOPOROSIS,SCREENING,ADULT,TRAUMA AND ORTHOPAEDICS,DISEASE MANAGEMENT,MUSCULOSKELETAL,CONDITIONS,OSTEOPOROSIS,BONE DISORDERS,ACCIDENT PREVENTION,METABOLIC BONE DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA) performs pre-assessments of the literature, before deciding whether to&amp;nbsp;undertake a health technology assessment. Pre-assessments are not systematic reviews, but involve a limited&amp;nbsp;literature search, and provide a quick guide to current information on&amp;nbsp;a topic. 
&lt;P align=left&gt;This pre-assessment is on the topic of bone mineral density screening for osteoporosis. They conclude that "available evidence does not support the use of&amp;nbsp;bone mineral density&amp;nbsp;measurement for population screening of asymptomatic individuals".&lt;/P&gt;
&lt;P align=left&gt;Please note that this resource is &amp;gt;5 years old&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>331682</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/BOWELSC_STNF_FEB07.pdf]]&gt;</url>
    <title>Bowel screening programme: clinical standards ~ February 2007</title>
    <publicationDate>2007-02-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ COLORECTAL (BOWEL) CANCER,SCREENING,ADULT,GASTROENTEROLOGY &amp; LIVER DISEASES,SCREENING,CANCER,RECENT ADDITIONS,COLON &amp; RECTUM,DISEASE PREVENTION,FEBRUARY 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing support to NHSScotland on effective clinical practice and service improvements. &lt;/P&gt;
&lt;P&gt;This document introduces the NHS Quality Improvement Scotland clinical standards for&amp;nbsp;bowel screening. It comprises&amp;nbsp;six standards:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;general 
&lt;LI&gt;call-recall 
&lt;LI&gt;the screening process 
&lt;LI&gt;the laboratory process 
&lt;LI&gt;pre-colonoscopy assessment 
&lt;LI&gt;colonoscopy and histopathology&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;The standards can be found in section five.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69846</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/breast_overview.pdf]]&gt;</url>
    <title>Breast Screening  - National Overview ~ November 2003</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. 
&lt;P align=left&gt;This report* presents a national overview of breast screening services in Scotland. 
&lt;P align=left&gt;&lt;EM&gt;* This report is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;&lt;A href="nelh:331604:0" name=internalLink&gt;
&lt;P align=left&gt;An update to this report was published in 2006&lt;/P&gt;
&lt;P align=left&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64049</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp39.pdf]]&gt;</url>
    <title>Breast Screening Resource Pack for Training Primary Care Nurses</title>
    <publicationDate>2003-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,PRIMARY CARE,BREAST CANCER,ADULT,IMPLEMENTATION,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=justify&gt;This resource pack is a revision of the Resource Pack for Training Primary Care Nurses, which was published by the NHS Breast Screening Programme (NHSBSP) in 1996. It is&amp;nbsp;aimed at &amp;nbsp;those who design and run courses for primary health care teams. 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64062</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/a-pocket-guide.html]]&gt;</url>
    <title>Breast Screening: A Pocket Guide</title>
    <publicationDate>2008-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ BENEFITS &amp; HARMS,MANAGEMENT,BREAST CANCER,ADULT,IMPLEMENTATION,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Breast screening guide updated in Aril 2008</description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This is a simple guide to breast screening produced by the NHS&amp;nbsp;Breast Screening Programme.&lt;/P&gt;
&lt;P align=left&gt;It was updated in April 2008.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82297</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/Breast%20Screening.pdf]]&gt;</url>
    <title>Breast screening: clinical standards (December 2002)</title>
    <publicationDate>2002-12-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. 
&lt;P&gt;This document introduces the NHS Quality Improvement Scotland clinical standards for breast cancer screening. It comprises six standards – including call-recall, the screening process and surgical referral. The actual standards are contained in section 9.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392574</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://onlinelibrary.wiley.com/doi/10.1002/gps.2306/abstract]]&gt;</url>
    <title>Brief cognitive screening instruments: an update</title>
    <publicationDate>2010-02-01T00:00:00</publicationDate>
    <publisher>International Journal of Geriatric Psychiatry</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,OLD AGE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Dementia is under diagnosed in the elderly. The Mini Mental State Exam has significant limitations but is most frequently used instrument and best value in the community and primary care is to rule out dementia. Other instruments are recognised consistently for use in primary care while other newer instruments are gaining credibility due to the improvement of sensitivity, addressing frontal/executive functioning and decreasing susceptibility to cultural and educational biases.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline was searched to find articles focussing on brief screening methods in primary care and geriatric services. Reference lists were also searched for relevant contributing articles. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 679 abstracts were retrieved. This review focussed on instruments recommended from previous reviews of cognitive screening and those identified as being most commonly used in primary care and geriatric settings. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Ismail Z. Rajji TK. Shulman KI. Brief cognitive screening instruments: an update. International Journal of Geriatric Psychiatry 2010; 25(2):111-20&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://onlinelibrary.wiley.com/doi/10.1002/gps.2306/pdf" target="_blank"&gt;Full text freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382011</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/20403013]]&gt;</url>
    <title>Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review</title>
    <publicationDate>2010-04-01T00:00:00</publicationDate>
    <publisher>Addiction, Wiley-Blackwell</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Although three questionnaires (T-ACE, TWEAK and AUDIT-C) were found to be potentially useful further evaluation is needed before they are used as stand alone tools.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Databases, from their start dates to June 2008, and reference lists of eligible papers and related reviews, were searched, for cohort or cross-sectional studies that compared brief alcohol screening questionnaires with reference criteria.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 5 studies, including 6724 participants, were reviewed. Seven screening&amp;nbsp;questionnaires were evaluated.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Burns E, Gray R, Smith LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. &lt;EM&gt;Addiction&lt;/EM&gt; 2010; 105(4):601-14&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20403013" target="_blank"&gt;PubMed abstract available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212832</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://caonline.amcancersoc.org/cgi/reprint/60/2/99]]&gt;</url>
    <title>Cancer screening in the United States, 2010: A review of the current American Cancer Society guidelines and issues in cancer screening</title>
    <publicationDate>2010-03-31T00:00:00</publicationDate>
    <publisher>American Cancer Society</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,BREAST CANCER,CERVICAL CANCER,PROSTATE,LUNG,COLORECTAL (BOWEL) CANCER,SCREENING,CANCER,ADULT,FEBRUARY 2010,RECENT ADDITIONS,CANCER,SCREENING,DISEASE PREVENTION,COLON &amp; RECTUM,GASTROENTEROLOGY &amp; LIVER DISEASES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>American guidelines for detection of cancer</description>
    <body>&lt;![CDATA[ &lt;P&gt;The American Cancer Society summarises their current&lt;SUP&gt; &lt;/SUP&gt;guidelines, discusses recent evidence and policy changes that&lt;SUP&gt; &lt;/SUP&gt;have implications for cancer screening.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63677</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-gpg7.pdf]]&gt;</url>
    <title>Ceasing Women From The NHS Breast Screening Programme</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,BREAST CANCER,IMPLEMENTATION,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT color=#221e1f&gt;&lt;FONT color=#221e1f&gt;
&lt;P align=justify&gt;Document outlining guidance on when women may be ceased from the breast screening programme in England.&lt;/FONT&gt; &lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69864</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp-gpg1.pdf]]&gt;</url>
    <title>Ceasing women from the NHS cervical screening programme</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER,WOMEN'S HEALTH,SCREENING,CERVICAL CANCER,GYNAECOLOGICAL TUMOURS,MALIGNANT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This document&amp;nbsp;contains guidance on when women&amp;nbsp;may be&amp;nbsp;ceased from the NHS Cervical Screening Programme (NHSCSP).&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93591</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://whqlibdoc.who.int/publications/2002/9241545720.pdf]]&gt;</url>
    <title>Cervical cancer screening in developing countries: report of a WHO consultation</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>World Health Organization</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,SCREENING,GYNAECOLOGICAL TUMOURS,CERVICAL CANCER,WOMEN'S HEALTH,SCREENING,ADULT,INTERNATIONAL PERSPECTIVE,MALIGNANT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Report of a WHO consultation on cervical cancer screening in developing countries. This report offers a summary of the evidence&amp;nbsp;for policy makers and clinicians&amp;nbsp;involved with the&amp;nbsp;establishment&amp;nbsp;of screening programmes.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69850</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/cervical_overview.pdf]]&gt;</url>
    <title>Cervical Screening - National Overview ~ November 2003</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. 
&lt;P align=left&gt;This report presents a national overview of cervical cancer screening services in Scotland.&lt;/P&gt;&lt;A href="nelh:331608:0" name=internalLink&gt;
&lt;P align=left&gt;An update to this report was published in August 2006&lt;/P&gt;
&lt;P align=left&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69865</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp18.pdf]]&gt;</url>
    <title>Cervical Screening Call and Recall: Guide to Administrative Good Practice</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GYNAECOLOGICAL TUMOURS,CERVICAL CANCER,SCREENING,WOMEN'S HEALTH,CERVICAL CANCER,ADULT,IMPLEMENTATION,SCREENING,MANAGEMENT,MALIGNANT,STANDARDS OF PRACTICE,GOOD PRACTICE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This guidaince has been&amp;nbsp;produced&amp;nbsp;by the National Cervical Screening User Group to assist staff in the day to day operation of the call and recall system for the cervical screening programme.]]&gt;</body>
  </document>
  <document>
    <id>69931</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/2003-csre.pdf]]&gt;</url>
    <title>Cervical screening results explained: a guide for primary care</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>Cancer Research UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER,MANAGEMENT,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;The purpose of these guidelines, produced for the NHS Cervical&amp;nbsp;Screening Programme,&amp;nbsp;is to provide general practitioners with an easy reference for interpreting cervical screening results and taking appropriate action where indicated.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69935</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/cervicalpocket2004.pdf]]&gt;</url>
    <title>Cervical screening: a pocket guide</title>
    <publicationDate>2004-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,WOMEN'S HEALTH,GYNAECOLOGICAL TUMOURS,CERVICAL CANCER,SCREENING,ADULT,SCREENING,MALIGNANT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a simple guide&amp;nbsp;to cervical screening, produced by the NHS Cervical Screening Programme,&amp;nbsp;designed for anyone who works in or takes an interest in the cervical screening programme.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>331685</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/Cervical%20Screening%20Sep%202002.pdf]]&gt;</url>
    <title>Cervical screening: clinical standards ~ September 2002</title>
    <publicationDate>2002-09-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing support to NHSScotland on effective clinical practice and service improvements. &lt;/P&gt;
&lt;P&gt;This document introduces the NHS Quality Improvement Scotland clinical standards for&amp;nbsp;cervical screening. It comprises&amp;nbsp;five standards:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;general 
&lt;LI&gt;call-recall and failsafe 
&lt;LI&gt;smear-taking 
&lt;LI&gt;laboratory reporting 
&lt;LI&gt;colposcopy&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;BR&gt;The standards can be found in section five.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61017</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61017]]&gt;</url>
    <title>Child Health Sub-Group Report  - growth disorders</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCHOOL ENTRY,HEIGHT,SPECIALTIES,SCREENING,CHILD,ENDOCRINOLOGY,CHILD HEALTH]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of growth disorders against NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report  - growth disorders&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report, produced by the Child Health Sub-Group, assesses growth disorders in children against the NSC criteria. 
&lt;P&gt;The report makes many recommendations about the monitoring of children's height and weight, and training for staff. 
&lt;OL&gt;
&lt;P&gt;&lt;/P&gt;&lt;/OL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61093</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61093]]&gt;</url>
    <title>Child Health Sub-Group Report - biotinidase deficiency</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,NEWBORN,SPECIALTIES,BIOTINIDASE DEFICIENCY,SCREENING,CHILD HEALTH,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of biotinidase deficiency screening against National Screening Committee criteria.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - biotinidase deficiency&lt;/pageTitle&gt;&lt;pageBody&gt;This report, produced for the National Screening Committee (NSC), evaluates biotinidase deficiency screening against the NSC criteria.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88200</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88200]]&gt;</url>
    <title>Child Health Sub-Group Report - congenital cataract</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CHILD,SCREENING,CHILD HEALTH,SCREENING,OPHTHALMOLOGY,NEONATOLOGY,CATARACT,EYES,SPECIALTIES,NEONATAL,PUBLICATIONS,EYES,CONGENITAL MALFORMATIONS,REPORTS,OPHTHALMOLOGY,EYES AND VISION,PHYSICAL (&lt;72HRS),NEWBORN,PHYSICAL (6-8 WKS),CATARACT,LENS,CONDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of neonatal screening for congenital cataract against NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - congenital cataract&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report by the Child Health Sub-Group evaluates congenital cataract screening (which forms part of the general physical examination at birth and at 6-8 weeks)&amp;nbsp;against the NSC criteria. &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56913</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56913]]&gt;</url>
    <title>Child Health Sub-Group Report - cystic fibrosis</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS,RESPIRATORY,CHILD HEALTH,SPECIALTIES,CYSTIC FIBROSIS,ANTENATAL,SCREENING,CYSTIC FIBROSIS,GENETIC CONDITIONS A-Z,SYSTEMS &amp; SYMPTOMS,GENETICS - PRACTICE &amp; ISSUES,CYSTIC FIBROSIS (CF),PREGNANCY,CONDITIONS C,GENETIC SCREENING (FOR CONDITIONS),BLOODSPOT (&lt;1WK),NEWBORN,BLOOD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of cystic fibrosis against NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - cystic fibrosis&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=justify&gt;This report by the Child Health Sub-Group evaluates cystic fibrosis against the NSC criteria. Both antenatal and neonatal screening have been considered, but this report concentrates mainly on neonatal screening. 
&lt;P align=justify&gt;The report recommends that&amp;nbsp;"...on the evidence available, a national neonatal screening programme [for cystic fibrosis]&amp;nbsp;should not be introduced. However, as one fifth of babies are already being screened in the UK, considerations of equity could not be ignored. The Minister of State for Health decided that screening should be introduced and an implementation group has been set up".&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88203</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88203]]&gt;</url>
    <title>Child Health Sub-Group Report - developmental and behavioural problems</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,REPORTS,ALLIED HEALTH PROFESSIONALS,PUBLICATIONS,DEVELOPMENT &amp; BEHAVIOUR,SPECIALTIES,SPEECH AND LANGUAGE,AUTISTIC SPECTRUM DISORDERS,MOVEMENT DISORDERS,ATTENTION DEFICIT AND HYPERKINETIC DISORDERS,NEUROLOGY,CHILD HEALTH,COMMUNITY CHILD HEALTH,SCREENING,CHILD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluates developmental and behavioural problems against the NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - developmental and behavioural problems&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report by the Child Health Sub-Group evaluates&amp;nbsp;developmental and behavioural problems&amp;nbsp;against the NSC criteria.&lt;/P&gt;
&lt;P&gt;The report concludes that: "screening for these complex developmental conditions does not meet the NSC criteria. This does not mean they are unimportant – they represent a substantial volume of pathology, distress and probably, by implication, educational failure with its associated adverse outcomes."&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>59703</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=59703]]&gt;</url>
    <title>Child Health Sub-Group Report - duchenne muscular dystrophy</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,MUSCULAR DYSTROPHY,MUSCULAR DYSTROPHY,SCREENING,SPECIALTIES,CHILD HEALTH,NEUROLOGY,GENETIC CONDITIONS,SYSTEMS &amp; SYMPTOMS,WEAKNESS &amp; WASTING (NEUROMUSCULAR DISORDERS),NEWBORN,DUCHENNE MUSCULAR DYSTROPHY (DMD),NOT ROUTINELY OFFERED,CONDITIONS D-F]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Assessment of duchenne muscular dystrophy against the National Screening Committee criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - duchenne muscular dystrophy&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report, produced by the Child Health Sub-Group of the National Screening Committee (NSC), looks at the feasibility of&amp;nbsp;duchenne muscular dystrophy screening, by assessing it against the&amp;nbsp;NSC criteria. 
&lt;P&gt;The summary of recommendations states that "t&lt;SPAN lang=EN-GB&gt;he Child Health Sub-group of the NSC considered the evidence presented at the seminar in March 2004 and concluded that neonatal screening for duchenne muscular dystrophy could not be recommended. This decision was endorsed by the NSC."&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61021</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61021]]&gt;</url>
    <title>Child Health Sub-Group Report - dysplasia of the hip</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CHILD HEALTH,SCREENING,CHILD,SCREENING,SPECIALTIES,HIPS,PHYSICAL (6-8 WKS),HIPS,PHYSICAL (&lt;72HRS),NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of hip dysplasia (in children) against the NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - dysplasia of the hip&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report assesses developmental dysplasia of the hip (DDH)&amp;nbsp;and congenital dislocation of the hip (CDH), against the NSC criteria.&lt;FONT color=#00007e&gt; 
&lt;P align=left&gt;The report concludes by stating that "if proposed now as a new programme CDH/DDH screening would probably not be accepted. However, it is so ingrained in the clinical practice of so many people that it would be almost impossible to stop it, unless overwhelming evidence of ineffectiveness could be obtained". &lt;/FONT&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88201</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88201]]&gt;</url>
    <title>Child Health Sub-Group Report - speech and language delay</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SPEECH &amp; LANGUAGE DELAY,REPORTS,ALLIED HEALTH PROFESSIONALS,PUBLICATIONS,SPECIALTIES,SPEECH AND LANGUAGE,SCREENING,CHILD HEALTH,SCREENING,CHILD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluates speech and language screening against the NSC criteria.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - speech and language delay&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report by the Child Health Sub-Group evaluates speech and language screening against the NSC criteria.&lt;/P&gt;
&lt;P&gt;The report concludes that "at the present time, a formal screening process is not appropriate for delay in speech and language acquisition (DSLA).&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;It is nevertheless an important topic and should be kept under review."&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88202</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88202]]&gt;</url>
    <title>Child Health Sub-Group Report - vision screening</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CHILD,SCREENING,CHILD HEALTH,SCREENING,OPHTHALMOLOGY,SPECIALTIES,PUBLICATIONS,REPORTS,EYES AND VISION,VISION,SCHOOL ENTRY,CONDITIONS,LOW VISION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluates vision screening against the NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Child Health Sub-Group Report - vision screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report by the Child Health Sub-Group evaluates vision screening against the NSC criteria.&lt;/P&gt;
&lt;P&gt;The report concludes that: "it is recommended that all children should be screened for visual impairment between four and five years of age. This should either be conducted by orthoptists or by professionals trained and supported by orthoptists. Once this programme is in place, the school entry vision screening programme should cease. No other preschool vision screening can be justified".&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>212750</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=15459402&amp;query_hl=14&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Chlamydia trachomatis in the United Kingdom: a systematic review and analysis of prevalence studies</title>
    <publicationDate>2004-10-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,CHLAMYDIA,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,BACTERIAL,MALE UROGENITAL DISORDERS,CHLAMYDIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Sex. Transm. Infect.</description>
    <body>&lt;![CDATA[ &lt;P&gt;Sex Transm Infect. 2004 Oct;80(5):331-3. &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;OBJECTIVE: To undertake a systematic review to obtain estimates of genital Chlamydia trachomatis prevalence in various populations in the United Kingdom and Ireland&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;CONCLUSION: The chlamydia prevalence estimates by age and setting from the model may be used to inform chlamydia screening strategies&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Please note this review is &amp;gt;5 years old&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325131</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=11111]]&gt;</url>
    <title>Chorionic villus sampling (CVS) and amniocentesis - for health professionals</title>
    <publicationDate>2009-07-31T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>BRIEFING</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),WOMEN'S HEALTH,COMPLICATED PREGNANCY,ANTENATAL PROBLEMS,PRENATAL DIAGNOSIS,11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This information sheet is intended to provide a guide for health professionals not usually involved in chorionic villus sampling (CVS) and amniocentesis procedures but who may be asked questions by women about these procedures. CVS is sometimes also called chorionic villus biopsy or placental biopsy (CVB or PB).&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63686</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp49se.pdf]]&gt;</url>
    <title>Clinical guidelines for breast cancer screening assessment</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,MANAGEMENT,BREAST CANCER,IMPLEMENTATION,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This guidance sets out the minimum standards required for satisfactory breast screening assessment in the NHS Breast Screening Programme.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>102582</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/10/4/124]]&gt;</url>
    <title>Colonoscopy detected colon polyps better than air contrast barium enema or computed tomographic colonography</title>
    <publicationDate>2005-08-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ COLORECTAL (BOWEL) CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Colonoscopy detected colon polyps better than air contrast barium enema or computed tomographic colonography. Evidence-Based Medicine&amp;nbsp;2005;10:124.&lt;/P&gt;
&lt;P&gt;&lt;A name=""&gt;&lt;!-- null --&gt;&lt;/A&gt;This summary is based on the original article: Rockey DC, Paulson E, Niedzwiecki D, &lt;I&gt;et al&lt;/I&gt;. Analysis of air contrast barium enema, computed tomographic colonography, and colonoscopy: prospective comparison. &lt;I&gt;Lancet&lt;/I&gt; 2005;&lt;B&gt;365&lt;/B&gt;:305–11.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>398358</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000370]]&gt;</url>
    <title>Colorectal cancer screening for average-risk north americans: an economic evaluation</title>
    <publicationDate>2010-11-23T00:00:00</publicationDate>
    <publisher>PLoS</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,ECONOMICS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Screening for colorectal cancer with fecal immunochemical test reduces the risk of colorectal cancer and deaths related to colorectal cancer. Health care costs are lower in comparison to no screening and the other screening strategies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Incremental cost-utility analysis using a Markov model comparing guaiac-based fecal occult blood test of fecal immunochemical test annually, fecal DNA every 3 years, flexible sigmoidoscopy or computed tomographic colonography every 5 years, colonoscopy every 10 years and no screening natural history.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Assuming mid-range testing characteristics, the annual fecal immunochemical test was more effective and less costly than no screening and the other strategies considered, but not fecal immunochemical test with high test performance characteristics. The number of cancers could be reduced from 4,857 to 1,782 and the number of deaths from 1,393 to 457, while saving CAN$68 per person during the lifetimes of 100,000 patients with average risk. When the test performance was reduced, or the cost of managing colorectal cancer was reduced the strategy became more expensive than no screening although it did remain economically attractive.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Heitman SJ, Hilsden RJ, Au F et al. Colorectal cancer screening for average-risk north americans: an economic evaluation. PLoS Medicine 2010; 7(11):e1000370&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000370" target="_blank"&gt;Full text freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>123705</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/bowel/scharr.pdf]]&gt;</url>
    <title>Colorectal cancer screening options appraisal: cost effectiveness, cost-utility and resource impact of alternative screening options for colorectal cancer</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>School of Health and Related Research (ScHARR)</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ECONOMICS,COLORECTAL (BOWEL) CANCER,SCREENING,ADULT,FLEXIBLE SIGMOIDOSCOPY,CANCER,SCREENING,STOOL TESTS,FAECAL BLOOD,GASTROENTEROLOGY &amp; LIVER DISEASES,COLON &amp; RECTUM,GASTROINTESTINAL ENDOSCOPY,DIAGNOSTIC PROCEDURES,DISEASE PREVENTION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;The aim of this study was to conduct a detailed assessment of research evidence and to model costs, benefits and capacity implications of alternative screening options for colorectal cancer in England. Eight screening options using faecal occult blood testing, flexible sigmoidoscopy, or a combination of the two modalities are compared to a policy of ‘no screening.’&lt;/P&gt;
&lt;P align=left&gt;The report was prepared by ScHARR for the English Bowel Cancer Screening Working Group.&lt;FONT size=5 face=Arial&gt;&lt;I&gt;&lt;B&gt;&lt;B&gt;&lt;I&gt;&lt;FONT size=5 face=Arial&gt;&lt;/P&gt;&lt;/B&gt;&lt;/I&gt;&lt;/FONT&gt;&lt;/B&gt;&lt;/I&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>389080</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://clinicalevidence.bmj.com/ceweb/conditions/dsd/0414/0414-get.pdf]]&gt;</url>
    <title>Colorectal cancer: screening</title>
    <publicationDate>2007-06-01T00:00:00</publicationDate>
    <publisher>Clinical Evidence, BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Author's conclusions&lt;/STRONG&gt;: Effectiveness and safety of colonoscopy, computed tomography colography, double contrast barium enema, faecal occult blood testing and flexible sigmoidoscopy were reviewed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Important databases, including Medline, Embase, The Cochrane Library and others, were searched up to November 2006. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 19 systematic reviews were included in this review to answer the question 'What are the effects of screening for colorectal cancer?'&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Lewis CL. Colorectal cancer: screening. Clinical Evidence 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://clinicalevidence.bmj.com/ceweb/conditions/dsd/0414/0414-get.pdf" target="_blank"&gt;Full text available via Athens login&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>311623</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.retinalscreening.nhs.uk/userFiles/File/Comissioning%20toolkit.pdf]]&gt;</url>
    <title>Commissioning Systematic Diabetic Retinopathy Screening</title>
    <publicationDate>2007-10-01T00:00:00</publicationDate>
    <publisher>National Screening Programme for Diabetic Retinopathy</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ COMMISSIONING,ENDOCRINE,EYE AND VISION PROBLEMS,DISEASE/CONDITION GROUPS,TOOLKITS,DIABETES,ADULT,SCREENING,CHRONIC COMPLICATIONS,DIABETIC RETINOPATHY,RETINOPATHY,CAUSES,MANAGEMENT,EYE DISEASES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Commissioning Tookit is&amp;nbsp;designed to assist those commissioning diabetic retinopathy screening&amp;nbsp;programmes to ensure that&amp;nbsp;all core ingredients are provided for, and to provide tools to ensure that effective cost comparisons can be carried out.]]&gt;</body>
  </document>
  <document>
    <id>69831</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/20699%20Evidence%20Note%207.pdf]]&gt;</url>
    <title>Comparison of digital mammography and film screen mammography</title>
    <publicationDate>2004-07-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BREAST CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. 
&lt;P&gt;This evidence briefing&amp;nbsp;has been produced&amp;nbsp;for health service planners and practitioners, and provides a summary of the use of digital mammography and film screen mammography.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70104</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.state.mn.us/htac/colon.htm]]&gt;</url>
    <title>Computed tomographic colonography (virtual colonoscopy)</title>
    <publicationDate>2002-06-01T00:00:00</publicationDate>
    <publisher>Health Technology Advisory Committee, Minnesota</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,GASTROENTEROLOGY &amp; LIVER DISEASES,DIAGNOSTIC PROCEDURES,CT / CAT SCAN,VIRTUAL ENDOSCOPY,RECENT ADDITIONS,RADIOLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Health Technology Advisory Committee in Minnesota, USA&amp;nbsp;provides unbiased, scientifically based assessments and recommendations on new and emerging technologies. Note that this committee was discontinued in July 2002 due to budget cuts, so the publications will not be updated subsequently. 
&lt;P&gt;This report concludes that "computed tomographic colonography (CTC) is a safe procedure. Further research is needed before CTC can be recommended as a screening tool. The sensitivity and specificity of CTC needs to improve to be comparable to that of colonoscopy".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70132</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_computed_tomographic_colonography_for_detection_of_colorectal_polyps_and_neoplasms.html]]&gt;</url>
    <title>Computed Tomographic Colonography for Detection of Colorectal Polyps and Neoplasms</title>
    <publicationDate>2004-08-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GASTROENTEROLOGY &amp; LIVER DISEASES,SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,NON-MALIGNANT NEOPLASMS,RADIOLOGY,RECENT ADDITIONS,CANCER,VIRTUAL ENDOSCOPY,CT / CAT SCAN,POLYPS,DIAGNOSTIC PROCEDURES,COLON &amp; RECTUM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of&amp;nbsp;computed tomographic colonography for detecting colorectal neoplasms.&amp;nbsp;The Technology Assessment Committee summarised by stating that: "computed tomographic colonography (CTC) is a safe procedure with minor side effects reported. CTC appears to be superior, in terms of detection of colorectal polyps and neoplasms, to no examination, fecal occult blood test, double-contrast barium enema, and flexible sigmoidoscopy. CTC has not been proven to be superior to conventional colonoscopy".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>114196</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev_tomocolon_100103.pdf]]&gt;</url>
    <title>Computed tomographic colonography: An Evidence-Based Analysis</title>
    <publicationDate>2003-10-01T00:00:00</publicationDate>
    <publisher>Ministry of Health and Long-Term Care, Canada</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The&amp;nbsp;Medical Advisory Secretariat, Ontario, Canada&amp;nbsp;provides evidence-based policy advice on the coordinated uptake of new health technologies and health services, by conducting systematic reviews of scientific evidence and consultation with experts in the medical community.&lt;/P&gt;
&lt;P&gt;This Health Technology Scientific literature review aims to evaluate the safety and effectiveness of&amp;nbsp;virtual colonography&amp;nbsp;as a screening tool in colorectal cancer. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66855</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sbu.se/upload/Publikationer/Content0/3/Computed_tomography_screening_lung_cancer.pdf]]&gt;</url>
    <title>Computed tomography in screening for lung cancer</title>
    <publicationDate>2003-05-27T00:00:00</publicationDate>
    <publisher>Swedish Council on Technology Assessment in Health Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Alert is a system for identification and early assessment concerning new methods in health care. The Alert reports are produced by the Swedish Council on Technology Assessment in Health Care, and&amp;nbsp;describe the new methods and their effects. 
&lt;P&gt;This report summarises the methods and effects for computed tomography (CT)&amp;nbsp;in lung cancer screening. It concludes that "currently, there is good scientific documentation of the capacity for low-dose CT to detect lung cancer at an early stage"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>300844</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=10850]]&gt;</url>
    <title>Consent standards for screening fetal anomalies during pregnancy</title>
    <publicationDate>2007-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ FETAL ANOMALIES,INFORMED DECISION-MAKING,18-20 WEEKS,ANTENATAL,SCREENING,WOMEN'S HEALTH,FETAL ANOMALY,NEURAL TUBE DEFECTS,SCREENING,COMPLICATED PREGNANCY,ANTENATAL PROBLEMS,ANTENATAL CARE,NORMAL PREGNANCY,CONSENT,GOOD PRACTICE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Describes the underlying principles and standards for fetal anomaly screening consent.</description>
    <body>&lt;![CDATA[ This&amp;nbsp;UK National Screening Committee document describes the underlying principles and standards for fetal anomaly screening consent.]]&gt;</body>
  </document>
  <document>
    <id>311622</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/publications/cs4.pdf]]&gt;</url>
    <title>Consent to Cancer Screening</title>
    <publicationDate>2009-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,CERVICAL CANCER,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ NHS Cancer screening programme document&amp;nbsp;looking at&amp;nbsp;consent issues in breast, cervical and bowel cancer screening.]]&gt;</body>
  </document>
  <document>
    <id>332203</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp60v2.pdf]]&gt;</url>
    <title>Consolidated guidance on standards for the NHS Breast Screening Programme</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,QUALITY ASSURANCE,SCREENING,ADULT,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This publication brings together standards for the NHS Breast Screening Programme in a single document. The standards have been developed by different professional quality assurance (QA) groups at different times. Some standards have been revised recently; some are still in the process of being revised. Because of this, there are inconsistencies in terminology and the presentation of standards. In addition, some standards may need to be revised as new techniques (such as digital mammography) come into routine use. This is the second version of the document which exists only as a PDF. The intention is to review it and publish a revised edition in hard copy when some of the issues have been resolved.]]&gt;</body>
  </document>
  <document>
    <id>83119</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://cpd.screening.nhs.uk/]]&gt;</url>
    <title>Continuous professional development for screening</title>
    <publicationDate>2009-04-14T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,NEWBORN,BLOODSPOT (&lt;1WK),11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM),18-20 WEEKS,WOMEN'S HEALTH,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),FETAL ANOMALY,IMPLEMENTATION,ANTENATAL,SCREENING,8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Cross-cutting education and training resources for antenatal and newborn screening</description>
    <body>&lt;![CDATA[ &lt;P&gt;This website contains National Antenatal and Newborn Screening education and training resources developed by the National Screening Committee (NSC). It was developed to provide a single site of access&amp;nbsp;to all national screening resources, including those for Down's Syndrome, Fetal Anomaly, Sickle Cell and Thalassaemia, Infectious diseases and Newborn blood spot. The resources are appropriate for all health care professionals involved in screening.&lt;/P&gt;
&lt;P&gt;The UK National Screening Committee's Continuing Professional Development website for England is a&amp;nbsp;‘one stop' website bringing together all the cross-cutting education and training programmes and resources - meeting the continuing professional development (CPD) needs of health professionals involved in NHS antenatal and newborn screening.&lt;/P&gt;
&lt;P&gt;Whether you're responsible for facilitating education and training locally or want to find out more about the latest developments in screening, this website provides the ideal starting point from which to explore the full range of NSC education programmes, e-resources, and other relevant information and publications.&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96105</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/6/187?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123074664701_428&amp;stored_search=&amp;FIRSTINDEX=40&amp;journalcode=ebmed]]&gt;</url>
    <title>Conventional cervical smears were better than monolayer cytology or human papillomavirus testing for detecting cervical intraepithelial neoplasia</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Conventional cervical smears were better than monolayer cytology or human papillomavirus testing for detecting cervical intraepithelial neoplasia. Evidence-Based Medicine 2003; 8:187. &lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Coste J, Cochand-Priollet B, de Cremoux P, et al.Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening.BMJ 2003;326:733–6&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70569</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.state.mn.us/htac/creactive.htm]]&gt;</url>
    <title>C-reactive protein: screening of coronary artery disease</title>
    <publicationDate>2002-04-01T00:00:00</publicationDate>
    <publisher>Health Technology Advisory Committee, Minnesota</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ HEART DISEASE,CORONARY HEART DISEASE,SCREENING,CORONARY HEART DISEASE,LATER LIFE,SCREENING AND SURVEILLANCE,ADULT,SCREENING,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Health Technology Advisory Committee in Minnesota, USA&amp;nbsp;provides unbiased, scientifically based assessments and recommendations on new and emerging technologies. Note that this committee was discontinued in July 2002 due to budget cuts, so the publications will not be updated subsequently. 
&lt;P&gt;This report concludes that "available evidence does not support the routine use of the C-Reactive protein (CRP) test for the diagnosis, management, or screening of patients with diagnosed disease, or in asymptomatic, healthy subjects".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>314462</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/criteria]]&gt;</url>
    <title>Criteria for appraising the viability, effectiveness and appropriateness of a screening programme</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CHILD,ANTENATAL,ADULT,SCREENING,OLD AGE,INFORMED DECISION-MAKING,QUALITY ASSURANCE,ECONOMICS,BENEFITS &amp; HARMS,NEWBORN,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>National Screening Committee criteria used to assess the suitability of screening for various conditions</description>
    <body>&lt;![CDATA[ &lt;P&gt;These National Screening Committee (NSC)&amp;nbsp;criteria are based on the World Health Organization (WHO) criteria developed in the 1960s (see &lt;EM&gt;Principles and Practices of screening for disease&lt;/EM&gt; by Wilson JM, and Junger YG. Geneva, World Health Organization, 1968), but take into account both more rigorous standards of evidence required to improve effectiveness, and the greater concern about adverse effects of screening.&lt;/P&gt;
&lt;P&gt;These criteria are used to assess the suitability of screening for various conditions, and a part of the evidence used to create NSC screening policies.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63597</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63597]]&gt;</url>
    <title>Current screening in the UK</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>University of Leicester</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B screening from a NSC workshop</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Current screening in the UK&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;outlines current group B streptococcus screening practices. 
&lt;P&gt;A &lt;A href="nelh:59860:0" name=internalLink&gt;more recent review&lt;/A&gt; was undertaken in November 2008
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>82277</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sogc.org/guidelines/public/118E-CO-August2002.pdf]]&gt;</url>
    <title>Cystic fibrosis carrier testing in pregnancy in Canada</title>
    <publicationDate>2002-08-01T00:00:00</publicationDate>
    <publisher>Society of Obstetricians and Gynaecologists of Canada</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED,CYSTIC FIBROSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This guideline aims to&amp;nbsp;assess the&amp;nbsp;role&amp;nbsp;of cystic fibrosis (CF) testing within the Canadian health care environment.The guideline has been&amp;nbsp;approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70379</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_densitometry_as_a_diagnostic_tool_for_the_identification_and_treatment_of_osteoporosis_in_women.html]]&gt;</url>
    <title>Densitometry as a Diagnostic Tool for the Identification and Treatment of Osteoporosis in Women</title>
    <publicationDate>2000-01-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ DISEASE MANAGEMENT,TRAUMA AND ORTHOPAEDICS,ADULT,SCREENING,INVESTIGATION,OSTEOPOROSIS,NOT ROUTINELY OFFERED,OLD AGE,METABOLIC BONE DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of&amp;nbsp;bone mineral density (BMD)&amp;nbsp;measurement&amp;nbsp;for the identification of osteoporosis. The Technology Assessment Committee summarised by stating that: "there is insufficient evidence to support mass screening for BMD; the need for BMD testing must be determined on an individual patient basis".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>155384</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=155384]]&gt;</url>
    <title>Dental screening in 6-9 year old children: NSC interim report</title>
    <publicationDate>2005-03-15T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ CHILD HEALTH,DENTISTRY,SCREENING,SCREENING,CHILD,SPECIALTIES,PUBLICATIONS,REPORTS,NOT ROUTINELY OFFERED,DENTAL DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Brief report about dental screening in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Dental screening in 6-9 year old children: NSC interim report&lt;/pageTitle&gt;&lt;pageBody&gt;Brief report to the National Screening Committee about dental screening in children aged 6-9 years old.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>387252</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://jpubhealth.oxfordjournals.org/cgi/content/abstract/fdp115]]&gt;</url>
    <title>Determinants of participation in colorectal cancer screening with faecal occult blood testing</title>
    <publicationDate>2009-12-16T00:00:00</publicationDate>
    <publisher>Journal of Public Health, Oxford Journals</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Participation in colorectal cancer screening depends on local circumstances. It is, therefore dificult to produce a general strategy for improving uptake. Locally targeted strategies are needed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic search of PubMed, Medline, Embase and PsycINFO.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Studies included looked at socio-demographic determinants of participation of colorectal screening by faecal occult blood testing&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: My von Euler-Chelpin, Klaus Brasso, Elsebeth Lynge. Determinants of participation in colorectal cancer screening with faecal occult blood testing. Journal of Public Health 2010; 32(3):395-405&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://jpubhealth.oxfordjournals.org/cgi/content/abstract/fdp115" target="_blank"&gt;Absract freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64111</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.retinalscreening.nhs.uk/pages/default.asp?id=9&amp;sID=80]]&gt;</url>
    <title>Development of a set of key quality assurance standards for diabetic retinopathy</title>
    <publicationDate>2008-09-01T00:00:00</publicationDate>
    <publisher>Diabetic Retinopathy Programme</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ DIABETIC RETINOPATHY,RETINA,DIABETIC RETINOPATHY,RETINOPATHY,CONDITIONS,MANAGEMENT,QUALITY ASSURANCE,EYE DISEASES,DIABETES,IMPLEMENTATION,ADULT,SCREENING,RETINOPATHY,EYES AND VISION,DIABETIC RETINOPATHY,CHRONIC COMPLICATIONS,CAUSES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;These quality assurance documents&amp;nbsp;describe the standards and criteria for the National Screening Programme for Sight-threatening Diabetic Retinopathy.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>60292</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60292]]&gt;</url>
    <title>Diabetes, Heart Disease and Stroke (DHDS) prevention pilot project. Project Description Winter 2003</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>PROTOCOL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DIABETES,DIABETIC RETINOPATHY,STROKE,CORONARY HEART DISEASE,MANAGEMENT,PRIMARY CARE,NOT ROUTINELY OFFERED,VASCULAR RISK,STROKE,ISCHAEMIC STROKE,PREVENTION,HAEMORRHAGIC STROKE,PREVENTION,PREVENTION,GENERAL / OTHER,MANAGEMENT ISSUES,NHS HEALTH IMPROVEMENT PROGRAMMES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Pilot project aiming to screen for diabetes and encourage healthy lifestyle changes in high-risk people aged 40 and over.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Diabetes, Heart Disease and Stroke (DHDS) prevention pilot project. Project Description Winter 2003&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;FONT face=TimesNewRoman&gt;
&lt;P align=left&gt;The Department of Health has allocated funding for the development of a Diabetes, Heart Disease, and Stroke (DHDS) Prevention Pilot Project under the auspices of the UK National Screening Committee (NSC). 
&lt;P align=left&gt;The purpose of the project is to screen for diabetes and encourage healthy lifestyle changes in people &lt;/FONT&gt;&lt;FONT face=TimesNewRoman,Bold&gt;aged 40 and over, &lt;/FONT&gt;&lt;FONT face=TimesNewRoman&gt;considered at high risk for diabetes on the basis of a prior diagnosis of cardiovascular disease and/or being overweight. &lt;/FONT&gt;&lt;FONT face=TimesNewRoman&gt;This report outlines the DHDS project.&lt;/FONT&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>82314</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ndrs.scot.nhs.uk/Links/Docs/Recommendations%20for%20Implementing%20DRS.pdf]]&gt;</url>
    <title>Diabetic retinopathy screening services in Scotland: recommendations for implementation</title>
    <publicationDate>2003-06-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DIABETIC RETINOPATHY,EYES AND VISION,CONDITIONS,DIABETIC RETINOPATHY,RETINA,RETINOPATHY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. &lt;/P&gt;&lt;FONT face=Arial&gt;
&lt;P align=left&gt;This report by the Diabetic Retinopathy Screening Implementation Group (DRSIG) endorses the &lt;A href="http://www.ndrs.scot.nhs.uk/Links/Docs/hta1.pdf" name=internalLink target="_blank"&gt;Health Technology Board for Scotland's diabetic retinopathy screening report recommendations&lt;/A&gt; whilst extending and developing some of the report’s themes, particularly the practical issues of implementation.&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69856</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ndrs.scot.nhs.uk/Links/Docs/drstandards2004.pdf]]&gt;</url>
    <title>Diabetic retinopathy screening: clinical standards ~ March 2004</title>
    <publicationDate>2004-03-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ RETINOPATHY,DIABETIC RETINOPATHY,RETINA,CONDITIONS,EYE DISEASES,QUALITY ASSURANCE,CAUSES,RETINOPATHY,DIABETIC RETINOPATHY,EYES AND VISION,CHRONIC COMPLICATIONS,SCREENING,ADULT,DIABETES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. 
&lt;P&gt;This document introduces the NHS Quality Improvement Scotland clinical standards for diabetic retinopathy screening, which focus on organisation, recall, the screening process, proficiency testing and referral. The actual standards are contained in Section 9.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>318083</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/fullmono/mon1323.pdf]]&gt;</url>
    <title>Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation</title>
    <publicationDate>2009-06-16T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,HAEMOCHROMATOSIS,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The main aim of this study was to evaluate the use of DNA testing for detecting hereditary haemochromatosis in subgroups of patients suspected of having the disorder on the basis of clinical presentation and disturbed iron parameters, and in family members of those diagnosed with haemochromatosis.&lt;/P&gt;
&lt;P&gt;Full reference: Diagnostic strategies using DNA testing for hereditary haemochromatosis in at-risk populations: a systematic review and economic evaluation. &lt;EM&gt;Health Technology Assessment&lt;/EM&gt; 2009; Vol. 13: No. 23&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>187351</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/prostate/pcbs01.pdf]]&gt;</url>
    <title>Diagnostic value of systematic prostate biopsy methods in the investigation for prostate cancer</title>
    <publicationDate>2005-08-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,PROSTATE,CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a systematic review commissioned by the NHS Cancer Screening Programmes, conducted by NHS Centre for Reviews and Dissemination (CRD) and the Horton Centre, Switzerland. The objective of the review was to compare the diagnostic value and possible adverse effects of different systematic prostate biopsy schemes used in the diagnostic work up of men suspected of having prostate cancer.&lt;/P&gt;
&lt;P&gt;A summary version of the review is also available (pdf): &lt;A href="http://www.cancerscreening.nhs.uk/prostate/pcbs01-short.pdf" target="_blank"&gt;Prostate cancer biopsy schemes&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57337</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band74/b74-7.html]]&gt;</url>
    <title>Digital Rectal Examination (DRE) Screening for Prostate Cancer</title>
    <publicationDate>2000-04-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,PROSTATE,NOT ROUTINELY OFFERED,SCREENING,ADULT,CANCER,PROSTATE,SCREENING AND SURVEILLANCE,LATER LIFE,MALE UROGENITAL DISORDERS,PROSTATE DISORDERS,PROSTATE CANCER,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Digital Rectal Examination (DRE) Screening for Prostate Cancer&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band74/b74-7.html" target="_blank"&gt;Bandolier&lt;/A&gt; 
&lt;P&gt;Bandolier writes: 
&lt;P&gt;"Few of the studies discussed the method of digital rectal examination used or the sort of result from the digital rectal examination that constituted a positive test. The review considered a non-enlarged, smooth, symmetrical prostate with normal consistency to be normal, and test results were recalculated using this criterion where it was possible to do so. The review, concentrating on men without prostate problems, cannot speak about the usefulness of DRE for diagnosing prostate cancer in men with prostate symptoms. &lt;BR&gt;&lt;BR&gt;Bandolier found the statistical outcomes unhelpful, which is why we calculated the results on the basis of actual numbers of men classified correctly or incorrectly, on the basis of 1000 men and a primary care group. This seems to be much easier to understand than sensitivity and specificity, or other ways of expressing results of diagnostic tests. As shown in Bandolier 61&lt;STRONG&gt; &lt;/STRONG&gt;, most doctors seem to agree with us that we need new ways of expressing and using test results. &lt;BR&gt;&lt;BR&gt;The arguments for screening for prostate cancer are moot, and digital rectal examination alone would be unlikely to be used. When more sophisticated methods are evaluated, like PSA or newer laboratory tests, it will be interesting to see how many men are correctly and incorrectly diagnosed". 
&lt;P&gt;&amp;nbsp; 
&lt;H3&gt;References:&lt;/H3&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;A Hoogendam, F Buntinx, HCW de Vet. The diagnostic value of digital rectal examination in primary care screening for prostate cancer: a meta-analysis. Family Practice 1999 16: 621-626. 
&lt;LI&gt;MD Krahn, A Coombs, IG Levy. Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen. Canadian Medical Association Journal 1999 160: 49-57. &lt;BR&gt;&lt;/LI&gt;&lt;/OL&gt;]]&gt;</body>
  </document>
  <document>
    <id>66831</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.mihsr.monash.org/cce/res/pdf/b/953.pdf]]&gt;</url>
    <title>Dipstick urinalysis for screening of childhood urinary tract infection</title>
    <publicationDate>2003-04-01T00:00:00</publicationDate>
    <publisher>Monash University, Australia</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,NOT ROUTINELY OFFERED,URINARY TRACT DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a Critical Appraisal produced by the Centre for Clinical Effectiveness, Monash University (Australia)&amp;nbsp;to answer the question: Is dipstick urinalysis an appropriate method of screening for urinary tract infection in children? These critical appraisals are evaluative summaries of identified studies based on standard templates. 
&lt;P&gt;The appraisal concluded that "there is good evidence that in children aged 2-10 years old, dipstick urinalysis combing leukocyte and nitrite testing is an effective and appropriate screening method for urinary tract infection"&lt;FONT color=#ffffff size=2 face=Verdana&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212768</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16262737&amp;query_hl=10&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Do growth monitoring and promotion programs answer the performance criteria of a screening program? A critical analysis based on a systematic review</title>
    <publicationDate>2005-11-01T00:00:00</publicationDate>
    <publisher>Blackwell Synergy</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ CHILD,SCREENING,SCHOOL ENTRY,HEIGHT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Trop Med Int Health</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;&amp;nbsp;&lt;/STRONG&gt;&lt;SPAN title="Tropical medicine &amp;amp; international health : TM &amp;amp; IH"&gt;Trop Med Int Health.&lt;/SPAN&gt; 2005 Nov;10(11):1121-33.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;OBJECTIVE:&amp;nbsp;&amp;nbsp;to review whether&amp;nbsp;growth monitoring programmes (GMP) answer the theoretical grounds of a screening and intervention program.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;CONCLUSION: there is too little scientific evidence to indiscriminately support international promotion of GMP.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70570</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/200_cholesterol_cetap_e.pdf]]&gt;</url>
    <title>Does skin cholesterol testing provide benefit?</title>
    <publicationDate>2002-07-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CORONARY HEART DISEASE,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA)&amp;nbsp;publishes Issues in Emerging Health Technologies, a series of bulletins highlighting technologies. 
&lt;P align=left&gt;This bulletin looks at the use of a detector solution to measure the amount of cholesterol that has accumulated in a person's skin. This report states that "this test is not intended to be used as a screening tool for coronary artery disease in the general population. Evidence from non-randomized, non-blinded clinical trials suggests a correlation between higher skin cholesterol levels and the presence of severe coronary arterial lesions".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>329827</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://healthguides.mapofmedicine.com/choices/map/down_s_syndrome_screening1.html]]&gt;</url>
    <title>Down's syndrome screening</title>
    <publicationDate>2009-08-21T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>CARE PATHWAY</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),ULTRASOUND,11-14 WEEKS,BEFORE 16 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Map of Medicine care pathway for Down's syndrome screening</description>
    <body>&lt;![CDATA[ The Map of Medicine provides&amp;nbsp;a way of visualising the Down's syndrome screening pathway&amp;nbsp;that pregnant women&amp;nbsp;are offered&amp;nbsp;as part of their antenatal care.]]&gt;</body>
  </document>
  <document>
    <id>69944</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/195_No6_colorectalcancer_preassess_e.pdf]]&gt;</url>
    <title>Economic evaluation of population-based screening for colorectal cancer</title>
    <publicationDate>2002-05-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,ECONOMICS,GASTROENTEROLOGY &amp; LIVER DISEASES,RECENT ADDITIONS,CANCER,COLON &amp; RECTUM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA) performs pre-assessments of the literature, before deciding whether to&amp;nbsp;undertake a health technology assessment. Pre-assessments are not systematic reviews, but involve a limited&amp;nbsp;literature search, and provide a quick guide to current information on&amp;nbsp;a topic. 
&lt;P align=left&gt;This pre-assessment is on the topic of population-based screening for colorectal cancer. They summarised that " the report by the [Canadian] National Committee on Colorectal Cancer Screening (NCCCS) concluded that the potential benefits of population-based biennial screening of&amp;nbsp;colorectal cancer&amp;nbsp;using fecal occult blood test (FOBT) outweighs the potential harms, and they recommended that such a program be implemented"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382066</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/20584359]]&gt;</url>
    <title>Economic evaluation, human immunodeficiency virus infection and screening: a review and critical appraisal of economic studies</title>
    <publicationDate>2010-07-01T00:00:00</publicationDate>
    <publisher>International Journal of Technology Assessment in Health Care, Cambridge Journals</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ECONOMICS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: The results of most of the economic evaluations included were based on 'inappropriate static models'.&amp;nbsp;Further research, and&amp;nbsp;analysis by health economists into cost-effectiveness of screening for HIV,&amp;nbsp;is therfore recommended on the basis of this review.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: 3 electronic bibliographic databases searched from 1993-2008. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 84 studies were identified.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Dibosa-Osadolor O, Roberts T.Economic evaluation, human immunodeficiency virus infection and screening: a review and critical appraisal of economic studies. &lt;EM&gt;International Journal of Technology Assessment in Health Care&lt;/EM&gt; 2010; 26(3):301-8&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20584359" target="_blank"&gt;PubMed abstract available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95274</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-deodorant.doc]]&gt;</url>
    <title>Effect of deodorants on mammographic films</title>
    <publicationDate>2002-10-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,BREAST CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This National Co-ordinating Centre for&amp;nbsp;Mammography report investigates whether deodorants and anti-perspirants cause&amp;nbsp;specks (artefacts)&amp;nbsp;on mammographic films, and whether there&amp;nbsp;are differences between brands and types of deodorants. 
&lt;P&gt;This report concluded that: "it has been shown that deodorants and anti-perspirants do have sufficient contrast to be visible on mammograms and can potentially be the source of artefacts. Aluminium compounds appear to be the main source of the attenuation although even solid deodorants with no aluminium also showed low levels of contrast which may be visible on films. Only the one liquid deodorant with no aluminium could be ruled out as a possible source of artefacts".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>239454</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16464809&amp;query_hl=12&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Effectiveness of strategies to implement brief alcohol intervention in primary healthcare: A systematic review</title>
    <publicationDate>2006-03-01T00:00:00</publicationDate>
    <publisher>Taylor and Francis</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,PRIMARY CARE,MANAGEMENT,SCREENING,PRIMARY CARE SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,ALCOHOL PROBLEMS,ADULT,DETERMINANTS,PUBLIC HEALTH,ALCOHOL CONSUMPTION,INDIVIDUAL BEHAVIOUR,MANAGEMENT &amp; INTERVENTIONS,LIFESTYLE,SOCIAL DETERMINANTS,SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Scandinavian J of Primary Health Care</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="Scandinavian journal of primary health care"&gt;Scand J Prim Health Care.&lt;/SPAN&gt; 2006 Mar;24(1):5-15&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE: To review systematically the available literature on implementation of brief alcohol interventions in primary healthcare in order to determine the effectiveness of the implementation efforts by the health are providers.&lt;/P&gt;
&lt;P&gt;CONCLUSION: Intervention effectiveness (material utilization, screening, and brief intervention rates) generally increased with the intensity of the intervention effort, i.e. the amount of training and/or support provided&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64560</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://old.hamilton.ca/phcs/ephpp/Research/Full-Reviews/CXCA-Clinicbased.pdf]]&gt;</url>
    <title>Effectiveness of strategies to increase cervical cancer screening in clinic-based settings: a systematic review of the literature 1989-1999</title>
    <publicationDate>2000-01-01T00:00:00</publicationDate>
    <publisher>Ontario Ministry of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER,INFORMED DECISION-MAKING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review on uptake of cervical cancer screening produced by a Public Health programme in Ontario, Canada</description>
    <body>&lt;![CDATA[ &lt;FONT size=3 face=Arial&gt;
&lt;P&gt;&lt;/FONT&gt;Effectiveness of strategies to increase cervical cancer screening in clinic-based settings: a systematic review of the literature 1989-1999. Black M, Yamada J, Mann V, Cava M, Micucci S. Hamilton, ON, Canada: City of Hamilton, Social and Public Health Services Division 2000: 76. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Effective Public Health Practice Project (EPHPP) is a key initiative of the Public Health Research, Education and Development Program in Ontario, Canada, and conducts systematic reviews on the effectiveness of public health interventions. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This review aimed to determine the effectiveness of strategies to increase cervical cancer screening, and concluded that reminder systems may offer considerable gains in Pap smear rates, providing that they are applied judiciously to appropriate groups of women.&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>239452</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=15151349&amp;query_hl=6&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Engaging general practitioners in the management of hazardous and harmful alcohol consumption: results of a meta-analysis</title>
    <publicationDate>2004-03-01T00:00:00</publicationDate>
    <publisher>Rutgers University</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,PRIMARY CARE,NOT ROUTINELY OFFERED,POPULATION BASED &amp; PREVENTATIVE SERVICES,PRIMARY CARE SERVICES,SCREENING,ADULT,ALCOHOL PROBLEMS,SCREENING,PUBLIC HEALTH,DETERMINANTS,SOCIAL DETERMINANTS,LIFESTYLE,MANAGEMENT &amp; INTERVENTIONS,INDIVIDUAL BEHAVIOUR,ALCOHOL CONSUMPTION,SERVICES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Journal of Studies on Alcohol</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="Journal of studies on alcohol"&gt;J Stud Alcohol.&lt;/SPAN&gt; 2004 Mar;65(2):191-9.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE: A systematic review was undertaken of studies that test the effectiveness of different strategies used to increase general practitioners' rates of screening for and giving advice about hazardous and harmful alcohol consumption.&lt;/P&gt;
&lt;P&gt;CONCLUSIONS: Although the small numbers of programs studied suggest caution be used in interpreting the results, it seems it is possible to increase the engagement of general practitioners in screening and giving advice for hazardous and harmful alcohol consumption. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>259232</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/bowel/pilot-2nd-round-evaluation.pdf]]&gt;</url>
    <title>English pilot of bowel cancer screening: an evaluation</title>
    <publicationDate>2006-08-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Evaluation of colorectal cancer pilot programme</description>
    <body>&lt;![CDATA[ &lt;FONT face="Times New Roman"&gt;
&lt;P align=left&gt;This report describes the screening outcome measures for the second round of the English bowel cancer screening Pilot, and the sensitivity of the screening in the first round.&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>387824</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/downloads/pub/evidence/pdf/crcuse/crcuse.pdf]]&gt;</url>
    <title>Enhancing the use and quality of colorectal cancer screening</title>
    <publicationDate>2010-02-01T00:00:00</publicationDate>
    <publisher>Agency for Healthcare Research and Quality</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,IMPLEMENTATION,COLORECTAL (BOWEL) CANCER,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Multiple problems of underuse, overuse and misuse of colorectal cancer screening exist.&amp;nbsp; Some interventions look promising but further research, tailored to specific populations, is needed to design and test interventions to both increase screening as well as reduce overuse and misuse.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, The Cochrane Library and the Cochrane Central Trials Registry were searched for English language studies published between Jabuary 1998 and September 2009. This was supplemented by hand searches.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 116 articles, including 72 studies were included&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Holden DJ, Harris R, Porterfield DS, et al. &lt;EM&gt;Enhancing the use and quality of colorectal cancer screening&lt;/EM&gt;. Evidence Report/Technology Assessment Number 190, AHRQ Publication No. 10-E002 February 2010&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ahrq.gov/downloads/pub/evidence/pdf/crcuse/crcuse.pdf" target="_blank"&gt;Full text PDF report freely accessible&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>187297</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/publications/cs2.pdf]]&gt;</url>
    <title>Equal access to breast and cervical screening for disabled women</title>
    <publicationDate>2006-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BREAST CANCER,CERVICAL CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Describes good practice to ensure that disabled women have the same rights of access to breast and cervical screening</description>
    <body>&lt;![CDATA[ &lt;P&gt;This report&amp;nbsp;summarises guidance on access to healthcare for disabled people, including the principles of screening and consent issues.&amp;nbsp;Aimed at staff who work in the screening programmes, family members and carers.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69922</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp17.pdf]]&gt;</url>
    <title>Ergonomic working standards for personnel engaged in the preparation, scanning and reporting of cervical screening slides</title>
    <publicationDate>2003-09-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,IMPLEMENTATION,CERVICAL CANCER,WOMEN'S HEALTH,SCREENING,CERVICAL CANCER,GYNAECOLOGICAL TUMOURS,BENEFITS &amp; HARMS,MANAGEMENT,GOOD PRACTICE,STANDARDS OF PRACTICE,MALIGNANT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This document published by the NHS Cervical Screening Programme&amp;nbsp;outlines ergonomic working standards for personnel involved in the preparation, scanning and reporting of cervical slides. This document supercedes the original Medical Devices Agency (MDA) version entitled "Minimum Ergonomic Standards for Personnel Engaged in the Preparation Scanning and Reporting of Cervical Screening Slides MDA/97/31".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64115</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.retinalscreening.nhs.uk/userFiles/File/DiabeticRetinopathyScreeningWorkbookRelease43_2009-06-23.pdf]]&gt;</url>
    <title>Essential elements in developing a diabetic retinopathy screening programme. Workbook 4.3</title>
    <publicationDate>2009-06-01T00:00:00</publicationDate>
    <publisher>Diabetic Retinopathy Programme</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CONDITIONS,RETINOPATHY,DIABETIC RETINOPATHY,RETINA,DIABETIC RETINOPATHY,CAUSES,CHRONIC COMPLICATIONS,DIABETIC RETINOPATHY,EYES AND VISION,RETINOPATHY,SCREENING,ADULT,IMPLEMENTATION,DIABETES,EYE DISEASES,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This Workbook is designed to inform and assist Strategic Health Authorities and Primary Care Trusts integrate current or planned diabetic retinopathy screening programmes with the Diabetic Retinopathy Screening Programme in England. It updates Workbook&amp;nbsp;4.2&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>260861</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260861]]&gt;</url>
    <title>Essential elements in developing an Abdominal Aortic Aneurysm (AAA) Screening &amp; Surveillance Programme</title>
    <publicationDate>2010-05-31T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The Standard Operating Procedures for an AAA screening programme</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Essential elements in developing an Abdominal Aortic Aneurysm (AAA) Screening &amp; Surveillance Programme&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The Standard Operating Procedures and Workbook have been developed to inform and assist those establishing and implementing an AAA Screening Programme within the NHS AAA Screening Programme in England.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57654</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57654]]&gt;</url>
    <title>Ethnic issues in screening</title>
    <publicationDate>2004-02-25T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,MANAGEMENT,ETHNICITY AND HEALTH,MANAGEMENT AND POLICY,RESEARCH AND DEVELOPMENT,RACE EQUALITY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A review for the the National Screening Committee on ethnic issues in screening.
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Ethnic issues in screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;This report investigates the following questions: 
&lt;P&gt;What is the National Screening Committee legally obliged to provide to ensure equity of access to its programmes? 
&lt;P&gt;What guidance does the Department of Health and other organisations provide to healthcare providers to ensure access to healthcare for people from minority ethnic groups? 
&lt;P&gt;Are there any barriers in terms of access to screening programmes, communication during the consultation, or barriers to follow-up for people from minority ethnic backgrounds? 
&lt;P&gt;What are the possible solutions to ensure equity of access and a uniform standard of care?&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>78033</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/colorectal/ethnicity-finalreport.pdf]]&gt;</url>
    <title>Ethnicity: UK colorectal cancer screening pilot</title>
    <publicationDate>2003-03-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GASTROENTEROLOGY &amp; LIVER DISEASES,COLORECTAL (BOWEL) CANCER,SCREENING,ADULT,SCREENING,CANCER,RECENT ADDITIONS,CANCER,DISEASES AND CONDITIONS,ETHNICITY AND HEALTH,COLON &amp; RECTUM,DISEASE PREVENTION,OTHER,GASTROENTEROLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This study,&amp;nbsp;focuses on potential issues for ethnic populations associated with the introduction of colorectal cancer screening. It was commissioned by the Policy Research Programme at the Department of Health as an addition to the main evaluation of the UK Colorectal Cancer Screening Pilot. 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;For more details about the colorectal cancer screening pilot, see the Cancer Screening Programmes website: &lt;A href="http://www.cancerscreening.nhs.uk/colorectal/index.html" target="_blank"&gt;http://www.cancerscreening.nhs.uk/colorectal/index.html&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>388831</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=44]]&gt;</url>
    <title>Evaluation of antenatal screening for Group B Streptococcal (GBS) carriage against NSC Handbook criteria</title>
    <publicationDate></publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses Group B Streptococcal carriage against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>63586</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63586]]&gt;</url>
    <title>Evaluation of antenatal screening for Group B Streptococcal carriage against NSC Criteria</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>National Perinatal Epidemiology Unit</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B screening from a NSC workshop</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of antenatal screening for Group B Streptococcal carriage against NSC Criteria&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;looks at the evaluation of antenatal screening for streptococcus B against the National Screening Committee criteria.
&lt;P&gt;&amp;nbsp;
&lt;P&gt;A more &lt;A href="http://www.screening.nhs.uk/groupbstreptococcus" target="_blank"&gt;recent evaluation&lt;/A&gt; of antenatal screening for Group B Streptococcal (GBS) carriage against NSC Handbook Criteria was carried out in October 2008.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57342</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat1.chapter.6794]]&gt;</url>
    <title>Evaluation of Cervical Cytology</title>
    <publicationDate>1999-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,ADULT,SCREENING,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;STRONG&gt;&lt;SPAN class=chapter-header&gt;Evaluation of Cervical Cytology**&lt;/SPAN&gt;&lt;BR&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;A name=id16850406&gt;&lt;/A&gt;&lt;A name=6795&gt;&lt;/A&gt;
&lt;P&gt;Evidence Report/Technology Assessment&lt;BR&gt;
&lt;P&gt;Number 5, 1999&lt;BR&gt;&lt;BR&gt;
&lt;P&gt;Prepared for: &lt;BR&gt;Agency for Health Care Policy and Research, USA 
&lt;P&gt;A &lt;A href="http://www.ahrq.gov/clinic/epcsums/cervsumm.htm" target="_blank"&gt;summary&lt;/A&gt; of this report is also available. 
&lt;P&gt;Overview: "Despite the indisputably dramatic impact of Pap screening, there is still uncertainty about the details of Pap smear performance, and much could be done to improve the performance of the test and followup of patients after screening. Controversy about the details of Pap smear performance is manifest in differing recommendations about the frequency of screening and the age (if any) at which screening may safely be stopped. A significant proportion of patients and providers fail to comply with even the least demanding recommendations for Pap screening frequency. Numerous barriers to screening have been identified that reduce access to Pap smears and other preventive services. 
&lt;P&gt;Recently, efforts to improve Pap smear performance have focused on reducing the number of false negative smears, that is, cases in which premalignant or malignant cells have been misdiagnosed as normal. Recently, several technologies have been developed to optimize Pap test screening by reducing the false negative rate. These technologies are a major focus of this report." 
&lt;P&gt;** &lt;EM&gt;Note that this report is &amp;gt; 5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>301131</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=8798]]&gt;</url>
    <title>Evaluation of early screening for hearing disability against NSC Handbook Criteria</title>
    <publicationDate>2008-11-13T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ EAR &amp; AUDITORY SYSTEM DISORDERS,GENERAL EAR &amp; AUDITORY,HEARING DISORDERS/ DEAFNESS,NOT ROUTINELY OFFERED,CONDITIONS,SCREENING,ADULT,DEAFNESS,ENT AND AUDIOLOGY,SERVICE DELIVERY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Review of adult hearing against NSC screening criteria</description>
    <body>&lt;![CDATA[ Paper assessing adult hearing against the National Screening Committee (NSC) screening criteria.]]&gt;</body>
  </document>
  <document>
    <id>78026</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/bowel/pilot-evaluation.html]]&gt;</url>
    <title>Evaluation of English bowel (colorectal) cancer screening pilot</title>
    <publicationDate>2006-08-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,GASTROENTEROLOGY &amp; LIVER DISEASES,COLON &amp; RECTUM,DISEASE PREVENTION,CANCER,SCREENING,RECENT ADDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The research and development directorate at the Department of Health commissioned an independent evaluation of the UK Pilot, which ran from 2000-2002. There was a single study of both the English and Scottish sites conducted by a multi-disciplinary evaluation team.&lt;/P&gt;
&lt;P&gt;The evaluation team produced annual reports for three years. The reports were made available to the Pilot Steering Group and the National Screening Committee to help to decide whether to introduce bowel cancer on a national level. &lt;A href="http://www.cancerscreening.nhs.uk/bowel/finalreport.pdf" target="_blank"&gt;The final report and its supplementary report&lt;/A&gt; were published in July 2003.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.cancerscreening.nhs.uk/bowel/pilot-2nd-round-evaluation.pdf" target="_blank"&gt;The report into the second round of the English bowel cancer screening pilot&lt;/A&gt; was published in August 2006.&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61006</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61006]]&gt;</url>
    <title>Evaluation of Haemochromatosis Screening against NSC Handbook Criteria</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,HAEMOCHROMATOSIS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Assessment of haemochromatosis screening against the NSC criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of Haemochromatosis Screening against NSC Handbook Criteria&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report assesses haemochromatosis screening against the NSC criteria. 
&lt;P align=left&gt;The report concludes that "haemochromatosis screening should be investigated further" and recommends that the NSC should commission "trials of screening or demonstrations projects".&lt;FONT face="Times New Roman,Times New Roman"&gt; &lt;/FONT&gt;&lt;/P&gt;
&lt;P align=left&gt;A &lt;A href="http://www.screening.nhs.uk/policydb_download.php?doc=71" target="_blank"&gt;more recent report assessing haemochromatosis against the NSC criteria&lt;/A&gt; was published in December 2009 as part of the policy review process of the UK National Screening Committee. &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>187341</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/evaluation-hpv-2006feb.pdf]]&gt;</url>
    <title>Evaluation of HPV/LBC cervical screening pilot studies</title>
    <publicationDate>2004-10-01T00:00:00</publicationDate>
    <publisher>Institute of Cancer Research</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,CERVICAL CANCER,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This document reports on a pilot project to evaluate the effects, costs and practical implications of introducing Liquid-based cytology (LBC) technology into the NHS Cervical Screening Programme.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325441</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325441]]&gt;</url>
    <title>Evaluation of screening for asymptomatic herpes simplex virus type 2 infection against NSC Handbook criteria</title>
    <publicationDate>2005-01-25T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,GENITAL HERPES,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of screening for asymptomatic herpes simplex virus type 2 infection against NSC Handbook criteria&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;A review of screening for asymptomatc herpes simplex virus type 2 infection agains the criteris of the UK National Screening Committee. This review forms part of the evidence base on which the current &lt;A href="nelh:51535:0" name=internalLink&gt;UK NSC screening policy&lt;/A&gt; is based.&lt;/P&gt;
&lt;P&gt;An &lt;A href="nelh:51536:0" name=internalLink&gt;earlier&amp;nbsp;review&lt;/A&gt; was conducted in 2001&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386795</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=56]]&gt;</url>
    <title>Evaluation of screening for oral cancer against NSC Criteria</title>
    <publicationDate>2009-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,ORAL,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses oral cancer against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>60971</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60971]]&gt;</url>
    <title>Evaluation of screening for postnatal depression against the NSC handbook criteria</title>
    <publicationDate>2001-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,ADULT,DEPRESSION,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,POSTNATAL DEPRESSION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of postnatal depression against NSC criteria.
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of screening for postnatal depression against the NSC handbook criteria&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report for the NSC by Dr. Judy Shakespeare evaluates postnatal depression against the NSC criteria.&lt;/P&gt;
&lt;P&gt;Although this report is more than&amp;nbsp;five years old it is still&amp;nbsp;referred to in the current&amp;nbsp;UK NSC policy&amp;nbsp;on screening for postnatal depression.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>123519</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=123519]]&gt;</url>
    <title>Evaluation of the newborn hearing screening programme (NHSP) in England</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,HEARING,MANAGEMENT,NEWBORN,PHYSICAL (&lt;72HRS),NEWBORN HEARING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This is the report of the evaluation of the first phase of implementation of the newborn hearing screening programme</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of the newborn hearing screening programme (NHSP) in England&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=justify&gt;The aim of this evaluation was to appraise the benefits, effects, costs and practical implications of the pilot implementation of the national model for newborn hearing screening.&amp;nbsp;A number of recommendations are made for future policy and practice. &lt;/P&gt;
&lt;P align=justify&gt;See the &lt;A href="http://libraries.nelh.nhs.uk/common/download.asp?resourceID=123539" target="_blank"&gt;appendices&lt;/A&gt; for this document.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>123539</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=123539]]&gt;</url>
    <title>Evaluation of the newborn hearing screening programme (NHSP) in England - volume two: appendices</title>
    <publicationDate>2004-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,HEARING,MANAGEMENT,NEWBORN,PHYSICAL (&lt;72HRS),NEWBORN HEARING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>These are the appendices for the report of the evaluation of the first phase of implementation of the NHSP</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of the newborn hearing screening programme (NHSP) in England - volume two: appendices&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;These are the appendices for the report &lt;A href="nelh:123519:0" name=internalLink&gt;Evaluation of the newborn hearing screening programme (NHSP) in England&lt;/A&gt;, which aimed to evaluate&amp;nbsp;the benefits, effects, costs and practical implications of the pilot implementation of the national model for newborn hearing screening.&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>70950</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=70950]]&gt;</url>
    <title>Evaluation of type 2 diabetes mellitus screening against the NSC handbook criteria</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DIABETES,TYPE 2,DIABETES,CAUSES,NOT ROUTINELY OFFERED,VASCULAR RISK]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of diabetes screening against National Screening Committee criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of type 2 diabetes mellitus screening against the NSC handbook criteria&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN class=detail_text&gt;This report, produced by the National Screening Committee (NSC), assesses diabetes screening against the&amp;nbsp;NSC criteria.&lt;/SPAN&gt;&lt;SPAN class=detail_text&gt;&lt;/P&gt;
&lt;P&gt;Although this report is more than&amp;nbsp;five years old it is still&amp;nbsp;referred to in the current&amp;nbsp;UK NSC policy&amp;nbsp;on screening for type 2 diabetes.&lt;/P&gt;
&lt;P&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60466</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60466]]&gt;</url>
    <title>Evaluation of Urinary Tract Malignancy (Bladder Cancer) Screening against NSC Criteria</title>
    <publicationDate>2002-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,BLADDER,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE BLADDER DISORDERS,BLADDER CANCER,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Assessment of bladder cancer screening against NSC criteria.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Evaluation of Urinary Tract Malignancy (Bladder Cancer) Screening against NSC Criteria&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN class=detail_text&gt;Bladder cancer screening&amp;nbsp;is assessed against the National Screening Committee's criteria for appraising the viability, effectiveness and appropriateness of a screening programme.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;A &lt;A href="nelh:386787:0" name=internalLink&gt;more recent review&lt;/A&gt; was published in 2010.&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57339</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band22/b22-4.html]]&gt;</url>
    <title>Evidence-based screening</title>
    <publicationDate>1995-12-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ INFORMED DECISION-MAKING,BENEFITS &amp; HARMS,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Evidence-based screening 
&lt;P&gt;See the review in &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band22/b22-4.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;Gill Grimshaw&amp;nbsp;writes: 
&lt;P&gt;"Effective screening is as much a matter of good administration as it is of good medicine. For those contemplating introducing screenings two crucial questions should be answered:- 
&lt;UL&gt;
&lt;LI&gt;Can the proposed test be shown to be cost-effective - is it worth doing? 
&lt;LI&gt;Can the test be delivered and the results responded to consistently for all those at risk - can it be done? " &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;EM&gt;** Note that this review is &amp;gt; 5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63687</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp57.pdf]]&gt;</url>
    <title>External Quality Assessment Scheme for Breast Screening Histopathology</title>
    <publicationDate>2003-10-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,IMPLEMENTATION,SCREENING,BREAST CANCER,MANAGEMENT,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report outlines the quality assessment scheme&amp;nbsp;for breast screening histopathology, and consists of a general description and standard operating procedures.]]&gt;</body>
  </document>
  <document>
    <id>69871</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp19.pdf]]&gt;</url>
    <title>External Quality Assessment Scheme for the Evaluation of Papanicolaou Staining in Cervical Cytology, Protocol and Standard Operating Procedures</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,ADULT,IMPLEMENTATION,SCREENING,QUALITY ASSURANCE,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The purpose of this NHS Cervical Screening Programme&amp;nbsp;document is to ensure that standards are set for routine staining in cervical cytology so that performance can be monitored and practice improved where necessary.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95745</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/6/3/89?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122642527830_206&amp;stored_search=&amp;FIRSTINDEX=0&amp;journalcode=ebmed]]&gt;</url>
    <title>Faecal occult blood screening reduced the incidence of colorectal cancer</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Faecal occult blood screening reduced the incidence of colorectal cancer. Evidence-Based Medicine 2001; 6:89.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000 Nov 30;343:1603–7.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95226</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nice.org.uk/guidance/cg41/niceguidance/pdf/English/?template=download.aspx]]&gt;</url>
    <title>Familial breast cancer</title>
    <publicationDate>2006-10-25T00:00:00</publicationDate>
    <publisher>National Institute of Clinical Excellence</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>NICE update of advice on familial breast cancer</description>
    <body>&lt;![CDATA[ &lt;FONT face=Arial&gt;
&lt;P align=left&gt;This guideline produced for NICE and the National Collaborating Centre for Primary Care (NCCPC) sets out how health professionals should identify and care for women who are at risk of developing breast cancer because of a history of the condition in their family.&lt;/P&gt;
&lt;P&gt;This guideline is an update of advice on familial breast cancer that NICE produced in 2004. The advice on magnetic resonance imaging (MRI) for breast cancer screening has changed, but all the other advice is the same. &lt;/P&gt;
&lt;P align=left&gt;A quick reference guide to this&amp;nbsp;guideline&amp;nbsp;is also available: &lt;A href="http://www.nice.org.uk/guidance/cg41/quickrefguide/pdf/English/?template=download.aspx" target="_blank"&gt;http://www.nice.org.uk/guidance/cg41/quickrefguide/pdf/English/?template=download.aspx&lt;/A&gt;&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>95311</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screeningservices.org/btw/fh01/]]&gt;</url>
    <title>Family History screening</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Breast Test Wales</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ ECONOMICS,BREAST CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P class=indent&gt;This Family History screening website outlines a&amp;nbsp;research project seeking to evaluate the effectiveness of mammographic surveillance for women under 50 with a family history of breast cancer. The study will also examine the cost-effectiveness of regular mammography, compared to no screening.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>329832</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://healthguides.mapofmedicine.com/choices/map/fetal_anomaly_screening1.html]]&gt;</url>
    <title>Fetal anomaly screening</title>
    <publicationDate>2009-08-21T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>CARE PATHWAY</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEURAL TUBE DEFECTS,FETAL ANOMALY,18-20 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Map of Medicine care pathway for fetal anomaly screening</description>
    <body>&lt;![CDATA[ The Map of Medicine provides&amp;nbsp;a way of visualising the&amp;nbsp;fetal anomaly&amp;nbsp;screening pathway&amp;nbsp;that pregnant women&amp;nbsp;are offered&amp;nbsp;as part of their antenatal care.]]&gt;</body>
  </document>
  <document>
    <id>269364</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269364]]&gt;</url>
    <title>Fetal Anomaly Ultrasound Screening Programme Study: Literature Survey. Final Report</title>
    <publicationDate>2007-06-01T00:00:00</publicationDate>
    <publisher>Social Research &amp; Regeneration Unit</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEURAL TUBE DEFECTS,FETAL ANOMALY,18-20 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature survey on research literature related to second trimester ultrasound screening for fetal anomalies</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Fetal Anomaly Ultrasound Screening Programme Study: Literature Survey. Final Report&lt;/pageTitle&gt;&lt;pageBody&gt;This literature survey on second trimester ultrasound screening for fetal anomalies was conducted by the Social Research and Regeneration Unit, University of Plymouth, and commissioned by the National Screening Committee.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>67243</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sbu.se/en/Published/Alert/Fetal-nuchal-translucency-in-early-detection-of-Downs-syndrome/]]&gt;</url>
    <title>Fetal nuchal translucency in early detection of Down´s syndrome</title>
    <publicationDate>2001-10-22T00:00:00</publicationDate>
    <publisher>Swedish Council on Technology Assessment in Health Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ 11-14 WEEKS,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Alert is a system for identification and early assessment concerning new methods in health care. The Alert reports are produced by the Swedish Council on Technology Assessment in Health Care, and&amp;nbsp;describe the new methods and their effects. 
&lt;P&gt;This report summarises fetal nuchal translucency in early detection of Down´s syndrome. It concludes that&amp;nbsp;" the use of fetal nuchal translucency to assess the risk for Down´s syndrome should take place only within the framework of scientific studies that encompass research on the acceptance of the method, the characteristics of the method in broad application, and its ethical, psychological, and economic consequences. It is essential to complete the ongoing controlled trials prior to general dissemination of the method in healthcare"&lt;/P&gt;
&lt;P&gt;A&amp;nbsp;more recent review of the literature is reported in &lt;A href="nelh:332137:0" name=internalLink&gt;Methods of Early Prenatal Diagnosis, SBU report 182&lt;/A&gt;, published 2006.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>59838</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/documents/digitalasset/dh_084456.pdf]]&gt;</url>
    <title>First Report of the National Screening Committee</title>
    <publicationDate>1998-04-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHILD,ADULT,IMPLEMENTATION,BENEFITS &amp; HARMS,QUALITY ASSURANCE,INFORMED DECISION-MAKING,OLD AGE,NEWBORN,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This is the first National Screening Committee report, which outlines the main issues in screening in the UK. It covers definitions and purpose of screening, quality assurance, the research base, and&amp;nbsp;the criteria used to appraise the viability of a screening programme. 
&lt;P align=left&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70134</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_first_trimester_prenatal_testing_for_down_syndrome_using_nuchal_tanslucency.html]]&gt;</url>
    <title>First Trimester Prenatal Testing for Down Syndrome using Nuchal Translucency</title>
    <publicationDate>2002-04-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),11-14 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of&amp;nbsp;nuchal translucency testing for Down's Syndrome. The Technology Assessment Committee summarised by stating that: "nuchal transulcency (NT) or the combined test in the first trimester have the potential to detect 64%-91% of Down syndrome cases with a 5% false positive rate. The positive predictive values for NT alone were 1.5%-5.8%. However, the efficacy and practicality of first trimester testing have not been proven"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>322797</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://aaa.screening.nhs.uk/getdata.php?id=228]]&gt;</url>
    <title>Framework for improving the results of elective AAA repair</title>
    <publicationDate>2009-03-01T00:00:00</publicationDate>
    <publisher>The Vascular Society of Great Britain &amp; Ireland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,QUALITY ASSURANCE,BENEFITS &amp; HARMS,ABDOMINAL AORTIC ANEURYSM,APR-JUNE 10,DIAGNOSIS,VASCULAR,IMAGING,DISEASE MANAGEMENT,POST-OPERATIVE MANAGEMENT,PREOPERATIVE MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ After consultation with the membership in March 2009, the Council of the Vascular Society of Great Britain and Ireland endorses the following framework for quality improvement in elective AAA surgery. Notes at the end of the guidelines will aid surgeons who may need to introduce changes to their vascular practice. A fuller version of the notes is available on the VSGBI website - &lt;A href="http://www.vascularsociety.org.uk/" target="_blank"&gt;www.vascularsociety.org.uk&lt;/A&gt; The details of the framework are due for review in 2011.&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>345770</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://springerlink.com/content/k7176gl821505165/fulltext.pdf]]&gt;</url>
    <title>Gastric cancer screening using the serum pepsinogen test method.</title>
    <publicationDate>2006-11-25T00:00:00</publicationDate>
    <publisher>Gastric Cancer, Springer</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ STOMACH,CANCER,ADULT,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Author's conclusions&lt;/STRONG&gt;: The pepsinogen test method can be used as a screening test for high-risk subjects, rather than as a tool for screening for cancer itself.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Meta-analysis of 42 studies&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 42 studies were included. 27 were population-based screening studies that incorporated 296,553 individuals, and 15 were of selected groups incorporating 4,385 individuals.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Miki K. Gastric cancer screening using the serum pepsinogen test method. &lt;EM&gt;Gastric Cancer&lt;/EM&gt; 2006;9(4):245-53&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://springerlink.com/content/k7176gl821505165/fulltext.pdf" target="_blank"&gt;Full text PDF freely available&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This meta-analysis has not been critically appraised.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://springerlink.com/content/k7176gl821505165/fulltext.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82318</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_genetic_carrier_testing_for_cystic_fibrosis.html]]&gt;</url>
    <title>Genetic carrier testing for cystic fibrosis</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,CYSTIC FIBROSIS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks genetic carrier testing for cystic fibrosis (CF).&amp;nbsp;The Technology Assessment Committee summarised by stating that: "genetic carrier testing for CF should be offered to individuals planning a pregnancy or seeking prenatal care if they have a family history of CF, if they are reproductive partners of individuals who have CF, or if they or their partner are Caucasian (including Ashkenazi Jews)."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>77975</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=77975]]&gt;</url>
    <title>Genetic screening in the Ashkenazi Jewish population - is there a case for more testing?</title>
    <publicationDate>2005-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED,BEFORE 16 WEEKS,TAY SACHS,CYSTIC FIBROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A report for the National Screening Committee looking at whether current screening in the Jewish population should be extended.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Genetic screening in the Ashkenazi Jewish population - is there a case for more testing?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This is a report of a National Screening Committee meeting on genetic screening in the Ashkenazi Jewish population. Screening for Tay Sachs disease in this population is well established, but there have been requests for screening for other disorders such as Canavans disease, familial dysautonomia, Gauchers disease and&amp;nbsp;cystic fibrosis. Other areas addressed in the report are the psychosocial, ethical, and economic aspects of such screening.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>156252</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nuffieldbioethics.org/fileLibrary/pdf/genetic_screening.pdf]]&gt;</url>
    <title>Genetic screening: ethical issues</title>
    <publicationDate>1993-12-01T00:00:00</publicationDate>
    <publisher>Nuffield Council on Bioethics</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,INFORMED DECISION-MAKING,BENEFITS &amp; HARMS,CHILD,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Nuffield Council report and supplement on ethical issues in genetic screening</description>
    <body>&lt;![CDATA[ This&amp;nbsp;Nuffield Council report on genetic screening examines issues such a consent to being screened, counselling and the storage and use of genetic information for legal purposes. The main report was published in 1993 - a&amp;nbsp;supplement to this report was published in 2006 (see related links below)&amp;nbsp;and concluded that "the ethical principles identified in the 1993 Report remained relevant for guiding current research and practice".]]&gt;</body>
  </document>
  <document>
    <id>69810</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_genetic_testing_for_hereditary_nonpolyposis_colorectal_cancer__hnpcc_.html]]&gt;</url>
    <title>Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC)</title>
    <publicationDate>2002-10-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,COLORECTAL (BOWEL) CANCER,GASTROENTEROLOGY &amp; LIVER DISEASES,CANCER,RECENT ADDITIONS,COLON &amp; RECTUM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of&amp;nbsp;genetic testing for hereditary nonpolyposis&amp;nbsp;colorectal cancer (HPNCC)&amp;nbsp;and summarises by stating that "genetic testing of HNPCC can reduce the number of surveillance colonoscopies and help target surveillance at high-risk patients, however, studies of the effect of genetic testing of HNPCC on more substantial outcomes such as mortality are limited."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64040</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/publications/learning-revises20010911.pdf]]&gt;</url>
    <title>Good practice in breast and cervical screening for women with learning disabilities</title>
    <publicationDate>2000-10-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ INFORMED DECISION-MAKING,BREAST CANCER,CERVICAL CANCER,SCREENING,HEALTH,LEARNING DISABILITIES,ADULT,CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This&amp;nbsp;guidance aims to describe good practice to ensure that women with learning disabilities have the same rights of access as all other women to the NHS Breast Screening Programme (NHSBSP) and the NHS Cervical Screening Programme (NHSCSP).&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63590</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63590]]&gt;</url>
    <title>Group B streptococcal disease: epidemiology and natural history</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>St. George's Hospital Medical School</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B  from a NSC workshop</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Group B streptococcal disease: epidemiology and natural history&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;outlines the epidemiology and natural history of group B streptococcal disease.
&lt;P&gt;&amp;nbsp;
&lt;P&gt;A &lt;A href="http://www.screening.nhs.uk/groupbstreptococcus" target="_blank"&gt;more recent&amp;nbsp;evaluation of antenatal screening for Group B Streptococcal (GBS) carriage&lt;/A&gt; against NSC Handbook Criteria was undertaken in 2008.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>322788</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=322788]]&gt;</url>
    <title>Guidance for Public Health and Commissioners</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,SCREENING,ADULT,IMPLEMENTATION,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Guidance for Public Health and Commissioners&lt;/pageTitle&gt;&lt;pageBody&gt;This guide is aimed at public health leads and commissioners, to help inform the process of implementing the NHS Abdominal Aortic Aneurysm Screening Programme (NAAASP).&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>94563</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.americanheart.org/downloadable/heart/1032279013658exercise.pdf]]&gt;</url>
    <title>Guideline update for exercise testing</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>American Heart Association</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CORONARY HEART DISEASE,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a report of the American College of Cardiology(ACC) /American Heart Association (AHA)&amp;nbsp;Task Force on Practice Guidelines looking at exercise testing. The ACC/AHA Task Force make recommendations regarding the appropriate use of testing in the diagnosis and treatment of patients with known or suspected cardiovascular disease. This report revises the guidelines for exercise testing originally published in September 1986, in the light of new studies.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>300989</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10956]]&gt;</url>
    <title>Guidelines for newborn blood spot sampling</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NORMAL PREGNANCY,POSTNATAL CARE,WOMEN'S HEALTH,SCREENING,NEWBORN,BLOODSPOT (&lt;1WK),NEONATAL AND INFANT CARE,GENERAL EXAMINATION AND SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Blood spot sampling guidelines</description>
    <body>&lt;![CDATA[ Blood spot sampling guidelines for newborn screening, produced by the National Screening Committee. These guidelines update the 2005 guideline 'taking the newborn blood spot sample'.]]&gt;</body>
  </document>
  <document>
    <id>64025</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp50.pdf]]&gt;</url>
    <title>Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening</title>
    <publicationDate>2001-06-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,BREAST CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;The purpose of this document is to update pathologists on the role and use of fine needle aspiration cytology (FNAC) and core biopsy in breast screening assessment.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>79697</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.acb.org.uk/docs/sweat.pdf]]&gt;</url>
    <title>Guidelines for the performance of the sweat test for the investigation of cystic fibrosis in the UK</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>The Association of Clinical Biochemists</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,STAFF USE,GENETIC CONDITIONS,CYSTIC FIBROSIS,SCREENING,CYSTIC FIBROSIS,SPECIALTIES,NEONATAL,GUIDELINES/EBM,CHILD HEALTH,RESPIRATORY,SCREENING,SYSTEMS &amp; SYMPTOMS,CYSTIC FIBROSIS (CF),CONDITIONS C,BLOODSPOT (&lt;1WK),NEWBORN,BLOOD]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;A multi-disciplinary worrking group has developed this guideline on sweat testing for cystic fibrosis. &lt;/P&gt;
&lt;P&gt;The report was produced with representation from:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Association of Clinical Biochemists 
&lt;LI&gt;British Paediatric Respiratory Society 
&lt;LI&gt;British Thoracic Society 
&lt;LI&gt;Cystic Fibrosis Trust 
&lt;LI&gt;Royal College of Paediatrics &amp;amp; Child Health 
&lt;LI&gt;Royal College of Pathologists 
&lt;LI&gt;UK National External Quality Assessment Schemes&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;These guidelines have been &lt;A href="http://www.rcpch.ac.uk/doc.aspx?id_Resource=1539" target="_blank"&gt;appraised by the Royal College of Paediatrics and Child Health&lt;/A&gt;.&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63672</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp40.pdf]]&gt;</url>
    <title>Guidelines on quality assurance visits</title>
    <publicationDate>2000-10-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,ADULT,BREAST CANCER,QUALITY ASSURANCE,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;These guidelines describe the organisation of quality assurance in the NHS Breast Screening Programme (NHSBSP). They have been written with reference to the breast screening programme in England.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70631</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.state.mn.us/htac/ctdr.htm]]&gt;</url>
    <title>Helical computed tomography (CT) for lung cancer screening for asymptomatic patients</title>
    <publicationDate>2000-11-01T00:00:00</publicationDate>
    <publisher>Health Technology Advisory Committee, Minnesota</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Health Technology Advisory Committee in Minnesota, USA&amp;nbsp;provides unbiased, scientifically based assessments and recommendations on new and emerging technologies. Note that this committee was discontinued in July 2002 due to budget cuts, so the publications will not be updated subsequently. 
&lt;P&gt;This report concludes that "while helical computed tomography (CT) scans may be able to detect pulmonary nodules at an earlier stage, at the present time there is no evidence from randomized controlled trials that screening asymptomatic individuals for lung cancer with helical CT scan increases actual survival time or reduces lung cancer-related mortality".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69665</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=69665]]&gt;</url>
    <title>HIV associated anal cancer- incidence &amp; outcome of treatment</title>
    <publicationDate>2004-12-06T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,ANAL,CANCER,ADULT,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,HIV,VIRAL,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This is a powerpoint presentation produced for a workshop on anal cancer screening</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;HIV associated anal cancer- incidence &amp;amp; outcome of treatment&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN class=detail_text&gt;&lt;SPAN class=detail_text&gt;&lt;SPAN class=detail_text&gt;A National Screening Committee workshop on anal cancer screening for&amp;nbsp;was held in London on&amp;nbsp;December 6th&amp;nbsp;2004. This powerpoint presentation by Mark Bower, Consultant Medical Oncologist at Chelsea and Westminster Hospital, discusses HIV-associated anal cancer.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>78212</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=78212]]&gt;</url>
    <title>HIV in pregnancy: impact of antenatal testing</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Institute of Child Health</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,ANTENATAL,SCREENING,HIV]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation produced for an antenatal and newborn screening conference</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;HIV in pregnancy: impact of antenatal testing&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN class=detail_text&gt;This is a powerpoint presentation about antenatal testing for HIV in pregnancy, that was produced for the 2nd North West Regional Antenatal &amp;amp; Newborn Screening Conference held on 31st Jan 2005.&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>70184</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_hpv_dna_testing_for_the_screening_and_monitoring_of_cervical_cancer.html]]&gt;</url>
    <title>HPV DNA testing for the screening and monitoring of cervical cancer</title>
    <publicationDate>2005-10-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of&amp;nbsp;human papillomavirus (HPV) DNA testing for cervical cancer. The Technology Assessment Committee summarised by stating that "the evidence does not support the use of HPV DNA testing alone as a primary screening tool. Therefore, HPV DNA testing should not be used as a standalone test..."&lt;/P&gt;&lt;FONT size=1 face=Palatino-Roman&gt;
&lt;P align=left&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>67282</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sbu.se/en/Published/Alert/Human-papillomavirus-testing-in-primary-cervical-cancer-screening/]]&gt;</url>
    <title>Human papillomavirus testing in primary cervical cancer screening</title>
    <publicationDate>2000-05-10T00:00:00</publicationDate>
    <publisher>Swedish Council on Technology Assessment in Health Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Alert is a system for identification and early assessment concerning new methods in health care. The Alert reports are produced by the Swedish Council on Technology Assessment in Health Care, and&amp;nbsp;describe the new methods and their effects. 
&lt;P&gt;This report summarises human papillomavirus testing in primary cervical cancer screening. It concludes that "there is poor scientific documentation to show the effects of introducing HPV testing as a primary screening method aimed at reducing morbidity and mortality... there is no scientific evidence to show how screening programs that include HPV testing can be conducted in an optimum way - at what ages and at what intervals. Further assessments of model studies and randomized controlled trials, with the ultimate goal of reducing cancer incidence and increasing patient survival, are needed before the method can be routinely applied in primary screening programs"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61064</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.msac.gov.au/internet/msac/publishing.nsf/Content/8FD1D98FE64C8A2FCA2575AD0082FD8F/$File/Ref%2012b%20-%20Human%20papillomavirus%20testing%20in%20women%20with%20cytological%20prediction%20of%20low-grade%20abnormality%20-%20Assessment.pdf]]&gt;</url>
    <title>Human papillomavirus testing in women with cytological prediction of low-grade abnormality</title>
    <publicationDate>2002-08-01T00:00:00</publicationDate>
    <publisher>Medical Services Advisory Committee</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Human papillomavirus testing in women with cytological prediction of low-grade abnormality. Fennessy P, Raulli A, Abdulwadud O. Canberra, ACT, Australia: Medical Services Advisory Committee 2002: 97 (ref 12b) 
&lt;P&gt;The Medical Services Advisory Committee (MSAC) advises the Australian Minister for Health and Ageing on evidence relating to the safety, effectiveness and cost-effectiveness of new medical technologies and procedures. 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;FONT face=Garamond&gt;
&lt;P align=left&gt;This report summarises the assessment of the current evidence for the use of the HC-II test as an aid in triaging women who have undergone cervical screening.&lt;/P&gt;&lt;/FONT&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;The report recommends that "there is currently insufficient evidence to support public funding at this time for the use of the human papillomavirus test for triaging of women with equivocal cervical screening results". 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;There is also a &lt;A href="http://www.msac.gov.au/internet/msac/publishing.nsf/Content/8FD1D98FE64C8A2FCA2575AD0082FD8F/$File/Ref%2012b%20-%20Human%20papillomavirus%20testing%20in%20women%20with%20cytological%20prediction%20of%20low%20grade%20abnormality%20-%20Summary.pdf" target="_blank"&gt;one-page summary&lt;/A&gt; of this report available. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70264</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2001/Imaging.pdf]]&gt;</url>
    <title>Imaging in coronary heart disease</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>University of Birmingham</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CORONARY HEART DISEASE,ADULT,SCREENING,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;These New and Emerging Technology Briefings from the National Horizon Scanning Centre, University of Birmingham outline what the technology is, its likely patient group, the current treatment alternatives, the level and amount of research evidence available and a prediction of its relevance both clinically and to the wider NHS.&amp;nbsp; &lt;FONT face="Times New Roman"&gt;
&lt;P align=left&gt;This report looks at the use of cardiac imaging in the diagnosis and management of coronary heart disease (CHD). The imaging modalities considered include myocardial ultrasound, nuclear medicine, positron emission tomography, computerised tomography&amp;nbsp;and magnetic resonance imaging.&lt;/FONT&gt;&lt;FONT face="Times New Roman"&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63588</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63588]]&gt;</url>
    <title>Impact of prenatal antibiotics on neonatal sepsis</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>Institute of Child Health</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD HEALTH,SCREENING,ANTENATAL,STREPTOCOCCUS B,SPECIALTIES,NEONATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation from a NSC workshop on screening for streptococcus B</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Impact of prenatal antibiotics on neonatal sepsis&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;looks at the impact of prenatal antibiotics on neonatal sepsis, through a review of randomised controlled trials and surveillance studies.
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;BR&gt;A &lt;A href="http://www.screening.nhs.uk/groupbstreptococcus" target="_blank"&gt;more recent evaluation of antenatal screening for Group B Streptococcal (GBS) carriage&lt;/A&gt; against NSC Handbook Criteria was undertaken in 2008.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>67351</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=67351]]&gt;</url>
    <title>Improving outcomes for oral cancer</title>
    <publicationDate>2003-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,CANCER,ADULT,ORAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This National Screening Committee report summarises workshops convened to examine issues in oral cancer</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Improving outcomes for oral cancer&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee set up a series of workshops to examine the following issues in oral cancer: 
&lt;UL&gt;
&lt;LI&gt;Raising public awareness &lt;/LI&gt;
&lt;LI&gt;Improving professional awareness to facilitate earlier detection &lt;/LI&gt;
&lt;LI&gt;Organising support services for patients and improving pathways earlier treatment &lt;/LI&gt;
&lt;LI&gt;Identifying topics that would be priorities for research &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;This report&amp;nbsp;summaries the results from these workshops. It concludes that "there is an overwhelming need for more information about history of oral cancer. Greater awareness of the disease professionals and standardised referral pathways would facilitate treatment when necessary. The population should be aware of possible risk factors and early signs and symptoms".&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>69939</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/publications/cs1.pdf]]&gt;</url>
    <title>Inequalities of access to cancer screening: a literature review</title>
    <publicationDate>2003-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,CERVICAL CANCER,BREAST CANCER,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This review looks at the issue of access to cancer screening, &amp;nbsp;the relevant contents of two recent systematic reviews, and the findings of 56 empirical studies published between 1998 and 2003.&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325613</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325613]]&gt;</url>
    <title>Infectious Diseases in Pregnancy Screening Programme: report on 2005-2007 data</title>
    <publicationDate>2009-03-01T00:00:00</publicationDate>
    <publisher>Health Protection Agency</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,SYPHILIS,RUBELLA,HIV,HEPATITIS B,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>2007-2008 annual report from the Infectious Diseases in Pregnancy Screening Programme, including surveillance data from 2005-2007.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Infectious Diseases in Pregnancy Screening Programme: report on 2005-2007 data&lt;/pageTitle&gt;&lt;pageBody&gt;This is the first report of the Infectious Diseases in Pregnancy Screening (IDPS) Programme. It provides a summary of the activities of the IDPS Programme between autumn 2007 and spring 2008. It focuses on activity arising from a screening programme development workshop held in October 2007 and on screening uptake and positive test results for infections based on data collected in England between 2005 and 2007 by regional HPA teams and sent to the National Antenatal Infections Screening Monitoring (NAISM) Programme for analysis.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>63682</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp53.pdf]]&gt;</url>
    <title>Information &amp; advice for health professionals in breast screening</title>
    <publicationDate>2002-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,BREAST CANCER,SCREENING,IMPLEMENTATION,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This document is designed to provide information and advice to help health professionals answer common questions asked by women invited for breast cancer screening. It has been written for radiographers and other health professionals trained to take mammograms, but will also be useful for administrative staff and clinical nurse specialists.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382079</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/20587790]]&gt;</url>
    <title>Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis</title>
    <publicationDate>2010-07-21T00:00:00</publicationDate>
    <publisher>Journal of the National Cancer Institute, Oxford Journals</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' Conclusions&lt;/STRONG&gt;: Methods or strategies to increase repeat mammography need to be identified through further research.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Electronic databases searched up to 15 August 2009. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 25 eligible studies, reporting &amp;nbsp;were&amp;nbsp;included. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Vernon SW, McQueen A, Tiro J, et al. Interventions to promote repeat breast cancer screening with mammography: a systematic review and meta-analysis. &lt;EM&gt;Journal of the National Cancer Institute&lt;/EM&gt; 2010; 102(14):1023-39&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20587790" target="_blank"&gt;PubMed abstract available&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325640</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=9431]]&gt;</url>
    <title>Interventions to reduce inequity and inequality in accessing national screening programmes: a report for the UK National Screening Commitee</title>
    <publicationDate>2008-10-20T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHILD,ADULT,MANAGEMENT,NEWBORN,PUBLIC HEALTH,DETERMINANTS,SOCIAL DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,POPULATIONS,GROUPS,DISADVANTAGED GROUPS,SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,MONTHLY ADDITIONS,NOVEMBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This report was commissioned by the UK National Screening Committee (UK NSC) to investigate best practice to reduce inequalities in screening uptake. The investigation was carried out between June and September 2008. A literature review and survey of primary care organisations were carried out to identify interventions to improve equity in screening uptake.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A supplement to this report is also available: &lt;A href="nelh:325643:0" name=internalLink&gt;Analyses of inequality in national screening programmes using existing data systems&lt;/A&gt;.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>316617</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://tinyurl.com/oow8g4]]&gt;</url>
    <title>Intimate partner violence screening tools: a systematic review</title>
    <publicationDate>2009-05-01T00:00:00</publicationDate>
    <publisher>Elsevier Science Ltd</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,DETERMINANTS,DOMESTIC VIOLENCE,ADULT,SCREENING,PUBLIC HEALTH,SOCIAL DETERMINANTS,MONTHLY ADDITIONS,2009 SEPTEMBER,DOMESTIC VIOLENCE,ABUSE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Context&lt;/STRONG&gt;&lt;BR&gt;Intimate partner violence (IPV) screening remains controversial. Major medical organizations mandate screening, whereas the U.S. Preventive Services Task Force (USPSTF) cautions that there is insufficient evidence to recommend for or against screening. An effective IPV screening program must include a screening tool with sound psychometric properties. A systematic review was conducted to summarize IPV screening tools tested in healthcare settings, providing a discussion of existing psychometric data and an assessment of study quality.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Evidence acquisition&lt;BR&gt;&lt;/STRONG&gt;From the end of 2007 through 2008, three published literature databases were searched from their start through December 2007; this search was augmented with a bibliography search and expert consultation. Eligible studies included English-language publications describing the psychometric testing of an IPV screening tool in a healthcare setting. Study quality was judged using USPSTF criteria for diagnostic studies.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Evidence synthesis&lt;BR&gt;&lt;/STRONG&gt;Of 210 potentially eligible studies, 33 met inclusion criteria. The most studied tools were the Hurt, Insult, Threaten, and Scream (HITS, sensitivity 30%–100%, specificity 86%–99%); the Woman Abuse Screening Tool (WAST, sensitivity 47%, specificity 96%); the Partner Violence Screen (PVS, sensitivity 35%–71%, specificity 80%–94%); and the Abuse Assessment Screen (AAS, sensitivity 93%–94%, specificity 55%–99%). Internal reliability (HITS, WAST); test–retest reliability (AAS); concurrent validity (HITS, WAST); discriminant validity (WAST); and predictive validity (PVS) were also assessed. Overall study quality was fair to good.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions&lt;/STRONG&gt;&lt;BR&gt;No single IPV screening tool had well-established psychometric properties. Even the most common tools were evaluated in only a small number of studies. Sensitivities and specificities varied widely within and between screening tools. Further testing and validation are critically needed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Bibliographic details&lt;/STRONG&gt;: Rabin RF, Jennings JM, Campbell JC, Bair-Merritt MH.&amp;nbsp;Intimate partner violence screening tools: a systematic review. American Journal of Preventive Medicine 2009;36(5):439-445.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66833</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.mihsr.monash.org/cce/res/pdf/b/Report%20885.pdf]]&gt;</url>
    <title>Is cognistat (neuro-behavioural cognitive status exam) a superior cognitive screen than the mini-mental state exam in adult patients?</title>
    <publicationDate>2002-10-01T00:00:00</publicationDate>
    <publisher>Monash University, Australia</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a Critical Appraisal produced by the Centre for Clinical Effectiveness, Monash University (Australia)&amp;nbsp;to answer the question: Is Cognistat (Neuro-behavioural Cognitive Status Exam) a superior cognitive screen than the Mini-Mental State Exam in adult patients? These critical appraisals are evaluative summaries of identified studies based on standard templates.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382002</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/16451780]]&gt;</url>
    <title>Is pulse palpation helpful in detecting atrial fibrillation? A systematic review</title>
    <publicationDate>2006-02-01T00:00:00</publicationDate>
    <publisher>Quadrant HealthCom Inc</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED,ATRIAL FIBRILLATION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conslusions&lt;/STRONG&gt;: Pulse palpation is useful tool to rule out atrial fibrillation and may be&amp;nbsp;useful in opportunistic screening for undetected atrial fibrillation.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic search of Medline, Embase and reference lists of review articles for studies comparing pulse palpation with the electrocardiogram (ECG) diagnosis of atrial fibrillation. Search results then assessed&amp;nbsp;by two reviewers for eligibility and quality and to extract data.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 3 studies, including 2385 participants were included, comparing pulse palpation with ECG.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Cooke G, Doust J and Sanders S. Is pulse palpation helpful in detecting atrial fibrillation. &lt;EM&gt;Journal of Family Practice&lt;/EM&gt; 2006; 55(2):130-4&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/16451780" target="_blank"&gt;PubMed abstract available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>125465</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=125465]]&gt;</url>
    <title>Knowledge update on growth screening for preschool children 2004/2006</title>
    <publicationDate>2006-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCHOOL ENTRY,HEIGHT,NUTRITION,OBESITY,GROWTH CHARTS,OBESITY AND THINNESS,SPECIALTIES,STAFF USE,SCREENING,CHILD,CHILD HEALTH,ENDOCRINOLOGY,SCREENING,NUTRITION,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on growth screening for preschool children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on growth screening for preschool children 2004/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;May 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;The World Health Organisation (WHO) is to issue new guidelines on measuring the growth rates of babies (see &lt;A href="http://news.bbc.co.uk/1/hi/health/4938234.stm" target="_blank"&gt;BBC news health&lt;/A&gt;). The WHO publication on &lt;A href="http://www.who.int/bookorders/anglais/detart1.jsp?sesslan=1&amp;amp;codlan=1&amp;amp;codcol=15&amp;amp;codcch=660" target="_blank"&gt;Child Growth Standards&lt;/A&gt; is currently in press – the summary states that “&lt;EM&gt;a comprehensive review of the uses and interpretation of anthropometric references undertaken by WHO in the early 1990s concluded that new growth curves were needed to replace the existing international reference&lt;/EM&gt;”. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A systematic review of the routine monitoring of growth in children has been commissioned by the Health Technology Assessment (HTA) programme (&lt;A href="nelh:88623:0" name=internalLink&gt;A systematic review of the routine monitoring of growth in children of primary school age to identify growth related conditions&lt;/A&gt;). However, this report is not due for publication until mid 2007. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;In the interim, a literature search was performed to find citations on growth screening of preschool children published since the National Screening Committee &lt;A href="nelh:61017:0" name=internalLink&gt;Child Health Sub-Group report on growth disorders&lt;/A&gt; (Sept 2004)&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library, PubMed Related Article&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2004 to&amp;nbsp;March 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;90 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;growth screening for preschool children.&amp;nbsp;These&amp;nbsp;90 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID125465/nelhImp_0000_growth_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371430</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=371430]]&gt;</url>
    <title>Knowledge update on old age screening 2009</title>
    <publicationDate>2009-07-31T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,OLD AGE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of screening in old age</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on old age screening 2009&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find ciations relevant to old age screening (published between January 2003 and June 2009) was performed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>383362</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=383362]]&gt;</url>
    <title>Knowledge update on screening for alcohol problems in adults 2010</title>
    <publicationDate>2010-06-14T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ALCOHOL PROBLEMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for alcohol problems in adults 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for alcohol problems in adults (published between January 2008 and May 2010) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>239462</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=239462]]&gt;</url>
    <title>Knowledge update on screening for alcohol problems in primary care 2002/2006</title>
    <publicationDate>2007-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,PRIMARY CARE,MANAGEMENT,SCREENING,POPULATION BASED &amp; PREVENTATIVE SERVICES,PRIMARY CARE SERVICES,SCREENING,ALCOHOL PROBLEMS,ADULT,PUBLIC HEALTH,DETERMINANTS,ALCOHOL CONSUMPTION,INDIVIDUAL BEHAVIOUR,MANAGEMENT &amp; INTERVENTIONS,SOCIAL DETERMINANTS,LIFESTYLE,SERVICES,INFORMATION,MANAGEMENT &amp; POLICY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of screening for alcohol problems</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for alcohol problems in primary care 2002/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;February 2007]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black"&gt;A literature search was performed to find citations on alcohol screening published since the SIGN guideline&lt;/SPAN&gt; &lt;A href="http://www.sign.ac.uk/pdf/sign74.pdf" target="_blank"&gt;The management of harmful drinking and alcohol dependence in primary care&lt;/A&gt; (Sept 2003), which contains a section on detection and assessment – this covers screening tests for alcohol and biological markers. The last search date for this publication was 2001.&lt;SPAN style="COLOR: black"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library, National Library for Health&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2002 to&amp;nbsp;Dec 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;221 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;alcohol problems.&amp;nbsp;These&amp;nbsp;221 citations were classified in a way that health professionals involved in screening would recognise&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID239462/nelhImp_0001_alcohol_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant systematic reviews meeting our criteria&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>144336</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=144336]]&gt;</url>
    <title>Knowledge update on screening for Alzheimer's Disease 2003/2006</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ALZHEIMER'S DISEASE,OLD AGE,ADULT,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for Alzheimer's Disease</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for Alzheimer's Disease 2003/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;July 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on screening for Alzheimer’s Disease published since the National Screening Committee’s consideration of the topic in July 2003. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library, PsycInfo&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2003 to end&amp;nbsp;May 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;276 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;&amp;nbsp;Alzheimer's Disease.&amp;nbsp;These&amp;nbsp;276 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;IMG id=nelh_tempImage1 name=nelh_tempImage1 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID144336/nelhImp_0001_az_tree2.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>113106</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=113106]]&gt;</url>
    <title>Knowledge update on screening for anal cancer 2003/2005</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ADULT,ANAL,CANCER,SCREENING,COLON &amp; RECTUM,GASTROENTEROLOGY &amp; LIVER DISEASES,CANCER,RECENT ADDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for anal cancer 2003/05 - there is a more recent 2006 update available</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for anal cancer 2003/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library, January 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;This report shows the results of a comprehensive search for all the evidence on&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;anal cancer&amp;nbsp;that was published between Jan&amp;nbsp;2003 to&amp;nbsp;Dec 2005. &lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;A&amp;nbsp;more recent knowledge update has been conducted for 2006. See &lt;A href="nelh:235352:0" name=internalLink&gt;Annual knowledge update&amp;nbsp;on screening for anal cancer 2006&lt;/A&gt;&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>383367</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=383367]]&gt;</url>
    <title>Knowledge update on screening for atrial fibrillation 2010</title>
    <publicationDate>2010-07-28T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED,ATRIAL FIBRILLATION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for atrial fibrillation 2010&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;As part of the policy review process of the UK National Screening Committee, a literaature search for citations relevant to screening for atrial fibrillation (published between January 2005 and June 2010) was performed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb_download.php?doc=84" target="_blank"&gt;Appendix to knowledge update&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>383364</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=383364]]&gt;</url>
    <title>Knowledge update on screening for Canavan disease 2010</title>
    <publicationDate>2010-10-26T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEWBORN,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,CANNAVANS DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for Canavan disease 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the&amp;nbsp;UK National Screening Committee, a literature search to find citations relevant to screening for Canavan disease (published between January 2000 and&amp;nbsp;October 2010) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>112657</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=112657]]&gt;</url>
    <title>Knowledge update on screening for chlamydia in pregnancy 2003/2005</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ANTENATAL,SCREENING,CHLAMYDIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines the annual knowledge update on chlamydia screening in pregnancy for 2003/2005 - there is a more recent update available for 2006</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for chlamydia in pregnancy 2003/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;&lt;SPAN lang=EN-GB&gt;&lt;SPAN lang=EN-GB&gt;T&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN lang=EN-GB&gt;his report shows the results of a comprehensive search for all the evidence on&amp;nbsp;chlamydia screening in pregnancy&amp;nbsp;that was published between&amp;nbsp;Jan 2003&amp;nbsp;and&amp;nbsp;Dec 2005. &lt;/SPAN&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;SPAN lang=EN-GB&gt;A more recent knowledge update has been conducted for 2006. See &lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=235702&amp;amp;tabID=289" target="_blank"&gt;Annual knowledge update on screening for Chlamydia in pregnancy 2006&lt;/A&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371428</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=371428]]&gt;</url>
    <title>Knowledge update on screening for depression 2009</title>
    <publicationDate>2009-07-10T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DEPRESSION,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of screening for depression</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for depression 2009&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for depression (published between&amp;nbsp;January 2005 and June 2009)&amp;nbsp;was performed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>112023</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=112023]]&gt;</url>
    <title>Knowledge update on screening for domestic violence in pregnancy 2003/2005</title>
    <publicationDate>2005-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,NOT ROUTINELY OFFERED,DOMESTIC VIOLENCE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for domestic violence in pregnancy 2003/05 - there is a more recent 2005/06 update available</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for domestic violence in pregnancy 2003/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library, November 2005]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;This report shows the results of a comprehensive search for all the evidence on&amp;nbsp;&amp;nbsp;screening for domestic violence in pregnancy&amp;nbsp;that was published between Jan&amp;nbsp;2003 to&amp;nbsp;Oct 2005. &lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;A&amp;nbsp;more recent knowledge update has been conducted for 2005/2006. See &lt;A href="nelh:197194:0" name=internalLink&gt;Annual knowledge update on screening for domestic violence in pregnancy 2005/06&lt;/A&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>383363</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=383363]]&gt;</url>
    <title>Knowledge update on screening for familial dysautonomia 2010</title>
    <publicationDate>2010-10-26T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED,FAMILIAL DYSAUTONOMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for familial dysautonomia 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for familial dysautonomia (published between January 2000 and October 2010) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>383361</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=383361]]&gt;</url>
    <title>Knowledge update on screening for galactosaemia 2009</title>
    <publicationDate>2009-11-24T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN,NOT ROUTINELY OFFERED,GALACTOSEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for galactosaemia 2009&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;As part of the policy review process of the&amp;nbsp;UK National Screening Committee, a literature search to find citations relevant to screening for galacrosaemia (published between January 1996 and November 2009) was performed.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>112025</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=112025]]&gt;</url>
    <title>Knowledge update on screening for genital herpes in pregnancy 2000/2005</title>
    <publicationDate>2005-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,ANTENATAL,GENITAL HERPES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for genital herpes in pregnancy 2000/05 - there is a more recent 2005/06 update available</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for genital herpes in pregnancy 2000/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report shows the results of a comprehensive search for all the evidence on&amp;nbsp;genital herpes&amp;nbsp;screening that was published between Jan 2000 and&amp;nbsp;Oct 2005. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A more recent knowledge update has been conducted for 2005/2006. See &lt;A href="nelh:212588:0" name=internalLink&gt;Annual knowledge update on screening for genital herpes in pregnancy&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371429</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=371429]]&gt;</url>
    <title>Knowledge update on screening for glomerulonephritis 2009</title>
    <publicationDate>2009-10-29T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of screening for glomeulonephritis</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for glomerulonephritis 2009&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As part of the policy review process of the UK National Screening COmmittee, a literature search to find citations relevant to screening for glomerulonephritis (published between January 2001 and September 2009) was performed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>103304</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=103304]]&gt;</url>
    <title>Knowledge update on screening for group B streptococcus in pregnancy 2003/2005</title>
    <publicationDate>2005-08-24T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,STREPTOCOCCUS B,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for streptococcus B in pregnancy 2000/05 - there is a more recent 2005/06 update available</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for group B streptococcus in pregnancy 2003/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report shows the results of a comprehensive search for all the evidence on&amp;nbsp;group B streptococcus&amp;nbsp;screening in pregnancy&amp;nbsp;that was published between Jan&amp;nbsp;2003 to&amp;nbsp;Aug 2005. &lt;/P&gt;
&lt;P&gt;A&amp;nbsp;more recent knowledge update has been conducted for 2005/2006. See &lt;A href="nelh:186977:0" name=internalLink&gt;Annual knowledge update on screening for group B streptococcus 2005/2006&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>126556</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=126556]]&gt;</url>
    <title>Knowledge update on screening for haemochromatosis 2001/2006</title>
    <publicationDate>2006-05-30T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ HAEMOCHROMATOSIS,SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for haemochromatosis</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for haemochromatosis 2001/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;May 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;A systematic review looking at the usefulness and value of genetic testing for haemochromatosis has been commissioned by the Health Technology Assessment (HTA) programme - see &lt;/SPAN&gt;&lt;SPAN style="mso-bidi-font-weight: bold"&gt;&lt;A href="http://www.hta.nhsweb.nhs.uk/projectdata/1_project_record_notpublished.asp?PjtId=1502&amp;amp;SearchText=haemochromatosis" target="_blank"&gt;the clinical validity and utility of adding DNA testing to case identification strategies for haemochromatosis in at-risk populations&lt;/A&gt;&lt;/SPAN&gt;. However, this report is not due for publication until mid 2008.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;In the interim, a literature search was performed to find citations on screening for haemochromatosis published since the National Screening Committee report on the &lt;SPAN style="mso-ansi-language: EN; mso-bidi-font-weight: bold" lang=EN&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibraries/Download.aspx?resID=61006" target="_blank"&gt;Evaluation of Haemochromatosis Screening&lt;/A&gt; (2001).&lt;/SPAN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2001 to&amp;nbsp;April 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;142 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;haemochromatosis. &amp;nbsp;These&amp;nbsp;142 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID126556/nelhImp_0000_haem_tree.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>383365</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=383365]]&gt;</url>
    <title>Knowledge update on screening for Hepatitis B and C in minority ethnic communities 2010</title>
    <publicationDate>2010-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HEPATITIS C,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for Hepatitis B and C in minority ethnic communities 2010&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for Haepatitis B and C in minority ethnic communites (published between 1999 and 2010) was performed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb_download.php?doc=91" target="_blank"&gt;Appendix to knowledge update&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>392393</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=392393]]&gt;</url>
    <title>Knowledge update on screening for hepatitis C in pregnancy 2010</title>
    <publicationDate>2010-10-06T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,HEPATITIS C,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for hepatitis C in pregnancy 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for hepatitis C in pregnancy (published between January 2003 and September 2010)&amp;nbsp;was performed &lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>385294</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=385294]]&gt;</url>
    <title>Knowledge update on screening for iron deficiency anaemia in children 2010</title>
    <publicationDate>2010-01-29T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,IRON DEFICIENCY ANAEMIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for iron deficiency anaemia in children 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for iron deficiency anaemia in children (published between January 2000 and January 2010) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>385293</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=385293]]&gt;</url>
    <title>Knowledge update on screening for methylmalonic and propionic acidaemias 2009</title>
    <publicationDate>2009-11-23T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN,NOT ROUTINELY OFFERED,ORGANIC ACID METABOLISM DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for methylmalonic and propionic acidaemias 2009&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for methylmalonic and propionic acidaemias (published between January 1996 and October 2009) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>122259</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=122259]]&gt;</url>
    <title>Knowledge update on screening for neural tube defects 1999/2006</title>
    <publicationDate>2006-02-22T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ 18-20 WEEKS,NEURAL TUBE DEFECTS,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines the annual knowledge update on neural tube defect screening for 1999/2006 - there is a more recent update available for 2006/2007</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for neural tube defects 1999/2006&lt;/pageTitle&gt;&lt;pageBody&gt;This report outlines the annual knowledge update on neural tube defect screening for 1999/2006 - there is a more recent update available for &lt;A href="nelh:259215:0" name=internalLink&gt;2006/2007&lt;/A&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>112049</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=112049]]&gt;</url>
    <title>Knowledge update on screening for neuroblastoma 2000/2005</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEUROBLASTOMA,SCREENING,NOT ROUTINELY OFFERED,NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for neuroblastoma in babies and children 2000/2005 - there is a more recent 2005/06 update available</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for neuroblastoma 2000/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;This report shows the results of a comprehensive search for all the evidence on screening for neuroblastoma that was published between Feb 2000 to June 2005.&lt;/P&gt;
&lt;P&gt;A more recent knowledge update has been conducted for 2005/2006. See &lt;A href="nelh:156793:0" name=internalLink&gt;Annual knowledge update on screening for neuroblastoma&lt;/A&gt;.&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>112052</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=112052]]&gt;</url>
    <title>Knowledge update on screening for open-angle glaucoma 2001/2006</title>
    <publicationDate>2005-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ OLD AGE,NOT ROUTINELY OFFERED,SCREENING,ADULT,GLAUCOMA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for open-angle glaucoma
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for open-angle glaucoma 2001/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;&amp;nbsp;[Compiled by the Screening Specialist Library, October 2005]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#009933 size=1&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;FONT color=#009933 size=1&gt;UPDATED&lt;/FONT&gt;†&lt;EM&gt; &lt;/EM&gt;[&lt;EM&gt;In November 2006, the Eyes and Vision Library conducted a national knowledge week update on screening for glaucoma - see &lt;/EM&gt;&lt;A href="http://www.library.nhs.uk/eyes/ViewResource.aspx?resID=182443&amp;amp;tabID=290&amp;amp;catID=9856" target="_blank"&gt;&lt;EM&gt;Glaucoma screening&lt;/EM&gt;&lt;/A&gt;]&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A systematic review has been commissioned by the Health Technology Assessment (HTA) programme, with the aim of assessing&amp;nbsp;the extent to which screening for open angle glaucoma meets the UK National Screening Committee criteria for a screening programme (see &lt;A href="http://www.ncchta.org/project.asp?PjtId=1446" target="_blank"&gt;clinical and cost-effectiveness of screening for open angle glaucoma&lt;/A&gt;). However, this report is not due for publication until mid-2007. &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;In the interim,&amp;nbsp;a literature search was performed to find citations on glaucoma screening published since the date of the last National Screening Committee (NSC) workshop, and the publication of the report “&lt;A href="http://libraries.nelh.nhs.uk/common/download.asp?resourceID=61002" target="_blank"&gt;Evaluation of open angle glaucoma against the NSC criteria for screening viability, effectiveness and appropriateness&lt;/A&gt;” (both 2001).&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;A href="http://www.library.nhs.uk/eyes/ViewResource.aspx?resID=182443&amp;amp;tabID=290&amp;amp;catID=9856" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;SOURCES SEARCHED&lt;/B&gt;: Medline, Embase, Cochrane Library&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;DATES OF SEARCH&lt;/B&gt;: Jan 2001 to Oct 2005&lt;EM&gt;&amp;nbsp;&lt;/EM&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;101 citations were deemed to be relevant to&amp;nbsp;open-angle glaucoma&amp;nbsp;screening.&amp;nbsp;These&amp;nbsp;101 relevant citations were classified in a way that health professionals involved in screening would recognise:&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID112052/nelhImp_0000_glaucoma.jpg"&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>112055</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=112055]]&gt;</url>
    <title>Knowledge update on screening for pre-eclampsia 2003/2005</title>
    <publicationDate>2005-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ PRE-ECLAMPSIA,SCREENING,ANTENATAL,36 WEEKS,PRE-ECLAMPSIA,28 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for pre-eclampsia in pregnancy 2003/2005 - there is a more recent 2005/06 update available.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for pre-eclampsia 2003/2005&lt;/pageTitle&gt;&lt;pageBody&gt;This report shows the results of a comprehensive search for all the evidence on&amp;nbsp;pre-eclampsia screening that was published between Jan 2003 and&amp;nbsp;Oct 2005. 
&lt;P&gt;A more recent knowledge update has been conducted for 2005/2006. See &lt;A href="nelh:223693:0" name=internalLink&gt;Annual knowledge update on screening for pre-eclampsia&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>123550</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=123550]]&gt;</url>
    <title>Knowledge update on screening for prostate cancer 2004/2006</title>
    <publicationDate>2006-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ CANCER,ADULT,SCREENING,PROSTATE,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,PROSTATE CANCER,PROSTATE DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on prostate cancer screening</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for prostate cancer 2004/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;March 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;A literature search was performed to find citations on&amp;nbsp;prostate cancer screening published since the&amp;nbsp;&lt;A href="nelh:82796:0" name=internalLink&gt;review of prostate cancer screening&lt;/A&gt; (BJU volume 95, supplement 3, 2005) was prepared for the Prostate Cancer Risk Management&amp;nbsp;Scientific Research Group (April 2005). The last search date for this publication was February 2004.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;SOURCES SEARCHED&lt;/STRONG&gt;: Medline, Embase, Cochrane Library &lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;DATES OF SEARCH:&lt;/STRONG&gt; Jan&amp;nbsp;2004 to end&amp;nbsp;Jan 2006&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;STRONG&gt;RESULTS:&lt;/STRONG&gt;&amp;nbsp;474 citations were deemed to be relevant to&amp;nbsp;&amp;nbsp;prostate cancer screening.&amp;nbsp;These&amp;nbsp;474 citations were classified in a way that health professionals involved in screening would recognise:&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;IMG id=nelh_tempImage0 name=nelh_tempImage0 src="https://rmsadmin.nelh.nhs.uk/libraryImages/Screening/contentID123550/nelhImp_0011_tree_pc.jpg"&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;o:p&gt;The full report is available below. The titles and abstracts of the relevant citations are included in the report - no quality assurance is implied by their inclusion. Any relevant good quality systematic reviews&amp;nbsp;will have been entered as individual resources onto the Screening Library.&lt;/o:p&gt;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>392396</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=392396]]&gt;</url>
    <title>Knowledge update on screening for rubella susceptibility 2010</title>
    <publicationDate>2010-10-15T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,RUBELLA,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for rubella susceptibility 2010&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for rubella susceptibility (published January 2003 to&amp;nbsp;December 2006 and Spetember 2009 and&amp;nbsp;September 2010) was performed.&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>371432</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=371432]]&gt;</url>
    <title>Knowledge update on screening for stomach cancer 2009</title>
    <publicationDate>2009-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,STOMACH,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Literature search on topic of screening for stomach cancer</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for stomach cancer 2009&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As part of the policy review process of the UK National Screening Committee, a literature searhc to find citations relevant to screening for stomach cancer (published between January 2002 and July 2009) was performed. An additional meta-analysis (published after the original search was completed) has been included in this revised version of the update.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>392394</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=392394]]&gt;</url>
    <title>Knowledge update on screening for Tay Sachs 2010</title>
    <publicationDate>2010-10-26T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEWBORN,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for Tay Sachs 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of ther policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for Tay Sachs disease (published between January 2000 and October 2010) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>385291</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=385291]]&gt;</url>
    <title>Knowledge update on screening for toxoplasmosis 2010</title>
    <publicationDate>2010-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,TOXOPLASMOSIS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for toxoplasmosis 2010&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for toxoplasmosis in pregnancy (published between January 2007 and May 2010) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>121465</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=121465]]&gt;</url>
    <title>Knowledge update on screening for vision defects in newborns and children 2002/2005</title>
    <publicationDate>2006-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,EYES,EYES,NEWBORN,PHYSICAL (&lt;72HRS),VISION,SCHOOL ENTRY,PHYSICAL (6-8 WKS)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This report outlines a knowledge update on screening for vision defects in newborns and children 2002/05 - there is a more recent 2006 update available</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for vision defects in newborns and children 2002/2005&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE width="90%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;
&lt;P&gt;&lt;STRONG&gt;[Compiled by the Screening Specialist Library,&amp;nbsp;February 2006]&lt;/STRONG&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;This report shows the results of a comprehensive search for all the evidence on&amp;nbsp;&amp;nbsp;screening for&amp;nbsp;vision defects in newborns&amp;nbsp;and children&amp;nbsp;that was published between Jan&amp;nbsp;2002 to&amp;nbsp;Dec 2005. &lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;o:p&gt;A&amp;nbsp;more recent knowledge update has been conducted for 2006. See &lt;A href="nelh:250499:0" name=internalLink&gt;Annual knowledge update for vision screening in newborns &amp;amp; preschool children 2006&lt;/A&gt;&lt;/P&gt;&lt;/o:p&gt;
&lt;P style="TEXT-ALIGN: justify; LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;/o:p&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>385292</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=385292]]&gt;</url>
    <title>Knowledge update on screening for Wilson disease 2009</title>
    <publicationDate>2009-11-23T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Knowledge update on screening for Wilson disease 2009&lt;/pageTitle&gt;&lt;pageBody&gt;As part of the policy review process of the UK National Screening Committee, a literature search to find citations relevant to screening for Wilson disease (published between January 1996 and October 2009) was performed.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51364</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.gov.au/internet/msac/publishing.nsf/Content/ref12a-1/$FILE/msacref12a.pdf]]&gt;</url>
    <title>Liquid based cytology for cervical screening</title>
    <publicationDate>2002-08-01T00:00:00</publicationDate>
    <publisher>Medical Services Advisory Committee</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Liquid based cytology for cervical screening. Fennessy P, Raulli A, Abdulwadud O, Petherick E, Bryan E, Harris C, Medical Services Advisory Committee, Australia.&amp;nbsp;2002: 1-97 (ref 12a)&lt;BR&gt;
&lt;P&gt;The Medical Services Advisory Committee (MSAC) advises the Australian Minister for Health and Ageing on evidence relating to the safety, effectiveness and cost-effectiveness of new medical technologies and procedures. 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This report summarises the assessment of current evidence for cervical screening with liquid based cytology.&lt;/P&gt;&lt;FONT face=Garamond&gt;
&lt;P align=left&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;The report recommends that "there is insufficient evidence to support public funding of liquid based cytology for cervical screening at this time."&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;A &lt;A href="http://www.health.gov.au/internet/msac/publishing.nsf/Content/ref12a-1/$FILE/summaryref12a.pdf" target="_blank"&gt;one-page summary&lt;/A&gt; of the report&amp;nbsp;is also available. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>67283</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_liquid-based_cervical_cytology.html]]&gt;</url>
    <title>Liquid-Based Cervical Cytology</title>
    <publicationDate>2003-08-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=Palatino-Roman&gt;
&lt;P align=left&gt;&lt;/FONT&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of liquid-based cytology (LBC)&amp;nbsp;in place of conventional Pap smear methods. The Technology Assessment Committee summarised by stating that: 
&lt;P align=left&gt;"LBC is an option to conventional Pap testing for cervical cancer screening............of 11 studies cited in this report that presented test results as either satisfactory, satisfactory but limited by, or unsatisfactory, 8 found a higher rate of satisfactory samples with LBC. Between 75.6% and 97.7% of LBC preparations were satisfactory compared with 60.5% to 97.5% with conventional Pap preparations"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96103</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/3/79?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123074664701_428&amp;stored_search=&amp;FIRSTINDEX=40&amp;journalcode=ebmed]]&gt;</url>
    <title>Lubrication of the vaginal introitus and external speculum had no effect on Papanicolaou smear interpretation</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Lubrication of the vaginal introitus and external speculum had no effect on Papanicolaou smear interpretation. Evidence-Based Medicine 2003; 8:79.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Harer WB, Jr, Valenzuela G, Lebo D. Lubrication of the vaginal introitus and speculum does not affect Papanicolaou smears.Obstet Gynecol 2002;100:887–8&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64679</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspslung.htm]]&gt;</url>
    <title>Lung cancer screening: recommendation statement</title>
    <publicationDate>2004-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,LUNG,ADULT,CANCER,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer. The USPSTF concludes that "the evidence is insufficient to recommend for or against screening asymptomatic persons for lung cancer with either low dose computerized tomography (LDCT), chest x-ray (CXR), sputum cytology, or a combination of these tests". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66824</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.haps.bham.ac.uk/publichealth/horizon/outputs/documents/2007/april/Lungscreen.pdf]]&gt;</url>
    <title>Lungscreen for lung cancer detection in high risk patients</title>
    <publicationDate>2007-04-01T00:00:00</publicationDate>
    <publisher>University of Birmingham</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;These&amp;nbsp;'News on emerging technologies in healthcare' summaries&amp;nbsp;from the National Horizon Scanning Centre, University of Birmingham outline what the technology is, its likely patient group, the current treatment alternatives, the level and amount of research evidence available and a prediction of its relevance both clinically and to the wider NHS.&amp;nbsp; 
&lt;P align=left&gt;The briefing&amp;nbsp;reviews the&amp;nbsp;Lungscreen device for the detection of lung cancer in high-risk patients.&lt;/P&gt;
&lt;P align=left&gt;'This technology summary is based on information available at the time of research and a limited literature search. It is not intended to be a definitive statement on the safety, efficacy or effectiveness of the health technology covered and should not be used for commercial purposes.'&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69782</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_magnetic_resonance_imaging__mri__for_the_detection_of_breast_abnormalities.html]]&gt;</url>
    <title>Magnetic Resonance Imaging (MRI) for the Detection of Breast Abnormalities</title>
    <publicationDate>2003-12-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of magnetic resonance imaging (MRI) in breast cancer screening. The Technology Assessment Committee summarised by stating that: "MRI as a screening test for the low-risk general population has not been studied and should not be performed at this time. Mammography and ultrasound should be used for the initial evaluation of breast symptoms".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>123400</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hgc.gov.uk/UploadDocs/DocPub/Document/Making%20Babies%20Report%20-%20final%20pdf.pdf]]&gt;</url>
    <title>Making babies: reproductive decisions and genetic technologies</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>Human Genetics Commission</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>HGC report on looking at the decisions and choices made before and during a pregnancy</description>
    <body>&lt;![CDATA[ &lt;FONT color=#292526 face=ArialMT-Light&gt;
&lt;P align=left&gt;This report by the Human Genetics Commission e&lt;FONT color=#292526 face=ArialMT-Light&gt;xamines prenatal screening, preimplantation genetic testing, diagnostic and genetic services, and genetic aspects of assisted reproduction. Chapter 3&amp;nbsp;(prenatal and neonatal screening and diagnostic testing) starts on pg 29.&lt;/P&gt;&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>64878</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;ID=12003002221]]&gt;</url>
    <title>Mammography screening attendance: meta-analysis of the effect of direct-contact invitation</title>
    <publicationDate>2003-12-02T00:00:00</publicationDate>
    <publisher>Centre for Reviews and Dissemination</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BREAST CANCER,SCREENING,ADULT,INFORMED DECISION-MAKING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Mammography screening attendance: meta-analysis of the effect of direct-contact invitation&lt;BR&gt;Denhaerynck K, Lesaffre E, Baele J, Cortebeeck K, Van Overstraete E, Buntinx F. American Journal of Preventive Medicine 2003; 25(3): 195-203. 
&lt;P&gt;This review has been evaluated by reviewers&amp;nbsp;from the NHS Centre for Reviews and Dissemination (CRD), University of York, as potentially meeting the CRD quality criteria, and a structured abstract is in the process of being written. 
&lt;P&gt;An &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=pubmed&amp;amp;dopt=Abstract&amp;amp;list_uids=14507525" target="_blank"&gt;abstract&lt;/A&gt; for the article from Am J Preventive Medicine is available from PubMed.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>103225</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10895]]&gt;</url>
    <title>Master data dictionary 2008-2009 with addendum</title>
    <publicationDate>2009-03-26T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,POSTNATAL CARE,NORMAL PREGNANCY,WOMEN'S HEALTH,NEWBORN,BLOODSPOT (&lt;1WK),MANAGEMENT,NEONATAL AND INFANT CARE,NEWBORN BLOODSPOT,GENERAL EXAMINATION AND SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Newborn Bloodspot and Sickle Cell &amp; Thalassaemia Programmes data collection dictionary.</description>
    <body>&lt;![CDATA[ &lt;P&gt;This Data Collection and Performance Analysis Dictionary is a reference resource to support data collection for newborn blood spot screening. This tool has been developed with the Sickle Cell and Thalassaemia Screening programme, it is a joint collection tool for the two programmes&amp;nbsp;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66856</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sbu.se/en/Published/Alert/Maternal-serum-screening-for-Down-syndrome/]]&gt;</url>
    <title>Maternal serum screening for Down syndrome</title>
    <publicationDate>2001-05-03T00:00:00</publicationDate>
    <publisher>Swedish Council on Technology Assessment in Health Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ 14-20 WEEKS,DOWN'S SYNDROME (SERUM),ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Alert is a system for identification and early assessment concerning new methods in health care. The Alert reports are produced by the Swedish Council on Technology Assessment in Health Care, and&amp;nbsp;describe the new methods and their effects. 
&lt;P&gt;This report summarises the methods and effects for maternal serum screening&amp;nbsp; for Down's Syndrome. It concludes that "there is good scientific documentation on the diagnostic characteristics of the serum marker test. There is poor scientific documentation on a range of different consequences in clinical use. Using serum markers may have potential advantages, but until further evidence becomes available they should be used only in cases that allow scientific followup of the intended, and unintended, effects". 
&lt;P&gt;A&amp;nbsp;more recent review of the literature is reported in &lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=332137" target="_blank"&gt;Methods of Early Prenatal Diagnosis, SBU report 182&lt;/A&gt;, published 2006. 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>345772</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/15333273]]&gt;</url>
    <title>Meta-analysis on the validity of pepsinogen test fro gastric carcinoma, dysplasia or chronic atrophic gastritis screening</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>Journal of Medical Screening, Royal Society of Medicine Press</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,STOMACH,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Pepsinogen test definition should include pepsinogen I/II ratio as consistency was obtained, both in population based studies and in selected groups for those studies that used pepsinogen I serum levels together with pepsinogen I/II ratio for screening for gastric cancer in high-incidence regions other than Japan. Further studies of this test in the management of high-risk patients seem to be worthwhile.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Meta-analysis of 42 studies&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Results: 42 studies were included. 27 were population-based screening studies incorporating 296,553 individuals. 15 were of selected groups and incorporated 4,385 individuals.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Dinis-Ribeiro M, Yamaki G, Miki K, et al. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. &lt;EM&gt;Journal of Medical Screening&lt;/EM&gt; 2004;11(3):141-7&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full access available with NHS Athens account.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This meta-analysis has not been critically appraised.&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 11pt"&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>332137</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sbu.se/upload/Publikationer/Content1/1/Methods_of_Early_Prenatal_Diagnosis.pdf]]&gt;</url>
    <title>Methods of early prenatal diagnosis</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>Swedish Council on Technology Assessment in Health Care</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,FETAL ANOMALY,NEURAL TUBE DEFECTS,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),18-20 WEEKS,DOWN'S SYNDROME (SERUM),14-20 WEEKS,BEFORE 16 WEEKS,11-14 WEEKS,ULTRASOUND]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report presents the scientific evidence for the methods currently used, or in the process of being adopted, to detect fetal chromosomal and structural abnormalities during early pregnancy. Medical, social, psychological, ethical, health economic, quality assurance and safety aspects of early prenatal diagnosis were analysed. This summary reviews the questions addressed and the most important conclusions reached in each chapter of the report.]]&gt;</body>
  </document>
  <document>
    <id>87572</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/fullmono/mon1206.pdf]]&gt;</url>
    <title>Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling</title>
    <publicationDate>2008-03-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,PRE-ECLAMPSIA,PRE-ECLAMPSIA,36 WEEKS,28 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Objectives&lt;/STRONG&gt;: To investigate the accuracy of predictive tests for pre-eclampsia and the effectiveness of preventative interventions for pre-eclampsia. Also to assess the cost-effectiveness of strategies&lt;BR&gt;(test - intervention combinations) to predict and prevent pre-eclampsia.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Data sources&lt;/STRONG&gt;: Major electronic databases were searched to January 2005 at least.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Review methods&lt;/STRONG&gt;: Systematic reviews were carried out for test accuracy and effectiveness. Quality assessment was carried out using standard tools. For test accuracy, meta-analyses used a bivariate approach.&lt;BR&gt;Effectiveness reviews were conducted under the auspices of the Cochrane Pregnancy and Childbirth Group and used standard Cochrane review methods. The economic evaluation was from an NHS perspective and used a decision tree model.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: For the 27 tests reviewed, the quality of included studies was generally poor. Some tests appeared to have high specificity, but at the expense of compromised sensitivity. Tests that reached specificities&lt;BR&gt;above 90% were body mass index &amp;gt; 34, alpha-foetoprotein and uterine artery Doppler (bilateral notching). The only Doppler test with a sensitivity of over 60% was resistance index and combinations of indices. A few tests not commonly found in routine practice, such as kallikreinuria and SDS-PAGE proteinuria, seemed to offer the promise of high sensitivity, without compromising specificity, but these would require further investigation. For the 16 effectiveness reviews, the quality of included studies was variable. The largest review was of antiplatelet agents, primarily low-dose aspirin, and included 51 trials (36,500 women). This was the only review where&lt;BR&gt;the intervention was shown to prevent both preeclampsia and its consequences for the baby. Calcium supplementation also reduced the risk of preeclampsia, but with some uncertainty about the impact on outcomes for the baby. The only other intervention associated with a reduction in RR of pre-eclampsia was rest at home, with or without a nutritional supplement, for women with normal blood pressure. However, this review included just two small trials and its results should be interpreted with caution. The cost of most of the tests was modest, ranging from £5 for blood tests such as serum uric acid to approximately £20 for Doppler tests. Similarly, the cost of most interventions was also modest. In contrast, the best estimate of additional average cost associated with an average case of pre-eclampsia was high at approximately £9000. The results of the modelling revealed that prior testing with the test accuracy sensitivities and specificities identified appeared to offer little as a way of improving cost-effectiveness. Based on the evidence reviewed, none of the tests appeared sufficiently accurate to be clinically useful and the results of the model favoured no-test/treat-all strategies. Rest at home without any initial testing appeared to be the most cost-effective ‘test–treatment’ combination. Calcium supplementation to all women, without any initial testing, appeared to be the second most cost-effective. The economic model provided little support that any form of Doppler test has&lt;BR&gt;sufficiently high sensitivity and specificity to be costeffective for the early identification of pre-eclampsia. It also suggested that the pattern of cost-effectiveness was no different in high-risk mothers than the low-risk mothers considered in the base case.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions&lt;/STRONG&gt;: The tests evaluated are not sufficiently accurate, in our opinion, to suggest their routine use in clinical practice. Calcium and antiplatelet agents, primarily low-dose aspirin, were the interventions&lt;BR&gt;shown to prevent pre-eclampsia. The most costeffective approach to reducing pre-eclampsia is likely to be the provision of an effective, affordable and safe intervention applied to all mothers without prior testing to assess levels of risk. It is probably premature to suggest the implementation of a treat-all intervention strategy at present, however the feasibility and acceptability of this to women could be explored. Rigorous evaluation is needed of tests with modest cost whose initial assessments suggest that they may have high levels of both sensitivity and specificity. Similarly, there is a need for high-quality, adequately powered randomised controlled trials to investigate whether interventions such as advice to rest are indeed effective in reducing pre-eclampsia. In future, an economic&lt;BR&gt;model should be developed that considers not just pre-eclampsia, but other related outcomes, particularly those relevant to the infant such as perinatal death, preterm birth and small for gestational age. Such a&lt;BR&gt;modelling project should make provision for primary data collection on the safety of interventions and their associated costs.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Full reference&lt;/STRONG&gt;: Meads CA, Cnossen JS, Meher S, Juarez-Garcia A, ter Riet G, Duley L, &lt;EM&gt;et al&lt;/EM&gt;. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technology Assessment 2008;12(6).&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>88882</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/monitoring-nhsbsp-standards-v3.pdf]]&gt;</url>
    <title>Monitoring NHS Breast Screening Programme (NHSBSP) standards. A guide for quality assurance reference centres</title>
    <publicationDate>2005-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,IMPLEMENTATION,BREAST CANCER,QUALITY ASSURANCE,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Guide on quality assurance</description>
    <body>&lt;![CDATA[ &lt;P&gt;This publication by the NHS Breast Screening Programme (NHSBSP)&amp;nbsp;provides detailed instruction and guidance to Quality Assurance Reference Centres and other staff interested in measuring the performance of the NHSBSP. &lt;/P&gt;
&lt;P&gt;Updated Dec 2005.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69794</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/213_ct_cetap_e.pdf]]&gt;</url>
    <title>Multi-slice/helical computed tomography for lung cancer screening</title>
    <publicationDate>2003-06-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,CANCER,SCREENING,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA)&amp;nbsp;publishes Issues in Emerging Health Technologies, a series of bulletins highlighting technologies. 
&lt;P align=left&gt;This bulletin looks at the use of helical computed tomography for lung cancer screening and summarises by stating that "compared to chest radiography, multislice/helical computed tomography (CT) is able to detect lung cancers of smaller size and at an earlier stage...however, the rate of detecting benign lung nodules is high using these technologies.....presently, even for smokers, screening for lung cancer with multi-slice/helical CT would be premature".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69799</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/211_ct_scanning_cetap_e.pdf]]&gt;</url>
    <title>Multi-slice/spiral computed tomography for screening for coronary artery disease</title>
    <publicationDate>2003-02-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CORONARY HEART DISEASE,SCREENING,ADULT,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA)&amp;nbsp;publishes Issues in Emerging Health Technologies, a series of bulletins highlighting technologies. 
&lt;P align=left&gt;This bulletin looks at the use of spiral computed tomography (CT)&amp;nbsp;for screening for coronary artery disease and summarises by stating that "there is insufficient evidence at this time to suggest that asymptomatic people derive clinical benefit from undergoing coronary calcification screening using multislice computed tomography (MSCT) or spiral CT scanning"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63604</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.chlamydiascreening.nhs.uk/]]&gt;</url>
    <title>National Chlamydia Screening Programme (NCSP)</title>
    <publicationDate>2004-07-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,OUTCOMES,SEXUALLY TRANSMITTED INFECTIONS,GENITOURINARY DISEASES,SCREENING,ADULT,CHLAMYDIA,PUBLIC HEALTH,DETERMINANTS,SEXUAL HEALTH,INDIVIDUAL BEHAVIOUR,MALE SEXUALLY TRANSMITTED INFECTIONS,CHLAMYDIA,BACTERIAL,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This website provides information about chlamydia, the National Chlamydia Screening Programme (NCSP) and&amp;nbsp;access to local services for opportunistic chlamydia screening. &lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>103146</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/assetRoot/04/11/84/26/04118426.pdf]]&gt;</url>
    <title>National Chlamydia Screening Programme Phase 3 Guide</title>
    <publicationDate>2005-08-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,CHLAMYDIA,SCREENING,IMPLEMENTATION,ADULT,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,CHLAMYDIA,BACTERIAL,MALE SEXUALLY TRANSMITTED INFECTIONS,MALE UROGENITAL DISORDERS,CHLAMYDIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This guide has been put together to support Strategic Health Authorities and Primary Care Trusts establish the chlamydia screening programme in local areas. It contains information and materials that have been developed following experience with implementing the programme so far. The information is not prescriptive but aims to facilitate development of common structures, processes and outputs.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>60288</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60288]]&gt;</url>
    <title>National Down's Syndrome Screening Programme for England. A handbook for staff</title>
    <publicationDate>2004-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),IMPLEMENTATION,ANTENATAL,SCREENING,14-20 WEEKS,DOWN'S SYNDROME (SERUM),11-14 WEEKS,MANAGEMENT,DOWN'S SYNDROME]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A handbook written for those working within the Down's Syndrome Screening Programme.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Down's Syndrome Screening Programme for England. A handbook for staff&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This handbook has been written for those who will need to develop their services to meet the requirements for the Down's Syndrome Screening Programme for offering a screening test for all pregnant women.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260778</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260778]]&gt;</url>
    <title>National Down's Syndrome Screening Programme for England: 3rd annual programme report 2005/2006</title>
    <publicationDate>2006-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report outlining the progress of the Down's Syndrome screening programme</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Down's Syndrome Screening Programme for England: 3rd annual programme report 2005/2006&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The 3rd annual report for the Down's Syndrome Screening Programme outlining the progress.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>332207</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://cpd.screening.nhs.uk/getdata.php?id=1067]]&gt;</url>
    <title>National Education and Training Needs Analysis for Antenatal and the Newborn Blood Spot Screening Services across England 2007</title>
    <publicationDate>2007-04-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ IMPLEMENTATION,ANTENATAL,SCREENING,MANAGEMENT,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;national survey was carried out by the UK NSC Regional Teams and Education Lead in 2007 to ascertain education and training needs and preferred methodology in relation to the NHS antenatal and newborn screening programmes. Recommendations from the reports have informed the NHS education action plan.&lt;/P&gt;
&lt;P&gt;This follows on from&amp;nbsp;the &lt;A href="nelh:66392:0" name=internalLink&gt;Training Needs Analysis&amp;nbsp;survey in 2004&lt;/A&gt;.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>308877</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.shef.ac.uk/content/1/c6/01/84/53/Report%20for%20UKNSC.pdf]]&gt;</url>
    <title>National Evaluation of DHDS Diabetes Screening Pilot Programme</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>University of Sheffield</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ VASCULAR RISK,CAUSES,SCREENING,ADULT,DIABETES,TYPE 2]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Final evaluation report of the Diabetes Heart Disease and Stroke (DHDS) Prevention Project</description>
    <body>&lt;![CDATA[ This report presents the evaluation findings for the DHDS prevention project, and discusses some of the potential implications for the future development of vascular risk assessment and screening activity in general practice settings.]]&gt;</body>
  </document>
  <document>
    <id>260765</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260765]]&gt;</url>
    <title>National Fetal Anomaly Ultrasound Screening Programme for England - First Annual Report 2005-06</title>
    <publicationDate>2006-09-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ 18-20 WEEKS,ANTENATAL,SCREENING,FETAL ANOMALY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report sets out the programme development</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Fetal Anomaly Ultrasound Screening Programme for England - First Annual Report 2005-06&lt;/pageTitle&gt;&lt;pageBody&gt;This is the first report of the National Fetal Anomaly Ultrasound Screening Programme and sets out programme development over the past two years. &lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269344</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269344]]&gt;</url>
    <title>National Knowledge Week for Antenatal Care 1st - 7th October 2007</title>
    <publicationDate>2007-09-24T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Knowledge Week for Antenatal Care 1st - 7th October 2007&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage10 border=1 name=nelh_tempImage10 alt="Group of pregnant women waiting for a check-up" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269344/nelhImp_0005_pregnantwomen.jpg" width=200 height=133&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage1 border=1 name=nelh_tempImage1 alt="optimum testing times" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269344/nelhImp_0004_timeline.jpg" width=212 height=137&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="pregnant woman walking" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269344/nelhImp_0006_pregnancy.jpg" width=188 height=132&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;EM&gt;&lt;/EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;EM&gt;National Knowledge Weeks contain recent, relevant evidence and summaries written by health professionals, on particular topics. The screening specialist&amp;nbsp;collection and the women's health specialist&amp;nbsp;collection welcome you to&lt;/EM&gt;&lt;/EM&gt;&lt;EM&gt;&amp;nbsp;the National Knowledge Week on Antenatal Care 1st -7th&amp;nbsp;October 2007. As part of this National Knowledge Week:&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;EM&gt;the screening specialist&amp;nbsp;collection has&amp;nbsp;created&amp;nbsp;entries&amp;nbsp;on Antenatal and Newborn&amp;nbsp;Screening topics&amp;nbsp;- each&amp;nbsp;topic contains a summary written by a health professional with associated references, an &lt;A href="http://www.library.nhs.uk/screening/Page.aspx?pagename=EVIDENCE" target="_blank"&gt;annual evidence update&lt;/A&gt; and information to give pregnant women and/or parents&lt;/EM&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;UL&gt;
&lt;LI&gt;&lt;EM&gt;the women's health specialist&amp;nbsp;collection has created&amp;nbsp;entries&amp;nbsp;on Antenatal Care, including common pregnancy problems&lt;/EM&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Contents&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269308:0" name=internalLink&gt;&lt;A href="nelh:269308:0" name=internalLink&gt;Preconception Care&lt;/A&gt;&lt;A disabled href="nelh:269308:0" name=internalLink&gt;&lt;/A&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:268964:0" name=internalLink&gt;Screening for Sickle Cell and Thalassaemia&lt;/A&gt; (antenatal and newborn)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269084:0" name=internalLink&gt;Screening for Down's Syndrome&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:267585:0" name=internalLink&gt;Screening for Infectious Diseases in Pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269076:0" name=internalLink&gt;Screening for Fetal Anomalies&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269073:0" name=internalLink&gt;Newborn and Infant Physical Examination&lt;/A&gt; (NIPE)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269239:0" name=internalLink&gt;Newborn Bloodspot Screening&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/ent/ViewResource.aspx?resID=250766&amp;amp;tabID=290" target="_blank"&gt;Newborn Hearing Screening&lt;/A&gt; (this is an external link to the newborn hearing screening section of the National Knowledge Week&amp;nbsp;for&amp;nbsp;Hearing - &amp;nbsp;produced by the ENT and Audiology&amp;nbsp;specialist&amp;nbsp;collection in March 2007)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/womenshealth/Page.aspx?pagename=ANCNKWHOME" target="_blank"&gt;Antenatal Care&lt;/A&gt;&amp;nbsp;- including information needs, common pregnancy problems, antenatal care, ultrasound and&amp;nbsp;fetal heart rate monitoring&amp;nbsp;(this is an external link to the National Knowledge Week on Antenatal Care section produced by the women's health specialist collection)&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Contributors&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Summaries for screening sections:&lt;/EM&gt; Sandra Anglin, Lyn Bryant, Christine Cavanagh, Jean Chapple, Cathy Coppinger, David Elliman, Adam Fisher, John Marshall, Catherine Peckham, Allison Streetly, Fiona Vicente, Pat Ward&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Evidence updates,&amp;nbsp;project management, page design and creation:&lt;/EM&gt; Nicola Pearce-Smith&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Thanks to:&lt;/EM&gt; Jo Harcombe, Nic Rosen, all Antenatal and Child Health Screening Co-ordinators&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60457</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60457]]&gt;</url>
    <title>National Screening Committee policy - abdominal aortic aneurysm screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for abdominal aortic anuerysm (AAA) screening in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - abdominal aortic aneurysm screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Abdominal aortic aneurysm&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=46" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is an &lt;A href="http://aaa.screening.nhs.uk/" target="_blank"&gt;NHS Abdominal Aortic Aneurysm Screening Programme&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60458</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60458]]&gt;</url>
    <title>National Screening Committee policy - alcohol problem screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ALCOHOL MISUSE,ADULT CONDITIONS,MENTAL HEALTH,POPULATION BASED &amp; PREVENTATIVE SERVICES,POLICY,SCREENING,ALCOHOL PROBLEMS,ADULT,SCREENING,PUBLIC HEALTH,DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,INDIVIDUAL BEHAVIOUR,ALCOHOL CONSUMPTION,MANAGEMENT &amp; POLICY,HEALTHCARE &amp; HEALTH SERVICES,HEALTH SERVICES,SERVICES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for alcohol problems in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - alcohol problem screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Alcohol Problems&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=47" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60459</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60459]]&gt;</url>
    <title>National Screening Committee policy - Alzheimer's disease screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ALZHEIMER'S DISEASE,SCREENING,OLD AGE,MENTAL HEALTH,DEMENTIA,LATER LIFE,SCREENING AND SURVEILLANCE,DEMENTIA,ADULT,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for Alzheimer's disease in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - Alzheimer's disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;TABLE border=0 cellSpacing=0 cellPadding=0 width=639&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD vAlign=top width=639 colSpan=3&gt;
&lt;H2 align=left&gt;Alzheimer's Disease&lt;/H2&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position&amp;nbsp;&lt;/B&gt; 
&lt;P align=left&gt;Systematic population screening programme not recommended 
&lt;P align=left&gt;&amp;nbsp; 
&lt;P align=left&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=48" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt; 
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88267</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88267]]&gt;</url>
    <title>National Screening Committee policy - amino acid metabolism disorder screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD HEALTH,METABOLIC DISEASE,GUIDELINES/EBM,SCREENING,AMINO ACID METABOLISM DISORDERS,SPECIALTIES,NEONATAL,STAFF USE,NOT ROUTINELY OFFERED,NEWBORN,AMINO ACID METABOLISM DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for argininosuccinic acidaemia, citrullinaemia, homocystinuria, maple syrup urine disease and tyrosinaemia type I (in the newborn)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - amino acid metabolism disorder screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Amino acid metabolism disorders&lt;/H2&gt;
&lt;P&gt;This policy covers the following rare inherited amino acid metabolism disorders:&lt;/P&gt;
&lt;P&gt;Argininosuccinic acidaemia&lt;BR&gt;Citrullinaemia&lt;BR&gt;Homocystinuria&lt;BR&gt;Maple syrup urine disease&lt;BR&gt;Tyrosinaemia type I&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=61" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32240</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32240]]&gt;</url>
    <title>National Screening Committee policy - anaemia screening (in pregnancy)</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,WOMEN'S HEALTH,ANAEMIA,BEFORE 16 WEEKS,ANAEMIA,28 WEEKS,ANAEMIA,36 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for anaemia in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - anaemia screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Anaemia (in pregnancy)&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended, clinical practice guidelines covered by NICE&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=82" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&lt;I&gt;&lt;/I&gt;&amp;nbsp; 
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60460</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60460]]&gt;</url>
    <title>National Screening Committee policy - anal cancer screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,ANAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for anal cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - anal cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Anal cancer&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&amp;nbsp;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=50" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt; 
&lt;P align=justify&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp; &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>31710</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=31710]]&gt;</url>
    <title>National Screening Committee policy - asymptomatic bacteriuria screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,BACTERIURIA,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for asymptomatic bacteriuria in pregnancy.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - asymptomatic bacteriuria screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Asymptomatic bacteriuria in pregnancy&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current&amp;nbsp;policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended, clinical practice guidelines covered by NICE&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=83" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>94835</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=94835]]&gt;</url>
    <title>National Screening Committee policy - atrial fibrillation screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED,ATRIAL FIBRILLATION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for atrial fibrillation</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - atrial fibrillation screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Atrial fibrillation&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=49" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60310</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60310]]&gt;</url>
    <title>National Screening Committee policy - autism screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ AUTISM,CHILD,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for autism in childhood</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - autism screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Autism&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=33" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51534</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51534]]&gt;</url>
    <title>National Screening Committee policy - bacterial vaginosis screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ WOMEN'S HEALTH,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,ANTENATAL,SCREENING,NOT ROUTINELY OFFERED,BACTERIAL VAGINOSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for bacterial vaginosis in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - bacterial vaginosis screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Bacterial Vaginosis&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;BR&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=84" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32687</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32687]]&gt;</url>
    <title>National Screening Committee policy - biliary atresia screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,NEWBORN,BILIARY ATRESIA,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for biliary atresia.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - biliary atresia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Biliary atresia&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=62" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32692</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32692]]&gt;</url>
    <title>National Screening Committee policy - biotinidase deficiency screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,BIOTINIDASE DEFICIENCY,NEWBORN,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for biotinidase deficiency.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - biotinidase deficiency screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Biotinidase deficiency&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;National Screening Committee&amp;nbsp; current policy position&lt;/H2&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=63" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60477</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60477]]&gt;</url>
    <title>National Screening Committee policy - bladder cancer screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,CANCER,BLADDER,SCREENING,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,BLADDER CANCER,MALE BLADDER DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for bladder cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - bladder cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Bladder cancer&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee&amp;nbsp;current policy position&lt;/B&gt; 
&lt;P&gt;Systematic population screening programme not recommended
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=51" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32576</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32576]]&gt;</url>
    <title>National Screening Committee policy - blood group and RhD status, and red cell alloantibody screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,BLOOD GROUP &amp; RHD STATUS,WOMEN'S HEALTH,BEFORE 16 WEEKS,RED-CELL ALLOANTIBODIES,28 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for blood group and RhD status, and red cell alloantibody screening in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - blood group and RhD status, and red cell alloantibody screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Blood group and RhD status, and red cell alloantibodies (formerly haemolytic disease of the newborn)&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended, clinical practice guidelines covered by NICE&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=85" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60586</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60586]]&gt;</url>
    <title>National Screening Committee policy - bowel cancer screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ COLORECTAL (BOWEL) CANCER,ADULT,SCREENING,GASTROENTEROLOGY &amp; LIVER DISEASES,DISEASE PREVENTION,COLON &amp; RECTUM,RECENT ADDITIONS,SCREENING,CANCER,FEBRUARY 2010]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for bowel (colorectal) cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - bowel cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Bowel (colorectal) cancer&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position&amp;nbsp;&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=52" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;There is a National Screening Programme for &lt;A href="http://www.cancerscreening.nhs.uk/bowel/index.html" target="_blank"&gt;Bowel Cancer&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60580</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60580]]&gt;</url>
    <title>National Screening Committee policy - breast cancer screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,SCREENING,IMPLEMENTATION,ADULT,BREAST CANCER]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for breast cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - breast cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Breast cancer&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=53" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;There is a national screening programme for &lt;A href="http://www.cancerscreening.nhs.uk/breastscreen/index.html" target="_blank"&gt;Breast Cancer&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93705</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=93705]]&gt;</url>
    <title>National Screening Committee policy - Canavan's disease screening</title>
    <publicationDate>2006-07-31T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,NEWBORN,SCREENING,CANNAVANS DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on newborn screening for Canavan's disease</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - Canavan's disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Canavan's&amp;nbsp;disease&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=64" target="_blank"&gt;Full policy position&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60581</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60581]]&gt;</url>
    <title>National Screening Committee policy - cervical cancer screening</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,ADULT,IMPLEMENTATION,SCREENING,MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for cervical cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - cervical cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Cervical cancer&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy&amp;nbsp;position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=54" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt; 
&lt;P align=justify&gt;&amp;nbsp; 
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt; 
&lt;P&gt;There&amp;nbsp;are National Screening Programmes for cervical cancer in all four nations 
&lt;P&gt;&lt;STRONG&gt;England:&lt;/STRONG&gt; &lt;BR&gt;&lt;A href="http://www.cancerscreening.nhs.uk/cervical/index.html" target="_blank"&gt;NHS Cervical Screening Programme&lt;/A&gt; 
&lt;P&gt;&lt;STRONG&gt;Wales:&lt;/STRONG&gt; &lt;BR&gt;&lt;A href="http://www.screeningservices.org.uk/csw/" target="_blank"&gt;Cervical Screening Wales&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Scotland:&lt;/STRONG&gt; &lt;BR&gt;&lt;A href="http://www.nsd.scot.nhs.uk/services/screening/cervical.html" target="_blank"&gt;National Services Division Scotland: Cervical Screening&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Northern Ireland:&lt;/STRONG&gt; &lt;BR&gt;&lt;A href="http://www.cancerscreening.n-i.nhs.uk/cervical/toc.html" target="_blank"&gt;NI Cancer Screening Programmes: Cervical Screening&lt;BR&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60583</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60583]]&gt;</url>
    <title>National Screening Committee policy - chlamydia infection screening (in adults)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,CHLAMYDIA,MANAGEMENT,PROVISION OF CARE,SEXUAL HEALTH,OUTCOMES,GENITOURINARY DISEASES,SEXUALLY TRANSMITTED INFECTIONS,SCREENING,ADULT,IMPLEMENTATION,CHLAMYDIA,WOMEN'S HEALTH,PUBLIC HEALTH,DETERMINANTS,INDIVIDUAL BEHAVIOUR,SEXUAL HEALTH,MALE UROGENITAL DISORDERS,BACTERIAL,CHLAMYDIA,MALE SEXUALLY TRANSMITTED INFECTIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for chlamydia infection in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - chlamydia infection screening (in adults)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Chlamydia infection&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National&amp;nbsp;Screening&amp;nbsp;Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=3" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As part of the Department of Health's Sexual Health Strategy, the &lt;A href="http://www.chlamydiascreening.nhs.uk/index.htm" target="_blank"&gt;National Chlamydia Screening Programme&lt;/A&gt; primarily targets young women under 25, who access the sexual health services.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32072</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32072]]&gt;</url>
    <title>National Screening Committee policy - chlamydia screening (in pregnancy)</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,WOMEN'S HEALTH,CHLAMYDIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for chlamydia in pregnancy.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - chlamydia screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Chlamydia&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=86" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60996</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60996]]&gt;</url>
    <title>National Screening Committee policy - chronic kidney disease screening</title>
    <publicationDate>2008-12-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ KIDNEY DISEASE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,CHRONIC KIDNEY DISEASE,SCREENING OPTIONS,SCREENING TESTS,KIDNEY DISEASES,CHRONIC COMPLICATIONS,NEPHROPATHY,CAUSES,DIABETES,ADULT,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for kidney disease in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - chronic kidney disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Chronic Kidney Disease&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current p&lt;/B&gt;&lt;B&gt;olicy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=4" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>301336</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=301336]]&gt;</url>
    <title>National Screening Committee policy - coeliac disease screening</title>
    <publicationDate>2008-12-16T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ADULT,SCREENING,COELIAC DISEASE,FEBRUARY 2010,SCREENING,RECENT ADDITIONS,SMALL INTESTINE,COELIAC DISEASE,GASTROENTEROLOGY &amp; LIVER DISEASES,DISEASE PREVENTION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for coeliac disease in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - coeliac disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Coeliac disease &lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=5" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56188</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56188]]&gt;</url>
    <title>National Screening Committee policy - congenital adrenal hyperplasia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CONGENITAL ADRENAL HYPERPLASIA,NEWBORN,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for congenital adrenal hyperplasia</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - congenital adrenal hyperplasia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Congenital adrenal hyperplasia&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current&amp;nbsp;policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=65" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57177</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57177]]&gt;</url>
    <title>National Screening Committee policy - congenital cataract screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PHYSICAL (6-8 WKS),PHYSICAL (&lt;72HRS),NEWBORN,EYES,EYES,EYES AND VISION,CHILD,SCREENING,CONDITIONS,LENS,CATARACT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for congenital cataract</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - congenital cataract screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Congenital cataract&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=66" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a National Screening Programme for &lt;A href="http://newbornphysical.screening.nhs.uk/" target="_blank"&gt;Newborn and Infant Physical Examination&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57175</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57175]]&gt;</url>
    <title>National Screening Committee policy - congenital heart disease screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CARDIOVASCULAR DISEASES,DIAGNOSIS,CONDITIONS,GENERAL,CHILD HEALTH,CARDIOLOGY,SCREENING,SCREENING,CHILD,CONGENITAL HEART DISEASE,NEONATAL,SPECIALTIES,HEART,CONGENITAL HEART DISEASE,DIAGNOSIS,NEWBORN,PHYSICAL (&lt;72HRS),PHYSICAL (6-8 WKS),HEART]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for congenital heart disease</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - congenital heart disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Congenital heart disease&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National&lt;/STRONG&gt; &lt;STRONG&gt;Screening Committee current policy position &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=67" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a National Screening Programme for &lt;A href="http://newbornphysical.screening.nhs.uk/" target="_blank"&gt;Newborn and Infant Physical Examination&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56895</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56895]]&gt;</url>
    <title>National Screening Committee policy - congenital hypothyroidism screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,BLOODSPOT (&lt;1WK),CONGENITAL HYPOTHYROIDISM,HYPERTHYROIDISM,SPECIALTIES,STAFF USE,SCREENING,CHILD HEALTH,ENDOCRINOLOGY,GUIDELINES/EBM,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for congenital hypothyroidism</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - congenital hypothyroidism screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Congenital hypothyroidism&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/H2&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=68" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The &lt;A href="http://newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;UK Newborn Screening Programme Centre&lt;/A&gt;&amp;nbsp;oversees screening for congenital hypothyroidism.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57178</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57178]]&gt;</url>
    <title>National Screening Committee policy - cryptorchidism screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,TESTES,NEWBORN,PHYSICAL (&lt;72HRS),PHYSICAL (6-8 WKS),TESTES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for cryptorchidism in newborn baby boys</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - cryptorchidism screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Cryptorchidism &lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;N&lt;/B&gt;&lt;B&gt;ational Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=70" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a National Screening Programme for &lt;A href="http://newbornphysical.screening.nhs.uk/" target="_blank"&gt;Newborn and Infant Physical Examination&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;I&gt;&lt;/I&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35569</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35569]]&gt;</url>
    <title>National Screening Committee policy - cystic fibrosis screening (in pregnancy)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,WOMEN'S HEALTH,NOT ROUTINELY OFFERED,CYSTIC FIBROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for cystic fibrosis in pregnancy.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - cystic fibrosis screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Cystic Fibrosis (in pregnancy)&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt; 
&lt;P&gt;Systematic population screening programme not recommended
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=87" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56899</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56899]]&gt;</url>
    <title>National Screening Committee policy - cystic fibrosis screening (newborn)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,RESPIRATORY,CHILD HEALTH,SCREENING,SPECIALTIES,NEONATAL,CYSTIC FIBROSIS,CYSTIC FIBROSIS,BLOODSPOT (&lt;1WK),NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for cystic fibrosis in the newborn</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - cystic fibrosis screening (newborn)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Cystic Fibrosis (newborn)&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt; &lt;/H2&gt;
&lt;P&gt;Systematic population screening programme recommended
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=72" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt; 
&lt;P&gt;The &lt;A href="http://newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;UK Newborn Screening Centre Programme&lt;/A&gt;&amp;nbsp;oversees screening for cystic fibrosis.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35687</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35687]]&gt;</url>
    <title>National Screening Committee policy - cytomegalovirus screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,CYTOMEGALOVIRUS,WOMEN'S HEALTH,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for cytomegalovirus in pregnancy.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - cytomegalovirus screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Cytomegalovirus&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=88" target="_blank"&gt;&lt;STRONG&gt;Full policy and&amp;nbsp;supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93689</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=93689]]&gt;</url>
    <title>National Screening Committee policy - dental disease screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,NOT ROUTINELY OFFERED,DENTAL DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for dental disease in children.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - dental disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Dental disease&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&amp;nbsp;&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN lang=EN-GB&gt;&lt;SPAN lang=EN-GB&gt;Systematic population screening programme not recommended&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN lang=EN-GB&gt;&lt;SPAN lang=EN-GB&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN lang=EN-GB&gt;&lt;SPAN lang=EN-GB&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=32" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60968</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60968]]&gt;</url>
    <title>National Screening Committee policy - depression screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,ADULT CONDITIONS,SCREENING,ANTENATAL,ADULT,DEPRESSION,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,DEPRESSION,POSTNATAL DEPRESSION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for depression in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - depression screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Depression&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H3&gt;National Screening Committee current&amp;nbsp;policy position&lt;/H3&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=6" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;See also &lt;A href="nelh:60978:0" name=internalLink&gt;Postnatal depression in pregnancy&lt;/A&gt; and &lt;A href="nelh:346138:0" name=internalLink&gt;Postnatal depression&lt;/A&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60313</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60313]]&gt;</url>
    <title>National Screening Committee policy - developmental and behavioural problem screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CHILD,SCREENING,DEVELOPMENT &amp; BEHAVIOUR]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for developmental and behavioural problems in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - developmental and behavioural problem screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Developmental and behavioural problems&lt;/H2&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=34" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57180</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57180]]&gt;</url>
    <title>National Screening Committee policy - developmental dislocation of the hip</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ HIPS,PHYSICAL (6-8 WKS),PHYSICAL (&lt;72HRS),NEWBORN,HIPS,CHILD,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for developmental dislocation of the hip</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - developmental dislocation of the hip&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Developmental dislocation of the hip&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H3&gt;National Screening Committee current policy position &lt;/H3&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=71" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a National Screening Programme for &lt;A href="http://newbornphysical.screening.nhs.uk/" target="_blank"&gt;Newborn and Infant Physical Examination&lt;/A&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp; &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60981</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60981]]&gt;</url>
    <title>National Screening Committee policy - diabetes screening (in adults)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ VASCULAR RISK,STROKE,ISCHAEMIC STROKE,PREVENTION,PRIMARY PREVENTION,HAEMORRHAGIC STROKE,PREVENTION,CAUSES / RISK FACTORS,CAUSES / RISK FACTORS,PREVENTION,DIABETES MELLITUS,CAUSES / RISK FACTORS,OCT-DEC 08,CAUSES,DIABETES,TYPE 2,CAUSES,ADULT,SCREENING,CARDIOVASCULAR DISEASES,CAUSES AND RISK FACTORS,CONDITIONS,DIABETES MELLITUS,TYPE 1,DIABETES,NOT ROUTINELY OFFERED,LATER LIFE,SCREENING AND SURVEILLANCE,DIABETES,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for diabetes in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - diabetes screening (in adults)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Diabetes&lt;/H2&gt;
&lt;P align=justify&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=7" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60985</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60985]]&gt;</url>
    <title>National Screening Committee policy - diabetic retinopathy screening</title>
    <publicationDate>2005-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ RETINOPATHY,DIABETIC RETINOPATHY,RETINA,CONDITIONS,EYE DISEASES,MANAGEMENT,ADULT,SCREENING,IMPLEMENTATION,DIABETES,CAUSES,RETINOPATHY,DIABETIC RETINOPATHY,EYES AND VISION,CHRONIC COMPLICATIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for diabetic retinopathy in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - diabetic retinopathy screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Diabetic retinopathy&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=8" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;There is an &lt;A href="http://www.retinalscreening.nhs.uk/pages/" target="_blank"&gt;English National Screening Programme for Diabetic Retinopathy&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60987</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60987]]&gt;</url>
    <title>National Screening Committee policy - domestic violence screening (in adults)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MENTAL HEALTH,ADULT CONDITIONS,NOT ROUTINELY OFFERED,DOMESTIC VIOLENCE OR PARTNER ABUSE,DETERMINANTS,AGE GROUPS,ADULTS,DOMESTIC VIOLENCE,ADULT,SCREENING,PUBLIC HEALTH,SOCIAL DETERMINANTS,MONTHLY ADDITIONS,POPULATIONS,GROUPS,2009 SEPTEMBER,ABUSE,DOMESTIC VIOLENCE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for domestic violence in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - domestic violence screening (in adults)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Domestic violence&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=9" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61080</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61080]]&gt;</url>
    <title>National Screening Committee policy - domestic violence screening (in pregnancy)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL CARE,SCREENING,MENTAL HEALTH,ADULT CONDITIONS,DOMESTIC VIOLENCE OR PARTNER ABUSE,DOMESTIC VIOLENCE,NOT ROUTINELY OFFERED,DETERMINANTS,OUTCOMES,PREGNANCY &amp; CHILDBIRTH DISORDERS,SCREENING,NORMAL PREGNANCY,WOMEN'S HEALTH,ANTENATAL,PUBLIC HEALTH,SOCIAL DETERMINANTS,MONTHLY ADDITIONS,2009 SEPTEMBER,ABUSE,DOMESTIC VIOLENCE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for domestic violence in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - domestic violence screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Domestic Violence (pregnancy)&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=89" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;See also &lt;A href="http://www.library.nhs.uk/SCREENING/ViewResource.aspx?resID=60987&amp;amp;tabID=288&amp;amp;catID=5531" target="_blank"&gt;Domestic Violence&lt;/A&gt; in adults.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35689</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35689]]&gt;</url>
    <title>National Screening Committee policy - Down's Syndrome screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,SCREENING,ANTENATAL CARE,WOMEN'S HEALTH,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),NORMAL PREGNANCY,ANTENATAL,SCREENING,IMPLEMENTATION,GENETICS - PRACTICE &amp; ISSUES,SYSTEMS &amp; SYMPTOMS,MANAGEMENT,DOWN SYNDROME (DS),11-14 WEEKS,DOWN'S SYNDROME (SERUM),14-20 WEEKS,GENETIC SCREENING (FOR CONDITIONS),CONDITIONS D-F,PREGNANCY,HEART (CARDIO)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for Down's Syndrome in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - Down's Syndrome screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Down's Syndrome&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;BR&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=90" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Programme Centre in Exeter is responsible for both the &lt;A href="http://fetalanomaly.screening.nhs.uk/" target="_blank"&gt;NHS Fetal Anomaly Ultrasound Screening Programme and the Down's syndrome Screening Programme&lt;/A&gt;.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>94833</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=94833]]&gt;</url>
    <title>National Screening Committee policy - familial dysautonomia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,SCREENING,WOMEN'S HEALTH,NOT ROUTINELY OFFERED,FAMILIAL DYSAUTONOMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for familial dysautonomia in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - familial dysautonomia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Familial Dysautonomia&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp; 
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt; 
&lt;P&gt;Systematic population screening programme not recommended&amp;nbsp;
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=91" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt; 
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60325</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60325]]&gt;</url>
    <title>National Screening Committee policy - familial hypercholesterolaemia (hyperlipidaemia) screening (adults)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,ADULT,HYPERLIPIDAEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for familial hypercholesterolaemia in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - familial hypercholesterolaemia (hyperlipidaemia) screening (adults)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Familial hypercholesterolaemia (hyperlipidaemia) screening in adults&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=10" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>316084</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=316084]]&gt;</url>
    <title>National Screening Committee policy - familial hypercholesterolaemia (hyperlipidaemia) screening (children)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,HYPERLIPIDAEMIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for familial hypercholesterolaemia in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - familial hypercholesterolaemia (hyperlipidaemia) screening (children)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Familial hypercholesterolaemia (hyperlipidaemia) in children&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=35" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88277</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88277]]&gt;</url>
    <title>National Screening Committee policy - fatty-acid oxidation disorder screening</title>
    <publicationDate>2005-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,NOT ROUTINELY OFFERED,STAFF USE,SPECIALTIES,NEONATAL,FATTY ACID OXIDATION DISORDERS,SCREENING,GUIDELINES/EBM,METABOLIC DISEASE,CHILD HEALTH,SCREENING,FATTY ACID OXIDATION DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for carnitine uptake defect, long chain hydroxyacyl CoA dehydrogenase deficiency, medium chain acyl CoA dehydrogenase deficiency, trifunctional protein deficiency and very long chain acyl CoA dehydrogenase deficiency (in the newborn)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - fatty-acid oxidation disorder screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Fatty-acid oxidation disorders&lt;/H2&gt;
&lt;P&gt;This policy covers the following rare inherited&amp;nbsp;fatty acid&amp;nbsp;oxidation&amp;nbsp;disorders:&lt;/P&gt;
&lt;H2&gt;Carnitine uptake defect&lt;BR&gt;Long chain hydroxyacyl CoA dehydrogenase deficiency&lt;BR&gt;Trifunctional protein deficiency&lt;BR&gt;Very long chain acyl CoA dehydrogenase deficiency&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=73" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35693</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35693]]&gt;</url>
    <title>National Screening Committee policy - fetal anomaly screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ 18-20 WEEKS,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,WOMEN'S HEALTH,FETAL ANOMALY,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for fetal anomalies in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - fetal anomaly screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Fetal anomalies &lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=92" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Programme&lt;/B&gt; 
&lt;P&gt;There is a &lt;A href="http://fetalanomaly.screening.nhs.uk/" target="_blank"&gt;Fetal Anomaly Screening Programme&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp; &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32280</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32280]]&gt;</url>
    <title>National Screening Committee policy - fetomaternal alloimmune thrombocytopenia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,THROMBOCYTOPENIA,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on antenatal screening for fetomaternal alloimmune thrombocytopenia.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - fetomaternal alloimmune thrombocytopenia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Foetomaternal alloimmune thrombocytopenia &lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=57" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35756</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35756]]&gt;</url>
    <title>National Screening Committee policy - fragile X screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,FRAGILE X,WOMEN'S HEALTH,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for fragile X in pregnancy.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - fragile X screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2 align=left&gt;Fragile X&lt;/H2&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=93" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88275</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88275]]&gt;</url>
    <title>National Screening Committee policy - galactosaemia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,NOT ROUTINELY OFFERED,STAFF USE,NEONATAL,SPECIALTIES,SCREENING,GUIDELINES/EBM,METABOLIC DISEASE,CHILD HEALTH,SCREENING,GALACTOSEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for galactosaemia (in the newborn)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - galactosaemia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Galactosaemia&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=74" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93708</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=93708]]&gt;</url>
    <title>National Screening Committee policy - Gauchers disease screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN,NOT ROUTINELY OFFERED,GAUCHERS DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on newborn screening for Gauchers disease</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - Gauchers disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Gauchers&amp;nbsp;disease&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=75" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51535</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51535]]&gt;</url>
    <title>National Screening Committee policy - genital herpes screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ANTENATAL,SCREENING,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,WOMEN'S HEALTH,GENITAL HERPES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,HERPES,VIRAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for genital herpes in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - genital herpes screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Genital Herpes &lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&amp;nbsp;&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=94" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35688</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35688]]&gt;</url>
    <title>National Screening Committee policy - gestational diabetes screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CAUSES,GESTATIONAL DIABETES,SCREENING,ANTENATAL CARE,NOT ROUTINELY OFFERED,WOMEN'S HEALTH,NORMAL PREGNANCY,SCREENING,ANTENATAL,DIABETES,DIABETES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for diabetes in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - gestational diabetes screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2 align=left&gt;Gestational diabetes&lt;/H2&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=95" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61003</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61003]]&gt;</url>
    <title>National Screening Committee policy - glaucoma screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,GLAUCOMA,EYES AND VISION,LATER LIFE,SCREENING AND SURVEILLANCE,SCREENING,EYESIGHT,GLAUCOMA,NOT ROUTINELY OFFERED,GLAUCOMA,CONDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for glaucoma in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - glaucoma screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Glaucoma&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;N&lt;/B&gt;&lt;B&gt;ational Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=11" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>316209</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=316209]]&gt;</url>
    <title>National Screening Committee policy - glomerulonephritis</title>
    <publicationDate></publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,ADULT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for glomerulonephritis</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - glomerulonephritis&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Glomeulonehpritis&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=12" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>59860</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=59860]]&gt;</url>
    <title>National Screening Committee policy - group B streptococcus screening</title>
    <publicationDate>2008-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CHORIOAMNIONITIS,NOT ROUTINELY OFFERED,ANTENATAL,SCREENING,STREPTOCOCCUS B,WOMEN'S HEALTH,INFECTIONS,SCREENING,NORMAL PREGNANCY,ANTENATAL CARE,ANTENATAL PROBLEMS,INTRAPARTUM CARE,COMPLICATED PREGNANCY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for group B streptococcus in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - group B streptococcus screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Group B Streptococcus &lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=96" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60315</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60315]]&gt;</url>
    <title>National Screening Committee policy - growth screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,SCHOOL ENTRY,HEIGHT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for growth disorders in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - growth screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Growth&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=36" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61004</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61004]]&gt;</url>
    <title>National Screening Committee policy - haemochromatosis screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,HAEMOCHROMATOSIS,SCREENING,ADULT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for haemochromatosis in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - haemochromatosis screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Haemochromatosis&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=13" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60318</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60318]]&gt;</url>
    <title>National Screening Committee policy - hearing (child) screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ENT AND AUDIOLOGY,HEARING,SPECIALTIES,CHILD HEALTH,SCREENING,EAR,CHILD,SCREENING,HEARING DISORDERS/ DEAFNESS,GENERAL EAR &amp; AUDITORY,EAR &amp; AUDITORY SYSTEM DISORDERS,CONDITIONS,SCHOOL ENTRY,SPECIALTIES,AUDIOLOGY,ASSESSMENT AND TESTING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy for screening for hearing defects in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hearing (child) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hearing (child)&lt;/H2&gt;
&lt;P align=justify&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=37" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57183</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57183]]&gt;</url>
    <title>National Screening Committee policy - hearing (newborn) screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD HEALTH,EAR,SCREENING,HEARING,NEONATAL,SPECIALTIES,ENT AND AUDIOLOGY,HEARING DISORDERS/ DEAFNESS,GENERAL EAR &amp; AUDITORY,EAR &amp; AUDITORY SYSTEM DISORDERS,NEWBORN,PHYSICAL (&lt;72HRS),CONDITIONS,AUDIOLOGY,SPECIALTIES,NEONATAL SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for newborn hearing.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hearing (newborn) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hearing (newborn) &lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current&amp;nbsp;policy position &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=76" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a &lt;A href="http://hearing.screening.nhs.uk/" target="_blank"&gt;Newborn Hearing Screening Programme&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60960</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60960]]&gt;</url>
    <title>National Screening Committee policy - hearing loss screening</title>
    <publicationDate>2009-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CONDITIONS,NOT ROUTINELY OFFERED,GENERAL EAR &amp; AUDITORY,EAR &amp; AUDITORY SYSTEM DISORDERS,HEARING DISORDERS/ DEAFNESS,OLD AGE,ADULT,SCREENING,DEAFNESS,ENT AND AUDIOLOGY,AUDIOLOGY,SPECIALTIES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for hearing loss in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hearing loss screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hearing loss (adult)&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=14" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35759</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35759]]&gt;</url>
    <title>National Screening Committee policy - hepatitis B screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,WOMEN'S HEALTH,HEPATITIS B,SCREENING,ANTENATAL,RECENT ADDITIONS,SCREENING,PREGNANCY,DISEASE PREVENTION,LIVER,HEPATITIS,HEPATITIS B,GASTROENTEROLOGY &amp; LIVER DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,VIRAL,HEPATITIS B,MALE SEXUALLY TRANSMITTED INFECTIONS,MALE UROGENITAL DISORDERS,FEBRUARY 2010]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for hepatitis B in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hepatitis B screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hepatitis B&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee&amp;nbsp;current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=97" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is an NHS screening programme for&amp;nbsp;&lt;A href="http://infectiousdiseases.screening.nhs.uk/" target="_blank"&gt;Infectious Diseases in Pregnancy&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61085</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61085]]&gt;</url>
    <title>National Screening Committee policy - hepatitis C screening (in adults)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,ADULT,HEPATITIS C,HEPATITIS C,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,DISEASE PREVENTION,HEPATITIS C,LIVER,HEPATITIS,GASTROENTEROLOGY &amp; LIVER DISEASES,SCREENING,RECENT ADDITIONS,FEBRUARY 2010]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for hepatitis C in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hepatitis C screening (in adults)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hepatitis C&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current policy position&amp;nbsp;&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=15" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>35760</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=35760]]&gt;</url>
    <title>National Screening Committee policy - hepatitis C screening (in pregnancy)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,ADULT,HEPATITIS C,WOMEN'S HEALTH,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,HEPATITIS C,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,FEBRUARY 2010,GASTROENTEROLOGY &amp; LIVER DISEASES,HEPATITIS,LIVER,HEPATITIS C,DISEASE PREVENTION,PREGNANCY,SCREENING,RECENT ADDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for hepatitis C in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hepatitis C screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hepatitis C&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&amp;nbsp;&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=98" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51537</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51537]]&gt;</url>
    <title>National Screening Committee policy - HIV screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,ANTENATAL,SCREENING,HIV,WOMEN'S HEALTH,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY,VIRAL,HIV,MALE SEXUALLY TRANSMITTED INFECTIONS,MALE UROGENITAL DISORDERS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for human immunodeficiency virus (HIV) in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - HIV screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;HIV (in pregnancy)&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=100" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is an NHS&amp;nbsp;national screening programme for &lt;A href="http://infectiousdiseases.screening.nhs.uk/" target="_blank"&gt;Infectious Diseases&amp;nbsp;In Pregnancy&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51538</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51538]]&gt;</url>
    <title>National Screening Committee policy - HTLV-1 screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,WOMEN'S HEALTH,HTLV-I,SCREENING,ANTENATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for human t-cell leukaemia virus type 1 (HTLV-1) in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - HTLV-1 screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;HTLV-1 (human t-cell leukaemia virus type 1)&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=99" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>94834</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=94834]]&gt;</url>
    <title>National Screening Committee policy - hypertension (in adults) screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HYPERTENSION,CAUSES AND RISK FACTORS,CARDIOVASCULAR DISEASES,HIGH BLOOD PRESSURE,VASCULAR RISK]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for high blood pressure</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hypertension (in adults) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hypertension&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;&lt;/B&gt;&amp;nbsp; 
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&amp;nbsp; 
&lt;P&gt;Systematic population screening programme not recommended 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=16" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt; 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;The UK NSC recommended the introduction of a &lt;A href="http://screening.nhs.uk/cms.php?folder=2725" target="_blank"&gt;Vascular Risk Management Programme&lt;/A&gt; as a result of the Diabetes, Heart Disease and Stroke (DHDS) prevention project. Coronary heart disease is&amp;nbsp;included in this programme.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60319</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60319]]&gt;</url>
    <title>National Screening Committee policy - hypertension (in children) screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,CHILD,SCREENING,CHILD HEALTH,CARDIOLOGY,GENERAL,HYPERTENSION,DIAGNOSIS,DIAGNOSIS,CONDITIONS,CARDIOVASCULAR DISEASES,SPECIALTIES,HYPERTENSION,HYPERTENSION]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy in screening for hypertension in children.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hypertension (in children) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hypertension (in children)&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=38" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60324</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60324]]&gt;</url>
    <title>National Screening Committee policy - hypertrophic cardiomyopathy screening</title>
    <publicationDate>2008-12-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ HYPERTROPHIC CARDIOMYOPATHY,CARDIOVASCULAR DISEASES,CONDITIONS,ARRHYTHMIA,DIAGNOSIS,DIAGNOSIS,GENERAL,CHILD,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for hypertrophic cardiomyopathy in children
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - hypertrophic cardiomyopathy screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Hypertrophic cardiomyopathy (HCM)&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee Policy Position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=39" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60326</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60326]]&gt;</url>
    <title>National Screening Committee policy - iron deficiency anaemia screening (in children)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,IRON DEFICIENCY ANAEMIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for iron deficiency anaemia in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - iron deficiency anaemia screening (in children)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Iron deficiency anaemia&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=40" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>316195</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=316195]]&gt;</url>
    <title>National Screening Committee policy - kernicterus</title>
    <publicationDate>2007-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NOT ROUTINELY OFFERED,NEWBORN]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on kernicterus</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - kernicterus&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Kernicterus&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=77" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60328</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60328]]&gt;</url>
    <title>National Screening Committee policy - lead poisoning screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,LEAD POISONING,CHILD,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for lead poisoning in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - lead poisoning screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Lead poisoning&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=41" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61086</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61086]]&gt;</url>
    <title>National Screening Committee policy - lung cancer screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,LUNG,ADULT,CANCER,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for lung cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - lung cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Lung cancer&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=18" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57173</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57173]]&gt;</url>
    <title>National Screening Committee policy - medium chain acyl CoA dehydrogenase deficiency (MCADD) screening</title>
    <publicationDate>2007-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,SCREENING,GUIDELINES/EBM,METABOLIC DISEASE,CHILD HEALTH,NEONATAL,SPECIALTIES,MCADD,SCREENING,STAFF USE,GENETICS - PRACTICE &amp; ISSUES,NEWBORN,BLOODSPOT (&lt;1WK),GENETIC SCREENING (FOR CONDITIONS),CONDITIONS D-F,PREGNANCY,FATTY ACID OXIDATION DISORDERS (FOD) (MCAD)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for medium chain acyl CoA dehydrogenase deficiency (MCADD)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - medium chain acyl CoA dehydrogenase deficiency (MCADD) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Medium Chain Acyl CoA Dehydrogenase Deficiency (MCADD)&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&amp;nbsp;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=78" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The &lt;A href="http://newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;UK Newborn Screening Centre Programme&lt;/A&gt; oversees screening for MCADD&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56920</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56920]]&gt;</url>
    <title>National Screening Committee policy - muscular dystrophy screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,MUSCULAR DYSTROPHY,SCREENING,GENETIC CONDITIONS,WEAKNESS &amp; WASTING (NEUROMUSCULAR DISORDERS),SYSTEMS &amp; SYMPTOMS,NEWBORN,DUCHENNE MUSCULAR DYSTROPHY (DMD),GENETIC SCREENING (FOR CONDITIONS),NOT ROUTINELY OFFERED,CONDITIONS D-F,PREGNANCY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for Duchene muscular dystrophy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - muscular dystrophy screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Duchenne muscular dystrophy&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=79" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32581</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32581]]&gt;</url>
    <title>National Screening Committee policy - neonatal alloimmune thrombocytopenia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,THROMBOCYTOPENIA,NEWBORN,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for neonatal alloimmune throbocytopenia.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - neonatal alloimmune thrombocytopenia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Neonatal alloimmune thrombocytopenia&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=31" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61078</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61078]]&gt;</url>
    <title>National Screening Committee policy - neural tube defect (spina bifida) screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,WOMEN'S HEALTH,NEURAL TUBE DEFECTS,ANTENATAL CARE,NORMAL PREGNANCY,SCREENING,18-20 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for neural tube defect in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - neural tube defect (spina bifida) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Neural tube defects (spina bifida)&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=101" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a &lt;A href="http://fetalanomaly.screening.nhs.uk/" target="_blank"&gt;NHS Fetal Anomaly Screening Programme&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57184</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57184]]&gt;</url>
    <title>National Screening Committee policy - neuroblastoma screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,NEWBORN,NEUROBLASTOMA,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for neuroblastoma</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - neuroblastoma screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Neuroblastoma&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=80" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=justify&gt;&amp;nbsp; &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60330</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60330]]&gt;</url>
    <title>National Screening Committee policy - obesity screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,GENERAL,PREVENTION,OVERWEIGHT AND OBESITY,DIAGNOSIS,CARDIOVASCULAR DISEASES,OBESITY,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for obesity in children.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - obesity screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Obesity&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=42" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61087</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61087]]&gt;</url>
    <title>National Screening Committee policy - oral cancer screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,ORAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for oral cancer in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - oral cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Oral cancer&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt; 
&lt;P&gt;Systematic population screening programme not recommended
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=19" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>88276</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=88276]]&gt;</url>
    <title>National Screening Committee policy - organic acid metabolism disorder screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD HEALTH,METABOLIC DISEASE,GUIDELINES/EBM,SCREENING,NEONATAL,SPECIALTIES,STAFF USE,NOT ROUTINELY OFFERED,NEWBORN,ORGANIC ACID METABOLISM DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for beta-ketothiolase deficiency, glutaric acidaemia type I, hydroxymethylglutaric aciduria, isovaleric acidaemia, 3 Methylcrotonyl CoA carboxylase deficiency, methylmalonic acidaemia, multiple carboxylase deficiency and proprionic acidaemia (in the newborn)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - organic acid metabolism disorder screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;This policy covers the following rare inherited&amp;nbsp;organic acid metabolism&amp;nbsp;disorders:&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;Beta-ketothiolase deficiency&lt;BR&gt;Glutaric acidaemia type I&lt;BR&gt;Hydroxymethylglutaric aciduria&lt;BR&gt;Isovaleric acidaemia&lt;BR&gt;3 Methylcrotonyl CoA carboxylase deficiency&lt;BR&gt;Methylmalonic acidaemia, Cbl A and Cbl B forms&lt;BR&gt;Methylmalonic acidaemia, mutase deficiency form&lt;BR&gt;Multiple carboxylase deficiency&lt;BR&gt;Proprionic acidaemia&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=left&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=1" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P align=left&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61088</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61088]]&gt;</url>
    <title>National Screening Committee policy - osteoporosis screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,OSTEOPOROSIS,OLD AGE,OSTEOPOROSIS,LATER LIFE,SCREENING AND SURVEILLANCE,ADULT,SCREENING,CONDITIONS,MUSCULOSKELETAL,OSTEOPOROSIS,BONE DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for osteoporosis in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - osteoporosis screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Osteoporosis&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P align=justify&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=justify&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=20" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61149</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61149]]&gt;</url>
    <title>National Screening Committee policy - ovarian cancer screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS,SCREENING,CANCER,ADULT,OVARIAN,GENETIC CONDITIONS A-Z,FAMILY HISTORY OF CANCER,CONDITIONS A-B,SYSTEMS &amp; SYMPTOMS,PREGNANCY,GENETIC SCREENING (FOR CONDITIONS),NOT ROUTINELY OFFERED,BREAST &amp; OVARIAN CANCER (FAMILIAL)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for ovarian cancer in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - ovarian cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Ovarian cancer&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee Policy Position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=21" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57174</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57174]]&gt;</url>
    <title>National Screening Committee policy - phenylketonuria (PKU) screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS,SCREENING,PHENYLKETONURIA,GENETIC CONDITIONS A-Z,GENETICS - PRACTICE &amp; ISSUES,CONDITIONS N-R,SYSTEMS &amp; SYMPTOMS,PHENYLKETONURIA (PKU),PREGNANCY,GENETIC SCREENING (FOR CONDITIONS),NEWBORN,BLOODSPOT (&lt;1WK),SKIN &amp; BONE DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for phenylketonuria (PKU)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - phenylketonuria (PKU) screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Phenylketonuria (PKU)&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee Policy Position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=2" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The &lt;A href="http://newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;UK Newborn Screening Programme Centre&lt;/A&gt; oversees screening for phenylketonuria&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51547</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51547]]&gt;</url>
    <title>National Screening Committee policy - placenta praevia screening</title>
    <publicationDate>2008-12-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ 36 WEEKS,ANAEMIA,PLACENTA PRAEVIA,ANTENATAL,SCREENING,WOMEN'S HEALTH,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for placenta praevia in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - placenta praevia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Placenta Praevia &lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended, clinical practice guidelines covered by NICE&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=102" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346138</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=346138]]&gt;</url>
    <title>National Screening Committee policy - postnatal depression</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,ADULT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - postnatal depression&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Postnatal depression&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;National Screening Committee current policy position&lt;/H3&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=22" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/H3&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;See also &lt;A href="nelh:60978:0" name=internalLink&gt;Postnatal depression in pregnancy&lt;/A&gt; and &lt;A href="nelh:60968:0" name=internalLink&gt;Depression&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60978</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60978]]&gt;</url>
    <title>National Screening Committee policy - postnatal depression screening in pregnancy</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,ADULT,DEPRESSION,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,MENTAL HEALTH,ADULT CONDITIONS,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,POSTNATAL DEPRESSION,POSTNATAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for postnatal depression</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - postnatal depression screening in pregnancy&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Postnatal depression in pregnancy&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=103" target="_blank"&gt;&lt;STRONG&gt;Full policy and supporting evidence&lt;/STRONG&gt;&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;See also &lt;A href="nelh:60968:0" name=internalLink&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=60968&amp;amp;tabID=288&amp;amp;catID=1337" target="_blank"&gt;Depression&lt;/A&gt;&lt;/A&gt; and &lt;A href="nelh:346138:0" name=internalLink&gt;Postnatal depression&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51551</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51551]]&gt;</url>
    <title>National Screening Committee policy - pre-eclampsia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ 36 WEEKS,PRE-ECLAMPSIA,28 WEEKS,ANTENATAL,SCREENING,WOMEN'S HEALTH,PRE-ECLAMPSIA,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for pre-eclampsia in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - pre-eclampsia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Pre-eclampsia&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee Policy Position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended, clinical practice guidelines covered by NICE&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=104" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51552</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51552]]&gt;</url>
    <title>National Screening Committee policy - preterm labour screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,WOMEN'S HEALTH,SCREENING,ANTENATAL,NOT ROUTINELY OFFERED,PRETERM LABOUR]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on antenatal screening for predictors of preterm labour</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - preterm labour screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Predictors of preterm labour&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=105" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61153</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61153]]&gt;</url>
    <title>National Screening Committee policy - prostate cancer screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,PROSTATE,NOT ROUTINELY OFFERED,PROSTATE DISORDERS,PROSTATE CANCER,MALE UROGENITAL DISORDERS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for prostate cancer in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - prostate cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Prostate cancer&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=23" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51549</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51549]]&gt;</url>
    <title>National Screening Committee policy - psychiatric illness screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,ADULT CONDITIONS,MENTAL HEALTH,WOMEN'S HEALTH,SCREENING,ANTENATAL,PSYCHIATRIC ILLNESS,CHILD AND ADOLESCENT CONDITIONS,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for psychiatric illness in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - psychiatric illness screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Psychiatric Illness (during pregnancy)&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended, clinical practice guidelines covered by NICE&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=106" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>51566</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=51566]]&gt;</url>
    <title>National Screening Committee policy - rubella susceptibility screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,ANTENATAL,SCREENING,WOMEN'S HEALTH,RUBELLA,SCREENING,ANTENATAL CARE,NORMAL PREGNANCY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for rubella immunity in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - rubella susceptibility screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Rubella Susceptibility&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee Policy Position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=107" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;National Screening Programme&lt;/H3&gt;
&lt;P&gt;There is an &lt;A href="http://infectiousdiseases.screening.nhs.uk/" target="_blank"&gt;NHS Infectious Diseases in Pregnancy Programme&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60331</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60331]]&gt;</url>
    <title>National Screening Committee policy - scoliosis screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCOLIOSIS,CHILD,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for scoliosis in children.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - scoliosis screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Scoliosis&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee Policy Position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=43" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>346142</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=346142]]&gt;</url>
    <title>National Screening Committee policy - screening for varicella susceptibility</title>
    <publicationDate>2009-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for varicella susceptibility in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - screening for varicella susceptibility&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Varicella susceptibility&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;National Screening Committee current policy position&lt;/H3&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=81" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/H3&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>143394</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=143394]]&gt;</url>
    <title>National Screening Committee policy - screening for vascular risk</title>
    <publicationDate>2008-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PREVENTION,PREVENTION,DIAGNOSIS,DIAGNOSIS,HAEMORRHAGIC STROKE,MANAGEMENT ISSUES,RISK ASSESSMENT,ISCHAEMIC STROKE,HIGH BLOOD PRESSURE,STROKE,VASCULAR RISK,DIABETES,SCREENING,ADULT,PRIMARY PREVENTION,GENERAL,GENERAL,CONDITIONS,PREVENTION,CAUSES AND RISK FACTORS,CARDIOVASCULAR DISEASES,STROKE,DIABETES,CHRONIC COMPLICATIONS,CARDIOVASCULAR,CAUSES,OLD AGE,CORONARY HEART DISEASE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for vascular risk in adults</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - screening for vascular risk&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Vascular risk&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN lang=EN-GB&gt;&lt;BR&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;As a result of the Diabetes, Heart Disease and Stroke (DHDS) prevention project, the NSC recommended the introduction of a Vascular Risk Management Programme. The &lt;A href="http://www.screening.nhs.uk/getdata.php?id=9051" target="_blank"&gt;Handbook of Vascular Risk Assessment, Risk Reduction and Risk Management&lt;/A&gt; was published on March 3 2008.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=29" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61155</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61155]]&gt;</url>
    <title>National Screening Committee policy - screening in old age</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,LATER LIFE,SCREENING AND SURVEILLANCE,OLD AGE,SCREENING,HEART DISEASE,CARDIOVASCULAR RISK,MENTAL HEALTH,RISK OF FALLS,DIABETES,EYESIGHT,THYROID DISEASE,HEARING,CANCER,OSTEOPOROSIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening in old age</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - screening in old age&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Screening in old age&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=17" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32452</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32452]]&gt;</url>
    <title>National Screening Committee policy - sickle cell and thalassaemia screening (in pregnancy)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,IMPLEMENTATION,SCREENING,ANTENATAL,MANAGEMENT,SYSTEMS &amp; SYMPTOMS,CONDITIONS N-R,THALASSAEMIA,SICKLE CELL (SC) (SCD),ETHNICITY LINKED DISORDERS,ETHNICITY AND HEALTH,DISEASES AND CONDITIONS,SICKLE CELL &amp; THALASSAEMIA,8-10 WEEKS,CONDITIONS S-Z,BLOOD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for thalassaemia and sickle cell in pregnancy.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - sickle cell and thalassaemia screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Sickle Cell&amp;nbsp;and Thalassaemia screening&amp;nbsp;in pregnancy&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee Policy Position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=108" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is an &lt;A href="http://sct.screening.nhs.uk/" target="_blank"&gt;NHS Sickle Cell and Thalassaemia Screening Programme&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57171</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57171]]&gt;</url>
    <title>National Screening Committee policy - sickle cell disorders screening (in newborns)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS,SCREENING,IMPLEMENTATION,SPECIALTIES,NEONATAL,SICKLE CELL DISEASE,SICKLE CELL,CHILD HEALTH,HAEMATOLOGY,SCREENING,GENETIC CONDITIONS A-Z,SYSTEMS &amp; SYMPTOMS,CONDITIONS N-R,MANAGEMENT,SICKLE CELL (SC) (SCD),NEWBORN,BLOODSPOT (&lt;1WK),BLOOD]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for sickle cell disorders (in newborns)</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - sickle cell disorders screening (in newborns)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Sickle cell disorders&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=30" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The &lt;A href="http://newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;UK Newborn Screening Programme Centre&lt;/A&gt; oversees screening for sickle cell disorders in newborns.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60334</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60334]]&gt;</url>
    <title>National Screening Committee policy - speech and language delay screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,ENT AND AUDIOLOGY,NOT ROUTINELY OFFERED,CONDITIONS,LARYNX &amp; PHARYNX DISORDERS,DYSPHONIA/ APHONIA,SPEECH &amp; LANGUAGE DELAY,SPEECH AND LANGUAGE THERAPY,SPECIALTIES,VOICE DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for speech and language delay in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - speech and language delay screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Speech and language delay&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current&amp;nbsp;policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=44" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61154</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61154]]&gt;</url>
    <title>National Screening Committee policy - stomach cancer screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,STOMACH,CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for stomach cancer in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - stomach cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Stomach Cancer&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended
&lt;P&gt;&amp;nbsp;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=24" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61157</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61157]]&gt;</url>
    <title>National Screening Committee policy - stroke screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CARDIOVASCULAR RISK,SCREENING,OLD AGE,SCREENING AND SURVEILLANCE,STROKE,CAUSES AND PRIMARY PREVENTION,LATER LIFE,STROKE,SCREENING,ADULT,VASCULAR RISK,ISCHAEMIC STROKE,PREVENTION,DIAGNOSIS,HAEMORRHAGIC STROKE,TRANSIENT ISCHAEMIC ATTACK,DIAGNOSIS,PREVENTION,DIAGNOSIS,PREVENTION,RISK ASSESSMENT,MANAGEMENT ISSUES,STROKE]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for stroke in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - stroke screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Stroke&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&amp;nbsp;&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=25" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32233</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32233]]&gt;</url>
    <title>National Screening Committee policy - syphilis screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,SYPHILIS,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,SCREENING,ANTENATAL,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,BACTERIAL,SYPHILIS,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for syphilis in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - syphilis screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Syphilis&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=55" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is an &lt;A href="http://infectiousdiseases.screening.nhs.uk/" target="_blank"&gt;NHS Infectious Diseases in Pregnancy Screening Programme&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61077</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61077]]&gt;</url>
    <title>National Screening Committee policy - Tay Sachs disease screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,TAY SACHS,SCREENING,NORMAL PREGNANCY,ANTENATAL CARE,WOMEN'S HEALTH,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for Tay Sachs disease in pregancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - Tay Sachs disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Tay Sachs disease&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=56" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61158</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61158]]&gt;</url>
    <title>National Screening Committee policy - testicular cancer screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,CANCER,SCREENING,TESTICULAR,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,TESTICULAR/ SCROTAL DISORDERS,TESTICULAR CANCER]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for testicular cancer in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - testicular cancer screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Testicular cancer&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=26" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt; 
&lt;P align=justify&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61161</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61161]]&gt;</url>
    <title>National Screening Committee policy - thrombophilia screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,THROMBOPHILIA,SCREENING,ADULT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for thrombophilia in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - thrombophilia screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Thrombophilia&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=27" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>32586</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=32586]]&gt;</url>
    <title>National Screening Committee policy - thrombophilia screening (in pregnancy)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,WOMEN'S HEALTH,THROMBOPHILIA,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for thrombophilia in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - thrombophilia screening (in pregnancy)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Thrombophilia&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=58" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>61165</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61165]]&gt;</url>
    <title>National Screening Committee policy - thyroid disease screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CONDITIONS,THYROID &amp; PARATHYROID DISORDERS,ENT AND AUDIOLOGY,THYROID DISEASE,SCREENING,ADULT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for thyroid disease in adults.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - thyroid disease screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Thyroid disease&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position&lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=28" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>56185</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=56185]]&gt;</url>
    <title>National Screening Committee policy - toxoplasmosis screening</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,WOMEN'S HEALTH,SCREENING,NORMAL PREGNANCY,ANTENATAL CARE,TOXOPLASMOSIS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for congenital and aquired toxoplasmosis in pregnancy</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - toxoplasmosis screening&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Toxoplasmosis&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current&amp;nbsp;policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=59" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>316164</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=316164]]&gt;</url>
    <title>National Screening Committee policy - vasa praevia</title>
    <publicationDate>2008-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's policy on screening for Vasa praevia</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - vasa praevia&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Vasa praevia&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee current policy position &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Systematic population screening programme not recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=60" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60336</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60336]]&gt;</url>
    <title>National Screening Committee policy - vision defect screening (in children)</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PHYSICAL (&lt;72HRS),NEWBORN,VISION,SCHOOL ENTRY,EYES AND VISION,EYES,CHILD,SCREENING,LOW VISION,CONDITIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>The National Screening Committee's Policy on screening for vision defects in children</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee policy - vision defect screening (in children)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;H2&gt;Vision defects (amblyopia, refractive error, strabismus)&amp;nbsp;&lt;/H2&gt;
&lt;H2&gt;&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;B&gt;National Screening Committee current policy position &lt;/B&gt;&lt;/P&gt;
&lt;P&gt;Systematic population screening programme recommended&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;A href="http://www.screening.nhs.uk/policydb.php?policy_id=45" target="_blank"&gt;Full policy and supporting evidence&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60282</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60282]]&gt;</url>
    <title>National Screening Committee Programme Director's Report Autumn 2000-Spring 2002</title>
    <publicationDate>2002-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,QUALITY ASSURANCE,BENEFITS &amp; HARMS,MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>NSC Annual Report for 2002/2003.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;National Screening Committee Programme Director's Report Autumn 2000-Spring 2002&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This NSC Annual Report for&amp;nbsp;Autumn 2000-Spring 2002,&amp;nbsp;summarises the progress made since 2000. 
&lt;P&gt;See also the &lt;A href="http://rms.nelh.nhs.uk/screening/viewResource.asp?searchText=annual+report&amp;amp;searchZone=%2Fscreening%2FsearchResponse.asp&amp;amp;uri=http%3A//libraries.nelh.nhs.uk/common/resources/%3Fid%3D57641" target="_blank"&gt;Annual Report for 2002/2003&lt;/A&gt;.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>66392</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://cpd.screening.nhs.uk/getdata.php?id=10606]]&gt;</url>
    <title>National Training Needs Analysis for Antenatal Screening Services across England</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),SCREENING,IMPLEMENTATION,ANTENATAL,14-20 WEEKS,DOWN'S SYNDROME (SERUM),11-14 WEEKS,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=justify&gt;This report is a comprehensive training needs analysis for the provision of antenatal screening services in England.&amp;nbsp;It provides valuable&amp;nbsp;information&amp;nbsp;for staff&amp;nbsp;assisting in the facilitation and delivery of quality education and training.&lt;/P&gt;
&lt;P align=justify&gt;A subsequent survey on &lt;A href="nelh:332207:0" name=internalLink&gt;Education and Training Needs&lt;/A&gt; was carried out in 2007.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>114192</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.gov.on.ca/english/providers/program/mas/tech/reviews/pdf/rev_tandms_090102.pdf]]&gt;</url>
    <title>Neonatal screening of inborn errors of metabolism using tandem mass spectrometery</title>
    <publicationDate>2002-09-01T00:00:00</publicationDate>
    <publisher>Ministry of Health and Long-Term Care, Canada</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,BLOODSPOT (&lt;1WK),ECONOMICS,PHENYLKETONURIA,MCADD,CONGENITAL HYPOTHYROIDISM,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The&amp;nbsp;Medical Advisory Secretariat, Ontario, Canada&amp;nbsp;provides evidence-based policy advice on the coordinated uptake of new health technologies and health services, by conducting systematic reviews of scientific evidence and consultation with experts in the medical community.&lt;/P&gt;
&lt;P&gt;This Health Technology Scientific literature review looks at the effectiveness and cost-effectiveness of using tandem mass spectrometer for the neonatal screening of inborn errors of metabolism.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>250668</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1201767914747]]&gt;</url>
    <title>New Frontiers - National Chlamydia Screening Programme Annnual Report 2005/6</title>
    <publicationDate>2006-11-01T00:00:00</publicationDate>
    <publisher>Health Protection Agency</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CHLAMYDIA,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,BACTERIAL,CHLAMYDIA,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Annual report for the UK National Chlamydia Screening Programme</description>
    <body>&lt;![CDATA[ &lt;P&gt;Annual report describing&amp;nbsp;the third year of implementation of the UK National Chlamydia Screening&amp;nbsp;Programme.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63683</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/rg-01.pdf]]&gt;</url>
    <title>New ways of working in the NHS Breast Screening Programme</title>
    <publicationDate>2004-06-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,IMPLEMENTATION,SCREENING,BREAST CANCER,MANAGEMENT,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This report&amp;nbsp;presents a review of staffing levels and status of implementation for New Ways of Working in the NHS Breast Screening Programme (NHSBSP), and&amp;nbsp;reviews the progress of programme expansion against the Cancer Plan targets.&lt;FONT size=2 face=Arial&gt; 
&lt;P align=left&gt;&lt;/FONT&gt;&amp;nbsp;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>384893</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornphysical.screening.nhs.uk/getdata.php?id=10639]]&gt;</url>
    <title>Newborn and Infant Physical Examination - standards and competencies</title>
    <publicationDate>2008-03-31T00:00:00</publicationDate>
    <publisher>NHS Antenatal and Newborn Screening Programmes</publisher>
    <publicationType>CARE PATHWAY</publicationType>
    <topics>&lt;![CDATA[ SCREENING,EYES,HEART,TESTES,NEWBORN,PHYSICAL (&lt;72HRS),HIPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This document provides information on pathways, standards and competencies for the screening components of the Child Health Promotion Programme examinations, namely examination of the hips, eyes, testes and cardiovascular system.]]&gt;</body>
  </document>
  <document>
    <id>269073</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269073]]&gt;</url>
    <title>Newborn and Infant Physical Examination (National Knowledge Week)</title>
    <publicationDate>2007-09-13T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,SCREENING,OPHTHALMOLOGY,NEONATOLOGY,MUSCULOSKELETAL,CARDIOVASCULAR DISEASES,CONDITIONS,CARDIOLOGY,CHILD HEALTH,EYES,HEART,TESTES,CONGENITAL HEART DISEASE,CONGENITAL ABNORMALITIES,EXAMINATION OF THE NEONATE,CONGENITAL ABNORMALITIES,NEONATAL,SPECIALTIES,STAFF USE,PHYSICAL (&lt;72HRS),NEWBORN,DIAGNOSIS,CONGENITAL HEART DISEASE,HIPS,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Newborn and Infant Physical Examination (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="newborn eye examination" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269073/nelhImp_0003_nipe_eyes.jpg" width=176 height=124&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage1 border=1 name=nelh_tempImage1 alt="newborn heart examination" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269073/nelhImp_0004_nipe_heart.jpg" width=176 height=124&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="baby being held" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269073/nelhImp_0005_nipe.jpg" width=176 height=124&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Annual Evidence Updates: &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269259" target="_blank"&gt;Congenital Cataract&lt;/A&gt;, &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269175" target="_blank"&gt;Congenital Heart Disease&lt;/A&gt;, &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269194" target="_blank"&gt;Cryptorchidism&lt;/A&gt;, &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269182" target="_blank"&gt;Hip Dysplasia&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section has been written by Dr. David Elliman, National Screening Committee&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;The Newborn and Infant Physical Examination&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A detailed examination of the newborn baby soon after birth and again at 6-8 weeks has been considered routine for decades. However, apart from guidance on examination of the hips [1] and successive editions of the Hall report [&lt;A href="http://www.oup.com/uk/catalogue/?ci=9780198570844" target="_blank"&gt;2&lt;/A&gt;], there has been no central guidance on the examination, in general, or more specifically on the screening components. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Guidance on the examination was set out in the recent NICE guideline on Postnatal Care [&lt;A href="http://guidance.nice.org.uk/CG37/guidance/pdf/English/download.dspx" target="_blank"&gt;3&lt;/A&gt;]. Standards for the screening components:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;examination of the heart&lt;/LI&gt;
&lt;LI&gt;hips&lt;/LI&gt;
&lt;LI&gt;eyes&lt;/LI&gt;
&lt;LI&gt;and, in boys, the testes&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;have been drawn up by a multidisciplinary group under the auspices of the National Screening Committee. The same group has also looked at the competencies needed of the professionals who carry out the examination. These standards and competencies will be launched in the autumn. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Work will now be undertaken to ensure that healthcare workers are properly trained and that the examination and its outcome are audited to ensure that the standards are attained and maintained. Currently very little data is collected and so there is much work to be done before these goals can be attained.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Developmental Dysplasia of the Hip (DDH)&lt;/STRONG&gt;&lt;BR&gt;Previously known as ‘congenital dislocation of the hip’, the name was changed to emphasise that the condition is not always present at birth and is due to malformation of the socket of the ball and socket joint. There is no gold standard for diagnosis and so it is not possible to give accurate figures for the prevalence. The incidence of cases needing operative treatment is 1-2 per 1,000 liveborn infants. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;However many more infants have unstable hips that become stable while under observation. Treatment is aimed at stabilising the hips, initially with a splint. If this fails, an operation may be necessary.&lt;BR&gt;The mainstay of screening is clinical examination, using the Barlow and Ortolani tests. However, even when performed competently soon after birth and again at 6-8 weeks, late detected DDH is not eliminated. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Limited experience of ultrasound examination of the hips of all babies suggests that this may be more sensitive, but may be associated with considerable over-treatment. As treatment may itself damage the hip, this is an important consideration and is one of the reasons why universal ultrasound is not recommended. It is however recommended in babies with a history of clinically detected breech presentation during pregnancy or where there is a first degree family history of DDH.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Recent systematic reviews [&lt;A href="http://pediatrics.aappublications.org/cgi/content/full/117/3/e557" target="_blank"&gt;4&lt;/A&gt;],[&lt;A href="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;amp;ID=32006000274" target="_blank"&gt;5&lt;/A&gt;] have reiterated these concerns and pointed out that the evidence base for this screening programme is not strong. In particular there are no randomised controlled trials (RCTs) comparing the long term outcome after various forms of screening, compared with no screening. Because screening is so widespread, it is unlikely that such studies will ever be done. However it is incumbent on those who are responsible for screening programmes to ensure that staff are competent for the task and that the programme has appropriate quality controls in place.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Cryptorchidism (Undescended Testes –UDT)&lt;BR&gt;&lt;/STRONG&gt;Undescended testes are found in about 2% of male infants at birth. This figure goes down to about 1% at 3 months and then changes little over the next year. The condition is important for a number of reasons. It may be associated with other problems such as hypospadias and apparent bilateral undescended testes may be an indication of congenital adrenal hyperplasia. Undescended testes are associated with an increased risk of torsion, subfertility and malignancy. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;While there is little debate that boys with indescended testes should have treatment to fix the affected testis in the scrotum (orchidopexy), there is no good evidence that this changes the risk of malignancy developing and evidence of its effect on fertility is inconsistent [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=23%5Bvolume%5D%20AND%207%5Bissue%5D%20AND%20625%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;6&lt;/A&gt;]. As changes in the affected testis are seen early in life, it is generally agreed that surgery should take place before starting school. Many authorities recommend surgery between the first and second birthdays.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;It used to be assumed that when a boy was noted to have an undescended testis at an older age, this was because they had not been examined properly. Recently [&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7GX6-4KCGJ08-2&amp;amp;_user=10&amp;amp;_coverDate=10%2F31%2F2006&amp;amp;_rdoc=3&amp;amp;_fmt=summary&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%2320478%232006%23999979994%23632164%23FLA%23display%23Volume)&amp;amp;_cdi=20478&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=33&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=37bdce8ee682ff42e88889b459deae2d" target="_blank"&gt;7&lt;/A&gt;], it has become apparent that a proportion, at least, of these have testes that were at one stage normally placed, but have ascended. This issue will need to be addressed by the National Screening Committee.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Congenital Heart Disease (CHD)&lt;/STRONG&gt; [&lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ944.htm" target="_blank"&gt;8&lt;/A&gt;]&lt;BR&gt;Congenital heart disease covers a very wide spectrum of disease, from ventricular septal defects which often resolve spontaneously to conditions that have a very high mortality. The overall incidence is about 1 in 100 livebirths, but the incidence of the latter is only 1 in 1,000 live births. Of the order of 1 in 200 will need active treatment. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Screening is justified on the basis that planned surgery is more likely to result in a better outcome than emergency surgery, both in terms of mortality and morbidity. It is also likely to be less distressing for parents.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The main stay of the screening programme is physical examination of all elements of the cardiovascular system and a history of feeding. Echocardiography is only appropriate as part of further assessment, or as part of assessment of children at high risk, such as those with Down Syndrome. On the other hand, pulse oximetry may have a part to play and further work on this has been commissioned. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Whatever the primary screening modality, it is essential that there is timely access to an experienced clinician who can make a definitive diagnosis, in order to facilitate early surgical treatment if necessary.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abnormalities of the Eyes&lt;/STRONG&gt;&lt;BR&gt;This examination is designed to pick up structural abnormalities of the eyes, not to check vision. The main abnormalities being sought are ocular cataracts and retinoblastoma. They are rare (2 or 3 in 10,000 live births). Screening is based on inspection of the eyes and examination for the red reflex. Unfortunately detection rates are low [&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=9933197" target="_blank"&gt;9&lt;/A&gt;]. This may be due to poor examination technique.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&amp;nbsp;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[1] Standing Medical Advisory Committee. Screening for the detection of congenital dislocation of the hip in infants. London: Department of Health and Social Security, 1966. Revised 1986&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2] Hall DM and Elliman D, ed. (2006). &lt;A href="http://www.oup.com/uk/catalogue/?ci=9780198570844" target="_blank"&gt;Health for All Children&lt;/A&gt;. 4th ed. revised. Oxford: Oxford University Press.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[3]&amp;nbsp;NICE clinical guideline 37. &lt;A href="http://guidance.nice.org.uk/CG37/guidance/pdf/English/download.dspx" target="_blank"&gt;Routine postnatal care of women and their babies&lt;/A&gt;. 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[4]&amp;nbsp;Shipman SA, Helfand M, Moyer VA, Yawn BP. &lt;A href="http://pediatrics.aappublications.org/cgi/content/full/117/3/e557" target="_blank"&gt;Screening for developmental dysplasia of the hip: A systematic literature review for the US Preventive Services Task Force&lt;/A&gt;. Pediatrics 2006;117(3):e557-e576.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[5]&amp;nbsp;York: Centre for Reviews and Dissemination (CRD). Systematic review of the clinical and cost effectiveness of ultrasound in screening for developmental dysplasia of the hip in newborns.&amp;nbsp;April 2006. [&lt;A href="http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;amp;ID=32006000274" target="_blank"&gt;CRD abstract&lt;/A&gt;]. Note - original article: Woolacott N, Puhan MA, Misso K, Steurer S, Kleijnen J. &lt;A href="http://www.york.ac.uk/inst/crd/pdf/report28.pdf" target="_blank"&gt;CRD Report 28&lt;/A&gt;. 2005.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[6]&amp;nbsp;Murphy F, Paran TS, Puri P. Orchidopexy and its impact on fertility. Pediatric Surgery International 2007;23(7):625-632. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=23%5Bvolume%5D%20AND%207%5Bissue%5D%20AND%20625%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[7]&amp;nbsp;Martin JDC. Further evidence for acquired undescended testicle in the UK and its incompatibility with current recommendations in the Hall Report. Journal of Pediatric Urology 2006;2(5):392-397. [&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7GX6-4KCGJ08-2&amp;amp;_user=10&amp;amp;_coverDate=10%2F31%2F2006&amp;amp;_rdoc=3&amp;amp;_fmt=summary&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%2320478%232006%23999979994%23632164%23FLA%23display%23Volume)&amp;amp;_cdi=20478&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=33&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=37bdce8ee682ff42e88889b459deae2d" target="_blank"&gt;Journal website abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[8] Knowles R, Griebsch I, Dezateux C, Brown J,Bull C, Wren C. &lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ944.htm" target="_blank"&gt;Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis&lt;/A&gt;. Health Technol Assess 2005;9(44):1–168.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[9] Rahi J, Dezateux C.&amp;nbsp;&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=9933197" target="_blank"&gt;National cross sectional study of detection of congenital and infantile cataract in the United Kingdom: role of childhood screening and surveillance&lt;/A&gt;&amp;nbsp;&amp;nbsp; BMJ 1999;318:362-365.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;Annual evidence updates on newborn and infant physical screening 2006/07&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Screening Library has identified the&amp;nbsp;new&amp;nbsp;evidence&amp;nbsp;published over the last year, and the results of our search are classified and presented as evidence updates below&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269259" target="_blank"&gt;Congenital cataract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269175" target="_blank"&gt;Congenital Heart Disease&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269194" target="_blank"&gt;Cryptorchidism&lt;/A&gt; (undescended testes)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269182" target="_blank"&gt;Developmental dysplasia of the hip&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee policies on newborn physical examination, July 2006&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57177&amp;amp;tabID=288&amp;amp;catID=2012" target="_blank"&gt;Congenital cataract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57175&amp;amp;tabID=288&amp;amp;catID=2013" target="_blank"&gt;Congenital Heart Disease&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57178&amp;amp;tabID=288&amp;amp;catID=2015" target="_blank"&gt;Cryptorchidism&lt;/A&gt;&amp;nbsp;(undescended testes)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57180&amp;amp;tabID=288&amp;amp;catID=8730" target="_blank"&gt;Developmental dysplasia of the hip&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Additional references (selected from&amp;nbsp;the above annual evidence updates)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Guidance&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services. &lt;A href="http://www.ahrq.gov/downloads/pub/prevent/pdfser/hipdyssyn.pdf" target="_blank"&gt;Screening for Developmental Dysplasia of the Hip. Evidence Synthesis no. 42&lt;/A&gt;. March 2006.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;York: Centre for Reviews and Dissemination (CRD). Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review. May 2006. [&lt;A href="http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&amp;amp;ID=12005008298" target="_blank"&gt;CRD Structured abstract&lt;/A&gt;]. Note - original article: Woolacott NF, Puhan MA, Steurer J, Kleijnen J. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=15930025" target="_blank"&gt;BMJ 2005;330:1413&lt;/A&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Thangaratinam S, Daniels J, Ewer AK, Zamora J, Khan KS. Accuracy of pulse oximetry in screening for congenital heart disease in asymptomatic newborns: a systematic review. Archives of Disease in Childhood Fetal &amp;amp; Neonatal Edition 2007, 92(3):F176-80 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=92%5Bvolume%5D%20AND%203%5Bissue%5D%20AND%20F176%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;Other&amp;nbsp;information for health professionals &lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://hearing.screening.nhs.uk/toolbox/" target="_blank"&gt;NIPE toolbox&lt;/A&gt; (Newborn and 6-8 week Infant Physical Examination digital&amp;nbsp;toolbox) -&amp;nbsp;&amp;nbsp;contains listings of journal articles, books and reports, CD-Roms/videos, websites and simulators relevant to the physical examination of the newborn and 6-8 week infant.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information to give&amp;nbsp;parents&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Sept 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/index.htm" target="_blank"&gt;Screening tests for your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>103127</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10953]]&gt;</url>
    <title>Newborn blood spot screening in the UK - health professional handbook</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,WOMEN'S HEALTH,NORMAL PREGNANCY,POSTNATAL CARE,BLOODSPOT (&lt;1WK),NEWBORN,MANAGEMENT,NEONATAL AND INFANT CARE,GENERAL EXAMINATION AND SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This is a document in&amp;nbsp;the series produced by the UK Newborn Screening Programme Centre.&amp;nbsp;The Health Professonal Handbook is intended to support health professionals, especially midwives,&amp;nbsp;delivering newborn blood spot screening.&lt;/P&gt;
&lt;P align=left&gt;&lt;A href="http://www.ich.ucl.ac.uk/newborn/download/training/training_resources.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>103119</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10954]]&gt;</url>
    <title>Newborn blood spot screening in the UK - implementation and reporting guidance</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,NEWBORN,BLOODSPOT (&lt;1WK),SCREENING,IMPLEMENTATION,NEWBORN BLOODSPOT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This is a document in&amp;nbsp;the series produced by the UK Newborn Screening Programme Centre.&amp;nbsp;Implementation and reporting guidance is&amp;nbsp;designed to support the implementation of the Policies and Standards for Newborn Blood Spot Screening.&amp;nbsp;It aims to provide guidance to health professionals involved in the management of screening, particularly the newborn blood spot screening lead, Directors of Public Health, and antenatal and child health coordinators.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>79431</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10941]]&gt;</url>
    <title>Newborn blood spot screening in the UK - policies and standards</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,MANAGEMENT,BLOODSPOT (&lt;1WK),NEWBORN,IMPLEMENTATION,SCREENING,NEWBORN BLOODSPOT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT color=#292526 face=Sabon-Roman&gt;
&lt;P align=left&gt;This is a document in&amp;nbsp;the series produced by the UK Newborn Screening Programme Centre.&amp;nbsp;It&amp;nbsp;&amp;nbsp;is intended to inform health professionals involved in screening,&amp;nbsp;of the UK standards and policies for newborn blood spot screening. It covers the screening process and policy areas, including performance management, consent and communication and blood sampling guidelines. &lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>103137</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10932]]&gt;</url>
    <title>Newborn blood spot screening in the UK - training resources</title>
    <publicationDate>2005-04-01T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,NEWBORN,BLOODSPOT (&lt;1WK),SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This is a document in&amp;nbsp;the series produced by the UK Newborn Screening Programme Centre.&amp;nbsp; These resources&amp;nbsp;are intended to support trainers in delivering training about newborn blood spot screening, and will be especially useful for midwives. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>269239</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269239]]&gt;</url>
    <title>Newborn Bloodspot Screening (National Knowledge Week)</title>
    <publicationDate>2007-09-19T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ BLOODSPOT (&lt;1WK),NEWBORN,STAFF USE,CYSTIC FIBROSIS,SPECIALTIES,NEONATAL,MCADD,PHENYLKETONURIA,CONGENITAL HYPOTHYROIDISM,CHILD HEALTH,NEONATOLOGY,SCREENING,SCREENING,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Newborn Bloodspot Screening (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage7 border=1 name=nelh_tempImage7 alt="nurse performing heel prick test on newborn baby" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269239/nelhImp_0003_heelprick.jpg" width=200 height=132&gt;&amp;nbsp; &lt;/TD&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage12 border=1 name=nelh_tempImage12 alt="couple with newborn baby" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269239/nelhImp_0004_newborn.jpg" width=200 height=132&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage13 border=1 name=nelh_tempImage13 alt="newborn baby being weighed" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269239/nelhImp_0005_new_baby2.jpg" width=200 height=132&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Annual Evidence Updates:&amp;nbsp;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269280" target="_blank"&gt;Congenital hypothyroidism&lt;/A&gt;,&amp;nbsp;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=187226" target="_blank"&gt;Cystic Fibrosis&lt;/A&gt;,&amp;nbsp;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269283" target="_blank"&gt;MCADD&lt;/A&gt;,&amp;nbsp;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=260735" target="_blank"&gt;Phenylketonuria&lt;/A&gt;,&amp;nbsp;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=212461" target="_blank"&gt;Sickle cell&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section has been written by Christine Cavanagh/Cathy Coppinger, Programme Manager (job share), UK Newborn Screening Programme Centre&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;UK Newborn Screening Programme Centre: Bloodspot screening&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The &lt;A href="http://www.newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;UK Newborn Screening Programme Centre&lt;/A&gt; was established in 2002 with the overall objective of assuring high quality screening services for babies and their parents through the development of a quality assurance programme and performance management framework for the blood spot screening programmes. The first version of performance standards governing the overall programme together with a framework for its performance management were launched by the Programme Centre in December 2004 and are currently being reviewed. These have led to a more joined-up approach to assuring its quality. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;New blood sampling guidelines will be&amp;nbsp;available at the end October ’07&amp;nbsp;from the UK Newborn Screening Programme Centre: &amp;nbsp;&lt;A href="http://www.newbornbloodspot.screening.nhs.uk/" target="_blank"&gt;http://www.newbornbloodspot.screening.nhs.uk&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The national newborn screening programme for phenylketonuria (PKU) was introduced in 1969 and, for congenital hypothyroidism (CHT) in 1981. Today newborn screening is one of the largest such programmes in the UK and each year over 725,000 newborns are screened. The newborn blood spot screening programme has been and remains a very successful one, and the uptake of screening tests is high, with local audits showing that more than 99% of the babies born each year are being screened. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Each year approximately 400 babies with phenylketonuria or congenital hypothyroidism are identified through screening, allowing effective treatments to be started before irreversible neurological damage has occurred, preventing lifelong disability.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;More recently in England, screening for sickle cell disorders (SCD) [see the entry for Screening for Sickle Cell and Thalassaemia National Knowledge Week]&amp;nbsp;and cystic fibrosis (CF) has been introduced, and in February 2007 a screening programme was announced for screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) [&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57173&amp;amp;tabID=288&amp;amp;catID=1376" target="_blank"&gt;1&lt;/A&gt;]. Screening for all of these conditions utilises the same blood sample used for PKU and CHT screening, formally known as the ‘Guthrie’ card.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;MCADD is a rare inherited disorder of fatty acid metabolism. It occurs mainly among people of north-western European origin [&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;2&lt;/A&gt;] [&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;3&lt;/A&gt;] Males and females are affected equally. MCADD occurs when the enzyme called medium chain acyl-CoA dehydrogenase is either missing, or not functioning properly.&amp;nbsp; This enzyme breaks down fats from food, and from within the body, to convert into energy.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Babies affected by MCADD often do not show any symptoms straight after birth. Symptoms typically appear for the first time when a child is between 3 months and 3 years old [&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;2&lt;/A&gt;]. This usually happens following a period of fasting, infection, or stress, for example if the child feels unwell and does not want to eat, or vomits [&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;3&lt;/A&gt;]. Symptoms can be highly variable&amp;nbsp;[&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;3&lt;/A&gt;], but may include drowsiness or lethargy, diarrhoea, vomiting and fits. The child may go into a coma. This is called a metabolic crisis.&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;If MCADD is not identified early and treated, children affected by the disorder may experience repeated metabolic crises and result in breathing problems, seizures, brain damage, cardiac arrest or sudden death.&amp;nbsp; Conservative estimates suggest that without newborn screening, at least half of children born with MCADD will have a metabolic crisis and between 1 in 4 and up to 1 in 5 will die or experience severe disability&amp;nbsp;[&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;3&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=369%5Bvolume%5D%20AND%209555%5Bissue%5D%20AND%2037%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;5&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Research evidence suggests that between one in 10,000 and one in 20,000 babies born in the UK is affected by MCADD [&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;2&lt;/A&gt;]. Newborn screening throughout England should identify around 60 cases each year. It is thought that around 1 in 80 healthy people are carriers of MCADD.&amp;nbsp; These people do not have any symptoms.&amp;nbsp; However, if both parents are MCADD carriers, they have a one in four chance of having an affected child, in each pregnancy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In a large-scale pilot study conducted between 2004 and 2006, approximately three-quarters of a million babies were screened for MCADD in England. The study showed that newborn screening reliably identifies children affected by MCADD.&amp;nbsp; Identifying newborns affected by MCADD allows parents to use simple measures to avoid fasting and to ensure a regular, adequate energy intake for their child, thereby reducing the chances of severe, life-threatening episodes of illness. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;On the basis of these findings and evidence from other studies worldwide, the National Screening Committee, which advises Ministers on proposed screening programmes, recommended the introduction of an MCADD screening programme in England. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Several studies looking at screened cohorts with MCADD have reported that the children show no neurological impairment, but longer-term follow up is necessary before any firm conclusions can be drawn on this issue [&lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;3&lt;/A&gt;]. The evidence suggests that screening all babies for MCADD makes significant health gains as well as being financially viable. A systematic review conducted in 2004 concluded that the use of tandem mass spectrometry to screen for MCADD would be highly cost-effective [&lt;A href="http://www.hta.ac.uk/execsumm/summ812.htm" target="_blank"&gt;4&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=40%5Bvolume%5D%20AND%203-4%5Bissue%5D%20AND%20235%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;6&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Programme Centre is leading the implementation of MCADD screening in England. Those areas, which piloted the National protocol, now form Phase 1 of the screening programme. Phase 2 will be comprised of the areas served by the remaining seven screening laboratories in England, who were not involved in the pilot. It is planned that screening will be offered to all babies in the catchment areas of the remaining 7 laboratories by April 2009. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Phase1: Birmingham, Leeds, London (GOSH), London (Guy’s), Manchester, Sheffield.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;Phase 2: Cambridge, Bristol, Liverpool, London (Carshalton), Portsmouth, Newcastle and Oxford.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Cystic Fibrosis (CF)&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;In cystic fibrosis there is a problem transporting chloride across cell membranes. This affects certain organs in the body, particularly the pancreas and lungs. The thick secretions in these organs cause digestive problems and chest infections. The abnormal transport of chloride in sweat glands leads to an increased level of chloride in their sweat. This is the basis of the ‘sweat test’, often used to investigate suspected cases. As from&amp;nbsp;Sept 2007,&amp;nbsp;all of the UK screens for newborn CF.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Diagnosis of CF can be made by looking for alterations (mutations) in the CF gene. This gene is called the cystic fibrosis transmembrane regulator or CFTR gene. Alterations to this gene can cause CF. Whilst&lt;BR&gt;some alterations usually cause severe symptoms, others are more often associated with milder forms of CF.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Cystic fibrosis can affect the baby before birth. Fifteen per cent of affected babies are born with blocked intestines, a condition called meconium ileus. Without screening, about 70% of babies with CF show some symptoms by the time they have a diagnostic sweat test [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=151%5Bvolume%5D%20AND%201075%5Bpage%5D%20AND%201995%5Bpdat%5D" target="_blank"&gt;7&lt;/A&gt;].&amp;nbsp; These can include problems absorbing food, as well as breathing problems. One study found that all babies with CF examined during their first year had inflamed airways and in some it was present by four weeks.7 Eventually all patients with CF develop long-term chest infections. Now most people with CF can expect to live into adulthood [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=1792634&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;8&lt;/A&gt;]. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In the UK there are 40 babies born with cystic fibrosis in every 100,000 births, the equivalent of 4 in every 10,000 or one in every 2500 babies [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=8516189&amp;amp;ordinalpos=6&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;9&lt;/A&gt;]. Of the 750,000 babies born in the UK each year, about 300 babies have CF.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;CF is caused by a large number (over 1200 are known) of different alterations on the CFTR gene. The most common in the UK is called Delta F508. It accounts for between 55% and 85% of all detected CF alterations, depending on the area. UK screening laboratories only test for between 19 and 31 of the most common alterations out of the 1200+ identified. This means newborn screening will not identify some babies with rare alterations on the CFTR gene. Whilst most of the common alterations on the CFTR gene are known to cause CF (referred to from now on as ‘CF-causing alterations’), other alterations don’t cause CF, and others are not yet well understood.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Babies with CF are treated vigorously as soon as they are first diagnosed. New guidelines on sweat testing are now available [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=44%5Bvolume%5D%20AND%20pt%201%5Bissue%5D%20AND%2025%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;10&lt;/A&gt;]. Treatment of children with CF aims to do two things:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;improve nutrition by providing supplements containing enzymes to help digestion&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;reduce chest infections with frequent physiotherapy and either occasional or continuous&lt;BR&gt;&amp;nbsp;&amp;nbsp; antibiotics.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;BR&gt;Studies have demonstrated benefits, including in the areas of nutrition, cognitive function, pulmonary function, and survival. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17467549&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;11&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17200267&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;12&lt;/A&gt;] [&lt;A href="http://pediatrics.aappublications.org/cgi/content/full/118/3/888" target="_blank"&gt;13&lt;/A&gt;]. Newborn screening for CF may also reduce any delays in diagnosis, reducing anxiety and uncertainty about why the child is ill [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=7570403&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus" target="_blank"&gt;14&lt;/A&gt;]. Having said that, a confirmed diagnosis following newborn screening can also take time and cause parents anxiety [&lt;A href="http://www.hta.ac.uk/execsumm/summ833.htm" target="_blank"&gt;16&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=6%5Bvolume%5D%20AND%203%5Bissue%5D%20AND%20250%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;17&lt;/A&gt;]. New patient information is now available on CF and the laboratory tests involved [&lt;A href="http://cks.library.nhs.uk/patient_information_leaflet/Cystic_fibrosis" target="_blank"&gt;18&lt;/A&gt;] [&lt;A href="http://www.labtestsonline.org.uk/understanding/wellness/a_newborn-2.html" target="_blank"&gt;19&lt;/A&gt;]. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Longer-term benefits of screening are hard to assess, as improved treatments make living with CF better than in the past (whether or not a person is diagnosed through screening). Early diagnosis of a baby with CF through screening can also alert the parents to their risk of having other affected children. Treatment can slow down the effects of the disease, but cannot stop it progressing. Now, half of those with CF live to be over 30 years old.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Congenital Hypothyroidism (CHT)&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Congenital hypothyroidism (CHT) is a condition where, for one of a number of reasons, the thyroid gland doesn’t work when a baby is born and fails to make sufficient amounts of the thyroid hormone called thyroxine. The thyroid gland usually starts working in the unborn fetus from about 20 weeks gestation. The mother’s own thyroid doesn’t provide enough thyroxine to maintain sufficiently high levels in the fetus. Scientific and medical evidence has been growing that the tests used may not work properly for premature babies.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In summary all babies should have:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Repeat blood spot sample at equivalent of 35 weeks + 7 days&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Repeat blood test up to 1 chronological year of age for those not having the repeat test at the equivalent of 36 week&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Repeat using a blood spot card, unless have normal ranges for whole blood and wish to use that approach.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In very severe cases of CHT, babies are born with, or quickly develop, the following symptoms: a very low hair-line, a protruding tongue, cold skin, protruding tummy button, jaundice, feeding difficulties, constipation, and generally sluggish behaviour. However, only very few babies will have all of these symptoms and primary CHT is rarely diagnosed by clinical means in the newborn period. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;If babies with CHT are not treated, they fail to grow properly and will have ‘mild to severe’ mental disability. In the most severe cases children also have a lack of co-ordination, jerky movements and tremors. In general, patients with complete absence of the thyroid gland (called thyroid agenesis) are the most severely affected. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In the UK as a whole there are around 25 babies born with CHT in every 100,000 births, the equivalent of 2.5 in every 10,000, or about one in every 4000 births [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=151%5Bvolume%5D%20AND%201075%5Bpage%5D%20AND%201995%5Bpdat%5D" target="_blank"&gt;7&lt;/A&gt;]. Of the 750,000 babies born in the UK each year, 185 babies have CHT. Similar rates of CHT are reported in the USA and Europe [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=1307742&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;21&lt;/A&gt;]. It is less common in African and African-American children in the UK [&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=3134984" target="_blank"&gt;20&lt;/A&gt;] and USA [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=64%5Bvolume%5D%20AND%20531%5Bpage%5D%20AND%201992%5Bpdat%5D" target="_blank"&gt;22&lt;/A&gt;] but may be higher in children born to mothers of Indian, Pakistani and Bangladeshi origin&amp;nbsp;[&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=3134984" target="_blank"&gt;20&lt;/A&gt;]. More girls have CHT than boys in a ratio of 2.3 girls to every one boy [&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=3134984" target="_blank"&gt;20&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Phenylketonuria (PKU)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;People with PKU are unable to break down phenylalanine, an amino acid present in all foods. This is because the liver does not have enough of an enzyme called phenylalanine hydroxylase (PAH). This enzyme is needed to convert phenylalanine into tyrosine, which is&lt;BR&gt;essential for normal brain development after birth. People with PKU accumulate too much phenylalanine in the body and not enough tyrosine.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A baby with untreated phenylketonuria doesn’t usually show any signs of the condition for the first few months. By the time they are 6-12 months they show delayed mental development. By the time they are two years old they show serious and permanent mental disability. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In the UK as a whole there are 11 babies born with PKU in every 100,000 births [&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=1912773" target="_blank"&gt;23&lt;/A&gt;], the equivalent of about one baby in every 10,000. Of the 750,000 babies born in the UK each year, 80 have PKU. The likelihood of having PKU is related to your ethnic origin. PKU is twice as common in Ireland, where there are around 22 babies born with PKU in every 100,000 births. In contrast PKU is very uncommon amongst certain groups, including African-Americans and Ashkenazi Jews. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;If started early, treatment for PKU is very effective. It involves a special diet and extra minerals and vitamins.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;[1]. National Screening Committee policy - &lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57173&amp;amp;tabID=288&amp;amp;catID=1376" target="_blank"&gt;medium chain acyl CoA dehydrogenase deficiency (MCADD) screening&lt;/A&gt; Feb 2007. &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[2]. &amp;nbsp;Pollitt RJ, Green A, McCabe A, Booth A, Cooper NJ, Leonard JV, et al. &lt;A href="http://www.hta.ac.uk/execsumm/summ111.htm" target="_blank"&gt;Neonatal screening for inborn errors of metabolism: cost, yield and outcome&lt;/A&gt;. Health Technology Assessment 1997;1(7):1-203.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[3]. &amp;nbsp;Grosse SD, Khoury SJ, Greene CL, Crider KS, Pollitt RJ. The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: An update. Genetics in Medicine 2006;8(4):205-12. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16617240&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[4]. &amp;nbsp;Pandor A, Eastham J, Beverley C, et al. &lt;A href="http://www.hta.ac.uk/execsumm/summ812.htm" target="_blank"&gt;Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review&lt;/A&gt;. Health Technology Assessment 2004;8:12. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[5]. Wilcken B, Haas M, Joy P, Wiley V, Chaplin M, Black C et al. Outcome of neonatal screening for medium-chain acyl-CoA dehydrogenase deficiency in Australia: a cohort study. Lancet. 2007, 369(9555):37-42. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=369%5Bvolume%5D%20AND%209555%5Bissue%5D%20AND%2037%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[6]. Tran K, Banerjee S, Li H, Noorani HZ, Mensinkai S, Dooley K. Clinical efficacy and cost-effectiveness of newborn screening for medium chain acyl-CoA dehydrogenase deficiency using tandem mass spectrometry. Clinical Biochemistry. 2007, 40(3-4):235-41. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=40%5Bvolume%5D%20AND%203-4%5Bissue%5D%20AND%20235%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]. Free full text of CRD abstract: &lt;A href="http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&amp;amp;ID=32006000216" target="_blank"&gt;http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&amp;amp;ID=32006000216&lt;/A&gt; and free full text of HTA report: &lt;A href="http://www.cadth.ca/media/pdf/297_tandemmass_tr_e_no-appendices.p" target="_blank"&gt;http://www.cadth.ca/media/pdf/297_tandemmass_tr_e_no-appendices.p&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[7]. &amp;nbsp;Khan TZ, Wagener JS, Bost T, Martinez J, Accurso F, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Resp Crit Care Med 1995;151:1075-82. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=151%5Bvolume%5D%20AND%201075%5Bpage%5D%20AND%201995%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[8]. &amp;nbsp;Elborn JS, SHale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax 1991;46(12):881-5. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=1792634&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[9]. &amp;nbsp;Dodge J, Morrison S, Lewis PA, et al. Cystic fibrosis in the United Kingdom, 1968-1988: incidence, population and survival. Pediatr Perinat Epidemiol 1993;7(2):157-166. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=8516189&amp;amp;ordinalpos=6&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[10]. &amp;nbsp;Green A, Kirk J, Guidelines Development Group. Guidelines for the performance of the sweat test for the diagnosis of cystic fibrosis. Annals of Clinical Biochemistry. 2007, 44(Pt 1):25-34. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=44%5Bvolume%5D%20AND%20pt%201%5Bissue%5D%20AND%2025%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract]&lt;/A&gt;. Both the appraisal comments and the full evidence base can be found on &lt;A href="http://www.rcpch.ac.uk/doc.aspx?id_Resource=1719" target="_blank"&gt;http://www.rcpch.ac.uk/doc.aspx?id_Resource=1719&lt;/A&gt; . The full guidelines can also be found at &lt;A href="http://www.ukneqas.org.uk/nov2003guideline.pdf" target="_blank"&gt;http://www.ukneqas.org.uk/nov2003guideline.pdf&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[11]. Rock MJ. Newborn screening for cystic fibrosis. Clinics in Chest Medicine. 2007, 28(2):297-305. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17467549&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[12]. Sims EJ, Clark A, McCormick J, Mehta G, Connett G, Mehta A et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics. 2007, 119(1):19-28. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17200267&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[13]. Baussano I, Tardivo I, Bellezza-Fontana R, Forneris MP, Lezo A, Anfossi L et al. &lt;A href="http://pediatrics.aappublications.org/cgi/content/full/118/3/888" target="_blank"&gt;Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa&lt;/A&gt;. Pediatrics. 2006, 118(3):888-95 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[14] Dankert-Roelse JE, te Meerman GJ. Long term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening and treatment in a cystic fibrosis centre. Thorax 1995 Jul;50(7):712-8 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=7570403&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVAbstractPlus" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[16]. Green J, Hewison J, Bekker H, Bryant LD, Cuckle H. &lt;A href="http://www.hta.ac.uk/execsumm/summ833.htm" target="_blank"&gt;Psychological aspects of genetic screening of pregnant women and newborns: a systematic review&lt;/A&gt;.&amp;nbsp; Health Technology Assessment Programme 2004,&amp;nbsp;8(33).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[17]. Moran J, Quirk K, Duff AJ, Brownlee KG. Newborn screening for CF in a regional paediatric centre: the psychosocial effects of false-positive IRT results&amp;nbsp;on parents. Journal of Cystic Fibrosis. 2007, 6(3):250-4. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=6%5Bvolume%5D%20AND%203%5Bissue%5D%20AND%20250%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[18]. Clinical Knowledge Summaries (CKS). &lt;A href="http://cks.library.nhs.uk/patient_information_leaflet/Cystic_fibrosis" target="_blank"&gt;Patient information leaflet on Cystic Fibrosis&lt;/A&gt;. 2007.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[19]. Lab tests online UK 2007.&amp;nbsp; &lt;A href="http://www.labtestsonline.org.uk/understanding/analytes/sweat_chloride/glance.html" target="_blank"&gt;Sweat chloride test&lt;/A&gt;, &lt;A href="http://www.labtestsonline.org.uk/understanding/analytes/cf_gene/glance.html" target="_blank"&gt;CF Gene Mutation Testing&lt;/A&gt; and &lt;A href="http://www.labtestsonline.org.uk/understanding/analytes/trypsinogen/glance.html" target="_blank"&gt;Immunoreactive Trypsin&lt;/A&gt;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[20].&amp;nbsp;Grant DB, Smith I. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=3134984" target="_blank"&gt;Survey of neonatal screening for primary hypothyroidism in England, Wales, and Northern Ireland 1982-4&lt;/A&gt;. British Medical Journal 1988 May 14;296(6633):1355-8.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[21]. &amp;nbsp;Toublanc JE. Comparison of epidemiological data on congenital hypothyroidism in Europe with those of other parts of the world. Horm Res 1992;38:230-5. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=1307742&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[22]. &amp;nbsp;Lorey F, Cunningham G. Birth prevalence of primary congenital hypothyroidism by sex and ethnicity. Hum Biol 1992;64:531-8. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=64%5Bvolume%5D%20AND%20531%5Bpage%5D%20AND%201992%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[23]. Smith I, Cook B, Beasley M. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=1912773" target="_blank"&gt;Review of neonatal screening programme for phenylketonuria&lt;/A&gt;. British Medical Journal 1991 Aug 10;303(6798):333-5.&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 12pt; tab-stops: -9.0pt right 0cm; mso-layout-grid-align: none" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 12pt; tab-stops: 0cm right 27.0pt" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-bidi-font-size: 12.0pt" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;FONT face=Arial&gt;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 10pt; mso-bidi-font-family: Arial" lang=EN-GB&gt;&lt;o:p&gt;&lt;FONT face=Arial&gt;
&lt;P style="LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;/FONT&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;STRONG&gt;Annual evidence updates on newborn bloodspot screening 2006/07&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Screening Library has identified the new evidence published over the last year, and the results of our search are classified and presented as evidence updates below&lt;/P&gt;
&lt;P style="LINE-HEIGHT: 150%; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-ansi-language: EN-US" lang=EN-GB&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;FONT face=Arial&gt;&lt;/FONT&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="LINE-HEIGHT: 150%; FONT-SIZE: 10pt; mso-bidi-font-family: Arial; mso-bidi-font-size: 6.0pt; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269280" target="_blank"&gt;Congenital hypothyroidism&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=187226" target="_blank"&gt;Cystic Fibrosis&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269283" target="_blank"&gt;MCADD&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=260735" target="_blank"&gt;Phenylketonuria&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=212461" target="_blank"&gt;Sickle cell disease&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee policies on newborn bloodspot screening, July 2006&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=56895&amp;amp;tabID=288&amp;amp;catID=1374" target="_blank"&gt;Congenital hypothyroidism&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=56899&amp;amp;tabID=288&amp;amp;catID=2005" target="_blank"&gt;Cystic Fibrosis&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57173&amp;amp;tabID=288&amp;amp;catID=1376" target="_blank"&gt;MCADD&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57174&amp;amp;tabID=288&amp;amp;catID=1375" target="_blank"&gt;Phenylketonuria&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57171&amp;amp;tabID=288&amp;amp;catID=2037" target="_blank"&gt;Sickle cell disease&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;Additional reference (selected from&amp;nbsp;the above annual evidence updates)&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic review&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Grosse SD, Rosenfeld M, Devine OJ, Lai HJ, Farrell PM. Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis. Journal of Pediatrics.149(3):362-6, 2006 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=149%5Bvolume%5D%20AND%203%5Bissue%5D%20AND%20362%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;Other&amp;nbsp;information for health professionals &lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;Continuous professional development - resources to support the Antenatal and Newborn Screening Programmes: &lt;A href="http://www.screening.nhs.uk/cpd/bloodspot.htm" target="_blank"&gt;Newborn Bloodspot&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information to give parents&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Sept 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/index.htm" target="_blank"&gt;Screening tests for your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>329833</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://healthguides.mapofmedicine.com/choices/map/newborn_hearing_screening1.html]]&gt;</url>
    <title>Newborn hearing screening</title>
    <publicationDate>2009-07-16T00:00:00</publicationDate>
    <publisher>NHS Choices</publisher>
    <publicationType>CARE PATHWAY</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,PHYSICAL (&lt;72HRS),HEARING,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Map of Medicine care pathway for newborn hearing screening</description>
    <body>&lt;![CDATA[ The Map of Medicine provides a way of visualising the newborn hearing screening pathway that is offered to all newborn babies.]]&gt;</body>
  </document>
  <document>
    <id>311625</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://hearing.screening.nhs.uk/carepathways#fileid10773]]&gt;</url>
    <title>Newborn Hearing Screening Care Pathway</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>Newborn Hearing Screening Programme</publisher>
    <publicationType>CARE PATHWAY</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NORMAL PREGNANCY,POSTNATAL CARE,WOMEN'S HEALTH,HEARING,PHYSICAL (&lt;72HRS),NEWBORN,NEONATAL AND INFANT CARE,GENERAL EXAMINATION AND SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The NHSP Programme Centre has developed care pathway documentation to replace the old decision charts that described the screening protocol.]]&gt;</body>
  </document>
  <document>
    <id>95742</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.mhs.uk/getdata.php?id=10972]]&gt;</url>
    <title>Newborn screening for cystic fibrosis protocol</title>
    <publicationDate>2005-10-21T00:00:00</publicationDate>
    <publisher>UK Newborn Screening Programme Centre</publisher>
    <publicationType>PROTOCOL</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,STAFF USE,GENETIC CONDITIONS,CYSTIC FIBROSIS,SPECIALTIES,NEONATAL,CYSTIC FIBROSIS,IMPLEMENTATION,SCREENING,RESPIRATORY,SCREENING,CHILD HEALTH,GUIDELINES/EBM,MANAGEMENT,CYSTIC FIBROSIS (CF),SYSTEMS &amp; SYMPTOMS,CYSTIC FIBROSIS,NEWBORN,BLOODSPOT (&lt;1WK),CONDITIONS C,BLOOD]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The development of the national Cystic Fibrosis Screening Programme has included the production of a national laboratory algorithm, or protocol.]]&gt;</body>
  </document>
  <document>
    <id>187193</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5313a1.htm]]&gt;</url>
    <title>Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs</title>
    <publicationDate>2004-10-15T00:00:00</publicationDate>
    <publisher>Centers for Disease Control and Prevention</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CYSTIC FIBROSIS,NEWBORN,BLOODSPOT (&lt;1WK)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Outlines CDC recommendations for neontal cystic fibrosis screening</description>
    <body>&lt;![CDATA[ This report, compiled by the Centers for Disease Control and Prevention, USA, describes new research findings and outlines the recommendations of&amp;nbsp;a workshop on neonatal screening for cystic fibrosis.]]&gt;</body>
  </document>
  <document>
    <id>325361</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325361]]&gt;</url>
    <title>NHS Abdominal Aortic Aneurysm (AAA) Screening Programme: Information for Primary Care</title>
    <publicationDate>2009-09-02T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;NHS Abdominal Aortic Aneurysm (AAA) Screening Programme: Information for Primary Care&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The leaflet below has been developed to provide information to GPs about the NHS AAA Screening Programme.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>302088</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://aaa.screening.nhs.uk/]]&gt;</url>
    <title>NHS Abdominal Aortic Aneurysm Screening Programme</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>NHS website outlining AAA screening</description>
    <body>&lt;![CDATA[ The NHS is introducing a new screening programme for Abdominal Aortic Aneurysm and this website outline the details.]]&gt;</body>
  </document>
  <document>
    <id>82456</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/bowel/index.html]]&gt;</url>
    <title>NHS Bowel Cancer Screening Programme</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ DISEASE PREVENTION,COLON &amp; RECTUM,CANCER,SCREENING,GASTROENTEROLOGY &amp; LIVER DISEASES,OUTCOMES,CANCER,ADULTS,AGE GROUPS,OLDER PEOPLE,ADULT,COLORECTAL (BOWEL) CANCER,SCREENING,PUBLIC HEALTH,MONTHLY ADDITIONS,2009 FEBRUARY,GROUPS,POPULATIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ A national Bowel Cancer Screening Programme is currently being phased in across England and Wales and is&amp;nbsp;expected&amp;nbsp;to be&amp;nbsp;complete by the end of 2009. Men and women aged 60-69 will be invited to take part in screening every two years. This Programme website gives details about the phasing-in of&amp;nbsp;bowel cancer screening.]]&gt;</body>
  </document>
  <document>
    <id>82450</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/index.html]]&gt;</url>
    <title>NHS Breast Screening Programme</title>
    <publicationDate>2000-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,SCREENING,IMPLEMENTATION,ADULT,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the&amp;nbsp;NHS Breast Screening Programme website, which outlines the national programme. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>88885</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58.html]]&gt;</url>
    <title>NHS Breast Screening Programme (NHSBSP) guidelines for pathology reporting in breast disease</title>
    <publicationDate>2005-10-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is&amp;nbsp;a publication incorporating the&amp;nbsp;3rd edition&amp;nbsp;of the NHS Breast Screening Programme’s guidelines for pathology reporting in breast cancer screening and the&amp;nbsp;2nd edition&amp;nbsp;of The Royal College of Pathologists’ minimum dataset for breast cancer histopathology.&lt;/P&gt;
&lt;P&gt;Also available from this site is the NHSBSP wide bore needle biopsy form, the breast histopathology synoptic report and a the breast cancer grading poster that will accompanies this publication.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>112004</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp-annualreview2005.pdf]]&gt;</url>
    <title>NHS Breast Screening Programme Annual Review 2009</title>
    <publicationDate>2009-12-31T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This breast screening programme annual review contains information and&amp;nbsp;statistics about the numbers of women taking up invitations for breast screening.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.cancerscreening.nhs.uk/breastscreen/publications/archived-annual-reviews.html" target="_blank"&gt;Archived annual reviews&lt;/A&gt; are also available&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>56175</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/index.html]]&gt;</url>
    <title>NHS Cancer Screening Programmes</title>
    <publicationDate>2000-12-01T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,CERVICAL CANCER,BREAST CANCER,COLORECTAL (BOWEL) CANCER,IMPLEMENTATION,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;H3&gt;Cancer&lt;/H3&gt;
&lt;P&gt;This is the&amp;nbsp;NHS Cancer Screening Programme website, which outlines the national Bowel Cancer, Breast Cancer and&amp;nbsp;Cervical Cancer Screening Programmes. 
&lt;P&gt;There&amp;nbsp;is currently no organised screening programme for prostate cancer but details are given about&amp;nbsp;an informed choice programme, Prostate Cancer Risk Management. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69859</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/cervical-annual-review-2009.pdf]]&gt;</url>
    <title>NHS Cervical Screening 2009 Annual Review</title>
    <publicationDate>2009-12-31T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,IMPLEMENTATION,CERVICAL CANCER,WOMEN'S HEALTH,GYNAECOLOGICAL TUMOURS,CERVICAL CANCER,SCREENING,MANAGEMENT,MALIGNANT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This report reviews the NHS Cervical Cancer Screening Programme for 2009, including the major events that impacted on the programme.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.cancerscreening.nhs.uk/cervical/publications/archived-annual-reviews.html" target="_blank"&gt;Archived annual&amp;nbsp;reviews&lt;/A&gt; are also available.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82451</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/index.html]]&gt;</url>
    <title>NHS Cervical Screening Programme</title>
    <publicationDate>2000-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,ADULT,IMPLEMENTATION,SCREENING,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This is the&amp;nbsp;NHS Cervical Screening Programme website, which outlines the national programme.]]&gt;</body>
  </document>
  <document>
    <id>29193</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/]]&gt;</url>
    <title>NHS Fetal Anomaly Screening Programme</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,LEARNING DISABILITIES,HEALTH,SCREENING,ANTENATAL,IMPLEMENTATION,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),FETAL ANOMALY,LEARNING DISABILITY,MANAGEMENT,DOWN SYNDROME (DS),GENETICS - PRACTICE &amp; ISSUES,SYSTEMS &amp; SYMPTOMS,11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM),18-20 WEEKS,GENETIC SCREENING (FOR CONDITIONS),DOWN'S SYNDROME,CONDITIONS D-F,PREGNANCY,HEART (CARDIO)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This NHS Fetal Anomaly and Down's Syndrome&amp;nbsp;Screening Programme website is for all users of maternity services and health professionals involved in maternity care. It aims to provide information on all aspects of&amp;nbsp;Down's syndrome and fetal anomaly screening&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>31705</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=10848]]&gt;</url>
    <title>NHS Fetal Anomaly Screening Programme - screening for Down's syndrome: UK NSC Policy recommendations 2007-2010. Model of best practice</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ 11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM),MANAGEMENT,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),ANTENATAL,SCREENING,IMPLEMENTATION,DOWN'S SYNDROME]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>This document supercedes the 2003 model of best practice</description>
    <body>&lt;![CDATA[ &lt;P align=justify&gt;Model of Best Practice for Down's Syndrome Screening in England containing recommendations from the UK National Screening Committee.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>322117</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://infectiousdiseases.screening.nhs.uk/]]&gt;</url>
    <title>NHS Infectious Diseases in Pregnancy Screening Programme</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,MANAGEMENT,IMPLEMENTATION,SCREENING,ANTENATAL,SYPHILIS,HIV,RUBELLA,HEPATITIS B]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The infectious diseases in pregnancy screening programme offers screening to all pregnant women for four conditions: Hepatitis B, HIV, Rubella susceptibility and Syphilis.&lt;/P&gt;
&lt;P&gt;The website provides information on the four screened conditions for health professionals and the public.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>322119</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornphysical.screening.nhs.uk/]]&gt;</url>
    <title>NHS Newborn &amp; Infant Physical Examination Programme</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,MANAGEMENT,NEWBORN,PHYSICAL (&lt;72HRS)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The NHS Newborn and Infant Physical Examination Programme (NIPE) offers&amp;nbsp;parents of newborn babies the opportunity to have their child examined shortly after birth.&amp;nbsp; The examination includes a general physical check as well as an examination of the baby’s eyes, heart, hips and testes in boys.&amp;nbsp;The examination is repeated at 6 to 8 weeks, usually by a GP.&amp;nbsp;]]&gt;</body>
  </document>
  <document>
    <id>56179</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/]]&gt;</url>
    <title>NHS Newborn Bloodspot Screening Programme</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,CONGENITAL HYPOTHYROIDISM,PHENYLKETONURIA,CYSTIC FIBROSIS,SICKLE CELL DISEASE,GENETIC CONDITIONS,GENETIC CONDITIONS A-Z,SYSTEMS &amp; SYMPTOMS,GENETICS - PRACTICE &amp; ISSUES,CONDITIONS N-R,CYSTIC FIBROSIS (CF),MANAGEMENT,LEARNING DISABILITY,SICKLE CELL (SC) (SCD),NEWBORN,BLOODSPOT (&lt;1WK),GENETIC SCREENING (FOR CONDITIONS),NEWBORN BLOODSPOT,CONDITIONS S-Z,CONDITIONS C,PHENYLKETONURIA (PKU),PREGNANCY,BLOOD]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The UK Newborn Screening Programme Centre has been set up to support the establishment and maintenance of consistent standards in newborn bloodspot screening throughout the UK, for phenylketonuria, congenital hypothyroidism, cystic fibrosis and sickle cell conditions. This Centre will monitor these conditions, along with screening for other inborn errors of metabolism. 
&lt;P&gt;This is the Programme Centre&amp;nbsp;website.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>56180</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://hearing.screening.nhs.uk/]]&gt;</url>
    <title>NHS Newborn Hearing Screening Programme</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,EAR &amp; AUDITORY SYSTEM DISORDERS,HEARING DISORDERS/ DEAFNESS,GENERAL EAR &amp; AUDITORY,ENT AND AUDIOLOGY,GENETIC CONDITIONS,SCREENING,HEARING,IMPLEMENTATION,MANAGEMENT,HEARING LOSS / SPEECH DISORDERS,SYSTEMS &amp; SYMPTOMS,PREGNANCY,NEWBORN,PHYSICAL (&lt;72HRS),GENETIC SCREENING (FOR CONDITIONS),CONDITIONS,NEWBORN HEARING,NEONATAL SCREENING,SPECIALTIES,AUDIOLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The NHS Newborn Hearing Screening Programme (NHSP) ensures all parents are offered hearing screening for their new child within the first few weeks of life. It is a core service within the NHS in England and part of the family of Antenatal &amp;amp; Newborn Screening Programmes. 
&lt;P&gt;This is the Programme website.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>56178</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.retinalscreening.nhs.uk/pages/]]&gt;</url>
    <title>NHS Screening Programme for Sight-Threatening Diabetic Retinopathy</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CONDITIONS,DIABETIC RETINOPATHY,DIABETIC RETINOPATHY,RETINOPATHY,RETINA,MANAGEMENT,EYE DISEASES,GOVERNMENT / NHS,ORGANISATIONS,DIABETIC RETINOPATHY,EYES AND VISION,CHRONIC COMPLICATIONS,RETINOPATHY,DIAGNOSIS,CAUSES,SCREENING,ADULT,IMPLEMENTATION,DIABETES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This website outlines the&amp;nbsp;development of a National Screening Programme for Diabetic Retinopathy Screening in England.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>383253</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=9774]]&gt;</url>
    <title>NHS Screening Timeline</title>
    <publicationDate>2010-04-07T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER,CERVICAL CANCER,COLORECTAL (BOWEL) CANCER,DIABETIC RETINOPATHY,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The NHS Screening Timeline is a new visual representation of all national screening programmes available in the English NHS, particularly focusing on the adult and cancer programmes. &lt;/P&gt;
&lt;P&gt;It sits alongside the well established antenatal and newborn timeline, which shows optimum times for NHS antenatal and newborn screening tests to take place.&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>56181</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://sct.screening.nhs.uk/]]&gt;</url>
    <title>NHS Sickle Cell &amp; Thalassaemia Screening Programme</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>NHS</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ IMPLEMENTATION,SCREENING,ANTENATAL,SICKLE CELL DISEASE,SICKLE CELL,SPECIALTIES,NEONATAL,HAEMATOLOGY,GUIDELINES/EBM,CHILD HEALTH,SCREENING,STAFF USE,GENETIC CONDITIONS,GENETIC CONDITIONS A-Z,SYSTEMS &amp; SYMPTOMS,GENETICS - PRACTICE &amp; ISSUES,CONDITIONS N-R,MANAGEMENT,SICKLE CELL,8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA,GENETIC SCREENING (FOR CONDITIONS),NEWBORN,BLOODSPOT (&lt;1WK),SICKLE CELL (SC) (SCD),THALASSAEMIA,PREGNANCY,CONDITIONS S-Z,BLOOD]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This website outlines details of the NHS Sickle Cell and Thalassaemia Screening Programme including information about sickle cell and thalassaemia and other haemoglobin disorders, about the tests&amp;nbsp;that are&amp;nbsp;offered at different stages of life, and about how screening and care is being developed.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82463</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/assetRoot/04/05/75/19/04057519.pdf]]&gt;</url>
    <title>NSF Coronary Heart Disease Chapter 2: Preventing coronary heart disease in high risk patients</title>
    <publicationDate>2000-03-06T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NATIONAL SERVICE FRAMEWORK FOR CHD,ADULT,SCREENING,CORONARY HEART DISEASE,GENERAL,GENERAL,DIAGNOSIS,PREVENTION,CARDIOVASCULAR DISEASES,CONDITIONS,PREVENTION,DIAGNOSIS,CORONARY HEART DISEASE,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is Chapter 2 of the National Service Framework (NSF) for Coronary Heart Disease. It looks at systematic identification of patients with a high-risk of coronary heart disease and modifiable risk factors, systematic provision and documentation of the delivery of appropriate advice, treatment and the offering of regular review, and clinical audit.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66853</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.msac.gov.au/internet/msac/publishing.nsf/Content/8FD1D98FE64C8A2FCA2575AD0082FD8F/$File/Ref%2004%20-%20Nuchal%20translucencyNuchal%20translucency%20Report.pdf]]&gt;</url>
    <title>Nuchal translucency measurement in the first trimester of pregnancy for screening of trisomy 21 and other autosomal trisomies</title>
    <publicationDate>2002-05-01T00:00:00</publicationDate>
    <publisher>Medical Services Advisory Committee</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),11-14 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ 1&lt;/FIRSTPAGE&gt;&lt;FIRSTPAGEID&gt;1&lt;/FIRSTPAGEID&gt;&lt;PAGE&gt;&lt;PAGEID&gt;1&lt;/PAGEID&gt;&lt;PAGESEQUENCE&gt;-1&lt;/PAGESEQUENCE&gt;&lt;PAGETITLE&gt;&lt;/PAGETITLE&gt;&lt;PAGEBODY&gt;&lt;P&gt;This assessment report, produced by the Australian Medical Services Advisory Committee (MSAC), involved a systematic review of the literature and other available data on nuchal translucency (NT) measurement.&lt;FONT face=Garamond&gt;&lt;/FONT&gt;&lt;FONT face=Garamond&gt; 
&lt;P align=left&gt;The MSAC concluded that "NT&amp;nbsp;screening, and NT screening&amp;nbsp;in conjunction with first trimester maternal biochemical screening are safe and effective where provided by individuals with appropriate expertise in NTS".&lt;/P&gt;
&lt;P align=left&gt;There is also a &lt;A href="http://www.msac.gov.au/internet/msac/publishing.nsf/Content/AD35ED216E990FC7CA2571420004A192/$File/Ref%2004%20-%20NT%20Measurement.pdf" target="_blank"&gt;one page summary&lt;/A&gt; available.&lt;/FONT&gt;&lt;/P&gt;]]&amp;gt;&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;]]&gt;</body>
  </document>
  <document>
    <id>387912</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://apjcn.nhri.org.tw/server/APJCN/Volume19/vol19.3/abstracts.php#Nutritional_screening_in_community-dwelling_older_adults]]&gt;</url>
    <title>Nutritional screening in community-dwelling older adults: a systematic literature review</title>
    <publicationDate>2010-09-01T00:00:00</publicationDate>
    <publisher>Asia Pacific Journal of Clinical Nutrition, HEC Press</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,LATER LIFE,OLD AGE,NOT ROUTINELY OFFERED,HEALTH &amp; WELLBEING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Mini Nutritional Assessment-Short Form seems to be the most appropriate screening tool, although there is some evidence to support the use of two others ('Malnutrition Universal Screening Tool' and 'Seniors in the Community: Risk Evaluation for Eatin and Nutrition (SCREEN) II'). Further research is needed into the acceptability of screening, particularly on outcome and appropriate interventions&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, PubMed, Cinahl and the Cochrane Library were searched for nutrition screening tools that identify malnutrition or under-nutrition in adults over 65 who live in the community.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Ten screening tools were included and subjected to validity and/or reliability testing.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Phillips M, Foley A, Barnard R, et al. Nutritional screening in community-dwelling older adults: a systematic literature review. Asia Pacific Journal of Clinical Nutrition 2010; 19(3):440-9&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://apjcn.nhri.org.tw/server/APJCN/Volume19/vol19.3/abstracts.php#Nutritional_screening_in_community-dwelling_older_adults" target="_blank"&gt;Abstract available&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This systematic review/meta-analysis has not been critically appraised.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392493</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=79]]&gt;</url>
    <title>Option appraisal: screening for prostate cancer: report to the UK National Screening Committee</title>
    <publicationDate>2010-05-01T00:00:00</publicationDate>
    <publisher>School of Health and Related Research (ScHARR)</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,PROSTATE,ECONOMICS,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The aim of the study was to develop a mathematical model to estimate the costs, benefits and resource implications of alternative screening options for prostate cancer in the UK. The impacts of four screening options using the prostate specific antigen (PSA) blood test conducted are assessed in comparison to no screening and to each other:&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;a single screen at age 50 years, 
&lt;LI&gt;screening every four years from age 50 to 74 years, 
&lt;LI&gt;screening every two years from age 50 to 74 years, 
&lt;LI&gt;screening every year from age 50 to 74 years.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;In addition a range of further screening options investigating the impact of screening&lt;BR&gt;at different ages and over different durations have also been examined.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63675</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp52.pdf]]&gt;</url>
    <title>Organising a Breast Screening Programme</title>
    <publicationDate>2002-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,IMPLEMENTATION,BREAST CANCER,MANAGEMENT,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This&amp;nbsp;report sets out the principles for the organisation of local breast screening programmes. It is aimed at commissioners, quality assurance directors and directors of breast screening.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61089</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61089]]&gt;</url>
    <title>Osteoporosis and criteria for screening</title>
    <publicationDate>2002-02-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BONE DISORDERS,OSTEOPOROSIS,MUSCULOSKELETAL,CONDITIONS,SCREENING,ADULT,LATER LIFE,SCREENING AND SURVEILLANCE,OSTEOPOROSIS,OLD AGE,OSTEOPOROSIS,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Evaluation of osteoporosis screening against National Screening Committee criteria</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Osteoporosis and criteria for screening&lt;/pageTitle&gt;&lt;pageBody&gt;This report, produced by the National Screening Committee (NSC), assesses osteoporosis screening against the&amp;nbsp;NSC criteria.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>69770</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.aetmis.gouv.qc.ca/site/download.php?f=d45cbb01c38cbe4b6050278458f85860]]&gt;</url>
    <title>Osteoporosis and fractures among people aged 65 and over: recommendations for an integrated framework for action in Quebec</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,OSTEOPOROSIS,SCREENING AND SURVEILLANCE,LATER LIFE,OSTEOPOROSIS,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS), is the Québec (Canada)&amp;nbsp;government agency responsible for health services and technology assessment. They&amp;nbsp;produce reports on various matters relating to health management. 
&lt;P&gt;AETMIS have reviewed 11 international reports on osteoporosis screening, as a starting point for recommendations for a framework of action on fighting osteoporosis and fractures in Quebec. Their report concludes that "b&lt;FONT face=TimesNewRoman&gt;ased on the evidence, none of the 11 reports studied recommends universal bone density screening, i.e. among individuals who present no symptoms of osteoporosis and do not request the test".&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.aetmis.gouv.qc.ca/site/download.php?f=76a1b7b6c5c65578d06199d79f6559b6" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>320407</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.bmj.com/cgi/content/full/339/jul09_1/b2587]]&gt;</url>
    <title>Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends</title>
    <publicationDate>2009-07-09T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Abstract &lt;BR&gt;&lt;/STRONG&gt;Objective: To estimate the extent of overdiagnosis (the detection of cancers that will not cause death or symptoms) in publicly organised screening programmes. &lt;BR&gt;Design Systematic review of published trends in incidence of breast cancer before and after the introduction of mammography screening. &lt;/P&gt;
&lt;P&gt;Review methods: One author extracted data on incidence of breast cancer (including carcinoma in situ), population size, screening uptake, time periods, and age groups, which were checked independently by the other author. Linear regression was used to estimate trends in incidence before and after the introduction of screening and in older, previously screened women. Meta-analysis was used to estimate the extent of overdiagnosis. &lt;/P&gt;
&lt;P&gt;Results: Incidence data covering at least seven years before screening and seven years after screening had been fully implemented, and including both screened and non-screened age groups, were available from the United Kingdom; Manitoba, Canada; New South Wales, Australia; Sweden; and parts of Norway. The implementation phase with its prevalence peak was excluded and adjustment made for changing background incidence and compensatory drops in incidence among older, previously screened women. Overdiagnosis was estimated at 52% (95% confidence interval 46% to 58%). Data from three countries showed a drop in incidence as the women exceeded the age limit for screening, but the reduction was small and the estimate of overdiagnosis was compensated for in this review. &lt;/P&gt;
&lt;P&gt;Conclusions: The increase in incidence of breast cancer was closely related to the introduction of screening and little of this increase was compensated for by a drop in incidence of breast cancer in previously screened women. One in three breast cancers detected in a population offered organised screening is overdiagnosed. &lt;/P&gt;
&lt;P&gt;Full reference:&lt;BR&gt;Jørgensen KJ and Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. &lt;EM&gt;BMJ&lt;/EM&gt; 2009;339:b2587 &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382054</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ukpmc.ac.uk/abstract/MED/19575688;jsessionid=1880A01E019871A897E047317104DAC6.jvm4]]&gt;</url>
    <title>Performance characteristics of postpartum screening tests for type 2 diabetes mellitus in women with a history of gestational diabetes mellitus: a systematic review</title>
    <publicationDate>2009-07-01T00:00:00</publicationDate>
    <publisher>Journal of Women's Health, Mary Ann Liebert, Inc.</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,ADULT,DIABETES,NOT ROUTINELY OFFERED,NOT ROUTINELY OFFERED,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Compared to the oral glucose tolerance test (OGTT), fasting blood glucose (FBG)&amp;nbsp;on its own was not consistently sensitive to screen for type 2 diabetes in women with a history of gestational diabetes. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Electronic databases were searched up to October 2 2008. Titles and abstracts were reviewed by two investigators and assessed for quality. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 11 studies, including 13 evaluations, comparing OGTT with FBG&amp;nbsp;were included.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Bennett WL, Bolen S, Wilson LM et al. Performance characteristics of postpartum screening tests for type 2 diabetes mellitus in women with&amp;nbsp; a history of gestational diabetes mellitus: a systematic review. &lt;EM&gt;Journal of Women's Health &lt;/EM&gt;2009; 18(7):979-87&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://ukpmc.ac.uk/abstract/MED/19575688;jsessionid=1880A01E019871A897E047317104DAC6.jvm4" target="_blank"&gt;Full text freely available via UK PubMed Central&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>318088</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/fullmono/mon1233.pdf]]&gt;</url>
    <title>Performance of screening tests for child physical abuse in accident and emergency departments</title>
    <publicationDate>2008-12-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,OUTCOMES,INJURIES,SCREENING,CHILD,PUBLIC HEALTH,MONTHLY ADDITIONS,2009 JULY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The objective of this review was to determine the effectiveness of screening tests for physical abuse in injured children attending A&amp;amp;E departments in the UK.&lt;/P&gt;
&lt;P&gt;Full reference: Woodman J, Pitt M, Wentz R, Taylor B, Hodes D, Gilbert RE. Performance of screening tests for child physical abuse in accident and emergency departments. Health Technology Assessment 2008;12(33).&lt;BR&gt;&amp;nbsp;&lt;FONT size=2 face=Humanist521BT-Roman&gt;&lt;FONT size=2 face=Humanist521BT-Roman&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>398362</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.bmj.com/content/341/bmj.c5869.full]]&gt;</url>
    <title>Population based screening for chronic kidney disease: cost-effectiveness study</title>
    <publicationDate>2010-11-08T00:00:00</publicationDate>
    <publisher>BMJ</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ECONOMICS,NOT ROUTINELY OFFERED,KIDNEY DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Population based screening for chronic kidney disease is not cost effective by assessment of estimated glomerular filtration rate, overall or in subgroups of people with hypertension or older people. Targeted screening of people with diabetes is acceptable in comparison to other interventions funded by public health systems.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Cost utility analysis of screening with estimated glomerular filtration rate alone compared with no screening, defined by age, diabetes and presence or absence of proteinuria. Costs were estimated by age, diabetes and hypertension.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Population based screening was associated with an incremental cost of CAN$463 and a gain of 0.0044 QALYs per patient overall, meaning a cost per QALY gained of CAN$104900. In a cohort of 100,000 people, screening for chronic kidney disease would be expected to reduce the number of people who develop end stage renal disease over their lifetime from 675 to 657. The cost per QALY gained was CAN$22600 and CAN$572000 in subgroups of people with and without diabetes respectively. In a cohort of 100,000 people with diabetes, screening would be expected to reduce the number of people who develop end stage renal disease over their lifetime from 1796 to 1741. In people without diabetes with and without hypertension, the cost per QALY gained was CAN$334000 and CAN$1411100 respectively.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Manns B, Hemmelgarn B, Tonelli M et al. Population based screening for chronic kidney disease: cost-effectiveness study. BMJ 2010; 341:c5869 doi:10.1136/bmj.c5869&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.bmj.com/content/341/bmj.c5869.full" target="_blank"&gt;Full text freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82283</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nature.com/ejhg/journal/v11/n2s/pdf/5201113a.pdf]]&gt;</url>
    <title>Population genetic screening programmes: principles, techniques, practices, and policies</title>
    <publicationDate>2003-12-01T00:00:00</publicationDate>
    <publisher>Nature Publishing Group</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,MANAGEMENT,BENEFITS &amp; HARMS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ 1&lt;/FIRSTPAGE&gt;&lt;FIRSTPAGEID&gt;1&lt;/FIRSTPAGEID&gt;&lt;PAGE&gt;&lt;PAGEID&gt;1&lt;/PAGEID&gt;&lt;PAGESEQUENCE&gt;-1&lt;/PAGESEQUENCE&gt;&lt;PAGETITLE&gt;&lt;/PAGETITLE&gt;&lt;PAGEBODY&gt;&lt;P align=left&gt;This&amp;nbsp;review examines the professional and scientific views on the principles, techniques, practices, and policies that impact on the population genetic screening programmes in Europe. 
&lt;P&gt;&lt;/P&gt;
&lt;P align=left&gt;See also the &lt;A href="nelh:82279:0" name=internalLink&gt;recommendations on population genetic screening programmes &lt;/A&gt;by the European Society for Human Genetics.&lt;/P&gt;]]&amp;gt;&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;]]&gt;</body>
  </document>
  <document>
    <id>82279</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nature.com/ejhg/journal/v11/n2s/pdf/5201112a.pdf]]&gt;</url>
    <title>Population genetic screening programmes: technical, social and ethical issues</title>
    <publicationDate>2003-12-01T00:00:00</publicationDate>
    <publisher>Nature Publishing Group</publisher>
    <publicationType>CONSENSUS STATEMENT</publicationType>
    <topics>&lt;![CDATA[ BENEFITS &amp; HARMS,MANAGEMENT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ 1&lt;/FIRSTPAGE&gt;&lt;FIRSTPAGEID&gt;1&lt;/FIRSTPAGEID&gt;&lt;PAGE&gt;&lt;PAGEID&gt;1&lt;/PAGEID&gt;&lt;PAGESEQUENCE&gt;-1&lt;/PAGESEQUENCE&gt;&lt;PAGETITLE&gt;&lt;/PAGETITLE&gt;&lt;PAGEBODY&gt;&lt;P&gt;This policy document outlines the recommendations for population genetic screening programmes, from&amp;nbsp;the European Society of Human Genetics. 
&lt;P&gt;&lt;/P&gt;
&lt;P&gt;See also this &lt;A href="nelh:82283:0" name=internalLink&gt;review of the principles, techniques, practices and policies of population genetic screening programmes in Europe&lt;/A&gt;.&lt;/P&gt;]]&amp;gt;&lt;/PAGEBODY&gt;&lt;/PAGE&gt;&lt;/ARTICLE&gt;]]&gt;</body>
  </document>
  <document>
    <id>60473</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60473]]&gt;</url>
    <title>Population screening for bladder cancer and glomerulonephritis.</title>
    <publicationDate>2002-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,BENEFITS &amp; HARMS,BLADDER,CANCER,ADULT,SCREENING,KIDNEY DISEASE,KIDNEY DISEASES,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,GLOMERULONEPHRITIS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A review of the evidence for bladder cancer screening, with policy recommendations</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Population screening for bladder cancer and glomerulonephritis.&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This paper provides a review of evidence of the risks and benefits of population screening for bladder cancer and glomerulonephritis.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A more recent review on &lt;A href="http://www.screening.nhs.uk/policydb_download.php?doc=62" target="_blank"&gt;bladder cancer&lt;/A&gt; was produced in 2010.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>392490</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screenng.nhs.uk/policydb_download.php?doc=3]]&gt;</url>
    <title>Population screening for chronic kidney disease</title>
    <publicationDate>2010-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED,KIDNEY DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses chronic kidney disease against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>301143</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=8804]]&gt;</url>
    <title>Population screening for hypertrophic cardiomyopathy (HCM). A review of the literature</title>
    <publicationDate>2008-07-01T00:00:00</publicationDate>
    <publisher>Peninsula Technology Assessment Group (PenTAG)</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ HYPERTROPHIC CARDIOMYOPATHY,CHILD,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Report on screening for hypertrophic cardiomyopathy commissioned by NSC</description>
    <body>&lt;![CDATA[ &lt;P&gt;This report was commissioned by the National Screening Committee (NSC) in 2008. It updates a previous review of the evidence on screening for hypertrophic cardiomyopathy carried out for the NSC in 2003.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;The aim of the project reported here was to consider the extent to which existing evidence supports the implementation of a population screening programme for HCM.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392244</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://thorax.bmj.com/content/62/2/131.abstract]]&gt;</url>
    <title>Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature</title>
    <publicationDate>2007-02-01T00:00:00</publicationDate>
    <publisher>Thorax</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: There is currently insufficient evidence that screening for lung cancer by computed tomography is clinically effective in reducing mortality from lung cancer.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic literature review. 15 databases and internet resources searched from 1994 to December/January 2005.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Twelve studies, including two randomized controleed trials and 10 studies without control groups were included. The proportion of abnormal findings varied widely (5-51%). Prevalence of lung cancer detected was between 0.4% and 3.2%, with the number needed to screen to detect one lung cancer being between 31 and 249. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Black C, de Verteuil R, Walker S et al. Population screening for lung cancer using computed tomography, is there evidence of clinical effectiveness? A systematic review of the literature. Thorax 2007; 62(2)131-8&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full text available with NHS Athens account&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212744</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?orig_db=PubMed&amp;db=PubMed&amp;cmd=Search&amp;term=149%5Bvolume%5D+AND+3%5Bissue%5D+AND+362%5Bpage%5D+AND+2006%5Bpdat%5D]]&gt;</url>
    <title>Potential impact of newborn screening for cystic fibrosis on child survival: a systematic review and analysis</title>
    <publicationDate>2006-09-01T00:00:00</publicationDate>
    <publisher>Mosby</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CYSTIC FIBROSIS,BLOODSPOT (&lt;1WK),NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in J Pediatrics</description>
    <body>&lt;![CDATA[ &lt;P&gt;&amp;nbsp;&lt;SPAN title="The Journal of pediatrics"&gt;J Pediatrics. &lt;/SPAN&gt;2006 Sep;149(3):362-6.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE: to estimate impact of child mortality as a result of cystic fibrosis (CF)&amp;nbsp;potentially preventable by newborn screening. &lt;/P&gt;
&lt;P&gt;CONCLUSION: newborn screening for CF may result in improved child survival. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>269308</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269308]]&gt;</url>
    <title>Preconception Care (National Knowledge Week)</title>
    <publicationDate>2007-09-21T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Preconception Care (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="different fruit" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269308/nelhImp_0003_fruit.jpg" width=200 height=133&gt;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage1 border=1 name=nelh_tempImage1 alt="GP giving advice to a woman" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269308/nelhImp_0004_GPconsult.jpg" width=200 height=132&gt;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="different alcholic drinks" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269308/nelhImp_0005_drinking.jpg" width=200 height=132&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269331" target="_blank"&gt;Annual Evidence Update&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section has been written by Dr.&amp;nbsp;Jean Chapple, Child Health Screening Co-ordinator, London&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Preconception care&lt;/STRONG&gt;&lt;/P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;BR&gt;There are currently no UK national guidelines for preconception care, despite several national reports&amp;nbsp;&lt;A href="http://www.cemach.org.uk/getdoc/28695c42-0a1e-4fd6-8601-abd01ad6c162/Saving-Mothers-Lives-Report-2000-2002.aspx" target="_blank"&gt;[1]&lt;/A&gt; [&lt;A href="http://guidance.nice.org.uk/page.aspx?o=421757" target="_blank"&gt;2&lt;/A&gt;]&amp;nbsp;stressing the need for risk assessment, education and health promotion to maximise the chance of a healthy pregnancy, mother, baby and family. Information on preconception policy for specific groups of women is included in reports and patient web sites (for example, Diabetes UK [&lt;A href="http://www.diabetes.org.uk/About_us/Our_Views/Care_recommendations/Preconception_care_for_women_with_diabetes/" target="_blank"&gt;3&lt;/A&gt;])&amp;nbsp; but is not gathered together in one place for all women. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This is in contrast to the USA, where national guidance has been published by the Centers for Disease Control and Prevention&amp;nbsp; / The Agency for Toxic Substances and Disease Registry&amp;nbsp;Preconception Care Work Group [&lt;A href="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5506a1.htm" target="_blank"&gt;4&lt;/A&gt;] [&lt;A href="http://www.springerlink.com/content/vvq15756u6g2tx6h/fulltext.html" target="_blank"&gt;5&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Health professionals should emphasise that in each and every pregnancy, including women who have already had a baby:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;healthy lifestyles have a role for both potential parents to enhance the chances of conceiving a healthy child &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;risk assessment through screening (either by question or by technology) ensures that potential problems are spotted well in advance of the pregnancy and minimised&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A large proportion of pregnancies are unplanned but not necessarily unwanted. In 1990, one third of pregnancies in four London health districts were unplanned [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=2387033&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;6&lt;/A&gt;] compared to 42% in the 2004 Millennium cohort study [&lt;A href="http://www.cls.ioe.ac.uk/studies.asp?section=0001000200010012" target="_blank"&gt;7&lt;/A&gt;]. This suggests that preconception care should take place:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;opportunistically in primary care whenever a girl or a woman of child bearing age not using a reliable method of contraception attends [8]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;systematically in more formal settings for women actively planning a pregnancy and for those at high risk of complications – for example, women with diabetes&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;It is essential that any couple being referred for infertility assessment or assisted conception should have a complete preconception assessment and any investigations or treatment completed before any infertility treatment starts.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;We need to increase professional&amp;nbsp;[&lt;A href="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5506a1.htm" target="_blank"&gt;4&lt;/A&gt;] and public awareness of the importance of preconception health behaviour and of individual’s use of preconception care services using information and tools appropriate for varying ages, literacy levels, health literacy levels, and cultural and linguistic contexts. Women need to know that health conditions and medications can affect pregnancy outcomes and that pregnancy can affect a woman's health.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Opportunistic preconception care&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;Women should begin to be informed about preconception options from an early age. Initial screening comes in the form of questions:&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;For all women:&lt;/STRONG&gt; &lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Are you immune to rubella?&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;About 40 infants with congenital rubella syndrome have been reported in the UK since 1991; about a third of their mothers were infected abroad, most in their country of origin (imported infections), a third of mothers were born abroad but acquired infection in the UK, and a third were UK-born [&lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-231.asp" target="_blank"&gt;9&lt;/A&gt;]. Women are routinely offered screening for rubella during pregnancy, but this cannot provide protection for that pregnancy, and pregnancy is a contraindication to vaccination, but can highlight&amp;nbsp;the need for post partum immunisation. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As rates of MMR vaccination in childhood have declined and there are more births to women born outside the UK (21.9% of all births in England and Wales in 2006&amp;nbsp;[&lt;A href="http://www.statistics.gov.uk/CCI/nugget.asp?ID=369&amp;amp;Pos=6&amp;amp;ColRank=1&amp;amp;Rank=176" target="_blank"&gt;10&lt;/A&gt;] who may not have been offered rubella immunisation as part of a national programme, women without proof of vaccination should be offered it before pregnancy wherever possible.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Are you a carrier of a haemoglobinopathy?&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;One standard set by the NHS Sickle Cell and Thalassaemia Screening Programme in 2006&amp;nbsp;[&lt;A href="http://www.kcl-phs.org.uk/haemscreening/Documents/ProgrammeSTAN.pdf" target="_blank"&gt;11&lt;/A&gt;] is to ensure that screening tests for these diseases, including carrier status, are offered by 8-10 weeks of pregnancy. Ideally, preconception discussion, identification and testing, especially with women&amp;nbsp;whose family origin suggests that they may have a high risk genetic background, offers women more reproductive choices and less anxiety in pregnancy. Preconception&amp;nbsp;screening and genetic counselling have been successfully implemented in other countries, and this experience can provide&amp;nbsp;a good model&amp;nbsp;for the United Kingdom to learn from&amp;nbsp;[&lt;A href="http://www.bmj.com/cgi/content/full/329/7475/1115" target="_blank"&gt;11a&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Are you taking folic acid?&lt;/STRONG&gt;&lt;/P&gt;&lt;STRONG&gt;
&lt;P&gt;&lt;BR&gt;&lt;/STRONG&gt;In the absence of fortification of flour in the UK, all women should take 400 &lt;STRONG&gt;micro&lt;/STRONG&gt;grams of folic acid each day for at least 12 weeks before trying to get pregnant and for at least the first 12 weeks of pregnancy to reduce the risk of neural tube defects (NTDs) (and possibly orofacial) clefts by two thirds [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=140%5Bvolume%5D%20AND%2022%5Bissue%5D%20AND%202469%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;12&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16511885&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;13&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17177274&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;14&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A higher dose of folic acid (usually 4.0 to 5.0 &lt;STRONG&gt;milli&lt;/STRONG&gt;grams) is recommended for women at risk of folate deficiency [&lt;A href="http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=913" target="_blank"&gt;15&lt;/A&gt;]&amp;nbsp;such as those:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;being treated with anticonvulsant medicines&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;on kidney dialysis&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;with conditions such as liver disease, malabsorption (difficulty absorbing vitamins and minerals) or certain types of anaemia&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;All women planning a pregnancy should also aim to increase their dietary consumption of folic acid by eating green vegetables and fortified cereals.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Both women with diabetes and those on antiepileptic drugs may wish to take a high (4.0 - 5.0 &lt;STRONG&gt;milli&lt;/STRONG&gt;grams) dose of folic acid, although there is no evidence that an increased dose prevents NTDs, except for women who have had a previous pregnancy with an NTD [&lt;A href="http://www.rcog.org.uk/index.asp?PageID=541" target="_blank"&gt;15a&lt;/A&gt;]&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Important questions not specific to pregnancy but having a large effect on healthy outcome&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Do you or your partner smoke?&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;If yes, offer smoking cessation counselling. Smoking is associated with preterm birth, low birth weight, and other negative perinatal outcomes. Smoking around a baby increases the risk of sudden infant death.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Do you drink alcohol?&lt;/STRONG&gt;&lt;/P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;
&lt;P&gt;&lt;BR&gt;Whilst there is debate about a ‘safe’ level of drinking in pregnancy, current Government guidance is not to drink in pregnancy or when trying to conceive [&lt;A href="http://www.dh.gov.uk/en/News/DH_074968" target="_blank"&gt;16&lt;/A&gt;]. Health professionals can stress the risks of alcohol use (especially ‘binge’ drinking) during periods when pregnancy can occur which can change&amp;nbsp;behaviour&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=97%5Bvolume%5D%20AND%204%5Bissue%5D%20AND%20330%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;17&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=32%5Bvolume%5D%20AND%201%5Bissue%5D%20AND%201%5Bpage%5D%20AND%202007%5Bpdat%5D%20AND%20Floyd%5Bauthor%5D" target="_blank"&gt;18&lt;/A&gt;].&amp;nbsp;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Do you eat a healthy diet? Are you overweight?&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;/STRONG&gt;Being well-nourished is important during and after a pregnancy, for both the mother’s health and for the development of the fetus/baby&amp;nbsp;[&lt;A href="http://guidance.nice.org.uk/page.aspx?o=440481" target="_blank"&gt;18a&lt;/A&gt;]. A healthy weight prior to pregnancy reduces the risks for neural tube defects, preterm delivery, diabetes, Caesarean delivery, hypertension, and thromboembolic disease.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Past personal health - &lt;STRONG&gt;Does this woman have any chronic illnesses that require treatment or medication?&lt;/STRONG&gt; &lt;STRONG&gt;Does this woman need specialist review and advice before pregnancy?&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;It is important that any woman with a past or chronic illness is reminded opportunistically that in some conditions, planning a pregnancy can minimise the effects of the illness.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;It is important that information is sought in a non judgemental way – if a health professional appears antagonistic to a woman with a physical or mental health problem contemplating a pregnancy, some women will delay reporting the pregnancy and accessing antenatal care for fear that the clinician will want them to terminate the pregnancy or to put the baby into care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Examples include:&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;UL&gt;
&lt;LI&gt;Women with diabetes - improved control of diabetes and taking periconceptional folic acid can reduce the risk for birth defects 3-fold. The risk for major abnormalities was lower among women receiving preconception care than non-recipients (relative risk 0.36, 95% confidence interval 0.22 to 0.59) [&lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/precondi.html" target="_blank"&gt;19&lt;/A&gt;]. The rate of anomalies was 2.1% versus 6.5%. Separate preconception clinics (provided in 17% of units) are most likely to provide the dedicated time and expertise to meet the needs of these women [&lt;A href="http://www.cemach.org.uk/Publications/CEMACH-Publications/Maternal-and-Perinatal-Health.aspx" target="_blank"&gt;20&lt;/A&gt;] [&lt;A href="http://www.cemach.org.uk/getattachment/2c4f069c-f293-4b4f-a800-6abccf4c0661/Diabetes-in-Pregnancy.aspx" target="_blank"&gt;21&lt;/A&gt;].&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Clinicians should attempt to minimize the teratogenic potential of oral antiepileptic medications for women with epilepsy and ensure that these women take periconceptional folic acid to reduce the risks of NTDs&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Both women with diabetes and those on antiepileptic drugs may wish to take a high (400mg) dose of folic acid, although there is no evidence that an increased dose prevents NTDs&amp;nbsp; except for women who have had a previous pregnancy with an NTD&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;All women with congenital or acquired heart disease should discuss future pregnancies with a consultant cardiologist or physician with an interest and expertise in the care of adult congenital heart disease in pregnancy. Pregnancy care should be provided in close conjunction with a consultant obstetrician, preferably at a joint clinic [&lt;A href="http://www.cemach.org.uk/getdoc/28695c42-0a1e-4fd6-8601-abd01ad6c162/Saving-Mothers-Lives-Report-2000-2002.aspx" target="_blank"&gt;1&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Women on oral anticoagulants should consider changing to injectable preparations because of the risk of teratogenicity and bleeding in pregnancy&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The requirement for thyroid replacement therapy for women with hypothyroidism increases during pregnancy, and early intervention promotes healthy neurological development in children&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Women with acne being treated with isotretinoin should stop treatment before becoming pregnant because of teratogenicity&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Women who have phenylketonuria should be on a phenylalanine reduced diet before and during pregnancy to stop the disease damaging their own baby’s brain development&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Women with mental health problems benefit from a review of their care and increased support during and after pregnancy [&lt;A href="http://guidance.nice.org.uk/CG45/guidance/pdf/English" target="_blank"&gt;22&lt;/A&gt;], so health professionals should ask questions about past or present severe mental illness (including schizophrenia, bipolar disorder, psychosis in the postnatal period and severe depression), previous treatment by a psychiatrist/specialist mental health team (including inpatient care) and a family history of perinatal mental illness.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Planned preconception care&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;/STRONG&gt;In addition to the questions above, women actively planning a pregnancy should be asked about:-&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Current personal health and immunity&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;/STRONG&gt;Women need to minimise the risk of acquiring any infection during pregnancy. If they are at risk of sexually transmitted or blood borne infections such as chlamydia, syphilis, hepatitis B and HIV they should be offered testing and treatment before pregnancy. Women at risk of hepatitis B can be offered immunisation before pregnancy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Health professionals also have the opportunity to offer advice on avoiding infections during pregnancy, for example by better food hygiene&amp;nbsp;[&lt;A href="http://www.nice.org.uk/pdf/CG6_ANC_NICEguideline.pdf" target="_blank"&gt;23&lt;/A&gt;] to avoid food poisoning, avoiding foods like raw eggs to minimise the risk of a salmonella infection,&amp;nbsp;and washing hands after gardening and not cleaning cat litter trays to avoid toxoplasmosis.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Dental health - w&lt;/STRONG&gt;&lt;STRONG&gt;hen did you last visit the dentist?&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;/STRONG&gt;There is some evidence that having healthy teeth and gums help women to have healthy babies. Maternal periodontal disease is associated with preterm birth, development of preeclampsia and small for dates babies [&lt;A href="http://www.springerlink.com/content/t455439hu3443r3n/fulltext.html" target="_blank"&gt;24&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Family health - a&lt;/STRONG&gt;&lt;STRONG&gt;re there any inherited illnesses in your family or in the family of the intended father of your baby?&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Many women know little about the health of their partner’s family. A preconception visit can encourage them to ask their partner and his mother and their own family about any diseases which have affected other family members, allowing time to consult with a geneticist if indicated.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Life style - w&lt;/STRONG&gt;&lt;STRONG&gt;hat work do you do? Are you exposed to any chemicals? What environment do you live in? What do you do when you are not working? What hobbies do you have? Do you take recreational drugs?&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Toxins that can affect pregnancy that are common in industries where women traditionally work. These include heavy metals such as lead and cadmium, organic solvents, pesticides and herbicides, sterilising agents, anaesthetic gases and anti cancer drugs used in health care. Questions about life styles can allow choice about changing behaviour, using protective strategies or a move to another part of a factory [&lt;A href="http://www.springerlink.com/content/f128403146677778/fulltext.pdf" target="_blank"&gt;25&lt;/A&gt;]&amp;nbsp;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;/SPAN&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[1] Confidential Enquiry into Maternal and Child Health (CEMACH). &lt;A href="http://www.cemach.org.uk/getdoc/28695c42-0a1e-4fd6-8601-abd01ad6c162/Saving-Mothers-Lives-Report-2000-2002.aspx" target="_blank"&gt;Why Mothers Die 2000-2002&lt;/A&gt;. 2004&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2] National Institute of Health and Clinical Excellence (NICE). &lt;A href="http://guidance.nice.org.uk/page.aspx?o=421757" target="_blank"&gt;Maternal and Child Nutrition (MCN) consultation: Evidence Summary - preconception review&lt;/A&gt;. April 2007. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[3] Diabetes UK web site&amp;nbsp; - &lt;A href="http://www.diabetes.org.uk/About_us/Our_Views/Care_recommendations/Preconception_care_for_women_with_diabetes/" target="_blank"&gt;Preconception care for women with diabetes&lt;/A&gt;. 2006 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[4] Johnson K, Posner SF, Biermann J, Cordero JF, Atrash HK, Parker CS et al. &lt;A href="http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5506a1.htm" target="_blank"&gt;Recommendations to improve preconception health and health care--United States&lt;/A&gt;. A report of the CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. MMWR Recomm Rep 2006;55:1-23.&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[5] Atrash HK, Johnson K, Adams M, Cordero JF, Howse J. &lt;A href="http://www.springerlink.com/content/vvq15756u6g2tx6h/fulltext.html" target="_blank"&gt;Preconception care for improving perinatal outcomes: The time to act&lt;/A&gt;. Maternal &amp;amp; Child Health Journal.Vol.10(SUPPL.7)(pp 3-11), 2006&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[6] While A. Child: Care, Health and Development. Volume 16 Issue 4 Page 219-226, July 1990 .The incidence of unplanned and unwanted pregnancies among live births from health visitor records [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=2387033&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[7] Dex S, Heather J (eds). MCS 1. &lt;A href="http://www.cls.ioe.ac.uk/studies.asp?section=0001000200010012" target="_blank"&gt;Millennium Cohort Study First Survey: a user’s guide to initial findings&lt;/A&gt;. Centre for Longitudinal Studies: London; 2004. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[8] Duncombe G. Preconception counselling optimising reproductive health and wellbeing. Medicine Today.Vol.7(4)(pp 26-30), 2006.&amp;nbsp; No abstract available.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[9] Tookey P. &lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-231.asp" target="_blank"&gt;Surveillance report : Rubella in England, Scotland and Wales&lt;/A&gt;. Euro Surveill 2004;9(4):21-3 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[10]&amp;nbsp;National Statistics Online. &lt;A href="http://www.statistics.gov.uk/CCI/nugget.asp?ID=369&amp;amp;Pos=6&amp;amp;ColRank=1&amp;amp;Rank=176" target="_blank"&gt;Live Births&lt;/A&gt;. 7th June 2007 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[11] NHS Sickle Cell and Thalassaemia Screening Programme. &lt;A href="http://www.kcl-phs.org.uk/haemscreening/Documents/ProgrammeSTAN.pdf" target="_blank"&gt;Standards for the linked Antenatal and Newborn Screening Programme&lt;/A&gt;. November 2006&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[11a] Christianson A, Streetly A, Darr A. &lt;A href="http://www.bmj.com/cgi/content/full/329/7475/1115" target="_blank"&gt;Lessons from thalassaemia screening in Iran&lt;/A&gt;. BMJ 2004 Nov 13;329(7475):1115-7.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[12] Czeizel AE, Puho EH, Banhidy F. No association between periconceptional multivitamin supplementation and risk of multiple congenital abnormalities: a population-based case-control study. American Journal of Medical Genetics. Part A.140(22):2469-77, 2006 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=140%5Bvolume%5D%20AND%2022%5Bissue%5D%20AND%202469%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[13] Goldberg BB, Alvarado S, Chavez C, Chen BH, Dick LM, Felix RJ et al. Prevalence of periconceptional folic acid use and perceived barriers to the postgestation continuance of supplemental folic acid: survey results from a Teratogen Information Service. Birth Defects Res A Clin Mol Teratol 2006;76:193-9 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16511885&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[14] Yazdy MM, Honein MA, Xing J. Reduction in orofacial clefts following folic acid fortification of the U.S. grain supply. Birth Defects Research. 79(1):16-23, 2007 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17177274&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[15]&amp;nbsp;NHS Direct Online. &lt;A href="http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=913" target="_blank"&gt;Why do I need folic acid?&lt;/A&gt;&amp;nbsp;14th August 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[15a] Royal College of Obstetricians and Gynaecologists (RCOG). &lt;A href="http://www.rcog.org.uk/index.asp?PageID=541" target="_blank"&gt;Periconceptional Folic Acid and Food Fortification in the Prevention of Neural Tube Defects.&lt;/A&gt; Scientific Advisory Committee, Opinion Paper 4, April 2003 &lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[16] Department of Health. &lt;A href="http://www.dh.gov.uk/en/News/DH_074968" target="_blank"&gt;Alcohol and pregnancy&lt;/A&gt;. 25th May 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[17] Tough S, Benzies K, Newburn-Cook C, Tofflemire K, Fraser-Lee N, Faber A et al. What do women know about the risks of delayed childbearing? Canadian Journal of Public Health 97(4):330-4, 2006 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=97%5Bvolume%5D%20AND%204%5Bissue%5D%20AND%20330%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[18] Floyd RL, Sobell M, Velasquez MM, Ingersoll K, Nettleman M, Sobell L et al. Preventing alcohol-exposed pregnancies: a randomized controlled trial. American Journal of Preventive Medicine. 32(1):1-10, 2007 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=32%5Bvolume%5D%20AND%201%5Bissue%5D%20AND%201%5Bpage%5D%20AND%202007%5Bpdat%5D%20AND%20Floyd%5Bauthor%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[18a] National Institute for Health and Clinical Excellence (NICE). &lt;A href="http://guidance.nice.org.uk/page.aspx?o=440481" target="_blank"&gt;Maternal and child nutrition: draft guidance&lt;/A&gt;. July 2007. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[19] Ray JG et al. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: a meta-analysis. Quarterly Journal of Medicine 2001 94: 435-444. [&lt;A href="http://www.jr2.ox.ac.uk/bandolier/booth/hliving/precondi.html" target="_blank"&gt;Bandolier summary&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[20] Confidential Enquiry into Maternal and Child Health (CEMACH). Diabetes organisational survey. &lt;A href="http://www.cemach.org.uk/Publications/CEMACH-Publications/Maternal-and-Perinatal-Health.aspx" target="_blank"&gt;Maternity services in 2002 for women with type 1 and type 2 diabetes&lt;/A&gt;.&amp;nbsp;2004&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[21] Confidential Enquiry into Maternal and Child Health (CEMACH). &lt;A href="http://www.cemach.org.uk/getattachment/2c4f069c-f293-4b4f-a800-6abccf4c0661/Diabetes-in-Pregnancy.aspx" target="_blank"&gt;Diabetes in pregnancy. Are we providing the best care? Findings of a national enquiry&lt;/A&gt;. 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[22] National Institute for Health And Clinical Excellence (NICE). &lt;A href="http://guidance.nice.org.uk/CG45/guidance/pdf/English" target="_blank"&gt;Antenatal and postnatal mental health: clinical management and service guidance&lt;/A&gt;. April 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[23] National Institute for Health and Clinical Excellence (NICE). &lt;A href="http://www.nice.org.uk/pdf/CG6_ANC_NICEguideline.pdf" target="_blank"&gt;Antenatal care: Routine care for the healthy pregnant woman&lt;/A&gt;. Clinical Guideline 6. 2003&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[24] Boggess KA,.Edelstein BL. &lt;A href="http://www.springerlink.com/content/t455439hu3443r3n/fulltext.html" target="_blank"&gt;Oral health in women during preconception and pregnancy: Implications for birth outcomes and infant oral health.&lt;/A&gt; Maternal &amp;amp; Child Health Journal.Vol.10(SUPPL.7)(pp 169-174), 2006. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[25] McDiarmid MA, Gehle K. &lt;A href="http://www.springerlink.com/content/f128403146677778/fulltext.pdf" target="_blank"&gt;Preconception brief: occupational/ environmental exposures.&lt;/A&gt; Maternal and Child Health Journal. 2006:10:S123-S128.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&amp;nbsp;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Annual evidence update&amp;nbsp;on preconception care&lt;STRONG&gt;&amp;nbsp;2006/07&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Screening Library has identified the&amp;nbsp;new&amp;nbsp;evidence&amp;nbsp;published over the last year, and the results of our search are classified and presented as an evidence update below. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269331" target="_blank"&gt;Preconception Care&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Additional references (&lt;STRONG&gt;selected from&amp;nbsp;the above annual evidence update)&lt;/STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;A whole issue of Maternal and Child Health Journal 2006 is devoted to the topic of&amp;nbsp;preconception care: Maternal and Child Health Journal : Preconception Care: Science, Practice, Challenges and Opportunities. &lt;A href="http://www.springerlink.com/content/t5g03236gw01/?p=1d4e629bb20b47e3a7834f7de2187a42&amp;amp;pi=11" target="_blank"&gt;Volume 10, Supplement 1&lt;/A&gt; / September, 2006. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Guidance&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;NICE Guidance currently being reviewed: Antenatal Care: routine care for the healthy pregnant woman. See review details [&lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;http://guidance.nice.org.uk/page.aspx?o=321982&lt;/A&gt;] Consultation period: &lt;SPAN class=ip_content_1_join&gt;4 September - 29 October 2007&lt;/SPAN&gt; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Boulet SL, Parker C, Atrash H. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=16710763" target="_blank"&gt;Preconception care in international settings&lt;/A&gt;. Maternal &amp;amp; Child Health Journal.10(5 Suppl):S29-35, 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Curtis M, Abelman S, Schulkin J, Williams JL, Fassett EM. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=16897374" target="_blank"&gt;Do we practice what we preach? A review of actual clinical practice with regards to preconception care guidelines&lt;/A&gt;. Maternal &amp;amp; Child Health Journal.Vol.10(SUPPL.7)(pp 53-58), 2006 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Gregory KD, Johnson CT, Johnson TR, Entman SS. The content of prenatal care. Update 2005. Womens Health Issues. 16(4):198-215, 2006 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16920524&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information to give&amp;nbsp;women&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;NHS Choices. &lt;A href="http://www.nhsdirect.nhs.uk/articles/article.aspx?articleId=430" target="_blank"&gt;Preconception&lt;/A&gt;.&amp;nbsp;21st November&amp;nbsp;2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Patient UK. &lt;A href="http://www.patient.co.uk/pdf/pilsL56.pdf" target="_blank"&gt;Planning to Become Pregnant?&lt;/A&gt;&amp;nbsp;26th January 2009&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>70633</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/genetics_tr_e.pdf]]&gt;</url>
    <title>Predictive genetic testing for breast and prostate cancer</title>
    <publicationDate>1999-01-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,BENEFITS &amp; HARMS,PROSTATE,BREAST CANCER,CANCER,ADULT,SCREENING,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,PROSTATE CANCER,PROSTATE DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA) Technology Reports are critical appraisals or systematic reviews of the literature&amp;nbsp;to provide a clear picture of the clinical effectiveness, cost-effectiveness and impact of health technologies in Canada. 
&lt;P&gt;This report** is a qualitative review that describes the current molecular basis of breast and prostate cancer and explores the ethical, psycho-social, and policy implications associated with genetic testing. One of the report's conclusions stated that "key ethical implications arising from genetic testing for hereditary breast and prostate cancer include informed consent, privacy and confidentiality, and familial implications. Predictive genetic testing for breast and prostate cancer has brought forth social issues such as the potential creation of a genetic subclass". 
&lt;P&gt;**&lt;EM&gt;Note that this report is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82298</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/Pregnancy%20%20Newborn%20Screening%20(Oct%202005).pdf]]&gt;</url>
    <title>Pregnancy and newborn screening: clinical standards ~ October 2005</title>
    <publicationDate>2004-08-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,NEWBORN,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland&amp;nbsp;exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing&amp;nbsp;support to NHSScotland on effective clinical practice and service improvements. &lt;/P&gt;
&lt;P&gt;This document introduces the NHS Quality Improvement Scotland clinical standards for&amp;nbsp;pregnancy and newborn&amp;nbsp;screening. It comprises&amp;nbsp;five standards:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;service provision and monitoring&lt;/LI&gt;
&lt;LI&gt;pregnancy screening: Down's syndrome and neural tube defects&lt;/LI&gt;
&lt;LI&gt;pregnancy screening: communicable diseases&lt;/LI&gt;
&lt;LI&gt;newborn: bloodspot screening&lt;/LI&gt;
&lt;LI&gt;newborn: hearing screening&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;The standards can be found in section five.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69942</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_prenatal_ultrasound_as_a_screening_test.html]]&gt;</url>
    <title>Prenatal Ultrasound as a Screening Test</title>
    <publicationDate>2002-10-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,BENEFITS &amp; HARMS,ULTRASOUND,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of prenatal ultrasound as a screening test. The Technology Assessment Committee summarised by stating that: "although routine ultrasound measurements are safe procedures, there are risks associated with false negative and false positive test results. Routine ultrasound in early pregnancy (before 24 weeks gestation) has not been shown to reduce perinatal mortality. Routine ultrasound in late pregnancy (after 24 weeks gestation) has not been shown to reduce perinatal mortality or morbidity".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>155379</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsdnch.htm]]&gt;</url>
    <title>Prevention of dental caries in preschool children: recommendations and rationale</title>
    <publicationDate>2004-04-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ DENTAL DISEASE,NOT ROUTINELY OFFERED,DETERMINANTS,EDUCATION,EDUCATION,CHILDREN,SCREENING,HEALTH PROTECTION,SCHOOLS,EDUCATIONAL SETTINGS,POPULATION BASED &amp; PREVENTATIVE SERVICES,CHILD,SCREENING,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,SERVICES,RESEARCH METHODS,METHODS,POPULATIONS,ANALYSIS &amp; RESEARCH,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for dental caries in preschool children. The USPSTF concludes that the "evidence is insufficient to recommend for or against routine risk assessment of preschool children by primary care clinicians for the prevention of dental disease." 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/downloads/pub/prevent/pdfser/dentser.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>111748</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ctfphc.org/Full_Text/CTF_GBS_TR_final.pdf]]&gt;</url>
    <title>Prevention of Early-onset Group B Streptococcal (GBS) infection in the newborn: systematic review and recommendations</title>
    <publicationDate>2001-05-01T00:00:00</publicationDate>
    <publisher>Canadian Task Force on Preventive Health Care</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,STREPTOCOCCUS B,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This report, published by the Candian Task Force on Preventive Health Care, systematically reviews the evidence relating to three different group B streptococcus screening strategies: universal screening of pregnant women and selective intrapartum chemoprophylaxis of colonised women with risk factors, universal screening of pregnant women and intrapartum chemoprophylaxis of all colonised women, and intrapartum chemoprophylaxis based on risk factors only.&lt;FONT face="Times New Roman"&gt;&lt;/P&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>84667</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hgc.gov.uk/UploadDocs/Contents/Documents/Final%20Draft%20of%20Profiling%20Newborn%20Report%2003%2005.pdf]]&gt;</url>
    <title>Profiling the newborn: a prospective gene technology?</title>
    <publicationDate>2005-03-01T00:00:00</publicationDate>
    <publisher>Human Genetics Commission</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,BENEFITS &amp; HARMS,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT color=#292526 face=GaramondMT&gt;
&lt;P align=left&gt;The Human Genetics Commission (HGC) and the UK National Screening Committee (NSC) were asked &lt;/FONT&gt;&lt;FONT color=#292526 face=GaramondMT&gt;to provide an initial analysis of the case for and against genetic profiling of babies at birth. &lt;FONT color=#292526 face=GaramondMT&gt;This report examines the case for and against genetically profiling babies at birth.&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>123899</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=14700715&amp;query_hl=2&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Promoting informed decisions about cancer screening in communities and healthcare systems</title>
    <publicationDate>2004-01-01T00:00:00</publicationDate>
    <publisher>Elsevier Science Ltd</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,COLORECTAL (BOWEL) CANCER,PROSTATE,BREAST CANCER,INFORMED DECISION-MAKING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="American journal of preventive medicine."&gt;Promoting informed decisions about cancer screening in communities and healthcare systems.&amp;nbsp;&amp;nbsp;Briss P, Rimer B, Reilley B et al. Am J Prev Med&lt;/SPAN&gt; 2004 Jan;26(1):67-80.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;"&lt;STRONG&gt;Objective&lt;/STRONG&gt;: This review specifically asked whether informed decision making (IDM) interventions (1) promote understanding of cancer screening, (2) facilitate participation in decision making about cancer screening at a level that is comfortable for individuals; or (3) encourage individuals to make cancer-screening decisions that are consistent with their preferences and values.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion&lt;/STRONG&gt;: The interventions were generally consistent in improving individuals' knowledge about the disease, accuracy of risk perceptions, or knowledge and beliefs about the pros and cons of screening and treatment options. However, few studies evaluated whether these interventions resulted in individuals participating in decision making at a desirable level, or whether they led to decisions that were consistent with individuals' values and preferences".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>301342</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=8810]]&gt;</url>
    <title>Proposal for assessing coeliac disease against UKNSC screening criteria</title>
    <publicationDate>2008-11-13T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,ADULT,COELIAC DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A review of coeliac disease screening</description>
    <body>&lt;![CDATA[ A review of coeliac disease screening&amp;nbsp;against NSC criteria.]]&gt;</body>
  </document>
  <document>
    <id>82453</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/prostate/index.html]]&gt;</url>
    <title>Prostate Cancer Risk Management</title>
    <publicationDate>2000-12-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CANCER,ADULT,SCREENING,PROSTATE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,PROSTATE CANCER,PROSTATE DISORDERS,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ There is no organised screening programme for prostate cancer in the UK,&amp;nbsp;but an informed choice programme, Prostate Cancer Risk Management, has been introduced.]]&gt;</body>
  </document>
  <document>
    <id>187348</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/prostate/informationpack.html]]&gt;</url>
    <title>Prostate Cancer Risk Management: UK information pack</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,PROSTATE,MANAGEMENT,PRIMARY CARE,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,PROSTATE DISORDERS,PROSTATE CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Booklet and information sheet for GPs</description>
    <body>&lt;![CDATA[ &lt;P&gt;This webpage provides access to an prostate cancer information pack, including a pdf&amp;nbsp;reference booklet and pdf patient information sheet. These packs aim to assist GPs in the counselling of men who enquire about testing for prostate cancer. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61061</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;ID=12003000507]]&gt;</url>
    <title>Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review</title>
    <publicationDate>2003-05-08T00:00:00</publicationDate>
    <publisher>Centre for Reviews and Dissemination</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS,ADULT,BREAST CANCER,SCREENING,GENETIC CONDITIONS A-Z,BENEFITS &amp; HARMS,SYSTEMS &amp; SYMPTOMS,CONDITIONS A-B,GENETICS - PRACTICE &amp; ISSUES,FAMILY HISTORY OF CANCER,BREAST &amp; OVARIAN CANCER (FAMILIAL),PREGNANCY,GENETIC SCREENING (FOR CONDITIONS)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review&lt;BR&gt;Butow P N, Lobb E A, Meiser B et al.&amp;nbsp;Medical Journal of Australia 2003; 178(2): 77-81 
&lt;P&gt;This review has been evaluated by reviewers&amp;nbsp;from the NHS Centre for Reviews and Dissemination (CRD), University of York, as potentially meeting the CRD quality criteria, and a structured abstract is in the process of being written. 
&lt;P&gt;This article is provided in free full text by the eMAJ: &lt;A href="http://www.mja.com.au/public/issues/178_02_200103/but10729_fm.html" target="_blank"&gt;http://www.mja.com.au/public/issues/178_02_200103/but10729_fm.html&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>78225</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=78225]]&gt;</url>
    <title>Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>University of Leeds</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,BEFORE 16 WEEKS,NEWBORN,BENEFITS &amp; HARMS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation produced for an antenatal and newborn screening conference</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Psychosocial aspects of genetic screening of pregnant women and newborns: a systematic review&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;SPAN class=detail_text&gt;This is a powerpoint presentation about a systematic review that&amp;nbsp;looked at the psychosocial aspects of genetic screening of pregnant women and newborns - it&amp;nbsp;was produced for the 2nd North West Regional Antenatal &amp;amp; Newborn Screening Conference held on 31st Jan 2005.&lt;/SPAN&gt; 
&lt;P&gt;&lt;SPAN class=detail_text&gt;This &lt;A href="http://www.library.nhs.uk/screening/viewResource.aspx?resid=255548&amp;amp;code=2a4d36000f48d984f0896b0aa2394a9c" target="_blank"&gt;systematic review&lt;/A&gt; has been published as a Health Technology Assessment report, and is available in full text from our Screening Library. &lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>69929</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/pm-08.html]]&gt;</url>
    <title>Qualifications and Training for Non-medical Laboratory Staff Working in the UK Cervical Screening Programme</title>
    <publicationDate>2000-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,WOMEN'S HEALTH,CERVICAL CANCER,IMPLEMENTATION,ADULT,SCREENING,STANDARDS OF PRACTICE,GOOD PRACTICE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=3 face=TimesNewRomanPSMT&gt;
&lt;P align=left&gt;This NHS Cervical Screening Programme (NHSCSP)&amp;nbsp;guidance&amp;nbsp;is intended to assist in the design and delivery of training in cervical cytology for the NHSCSP,&amp;nbsp;and&amp;nbsp;the cervical screening programmes in Scotland, Wales and Northern Ireland.&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>88886</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp59.pdf]]&gt;</url>
    <title>Quality assurance guidelines for breast cancer screening radiology</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,IMPLEMENTATION,BREAST CANCER,QUALITY ASSURANCE,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This is the second revision of the NHS Breast Screening Programme (NHSBSP) quality assurance guidelines for radiology.]]&gt;</body>
  </document>
  <document>
    <id>187298</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp63.pdf]]&gt;</url>
    <title>Quality assurance guidelines for mammography</title>
    <publicationDate>2006-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ These guidelines have been produced by the NHS Breast Screening Programme, and&amp;nbsp;deal with aspects of breast screening quality assurance and the quality control of radiographic procedures.]]&gt;</body>
  </document>
  <document>
    <id>322787</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=322787]]&gt;</url>
    <title>Quality Standards and Service Objectives</title>
    <publicationDate>2009-08-03T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,QUALITY ASSURANCE,MANAGEMENT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Quality Standards and Service Objectives&lt;/pageTitle&gt;&lt;pageBody&gt;This document defines quality standards and service objectives for Abdominal Aortic Aneurysm (AAA) screening programmes in the NHS.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>187021</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=16585299&amp;query_hl=4&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Rapid tests for group B streptococcus colonization in laboring women: a systematic review</title>
    <publicationDate>2006-04-01T00:00:00</publicationDate>
    <publisher>American Academy of Pediatrics</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,STREPTOCOCCUS B,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Pediatrics 2006. 117 (4): 1055-66. &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective&lt;/STRONG&gt;: to determine accuracy and rapidity of&amp;nbsp;group B Streptococcus (GBS) colonization tests&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion&lt;/STRONG&gt;: polymerase chain reaction (PCR) and optical immunoassay (OIA) are candidates for rapid GBS testing to determine the need for antibiotic prophylaxis to prevent neonatal GBS disease. &lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>111752</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.journals.uchicago.edu/doi/pdf/10.1086/426438]]&gt;</url>
    <title>Recommendations for the selective use of herpes simplex virus type 2 serological tests</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Infectious Diseases Society of America</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,GENITAL HERPES,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Recommendations for the selective use of herpes simplex virus type 2 serological tests. Guerry S et al. Clinical Infectious Diseases&amp;nbsp;2005;40:38-45.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This article is available in &lt;A href="http://www.journals.uchicago.edu/doi/pdf/10.1086/426438" target="_blank"&gt;free full text&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective&lt;/STRONG&gt;: to find evidence that supports screening in selected high-risk groups, by means of a systematic review of the literature on screening for herpes simplex virus.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions&lt;/STRONG&gt;: the review&amp;nbsp;concluded that screening is likely to be beneficial among those at high risk for sexually transmitted infections (STDs) and&amp;nbsp; HIV infection, HIV-infected patients, and patients with sex partners with genital herpes. In contrast, universal screening for HSV-2 infection in pregnant women is unlikely to be beneficial.&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>398364</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nature.com/ejhg/journal/v18/n7/abs/ejhg201013a.html]]&gt;</url>
    <title>Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening</title>
    <publicationDate>2010-03-03T00:00:00</publicationDate>
    <publisher>European Journal of Human Genetics</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,BENEFITS &amp; HARMS,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Prenatal and preconception guidance identifies a coherent framework to support the pursuit of reproductive benefits through population screening programmes.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Review of 53 unique guidelines addressing prenatal, preconception and newborn screening to examine how generating reproductive risk information is construed as a benefit of screening and what conditions support the realization of this benefit.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Most preconception and prenatal guidelines, where reproductive risk information was described as a primary benefit, required individuals be given choices to ensure the decision-making process was well-informaed. Except for 3 guidelines, newborn screening policy infrequently attended to the potential for reproductive benefits.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Bombard Y, Miller FA, Hayeems RZ et al. Reconsidering reproductive benefit through newborn screening: a systematic review of guidelines on preconception, prenatal and newborn screening. European Journal of Human Genetics 2010; 18(7):751-60&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.nature.com/ejhg/journal/v18/n7/abs/ejhg201013a.htmlv" target="_blank"&gt;Subscription or payment required&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>124022</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15950832&amp;query_hl=63&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>Elsevier Science Ltd</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,PROSTATE,NOT ROUTINELY OFFERED,INFORMED DECISION-MAKING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="Patient education and counseling."&gt;Reduction in uptake of PSA tests following decision aids: systematic review of current aids and their evaluations. Evans R, Edwards A, Brett J et. al. Patient Educ Couns.&lt;/SPAN&gt; 2005 Jul;58(1):13-26.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective&lt;/STRONG&gt;: to identify and appraise prostate specific antigen (PSA) decision aids and evaluations&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions&lt;/STRONG&gt;: PSA decision aids improve knowledge about PSA testing, at least in the short term. Men given these decision aids seem to be less likely to have the PSA test.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>52194</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=52194]]&gt;</url>
    <title>Review of antenatal screening for rubella immunity</title>
    <publicationDate>2003-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,RUBELLA,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A review by the Antenatal SubGroup on antenatal screening for rubella immunity</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Review of antenatal screening for rubella immunity&lt;/pageTitle&gt;&lt;pageBody&gt;This review provides conclusions, recommendations and background information on the current situation for antenatal screening for rubella immunity&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>260768</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=260768]]&gt;</url>
    <title>Review of antenatal ultrasound screening services - East Midlands</title>
    <publicationDate>2005-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ ULTRASOUND,BEFORE 16 WEEKS,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Report on antenatal ultrasound in the East Midlands</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Review of antenatal ultrasound screening services - East Midlands&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;This survey was commissioned by the Antenatal Subgroup of the National Screening Committee with the aim of mapping service provision across England.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>64027</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp54.pdf]]&gt;</url>
    <title>Review of radiation risk in breast screening</title>
    <publicationDate>2003-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER,BENEFITS &amp; HARMS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This review considers the risks and benefits of using ionising radiation to screen for breast cancer in the context of the NHS Breast Screening Programme.]]&gt;</body>
  </document>
  <document>
    <id>82796</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=82796]]&gt;</url>
    <title>Review of screening for prostate cancer</title>
    <publicationDate>2005-03-31T00:00:00</publicationDate>
    <publisher>British Journal of Urology</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,PROSTATE,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,PROSTATE DISORDERS,PROSTATE CANCER,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>BJU supplement outlining the estimates of ad-hoc screening for prostate cancer, informed decision making and PSA testing</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Review of screening for prostate cancer&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This review of prostate cancer screening was prepared for the Prostate Cancer Risk Management Programme Scientific Research Group, and has been published as a British Journal of Urology (BJU) supplement: BJU volume 95, supplement 3, April 2005.&lt;/P&gt;
&lt;P&gt;It contains an editorial and introduction to prostate cancer screening, and information about:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;the burden and natural history of prostate cancer&lt;/LI&gt;
&lt;LI&gt;outcomes of screening&lt;/LI&gt;
&lt;LI&gt;estimates of ad-hoc screening in England and Wales&lt;/LI&gt;
&lt;LI&gt;patient information and informed decision-making&lt;/LI&gt;
&lt;LI&gt;psychosocial impact of PSA testing&lt;/LI&gt;&lt;/UL&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>311620</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/content/extract/14/1/15?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;titleabstract=screen*&amp;searchid=1&amp;FIRSTINDEX=0&amp;fdate=1/1/2008&amp;resourcetype=HWCIT]]&gt;</url>
    <title>Review: faecal occult blood test screening reduces risk of colorectal cancer mortality</title>
    <publicationDate>2009-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Summary from EBM journal. Evidence-Based Medicine&amp;nbsp;2009;&lt;B&gt;14&lt;/B&gt;:15. &lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>311621</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/content/extract/13/6/172?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;titleabstract=screen*&amp;searchid=1&amp;FIRSTINDEX=0&amp;fdate=1/1/2008&amp;resourcetype=HWCIT]]&gt;</url>
    <title>Review: little evidence exists on the benefits and harms of screening for and treating gestational diabetes</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ DIABETES,ANTENATAL,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Summary from EBM journal. Evidence-Based Medicine 2008;&lt;B&gt;13&lt;/B&gt;:172.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96100</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/7/5/159?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123063357544_119&amp;stored_search=&amp;FIRSTINDEX=30&amp;journalcode=ebmed]]&gt;</url>
    <title>Review: questionnaires for detecting clinical depression in primary care have similar diagnostic accuracy</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DEPRESSION,MANAGEMENT,NOT ROUTINELY OFFERED,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Review: questionnaires for detecting clinical depression in primary care have similar diagnostic accuracy. Evidence-Based Medicine 2002; 7:159.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Williams JW Jr, Noël PH, Cordes JA, Ramirez G, Pignone M.Is this patient clinically depressed?JAMA 2002 Mar 6;287:1160–70.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63609</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/9/4/124]]&gt;</url>
    <title>Review: screening instruments had sensitivities of 67–100% and specificities of 53–98% for detecting major depression in older primary care patients</title>
    <publicationDate>2004-09-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ LATER LIFE,SCREENING AND SURVEILLANCE,ADULT,DEPRESSION,SCREENING,NOT ROUTINELY OFFERED,PRIMARY CARE,OLD AGE,MENTAL HEALTH,DEPRESSION,QUALITY ASSURANCE,SCREENING,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Review: screening instruments had sensitivities of 67–100% and specificities of 53–98% for detecting major depression in older primary care patients.&amp;nbsp;Evidence-Based Medicine 2004; 9:124 
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Watson LC, Pignone MP. Screening accuracy for late-life depression in primary care: a systematic review. J Fam Pract 2003;52:956–64. 
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96102</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/5/2/61?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123065000661_136&amp;stored_search=&amp;FIRSTINDEX=40&amp;journalcode=ebmed]]&gt;</url>
    <title>Review: screening tests are not as accurate as overnight polysomnography for the diagnosis of adult sleep apnoea</title>
    <publicationDate>2000-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Review: screening tests are not as accurate as overnight polysomnography for the diagnosis of adult sleep apnoea**. Evidence-Based Medicine 2000; 5:61.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Ross SD, Allen IE, Harrison KJ, et al. Systematic review of the literature regarding the diagnosis of sleep apnea. Evidence Report/Technology Assessment No 1. (Prepared by MetaWorks Inc. under contract no 290-97-0016.) AHCPR publication no. 99-E002. Rockville, MD: Agency for Health Care Policy and Research; February 1999.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;** Please note that this review is &amp;gt;5 years old&lt;/EM&gt;.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>239461</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmj.com/cgi/content/full/10/1/26]]&gt;</url>
    <title>Review: Sensitivity of the CAGE questionnaire for the DSM diagnosis of alcohol abuse and dependence in general clinical populations was 71% at cut points &gt;=2</title>
    <publicationDate>2005-10-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ALCOHOL PROBLEMS,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Informative abstract and expert commentary from Evidence-Based Medicine journal</description>
    <body>&lt;![CDATA[ &lt;P&gt;Review: sensitivity of the CAGE questionnaire for the DSM diagnosis of alcohol abuse and dependence in general clinical populations was 71% at cut points &amp;gt;=2. Evidence-Based Medicine 2005; 10:26&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Aertgeerts B, Buntinx F, Kester, A. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis. &lt;I&gt;J Clin Epidemiol&lt;/I&gt; 2004;&lt;B&gt;57&lt;/B&gt;:30–9. &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;amp;cmd=Retrieve&amp;amp;dopt=AbstractPlus&amp;amp;list_uids=15019008&amp;amp;query_hl=19&amp;amp;itool=pubmed_docsum" target="_blank"&gt;PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212798</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=15743856]]&gt;</url>
    <title>Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies</title>
    <publicationDate>2005-03-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,PRE-ECLAMPSIA,PRE-ECLAMPSIA,28 WEEKS,36 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in BMJ</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;&amp;nbsp;&lt;/STRONG&gt;&lt;SPAN title="BMJ (Clinical research ed.)"&gt;BMJ.&lt;/SPAN&gt; 2005 Mar 12;330(7491):565. Epub 2005 Mar 2&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;/A&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE: to determine the risk of pre-eclampsia associated with factors that may be present at antenatal booking.&lt;/P&gt;
&lt;P&gt;CONCLUSION: the risk factors identified, and the underlying evidence base, can be used to assess risk at booking so that a suitable surveillance routine to detect pre-eclampsia can be planned for the rest of the pregnancy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66406</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/qis_display_findings.jsp?pContentID=1209&amp;p_applic=CCC&amp;p_service=Content.show&amp;]]&gt;</url>
    <title>Routine ultrasound scanning before 24 weeks of pregnancy</title>
    <publicationDate>2004-02-19T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,INFORMED DECISION-MAKING,ULTRASOUND,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Routine ultrasound scanning before 24 weeks of pregnancy&lt;BR&gt;NHS Quality Improvement Scotland 2004 (Health Technology Assessment Report 5). &lt;/P&gt;
&lt;P&gt;This HTA seeks to determine the most clinically and cost effective programme of routine ultrasound scanning which can be offered to pregnant women in Scotland in the first 24 weeks of pregnancy.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>78217</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=78217]]&gt;</url>
    <title>Rubella - why test?</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Institute of Child Health</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,ANTENATAL,SCREENING,RUBELLA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation produced for an antenatal and newborn screening conference</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Rubella - why test?&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN class=detail_text&gt;This is a powerpoint presentation about&amp;nbsp;rubella testing&amp;nbsp;that was produced for the 2nd North West Regional Antenatal &amp;amp; Newborn Screening Conference held on 31st Jan 2005.&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>331604</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/BREASTSC_NOV_DEC06.pdf]]&gt;</url>
    <title>Scottish Breast Screening Programme 2006 Follow-up: Current status report ~ December 2006</title>
    <publicationDate>2006-12-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing support to NHSScotland on effective clinical practice and service improvements. &lt;/P&gt;
&lt;P&gt;This report presents an &lt;A href="nelh:69846:0" name=internalLink&gt;update to the national overview of breast cancer screening services in Scotland&lt;/A&gt;, published in November 2003&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>331608</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhshealthquality.org/nhsqis/files/CERVICALSC_NOV_AUG06.pdf]]&gt;</url>
    <title>Scottish Cervical Screening Programme 2006 Follow-up: Current Status Report ~ August 2006</title>
    <publicationDate>2006-08-01T00:00:00</publicationDate>
    <publisher>NHS Quality Improvement Scotland</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;NHS Quality Improvement Scotland exists to improve the quality of healthcare in Scotland, by setting standards, monitoring performance and providing support to NHSScotland on effective clinical practice and service improvements. &lt;/P&gt;
&lt;P&gt;This report presents an update to the &lt;A href="nelh:69850:0" name=internalLink&gt;national overview of cervical cancer screening services in Scotland&lt;/A&gt;, published in November 2003&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57340</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/booth/glossary/screen.html]]&gt;</url>
    <title>Screening - definition</title>
    <publicationDate>2004-04-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHILD,ADULT,BENEFITS &amp; HARMS,ECONOMICS,INFORMED DECISION-MAKING,QUALITY ASSURANCE,OLD AGE,MANAGEMENT,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Screening&lt;/STRONG&gt; - this is a definition contained in the Bandolier glossary 
&lt;P&gt;See the definition in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/booth/glossary/screen.html" target="_blank"&gt;Bandolier&lt;/A&gt; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82907</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=12004000118]]&gt;</url>
    <title>Screening accuracy for late-life depression in primary care: a systematic review</title>
    <publicationDate>2004-02-16T00:00:00</publicationDate>
    <publisher>NHS Centre for Reviews and Dissemination</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,DEPRESSION,ADULT,LATER LIFE,SCREENING AND SURVEILLANCE,NOT ROUTINELY OFFERED,PRIMARY CARE,SCREENING,OLD AGE,MENTAL HEALTH,DEPRESSION,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Screening accuracy for late-life depression in primary care: a systematic review. &lt;/STRONG&gt;Watson L C, Pignone M P. Journal of Family Practice 2003; 52(12): 956-964.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;This review has been evaluated by reviewers&amp;nbsp;from the NHS Centre for Reviews and Dissemination (CRD), University of York, as potentially meeting the CRD quality criteria, and a structured abstract is in the process of being written. &lt;/P&gt;
&lt;P&gt;The full text of this J Family Practice article is freely available from: &lt;A href="http://www.jfponline.com/Pages.asp?AID=1596&amp;amp;UID" target="_blank"&gt;http://www.jfponline.com/Pages.asp?AID=1596&amp;amp;UID&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392249</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/content/153/7/461.abstract]]&gt;</url>
    <title>Screening adults for bladder cancer: a review of the evidence for the US preventive services task force</title>
    <publicationDate>2010-10-05T00:00:00</publicationDate>
    <publisher>Annals of Internal Medicine, American College of Physicians</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,BLADDER,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: High quality evidence on whether screening adults for bladder cancer was not available and so further research is needed as to whether screening leads to better outcomes compared with no screening.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials and CancerLit section of PubMed were searched for studies in English. Inclusion criteris were randomized trials and controlled observational studies directly evaluating screening adults for bladder cancer compared with no screening or treatment of screen-detected bladder cancer with no treatment.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: No randomized trials or high quality controlled observational studies evaluated clinical outcomes associated with screening compared with no screening or treatment of screen-detected bladder cancer compared with no treatment. No study evaluated the sensitivity or specificity of tests used to screen and no study evaluated the harms associated with treatment of screen-detected bladder cancer compared with no treatment.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Chou R and Dana T. Screening adults for bladder cancer: a review of the evidence for the US preventive services task force. Annals of Internal Medicine 2010; 153(7):461-8&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.uspreventiveservicestaskforce.org/uspstf11/bladdercancer/bladcanrev.htm" target="_blank"&gt;Full text freely available from the US Preventive Services Task Force website&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>121806</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsdrin.htm]]&gt;</url>
    <title>Screening and behavioural counselling interventions in primary care to reduce alchol misuse</title>
    <publicationDate>2004-04-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,PRIMARY CARE,NOT ROUTINELY OFFERED,DETERMINANTS,PRIMARY CARE SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,SCREENING,ALCOHOL PROBLEMS,ADULT,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,INDIVIDUAL BEHAVIOUR,ALCOHOL CONSUMPTION,HEALTHCARE &amp; HEALTH SERVICES,HEALTH SERVICES,SERVICES,MONTHLY ADDITIONS,2008-JULY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening&amp;nbsp;and counselling for alcohol misuse.&amp;nbsp;The USPSTF recommends "screening and behavioral counseling interventions to reduce alcohol misuse by adults, including pregnant women, in primary care settings" but conclude that the evidence is insufficient to recommend "for or against screening and behavioral counseling interventions to prevent or reduce alcohol misuse by adolescents in primary care settings". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>345781</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cmaj.ca/cgi/reprint/178/8/997]]&gt;</url>
    <title>Screening and case-finding instruments for depression : a meta-analysis</title>
    <publicationDate>2008-04-08T00:00:00</publicationDate>
    <publisher>CMAJ Canadian Medical Association Journal, CMA Publications</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DEPRESSION,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Case-finding or screening questionnaires for depression do not appear to have any impact on detection and management for depression, if used in isolation.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: A Cochrane systematic review of randomized controlled trials&amp;nbsp;was performed. A meta-analysis was then performed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 16&amp;nbsp;trials incorporating 7,567 patients were reviewed. Screening and case-finding was found to modestly increase the recognition of depression by clinicians&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Gilbody S, Sheldon T, House A. Screening and case-finding instruments for depression: a meta-analysis. &lt;EM&gt;CMAJ Canadian Medical Association Journal&lt;/EM&gt; 2008;178(8):997-1003&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.cmaj.ca/cgi/reprint/178/8/997" target="_blank"&gt;Full text PDF&amp;nbsp;is freely available&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This meta-analysis has not been critically reviewed.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>387811</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://tva.sagepub.com/content/11/4/190.abstract]]&gt;</url>
    <title>Screening and intervention for domestic violence during pregnancy care: a systematic review</title>
    <publicationDate>2010-10-01T00:00:00</publicationDate>
    <publisher>Trauma Violence &amp; Abuse, Sage</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED,DOMESTIC VIOLENCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Screening for the identification of domestic violence during pregnancy was significantly more likely than nonstandardized, or no, screening. Recurrent screening improved rates. There was limited evidence that interventions reduced violence and further research is needed to establish those that are most effective.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method:&lt;/STRONG&gt; The Cochrane Library, Medline, Embase&amp;nbsp; and PsycINFO were searched between January 1995 and November 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Nine studies (five on screening, four on interventions) met the inclusion criteria of being in English and using either national or international comparative methodology.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: O'Reilly R, Beale B, Gillies D. Screening and intervention for domestic violence during pregnancy care: a systematic review. Trauma Violence &amp;amp; Abuse 2010; 11(4):190-201&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;U&gt;&lt;FONT color=#810081&gt;&lt;A href="http://tva.sagepub.com/content/11/4/190.abstract" target="_blank"&gt;Abstract available&lt;/A&gt;&lt;/FONT&gt;&lt;/U&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>122423</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsobch.htm]]&gt;</url>
    <title>Screening and interventions for overweight in children and adolescents</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ HEIGHT,SCHOOL ENTRY,NOT ROUTINELY OFFERED,OBESITY,BIOLOGICAL COMPOSITION,YOUNG PEOPLE,CHILDREN,POPULATION BASED &amp; PREVENTATIVE SERVICES,GUIDELINES,SCREENING,SCREENING,OBESITY,CHILD,PUBLIC HEALTH,DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,MANAGEMENT &amp; POLICY,FRAMES OF REFERENCE,SERVICES,POPULATIONS,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=detail_text&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for overweight in children and adolescents. The USPSTF concludes "that the evidence is insufficient to recommend for or against routine screening for overweight in children and adolescents as a means to prevent adverse health outcomes."&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94966</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://cpd.screening.nhs.uk/screeningchoices]]&gt;</url>
    <title>Screening Choices: a resource for health professionals offering antenatal and newborn care</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Screening Choices is a learning programme that has been developed to provide information and training to health professionals offering antenatal and newborn care to women. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64889</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsaneu.htm]]&gt;</url>
    <title>Screening for abdominal aortic aneurysm</title>
    <publicationDate>2005-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ECONOMICS,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for abdominal aortic aneurysm (AAA) and the supporting scientific evidence, and updates the 1996 recommendations. The USPSTF recommends: "one-time screening for abdominal aortic aneurysm (AAA) by ultrasonography in men aged 65 to 75 who have ever smoked" but makes no recommendation "for or against screening for AAA in men aged 65 to 75 who have never smoked". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95746</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/3/77?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122642527830_206&amp;stored_search=&amp;FIRSTINDEX=0&amp;journalcode=ebmed]]&gt;</url>
    <title>Screening for abdominal aortic aneurysm reduced death from AAA in older men</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Screening for abdominal aortic aneurysm reduced death from AAA in older men. Evidence-Based Medicine 2003; 8:77.&lt;/P&gt;
&lt;P&gt;This summary is based on the original article: The Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.Lancet 2002;360:1531–9.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>383261</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/content/142/3/198.full.pdf+html]]&gt;</url>
    <title>Screening for Abdominal Aortic Aneurysm. A Best evidence systematic review for the US PReventive Services Task Force</title>
    <publicationDate>2005-02-01T00:00:00</publicationDate>
    <publisher>Annals of Internal Medicine, American College of Physicians</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BENEFITS &amp; HARMS,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: 'For men aged 65-75 years, an invitation to attend AAA screening reduces AAA-related mortality.'&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline and the Cochrane Library were searched between 1994 and 2004. This was supplemented by reference lists from retrieved articles and suggestions from experts. Studies were reviewed and rated against predefined criteria.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Four population RCTs of AAA screening in men aged 65 years and older met the criteria and were included. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Fleming C, Whitlock EP, Beil TL,&amp;nbsp; et al.&amp;nbsp; Screening for Abdominal Aortic Aneurysm. A Best evidence Systematic Review for the US Preventive Services Task Force.&amp;nbsp; &lt;EM&gt;Annals of Internal Medicine&lt;/EM&gt; 2005; 142(3):203-11. &lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full text also available via the &lt;A href="http://www.ahrq.gov/clinic/uspstf05/aaascr/aaarev.htm" target="_blank"&gt;US Preventive Services Task Force website&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95744</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/4/125?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122642527830_206&amp;stored_search=&amp;FIRSTINDEX=0&amp;journalcode=ebmed]]&gt;</url>
    <title>Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,OLD AGE,ECONOMICS,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Screening for abdominal aortic aneurysms was cost effective for prolonging survival from AAA related death in older men. Evidence-Based Medicine 2003; 8:125.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Multicentre Aneurysm Screening Study Group.Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial.BMJ 2002;325:1135–8.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>250338</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=AbstractPlus&amp;list_uids=14690871&amp;query_hl=1&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Screening for alcohol abuse and dependence in older people using DSM criteria: a review</title>
    <publicationDate>2004-01-01T00:00:00</publicationDate>
    <publisher>Taylor and Francis</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,OLD AGE,SCREENING,ADULT,ALCOHOL PROBLEMS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Aging and Mental Health</description>
    <body>&lt;![CDATA[ &lt;P&gt;Aging and Mental Health. Jan 2004; 8(1): 76-82.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;OBJECTIVE: to review the quality of screening instruments for alcohol abuse and dependance used&amp;nbsp;in older people in a clinical setting&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;CONCLUSION: the geriatric version of the Michigan Alcohol Screening Test(MAST-G) and the CAGE (Cut-down, Annoyed, Guilty and Eye-opener) are the only instruments appropriate for alcohol screening in elderly people in a clinical setting&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63620</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsbvag.htm]]&gt;</url>
    <title>Screening for bacterial vaginosis in pregnancy to prevent preterm delivery</title>
    <publicationDate>2008-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BACTERIAL VAGINOSIS,NOT ROUTINELY OFFERED,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&amp;nbsp;This is the U.S. Preventive Services Task Force (USPSTF) recommendations on screening&amp;nbsp;bacterial vaginosis in pregnancy. The USPSTF concludes that&amp;nbsp;"the evidence is insufficient to assess the balance of benefits and harms of screening for bacterial vaginosis in asymtomatic pregnant women at high risk for preterm delivery". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64675</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsblad.htm]]&gt;</url>
    <title>Screening for bladder cancer in adults</title>
    <publicationDate>2004-06-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ADULT,BLADDER,CANCER,SCREENING,MALE BLADDER DISORDERS,BLADDER CANCER,MALE UROGENITAL DISORDERS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This document summarizes the U.S. Preventive Services Task Force (USPSTF)&amp;nbsp;recommendations on screening for bladder cancer in adults - they recommend "against routine screening for bladder cancer in adults". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/bladder/blacanup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>386787</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=62]]&gt;</url>
    <title>Screening for bladder cancer using the urinalysis/dipstick method. A report for the National Screening Committee</title>
    <publicationDate>2010-02-01T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,BLADDER,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses bladder cancer against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>59742</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsbrca.htm]]&gt;</url>
    <title>Screening for breast cancer</title>
    <publicationDate>2002-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER,ECONOMICS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for breast cancer. The USPSTF&amp;nbsp;recommends&amp;nbsp;"screening mammography, with or without clinical breast examination (CBE), every 1-2 years for women aged 40 and older" and concludes that "the evidence is insufficient&amp;nbsp;to recommend for or against routine CBE alone to screen for breast cancer,&amp;nbsp;and insufficent&amp;nbsp;for or against teaching or performing routine breast self-examination". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>123311</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp61.pdf]]&gt;</url>
    <title>Screening for Breast Cancer in England: Past and Future</title>
    <publicationDate>2006-02-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER,INFORMED DECISION-MAKING,QUALITY ASSURANCE,BENEFITS &amp; HARMS,ECONOMICS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report from the Advisory Committee on Breast Cancer Screening summarises results from the English breast cancer screening programme.]]&gt;</body>
  </document>
  <document>
    <id>64543</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspscerv.htm]]&gt;</url>
    <title>Screening for cervical cancer</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for cervical cancer. The USPSTF "strongly recommends screening for cervical cancer in women who have been sexually active and have a cervix" but "recommends against routinely screening women older than age 65 for cervical cancer if they have had adequate recent screening with normal Pap smears and are not otherwise at high risk for cervical cancer". 
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.chapter.4180" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70111</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.health.state.mn.us/htac/papupdate.htm]]&gt;</url>
    <title>Screening for Cervical Cancer: Recent Advances</title>
    <publicationDate>2002-06-01T00:00:00</publicationDate>
    <publisher>Health Technology Advisory Committee, Minnesota</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Health Technology Advisory Committee in Minnesota, USA&amp;nbsp;provides unbiased, scientifically based assessments and recommendations on new and emerging technologies. Note that this committee was discontinued in July 2002 due to budget cuts, so the publications will not be updated subsequently. 
&lt;P&gt;This report concludes that "one reason why Pap smear may have reached its optimal efficacy is the inherent limited sensitivity of the test... many studies have addressed impediments to cervical cancer screening and report that the most common impediments are: a lack of appreciation of the need for screening; the primary care provider does not suggest performing a Pap smear; and a belief that older patients did not require screening. These impediments to recommended screening make it imperative that the screening test used when recruiting unscreened or infrequently screened women has the highest sensitivity. Liquid-based cytology has the potential to increase the effectiveness of these&amp;nbsp;programs by reducing the risk of missed disease in infrequently screened women".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57344</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band51/b51-2.html]]&gt;</url>
    <title>Screening for chlamydia</title>
    <publicationDate>1998-05-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,WOMEN'S HEALTH,SEXUAL HEALTH,CHLAMYDIA,CHLAMYDIA,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,BACTERIAL,MALE UROGENITAL DISORDERS,CHLAMYDIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Screening for chlamydia&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band51/b51-2.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;Bandolier write: 
&lt;P&gt;"Screening is a complex issue, even when, as here, it appears to produce overall healthcare savings of $50 per woman screened. Muir Gray's book [6] is instructive when considering screening, as well as being a good read generally. In any complex organisation, and especially for screening programmes, performance is the key, and it depends on a number of factors: &lt;BR&gt;Performance = ((Motivation x Competence)/Barriers) &lt;BR&gt;&lt;BR&gt;A good strategy is to assume people are well motivated, to ensure that they have the necessary skills and to knock down the barriers which can hinder performance. Those barriers include inaccessible information, information overload, information irrelevance and insufficient time". 
&lt;H3&gt;References:&lt;/H3&gt;
&lt;OL type=1&gt;
&lt;LI&gt;MR Howell, TC Quinn, CA Gaydos. Screening for Chlamydia trachomatis in asymptomatic women attending family planning clinics. Annals of Internal Medicine 1998 128:277-84. 
&lt;LI&gt;AC Haddix, SD Hillia, WJ Kassler. The cost effectiveness of azithromycin for Chlamydia trachomatis infections in women. Sexually Transmitted Diseases 1995 22:274-80. 
&lt;LI&gt;AP Lea, HM Lamb. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women. Pharmacoeconomics 1997 12:596-611. 
&lt;LI&gt;T Stokes. Screening for Chlamydia in general practice: a literature review and summary of the evidence. Journal of Public Health Medicine 1997 19:222-32. 
&lt;LI&gt;D Scholes, A Stergachis, F Heidrich et al. Prevention of pelvic inflammatory disease by screening for cervical Chlamydial infection. New England Journal of Medicine 1996 334:1362-6. 
&lt;LI&gt;JA Muir Gray. Evidence-based Healthcare - how to make health policy and management decisions. Churchill Livingstone 1997. ISBN 0-443-05721-4 &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;** &lt;EM&gt;Note that this review is&amp;nbsp;&amp;gt;&amp;nbsp;10 years old&lt;/EM&gt;&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>301152</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=8776]]&gt;</url>
    <title>Screening for chronic kidney disease: an evidence based review for the National Screening Committee</title>
    <publicationDate>2008-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED,CHRONIC KIDNEY DISEASE,SCREENING OPTIONS,SCREENING TESTS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,KIDNEY DISEASES,KIDNEY DISEASE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A systematic review to assess the evidence for a screening programme for Chronic Kidney Disease</description>
    <body>&lt;![CDATA[ &lt;P&gt;This systematic review will assess the evidence for a screening programme for Chronic Kidney Disease (CKD) for the UK adult population using the NSC criteria. The purpose is to determine firstly whether a screening programme would be effective, feasible and cost-effective. Secondly, if it is, whether this programme should involve screening the population or should be restricted to high-risk groups. A secondary aim is to identify the gaps in the literature, which could form the basis for future research proposals.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64678</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspscolo.htm]]&gt;</url>
    <title>Screening for colorectal cancer</title>
    <publicationDate>2008-10-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,GASTROENTEROLOGY &amp; LIVER DISEASES,ECONOMICS,COLON &amp; RECTUM,CANCER,RECENT ADDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the&amp;nbsp;U.S. Preventive Services Task Force (USPSTF) recommendation on screening for colorectal cancer. The USPSTF "recommends screening for colorectal cancer using fecal occult blood testing, sigmoidoscopy, or colonoscopy in adults, beginning at age 50 years and continuing until age 75 years". 
&lt;P&gt;&lt;SPAN class=chapter-header&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/colorectal/colocost.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>75416</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspscghy.htm]]&gt;</url>
    <title>Screening for congenital hypothyroidism</title>
    <publicationDate>2008-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CONGENITAL HYPOTHYROIDISM,ENT AND AUDIOLOGY,CONDITIONS,THYROID &amp; PARATHYROID DISORDERS,HYPOTHYROIDISM,NEWBORN,BLOODSPOT (&lt;1WK)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for congenital hypothyroidism. The USPSTF "recommends screening for congenital hypothyroidism in newborns". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64892</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsacad.htm]]&gt;</url>
    <title>Screening for coronary heart disease</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CORONARY HEART DISEASE,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendations on screening for coronary heart disease. The USPSTF&amp;nbsp;"recommends against routine screening with resting electrocardiography (ECG), exercise treadmill test (ETT), or electron-beam computerized tomography (EBCT) scanning for coronary calcium for either the presence of severe coronary artery stenosis (CAS) or the prediction of coronary heart disease (CHD) events in adults at low risk for CHD events" and "found insufficient evidence to recommend for or against routine screening with ECG, ETT, or EBCT scanning for coronary calcium for either the presence of severe CAS or the prediction of CHD events in adults at increased risk for CHD events". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/chd/chdsum.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66598</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsdeme.htm]]&gt;</url>
    <title>Screening for dementia</title>
    <publicationDate>2003-06-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEUROLOGICAL CONDITIONS,DEMENTIA,ADULT,SCREENING,ALZHEIMER'S DISEASE,NOT ROUTINELY OFFERED,LATER LIFE,SCREENING AND SURVEILLANCE,DEMENTIA,OLD AGE,SCREENING,MENTAL HEALTH,DEMENTIA,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation&amp;nbsp;on screening for dementia. The USPSTF concludes that "the evidence is insufficient to recommend for or against routine screening for dementia in older adults" . 
&lt;P&gt;&amp;nbsp; 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/dementia/dementsum.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61069</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsaddepr.htm]]&gt;</url>
    <title>Screening for depression in adults</title>
    <publicationDate>2009-12-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DEPRESSION,LATER LIFE,DEMENTIA,SCREENING AND SURVEILLANCE,SCREENING,MENTAL HEALTH,DEMENTIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for depression in adults. The USPSTF recommends "&lt;A href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.chapter.1996" target="_blank"&gt;&lt;/A&gt;screening adults for depression when staff-assisted depression care supports are in place to assure accurate diagnosis, effective treatment, and follow-up"&lt;BR&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382015</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/19949145]]&gt;</url>
    <title>Screening for depression in adults in primary care settings: a systematic review</title>
    <publicationDate>2009-12-01T00:00:00</publicationDate>
    <publisher>Annals of Internal Medicine, American College of Physicians</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DEPRESSION,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Screening for depression is unlikely to improve outcomes&amp;nbsp;unless substantial care support is provided.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, DARE, PsycINFO were serched from 1998-2007. Suggestions from experts and bibliographies of recent reviews were also searched.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 33 articles were were abstracted, critically appraised and their data extracted by two investigators. Fair and good quality RCTs, controlled clinical trials, systematic reviews, meta-analases and large observational studies on the benefits and harms of screening adults for depression, the benefits of treating depression in older adults plus the harms of antidepressant medications were evaluated.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: O'Connor EA, Whitlock EP, Beil TL, et al. Screening for depression in adult patients in primary care settings: a systematic review of the evidence. &lt;EM&gt;Annals of Internal Medicine&lt;/EM&gt; 2009; 151(11):793-803&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full text available with NHS Athens account&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>345789</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/17874169]]&gt;</url>
    <title>Screening for depression in medical settings with the Patient Health Questionnaire (PHQ) : a diagnostic meta-analysis</title>
    <publicationDate>2007-10-13T00:00:00</publicationDate>
    <publisher>Journal of General Internal Medicine, Springer</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,DEPRESSION,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Patient Health Questionnaire (PHQ) 9 is acceptable as a screening instrument for depression, while further research is needed&amp;nbsp;to validate&amp;nbsp;PHQ2.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic search of Medline, PscLIT, Embase, Cinahl, Cochrane registers and study reference list. Heterogeneity was explored with metaregression.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 17 validation studies were included. 14 (incorporating 5,026 participant)&amp;nbsp;validated PHQ9 and three validated PHQ2. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Gilbody S, Richards D, Brealey S, Hewitt C. Screening for depression in medical settings with the Patient Health Questionnaire (PHQ): a diagnostic meta-analysis. &lt;EM&gt;Journal of General Internal Medicine&lt;/EM&gt; 2007;22(11):1596-602&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Full text available with NHS Athens login.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This meta-analysis has not been critically appraised.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>386783</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=73]]&gt;</url>
    <title>Screening for depression. A report for the UK National Screening Committee</title>
    <publicationDate>2010-02-01T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,DEPRESSION,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses depression against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>155128</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspshipd.htm]]&gt;</url>
    <title>Screening for developmental dysplasia of the hip</title>
    <publicationDate>2006-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,HIPS,PHYSICAL (6-8 WKS),HIPS,NEWBORN,PHYSICAL (&lt;72HRS)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=detail_text&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for development dysplasia of the hip. The USPSTF concludes that "evidence is insufficient to recommend routine screening for developmental dysplasia of the hip in infants as a means to prevent adverse outcomes."&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;A href="http://www.ahrq.gov/downloads/pub/prevent/pdfser/hipdyssyn.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;SPAN class=detail_text&gt;&lt;/SPAN&gt;&amp;nbsp; 
&lt;P&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325080</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325080]]&gt;</url>
    <title>Screening for Down's syndrome (Annual Evidence Update 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>Screening specialist collection</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),ULTRASOUND,11-14 WEEKS,BEFORE 16 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Down's syndrome (Annual Evidence Update 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=center&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;&lt;IMG id=nelh_tempImage7 border=1 name=nelh_tempImage7 alt="ultrasound scan showing nuchal tranlucency" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269084/nelhImp_0007_nt_ds.jpg" width=271 height=185&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage1 border=1 name=nelh_tempImage1 alt="Peformance of Down's Syndrome screening test" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269084/nelhImp_0006_ds_test.jpg" width=271 height=185&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;/P&gt;
&lt;P&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp; &lt;/SPAN&gt;&lt;/I&gt;&lt;/P&gt;
&lt;P&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;/I&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325106:0" name=internalLink&gt;Back to contents page&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325073:0" name=internalLink&gt;Screening for Down's syndrome evidence update&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;This section has been updated by Fiona McInnes, National Projects Officer, NHS Fetal Anomaly Screening Programme&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;Each human cell is made up of 46 chromosomes (23 pairs).&amp;nbsp; In Down's syndrome there are 3 copies of &lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;chromosome 21, totalling 47 chromosomes &lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;in all.. This explains why Down's Syndrome is also called&amp;nbsp;Trisomy 21. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;Down's Syndrome occurs in approximately 1: 800 births [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=2437951&amp;amp;dopt=AbstractPlus" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;1&lt;/SPAN&gt;&lt;/A&gt;].&amp;nbsp;This figure is similar in all populations and is an overall population risk. The incidence rises with the mother's age. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;Down’s syndrome screening&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;Down’s syndrome screening&amp;nbsp;is offered&amp;nbsp;in &lt;?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /&gt;&lt;st1:country-region w:st="on"&gt;&lt;st1:place w:st="on"&gt;England&lt;/st1:place&gt;&lt;/st1:country-region&gt; to&amp;nbsp;all pregnant women&amp;nbsp;and is part of a Government initiative to provide equity and access in the NHS -&amp;nbsp;the primary aim is to allow parents&amp;nbsp;to make informed choices concerning their pregnancy outcome.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;The policy for this was initiated in 2003 following the publication of the Model of Best Practice [&lt;A href="http://www.screening.nhs.uk/downs/model_bestpractice.pdf" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;1a&lt;/SPAN&gt;&lt;/A&gt;] (updated 2008) from the Department of Health, and underpinned by the NICE clinical guideline on routine antenatal care in&amp;nbsp;2003 [&lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;2&lt;/SPAN&gt;&lt;/A&gt;] (updated 2008), the Genetics White Paper in 2003 [&lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4019239.pdf" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;3&lt;/SPAN&gt;&lt;/A&gt;] and the National Service Framework for children (NSF) in&amp;nbsp;2004 [&lt;A href="http://www.dh.gov.uk/en/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/ChildrenServicesInformation/DH_4089111" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;4&lt;/SPAN&gt;&lt;/A&gt;].&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;The national Programme Centre on behalf of the UK National Screening Committee has the remit to set standards which are auditable and benchmarked. The Programme also manages the national implementation of the policy, working in close collaboration with the 9 regional teams (10 SHA’s).&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;The Programme objectives are:&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To offer screening to all pregnant women at the appropriate gestational age&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN&gt;&lt;SPAN style="mso-list: Ignore"&gt;&lt;SPAN style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To ensure that all pregnant women receive written information offered in a format they can access and understand before they enter the screening Programme&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To maximise the detection rate&amp;nbsp; and minimise the false positive rate of the test, and ensure that these rates conform to national standards&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To minimise harm associated with the screening Programme&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To ensure that all results are made available to all screened women on a timescale conforming to national standards&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To ensure that women who screen positive/high risk are given appropriate information and support to make the decision whether or not to have a diagnostic test, and that appropriate services are made available without delay&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To minimise harm and anxiety following a diagnosis of a Down’s syndrome fetus and manage the pregnancy according to the wishes of the parents&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To ensure that all relevant health professionals involved in the screening Programme have attained the necessary level of knowledge and skill&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To provide regular feedback of the effectiveness and quality of the service of the population screened to clinicians, managers and those who commission services&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN&gt;&lt;SPAN style="mso-list: Ignore"&gt;&lt;SPAN style="FONT: 7pt 'Times New Roman'"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 9pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;To improve all aspects of the Programme by a process of continuous quality assurance&amp;nbsp; &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;The Model of Best Practice (2008) recommends the following &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;Programme Outcomes and benchmark timeframes:&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB; mso-bidi-font-weight: bold"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;A detection rate (DR) for Down’s syndrome of greater than 75% of affected &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;pregnancies with a screen positive rate (SPR) of less than 3%. &lt;/SPAN&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;(Benchmark time frame: April 2007 to April 2010)&lt;/SPAN&gt;&lt;/I&gt;&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;A detection rate (DR) of greater than 90% of affected pregnancies with a &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;screen positive rate (SPR) of less than 2%. &lt;/SPAN&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;(Benchmark time frame: by April 2010) &lt;/SPAN&gt;&lt;/I&gt;&lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;I&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;/I&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;There are various screening strategies that will meet the 2010 target such as the combined screening test, using nuchal translucency (NT)&amp;nbsp;and biochemistry (undertaken before 14 weeks), and integrated testing (a&amp;nbsp;two stage test, undertaken between 10 and 20 weeks of pregnancy).&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;An &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=201751" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;annual evidence update&lt;/SPAN&gt;&lt;/A&gt; 2007/8 on screening for Down's Syndrome&amp;nbsp;has been reviewed and there are a small number of references on markers&amp;nbsp;deemed useful&amp;nbsp;for consideration.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;Markers&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;A study conducted in Asia on over 3000 second trimester fetuses&amp;nbsp;found that nasal bone length (NBL), a potential soft marker for Down's Syndrome,&amp;nbsp;appears to be shorter in Korean fetuses than Caucasian and Chinese fetuses [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17186563&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;7&lt;/SPAN&gt;&lt;/A&gt;]. This indicates that the&amp;nbsp;NBL&amp;nbsp;has a bias towards different ethnic populations.&lt;BR&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;It seems that the use of fetal cells in maternal blood (free fetal DNA)&amp;nbsp;is not yet a reliable marker for Down's syndrome, as demonstrated by&amp;nbsp;a study to quantify fetal&amp;nbsp;DNA levels in trisomy 21 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17152117&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;8]&lt;/SPAN&gt;&lt;/A&gt;&lt;/SPAN&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;A brief synopsis of the value of ADAM12 &lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;by measuring&amp;nbsp;levels in pregnancies prior to 10 weeks gestation is given in this study (10 pregnancies with T21 against a series of 62 gestational age matched samples as ‘controls’), and concludes that c&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;ombining the data from this study and from the only other published study with data prior to 10 weeks suggests that ADAM12s may have the potential as an early screening marker for trisomy 21 (9) Spencer K&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt; mso-fareast-language: EN-GB"&gt;&lt;/SPAN&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-bidi-font-size: 11.0pt; mso-ansi-language: EN" lang=EN&gt;References&lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 12pt; mso-fareast-language: EN-GB"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[1] Cuckle H., &lt;st1:place w:st="on"&gt;&lt;st1:City w:st="on"&gt;Wald&lt;/st1:City&gt; &lt;st1:State w:st="on"&gt;NJ&lt;/st1:State&gt;&lt;/st1:place&gt;, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphfetoprotein level. British Journal of Obstetrics and Gynaecology 1987; 94:387-402. [&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=2437951&amp;amp;dopt=Abstract" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[1a] Department of Health and UK National Screening Committee. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=10848" target="_blank"&gt;NHS Fetal Anomaly Screening Programme - Screening for Down's Syndrome: UK NSC Policy Recommendations 2007-2010: Model of best practice&lt;/A&gt;.&amp;nbsp;&amp;nbsp;2008&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[2] National Institute of Clinical Excellence (NICE) (October 2003).&amp;nbsp;&lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;Antenatal Care: routine care for the pregnant woman&lt;/SPAN&gt;&lt;/A&gt;. [This guidance was updated in 2008 - see reference below]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[3] Department of Health. &lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4019239.pdf" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;Genetics White Paper,&amp;nbsp; Our Inheritance Our Future, Realising the potential of genetics in the NHS&lt;/SPAN&gt;&lt;/A&gt;. 2003.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[4] Department of Health. &lt;A href="http://www.dh.gov.uk/en/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/ChildrenServicesInformation/DH_4089111" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;National Service Framework for children, young people and maternity services&lt;/SPAN&gt;&lt;/A&gt;. 2004.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[6] Laigaard J, Cuckle H, Wewer UM, Christiansen M. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation. Prenatal Diagnosis 2006, 26(8):689-91 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16752438&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[7] Jung E, Won HS, Lee PR, Kim A. Ultrasonographic measurement of fetal nasal bone length in the second trimester in Korean population. Prenatal Diagnosis 2007, 27(2):154-7 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17186563&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;[8] Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenatal Diagnosis 2007, 27(2):104-10 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17152117&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;&lt;SPAN style="COLOR: #0066cc; mso-bidi-font-size: 11.0pt"&gt;PubMed abstract&lt;/SPAN&gt;&lt;/A&gt;]&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&amp;nbsp;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;Further information&lt;/H2&gt;
&lt;P&gt;&lt;A href="nelh:325073:0" name=internalLink&gt;2009 Annual evidence update: antenatal screening for Down's syndrome&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:35689:0" name=internalLink&gt;UK NSC policy on screening for Down's syndrome during pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/" target="_blank"&gt;NHS Fetal Anomaly Screening Programme website&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=11016" target="_blank"&gt;NHS Fetal Anomaly Screening Programme Annual Report 2006-2008&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information for professionals&lt;/H2&gt;
&lt;P&gt;NHS Fetal Anomaly Screening Programme. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=11111" target="_blank"&gt;Chorionic villus sampling (CVS) and amniocentesis - for health professionals&lt;/A&gt;. 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Collaborating Centre for Women’s and Children’s Health. Commissioned by the National Institute for Health and Clinical Excellence. &lt;A href="http://www.nice.org.uk/Guidance/CG62/Guidance/pdf/English" target="_blank"&gt;Antenatal care: routine care for the healthy pregnant woman. CG62: full guidance&lt;/A&gt;. March 2008 (corrected June 2008).&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://cpd.screening.nhs.uk/fetalanomaly" target="_blank"&gt;Continuous professional development&lt;/A&gt; - resources to support the Antenatal and Newborn Screening Programmes&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NHS Fetal Anomlay Screening Programme. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=10849" target="_blank"&gt;Antenatal screening - working standards for Down's syndrome screening&lt;/A&gt;. 2007&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=60288" target="_blank"&gt;National Down’s Syndrome Screening Programme for England. A hanbook for staff&lt;/A&gt;. 2004. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Wald N J, Rodeck C, Hackshaw A K, Walters J, Chitty L, Mackinson A M. &lt;A href="http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&amp;amp;ID=32003000437" target="_blank"&gt;First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study&lt;/A&gt; (SURUSS). No.11, 2003: 88&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The NHS Fetal Anomaly Screening Programme has produced a number of pathways which will illustrate the screening process for fetal anomaly and Down's syndrome screening and also the governance responsibilities for health professionals.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/timelines" target="_blank"&gt;NHS Fetal Anomaly Screening Programme Pathways&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Patient information&lt;/H2&gt;
&lt;P&gt;The Elfrida Society. &lt;A href="http://fetalanomaly.screening.nhs.uk/screening.nhs.uk/getdata.php?id=11115" target="_blank"&gt;Testing for Down's syndrome during pregnancy: an easy read book&lt;/A&gt;. 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NHS Fetal Anomaly Screening Programme. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=11085" target="_blank"&gt;Amniocentesis test - information for parents&lt;/A&gt;. 2009.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NHS Fetal Anomaly Screening Programme. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=11026" target="_blank"&gt;Information for women on non invasive prenatal diagnosis (NIPD) and cell fre-fetal DNA (cffDNA)&lt;/A&gt;. 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Antenatal and Newborn Screening Programmes. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=10749" target="_blank"&gt;Testing for Down's syndrome during pregnancy&lt;/A&gt;. 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NHS Fetal Anomaly Screening Programme. &lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=11086" target="_blank"&gt;Chorionic villus sampling (CVS) - information for parents&lt;/A&gt;. 2009&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Lab tests online - searchable website designed to help consumers understand the many clinical lab tests that are part of routine care. See &lt;A href="http://www.labtestsonline.org.uk/understanding/conditions/pregnancy.html" target="_blank"&gt;pregnancy screening&lt;/A&gt; (2008).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Antenatal and Newborn Screening Programmes. &lt;A href="nelh:239537:0" name=internalLink&gt;Screening tests for you and your baby&lt;/A&gt;. 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NHS Fetal Anomaly Screening Programme. &lt;A href="http://fetal%20anomaly.screening.nhs.uk/getdata.php?id=10757" target="_blank"&gt;Having a mid-pregnancy ultrasound scan&lt;/A&gt;. 2007&lt;/P&gt;
&lt;H2&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;BR&gt;
&lt;P&gt;&lt;/P&gt;&lt;/H2&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;
&lt;H2&gt;
&lt;P style="LINE-HEIGHT: normal; MARGIN: 0cm 0cm 0pt; BACKGROUND: white" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&amp;nbsp;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269084</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269084]]&gt;</url>
    <title>Screening for Down's Syndrome (National Knowledge Week)</title>
    <publicationDate>2007-09-14T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),11-14 WEEKS,14-20 WEEKS,DOWN'S SYNDROME (SERUM)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Down's Syndrome (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage1 border=1 name=nelh_tempImage1 alt="Peformance of Down's Syndrome screening test" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269084/nelhImp_0006_ds_test.jpg" width=271 height=185&gt;&amp;nbsp;&amp;nbsp; &amp;nbsp;&amp;nbsp;&lt;IMG id=nelh_tempImage7 border=1 name=nelh_tempImage7 alt="ultrasound scan showing nuchal tranlucency" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269084/nelhImp_0007_nt_ds.jpg" width=271 height=185&gt;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;A href="http://www.screening.nhs.uk/anpublications/screening_tests.pdf" target="_blank"&gt;See bigger image of diagram&lt;/A&gt; (pg 19)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=201751" target="_blank"&gt;Annual Evidence Update&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section has been written by Pat Ward, Programme Director, NHS Fetal Anomaly Screening Programme&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Each human cell is made up of 46 chromosomes (23 pairs).&amp;nbsp; In Down's syndrome there is an extra chromosome making 47 in all, and this extra chromosome is the number 21. This gives three number 21 chromosomes and hence&amp;nbsp;explains why Down's Syndrome is also called&amp;nbsp;Trisomy 21. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Down's Syndrome occurs in approximately 1: 800 births [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=2437951&amp;amp;dopt=AbstractPlus" target="_blank"&gt;1&lt;/A&gt;].&amp;nbsp;This figure is similar in all populations and is an overall population risk. The incidence rises sharply with the mother's age. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Down’s syndrome screening&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Down’s syndrome screening&amp;nbsp; is offered&amp;nbsp;in England to&amp;nbsp;all pregnant women&amp;nbsp;and is part of the governments'&amp;nbsp; initiatives to provide equity and access in the NHS -&amp;nbsp;&amp;nbsp;the primary aim being to allow parents&amp;nbsp;to make informed choices concerning their pregnancy outcome.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The policy for this was initiated in 2003 following the publication of the Model of Best Practice [&lt;A href="http://www.screening.nhs.uk/downs/model_bestpractice.pdf" target="_blank"&gt;1a&lt;/A&gt;] from the Department of Health, and underpinned by the NICE clinical guideline on routine antenatal care in&amp;nbsp;2003 [&lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;2&lt;/A&gt;], the Genetics White Paper in 2003 [&lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4019239.pdf" target="_blank"&gt;3&lt;/A&gt;] and the National Service Framework for children (NSF) in&amp;nbsp;2004 [&lt;A href="http://www.dh.gov.uk/en/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/ChildrenServicesInformation/DH_4089111" target="_blank"&gt;4&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;The remit to implement this fully in England, and ensure that it adhered to set standards which could be auditable and benchmarked, was given to the UK National Screening Committee (NSC) who then set up a Programme Centre to take forward the various work streams.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Programme objectives are:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To offer screening to all pregnant women at the appropriate gestational age&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To ensure that all pregnant women receive written information, supplemented as appropriate, before they enter the screening programme&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To maximise the detection rate&amp;nbsp; and minimise the false positive rate of the test, and ensure that these rates conform to National Standards&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To minimise harm associated with the screening programme&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To ensure that all results are made available to all screened women on a timescale conforming to National Standards&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To ensure that women who screen positive/high risk are given appropriate information and support to make the decision whether or not to have a diagnostic test, and that appropriate services are made available without delay&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To minimise harm and anxiety following a diagnosis of a Down’s syndrome fetus and manage the pregnancy according to the wishes of the parents&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To ensure that all relevant health professionals involved in the screening programme have attained the necessary level of knowledge and skill&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To provide regular feedback of the effectiveness and quality of the service of the population screened to clinicians, managers and those who commission services&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;To improve all aspects of the programme by a process of continuous quality assurance&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;The present policy sets out that all women must be offered a screening test which meets a standard of a greater than 75% detection rate for a less than 3% false positive rate. This should have been achieved by April 2007. &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;There are various screening strategies that will meet this target such as the combined screening test, using Nuchal Translucency (NT)&amp;nbsp;and biochemistry (undertaken before 14 weeks), and integrated testing (a&amp;nbsp;two stage test, undertaken between 10 and 20 weeks of pregnancy).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;An &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=201751" target="_blank"&gt;annual evidence update&lt;/A&gt; on screening for Down's Syndrome&amp;nbsp;has been reviewed and there are a small number of references on markers&amp;nbsp;deemed useful&amp;nbsp;for consideration.&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Markers&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;One study&amp;nbsp;aimed to evaluate whether there&amp;nbsp;was a NT measurement, independent of gestational age, above which immediate diagnostic testing should be offered (without waiting for serum screening results) [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=195%5Bvolume%5D%20AND%20843%5Bpage%5D%20AND%20Comstock%5Bauthor%5D" target="_blank"&gt;5&lt;/A&gt;]. They concluded that if a NT measurement of 3.0mm or above is obtained, there is&amp;nbsp;minimal benefit in waiting for serum markers. This concurs with the cut-off of 3.0mm used in the Down's Syndrome Programme NT standards.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A&amp;nbsp;brief synopsis of the value of ADAM12 (a new marker) by measuring&amp;nbsp;levels in Down's Syndrome pregnancies at 9-12 weeks gestation is given in this study, but concludes that more data will be needed&amp;nbsp;to predict performance. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16752438&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;6&lt;/A&gt;]&lt;BR&gt;&amp;nbsp;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;A study conducted in Asia on over 3000 second trimester fetuses&amp;nbsp;found that nasal bone length (NBL), a potential soft marker for Down's Syndrome,&amp;nbsp;appears to be shorter in Korean fetuses than Caucasian and Chinese fetuses [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17186563&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;7&lt;/A&gt;]. This indicates that the&amp;nbsp;NBL&amp;nbsp;has a bias towards different ethnic populations.&lt;BR&gt;&amp;nbsp;&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;It seems that the use of fetal cells in maternal blood (free fetal DNA)&amp;nbsp;is not yet a reliable marker for Down's syndrome, as demonstrated by&amp;nbsp;a study to quantify fetal&amp;nbsp;DNA levels in trisomy 21 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17152117&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;8]&lt;/A&gt;&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;[1] Cuckle H., Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alphfetoprotein level. British Journal of Obstetrics and Gynaecology 1987; 94:387-402. [&lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=PubMed&amp;amp;list_uids=2437951&amp;amp;dopt=Abstract" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-SIZE: 10pt; mso-ansi-language: EN" lang=EN&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-SIZE: 10pt" lang=EN-GB&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;[1a] Department of Health. &lt;A href="http://www.screening.nhs.uk/downs/model_bestpractice.pdf" target="_blank"&gt;Model of Best Practice for providing Down's Syndrome screening services&lt;/A&gt;. &amp;nbsp;2003&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2] National Institute of Clinical Excellence (NICE) (October 2003).&amp;nbsp;&lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;Antenatal Care: routine care for the pregnant woman&lt;/A&gt;. &lt;A href="http://www.rcog.org.uk/resources/Public/pdf/Antenatal_Care.pdf" target="_blank"&gt;Full guidance document &lt;/A&gt;(304 pages) also available.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[3] Department of Health. &lt;A href="http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4019239.pdf" target="_blank"&gt;Genetics White Paper,&amp;nbsp; Our Inheritance Our Future, Realising the potential of genetics in the NHS&lt;/A&gt;. 2003.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[4] Department of Health. &lt;A href="http://www.dh.gov.uk/en/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/ChildrenServicesInformation/DH_4089111" target="_blank"&gt;National Service Framework for children, young people and maternity services&lt;/A&gt;. 2004.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[5] Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL et al. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? American Journal of Obstetrics &amp;amp; Gynecology. 2006, 195(3), 843-7. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=195%5Bvolume%5D%20AND%20843%5Bpage%5D%20AND%20Comstock%5Bauthor%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[6] Laigaard J, Cuckle H, Wewer UM, Christiansen M. Maternal serum ADAM12 levels in Down and Edwards' syndrome pregnancies at 9-12 weeks' gestation. Prenatal Diagnosis 2006, 26(8):689-91 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16752438&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[7] Jung E, Won HS, Lee PR, Kim A. Ultrasonographic measurement of fetal nasal bone length in the second trimester in Korean population. Prenatal Diagnosis 2007, 27(2):154-7 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17186563&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[8] Gerovassili A, Garner C, Nicolaides KH, Thein SL, Rees DC. Free fetal DNA in maternal circulation: a potential prognostic marker for chromosomal abnormalities? Prenatal Diagnosis 2007, 27(2):104-10 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17152117&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;DIV&gt;&amp;nbsp;&lt;/DIV&gt;
&lt;DIV&gt;&amp;nbsp;&lt;/DIV&gt;
&lt;P&gt;&lt;STRONG&gt;Annual evidence update on antenatal screening for&amp;nbsp;Down's Syndrome 2006/07&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=201751" target="_blank"&gt;Down's Syndrome&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee policy, July 2006&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=35689&amp;amp;tabID=288&amp;amp;catID=2007" target="_blank"&gt;Down's Syndrome screening&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Recent systematic reviews (selected from above evidence update)&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;O’Connell R, Stephenson M, Weir R. &lt;A href="http://nzhta.chmeds.ac.nz/publications/downs.pdf" target="_blank"&gt;Screening Strategies for Antenatal Down Syndrome Screening. A systematic review of the literature&lt;/A&gt;. New Zealand Health Technology Assessment Report November 2006 Volume 9 Number 4.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Hewison J, Nixon J, Fountain J, Cocks K, Jones C, Mason G et al. &lt;A href="http://www.ncchta.org/execsumm/summ1050.htm" target="_blank"&gt;Amniocentesis results: investigation of anxiety. The ARIA trial&lt;/A&gt;. Health Technology Assessment&amp;nbsp;&lt;STRONG&gt; &lt;/STRONG&gt;2006; Vol 10: number 50 &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other&amp;nbsp;information for health professionals &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;NICE Guidance currently being reviewed: Antenatal Care: routine care for the healthy pregnant woman (Oct 2003). See &lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;review details&lt;/A&gt;. Consultation period: &lt;SPAN class=ip_content_1_join&gt;4 September - 29 October 2007.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;Continuous professional development - resources to support the Antenatal and Newborn Screening Programmes: &lt;A href="http://www.screening.nhs.uk/cpd/downs.htm" target="_blank"&gt;Down's Syndrome&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/downs/home.htm" target="_blank"&gt;Down's Syndrome Screening Programme&lt;/A&gt; (DSSP) website&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Down’s Syndrome Screening Programme for England. &lt;A href="http://www.screening.nhs.uk/downs/working_standards.pdf" target="_blank"&gt;Antenatal screening – working standards&lt;/A&gt;. March 2004.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Down’s Syndrome Screening Programme for England. &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=60288" target="_blank"&gt;A hanbook for staff&lt;/A&gt;. 2004. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Down’s Syndrome Screening Programme for England. &lt;A title="View a detailed summary" href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=260778&amp;amp;tabID=290&amp;amp;catID=2007" target="_blank"&gt;3rd annual programme report 2005/2006&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Wald N J, Rodeck C, Hackshaw A K, Walters J, Chitty L, Mackinson A M. &lt;A href="http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&amp;amp;ID=32003000437" target="_blank"&gt;First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study&lt;/A&gt; (SURUSS). No.11, 2003: 88&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information to give pregnant&amp;nbsp;women&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Jan 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/" target="_blank"&gt;Screening tests for you and your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;pregnant women and their&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;Lab tests online - searchable website&amp;nbsp;designed to help consumers&amp;nbsp;understand the many clinical lab tests that are part of routine care. See &lt;A href="http://www.labtestsonline.org.uk/understanding/conditions/pregnancy.html" target="_blank"&gt;pregnancy screening&lt;/A&gt; (Aug 2006) and &lt;A href="http://www.labtestsonline.org.uk/understanding/wellness/a_newborn.html" target="_blank"&gt;screening tests for newborns&lt;/A&gt;&amp;nbsp; (July 2007)&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>75422</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspslead.htm]]&gt;</url>
    <title>Screening for elevated lead levels in childhood and pregnancy</title>
    <publicationDate>2006-12-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ CHILD,SCREENING,LEAD POISONING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for elevated lead levels in children and pregnant women. The USPSTF concluded that "evidence is insufficient to recommend for or against routine screening for elevated blood levels in asymptomatic children aged 1 to 5 who are at increased risk"&amp;nbsp; and "recommends against routine screening for elevated blood lead levels in asymptomatic children aged 1 to 5 years who are at average risk". In addition the USPSTF "recommends against routine screening for elevated blood lead levels in asymptomatic pregnant women".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66400</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsfamv.htm]]&gt;</url>
    <title>Screening for family and intimate partner violence</title>
    <publicationDate>2004-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,DOMESTIC VIOLENCE,NOT ROUTINELY OFFERED,SCREENING,ANTENATAL,ADULT,DOMESTIC VIOLENCE,PUBLIC HEALTH,DETERMINANTS,SOCIAL DETERMINANTS,MONTHLY ADDITIONS,DOMESTIC VIOLENCE,2009 SEPTEMBER,ABUSE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for family and intimate partner violence. The USPSTF&amp;nbsp;found "insufficient evidence to recommend for or against routine screening of parents or guardians for the physical abuse or neglect of children, of women for intimate partner violence, or of older adults or their caregivers for elder abuse".&amp;nbsp; 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/famviolence/famviolrev.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325082</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325082]]&gt;</url>
    <title>Screening for fetal anomalies (Annual Evidence Update 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>Screening specialist collection</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NEURAL TUBE DEFECTS,FETAL ANOMALY,BEFORE 16 WEEKS,18-20 WEEKS,ULTRASOUND]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for fetal anomalies (Annual Evidence Update 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P style="mso-element: footnote-list" align=center&gt;&lt;IMG id=nelh_tempImage13 border=1 name=nelh_tempImage13 alt="pregnant woman having an ultrasound scan" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269076/nelhImp_0007_ultrasound_fetal.jpg" width=174 height=133&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage5 border=1 name=nelh_tempImage5 alt="ultrasound scan of a fetal head" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269076/nelhImp_0008_headprofile.jpg" width=174 height=133&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;A href="nelh:325106:0" name=internalLink&gt;Back to contents page&lt;/A&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;A href="nelh:325075:0" name=internalLink&gt;Screening for fetal anomalies evidence update&lt;/A&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;A href="nelh:325076:0" name=internalLink&gt;Screening for neural tube defects evidence update&lt;/A&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;EM&gt;This section has been updated by Donna Kirwan, National Projects Officer NHS Fetal Anomaly Screening Programme, September 2009&lt;/EM&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;H3 style="mso-element: footnote-list"&gt;Introduction&lt;/H3&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&lt;BR&gt;Within the realms of the UK National Screening Committee (NSC), the overseeing body which is responsible for advising Ministers and governing screening programmes across the UK sits the NHS Fetal Anomaly Screening Programme (FASP), which is responsible for developing and promoting a national, quality assured obstetric ultrasound screening programme for England.&amp;nbsp; Together with its sister programme, the NHS Down’s Syndrome Screening Programme (DoSySP), which began life in 2001, they are now one fraternity with seven other antenatal and newborn screening programmes that reside under the umbrella of the Fetal, Maternal and Child Health (FMCH) division of the UK NSC.&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;Nowadays, virtually every pregnant woman will undergo some type of prenatal investigation during her pregnancy to understand more about her health and the baby she carries.&amp;nbsp; Antenatal screening is nothing new, except that there are now more tests available to offer.&lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Ultrasound scanning in the second trimester of pregnancy to detect structural abnormalities has been undertaken in the UK since the 1980s and as ultrasound machines have improved so have the expectations about what might be diagnosed.&amp;nbsp; Obstetric ultrasound is a ‘seasoned’ phenomenon, in that it is used world-wide clinically and associated with a large literature base in both the medical and public domains (ultrasound itself and the clinical application and psycho-social experiences of those either undergoing or providing the technology).&amp;nbsp; &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;The development of ultrasound as a screening test has been largely technology driven however the evidence base for its effectiveness is generally considered to be of poor quality.&amp;nbsp; Much of the evidence about the ability of ultrasound to diagnose specific conditions has come from small studies undertaken by ultrasound experts but in more recent years population studies evaluating ultrasound as a screening, as opposed to a diagnostic tool, have been less encouraging.&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;Evolution of the NHS Fetal Anomaly Screening Programme&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;In 2004, the Department of Health (DH) funded an NHS Fetal Anomaly Screening Programme (FASP) to oversee the implementation of standards to an agreed level of quality in order to provide flexible and responsive antenatal screening services to meet the needs of pregnant women having ultrasound and biochemistry, as evidence showed “some serious gaps and deficiencies” in the way services operated.&lt;SUP&gt;1&amp;nbsp;&lt;/SUP&gt;&amp;nbsp; &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;Under the auspices of Sir Muir Gray, Programmes Director of the UK National Screening Committee (UKNSC), Pat Ward, National FASP director, Professor Martin Whittle (Chair of the Ante Natal Sub Group of the UKNSC Steering Group) and expert stakeholders, a strategy was devised to develop standards and pathways for obstetric ultrasound.&amp;nbsp; As ultrasound invariably is capable of complementing chromosomal diagnosis of conditions such as Down’s syndrome, FASP and DoSySP were amalgamated.&amp;nbsp; &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Aims of the 18&lt;SUP&gt;+0&lt;/SUP&gt; to 20&lt;SUP&gt;+6&lt;/SUP&gt; weeks fetal anomaly ultrasound scan&lt;BR&gt;The purpose of the scan is to:&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Identify:&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; a.&amp;nbsp;Lethal abnormalities&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; b.&amp;nbsp;Abnormalities amenable to immediate neonatal treatment.&lt;BR&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp; c.&amp;nbsp;Abnormalities for which there may be intrauterine treatment.&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Offer a choice about whether or not to continue with a pregnancy in which the baby is abnormal.&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Plan appropriate management of the pregnancy and delivery.&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Enable the development of a care pathway for individual women &lt;/DIV&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P style="mso-element: footnote-list"&gt;For serious abnormalities and reasonably common ones four pathways should be considered:&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;a. Incompatible with life&lt;BR&gt;b.&amp;nbsp;With serious morbidity in life&lt;BR&gt;c.&amp;nbsp;Amenable to post natal treatment with relatively low morbidity&lt;BR&gt;d.&amp;nbsp;For possible antenatal treatment&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P style="mso-element: footnote-list"&gt;However, although these anomalies are identified, they are not always reported, thus up to date data is not always readily available.&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp; &lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;Reasons for ultrasound screening&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;Congenital abnormalities still remain one of the leading causes of perinatal morbidity and mortality and a wide variety of structural abnormalities can be detected prenatally by ultrasound scanning.&amp;nbsp; The optimum time period for undertaking fetal anomaly ultrasound is between 18 weeks to 20 weeks, 6 days gestation.&amp;nbsp; This allows time for the relevant referrals and investigations to be undertaken as well as giving the woman time to make any necessary decisions about the continuation of the pregnancy prior to the 24 week viability limit.&amp;nbsp; Obviously the earlier the screening can be performed, the greater time for subsequent action (although screening later may make the identification of some abnormalities easier). &lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;The understanding of the purpose of the scan is variable – from the woman’s perspective it is a chance to see the baby and confirm normality rather than a screening test to look for abnormalities.&amp;nbsp; From the clinical perspective it is considered to be a useful tool to identify problems which if present allow the clinician to develop management pathways which are likely to optimise outcome.&amp;nbsp; This dichotomy appears to have led to confusion over the purpose, limitations and benefits of the use of ultrasound screening.&lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;It is important that both women and health professional appreciate that the scan is a screening test and because of that it has limitations.&amp;nbsp; Invariably some conditions will be missed or misidentified.&amp;nbsp; Women should receive comprehensible information before the scan and should she choose to decline the screening test then this must be respected.&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;What makes this programme unique?&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;The uniqueness lies in the fact that the individual or person being directly screened is the fetus, unlike, for example screening for sickle cell and thalassaemia where the woman and genetic father are screened for their carrier status.&amp;nbsp; Whilst screening has the potential to save lives or improve quality of life through early diagnosis of serious conditions, it is not a fool-proof process and ultrasound, like any screening process can yield both false positive (the fetus wrongly reported as having a malformation/condition) and false negative results (the fetus wrongly reported as no having a malformation/condition).&amp;nbsp; Equally, practitioners do get it right and what is seen on scan is correct.&amp;nbsp; &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;In attempting to reduce parental anxiety referring for a re-scan by another colleague i.e. ‘member checking,’ takes place to refute or confirm the original ultrasound findings.&amp;nbsp; The business of screening is complex and involves many steps in a programme, from, identification of a population or in this case fetus at risk to diagnosis of a malformation/condition.&amp;nbsp; This is the very reason why the primary test in any screening programme should not been seen in isolation; rather the ‘whole cake’, not just the ‘slice’ should be considered.&amp;nbsp; Healthcare professionals are required to see beyond the ‘slice’ and realise that both ‘harm’ and ‘good’ can result.&amp;nbsp; &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;18&lt;SUP&gt;+0&lt;/SUP&gt; to 20&lt;SUP&gt;+6&lt;/SUP&gt; weeks fetal anomaly screening ‘base menu’&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;To ensure that practitioners operate consistently and make the purpose of the scan focused, specific fetal anatomical structures have been selected for assessment.&amp;nbsp;&amp;nbsp; An ‘ultrasound base menu’ has been developed which provides a list of seven anatomical structures and views which should be observed and recorded.&lt;BR&gt;These key structures lend themselves to detecting a number of abnormalities that should be screened for.&amp;nbsp; These abnormalities and the expected detection rates for them form the basis of the fetal anomaly screening programme.&amp;nbsp; It is understood that other conditions may be detected using the base menu, however because there is insufficient data to confidently predict the standard which should be achieved 11 conditions were chosen which Trust ultrasound services will be expected to audited from 2010.&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Detection rates&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Anencephaly: 98%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Open Spina Bifida: 90%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Serious Cardiac Heart abnormalities: 50%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Bilateral Renal Agenesis: 84% &lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Lethal Skeletal Dysplasia: 60%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Trisomy 18: 95%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Trisomy 13: 95%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Diaphragmatic Hernia: 60%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Exomphalos: 80%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Gastrochisis: 98%&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Cleft Lip: 75%&lt;/DIV&gt;&lt;/LI&gt;&lt;/OL&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;18&lt;SUP&gt;+0&lt;/SUP&gt; to 20&lt;SUP&gt;+6&lt;/SUP&gt; weeks fetal anomaly screening scan: National standards for England&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;Again in trying to promote scanning consistency amongst practitioners and also in response to the “...serious gaps and deficiencies” from the 2005 NSC national ultrasound survey, it was necessary to ‘standardise’ all aspects of obstetric ultrasound services, by developing a suite of national standards for England.&lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Back in 2000, a set of auditable standards, specific to practitioners, was produced by the Royal College of Obstetricians and Gynaecologists (RCOG)&lt;SUP&gt;2&lt;/SUP&gt;.&amp;nbsp; The aim of these was to ensure that services conformed to set ways of working.&amp;nbsp; As these were produced nearly a decade ago the landscape of obstetric practice has advanced in relation to practice, policy and technology.&lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;From April 2010, hospital Trusts will be expected to implement the new 18 to 20 weeks, 6 days a suite of auditable obstetric ultrasound screening standards, developed by the national programme centre.&amp;nbsp; The new standards will bring a sense of realism to what ultrasound screening can and, importantly, cannot achieve in terms of how services should be configured, the advice and information women should receive and the screening menu .&amp;nbsp; For the first time the standards will be explicit for both sonographers and women alike.&amp;nbsp; In addition it will enable robust auditing of the service.&amp;nbsp; Maternity services in England account for a significant proportion of the number and cost claims reported to the NHS Litigation Authority (NHSLA) each year.&amp;nbsp; However, with the advancement of the Programme’s standards, this ultimately should improve clinical performance and reduce risks in patient care.&lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;The standards are a “living” document which will require modification over time but it does provide the basic structure needed to deliver the service. The document would only relate to the 18+0 to 20+6 fetal anomaly ultrasound scan including information about specific structures to measure and observe and those to ignore (normal variant best practice statement, ultrasound base menu and cardiac protocol).&amp;nbsp; Given the purposes of the fetal anomaly scan, Down’s syndrome screening, first trimester ultrasound and nuchal translucency were excluded from the document.&amp;nbsp; It is anticipated that the standards will be used to promote flexible and responsive services for the purpose of improving the care for women and their babies. &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;Normal variant screening policy&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;There are several definitions to describe a soft marker but essentially, ‘a soft marker is an ultrasonic finding from 18 top 22 weeks of pregnancy which increases the risk of the fetus having a chromosomal anomaly (usually Trisomy 21).&lt;SUP&gt;3&lt;/SUP&gt; Screening for ‘soft markers’ has been an integral aspect of the obstetric ultrasound scan and for the past 20 years, and was contentious simply because of the maternal anxiety generated for a ‘less sensitive test’ which had limited data to justify its existence.&amp;nbsp; Additionally, there was not clinical agreement or standardisation amongst clinicians about what should be reported and in what combination and so prenatal treatment and maternal experiences varied.&amp;nbsp; &lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Prenatal diagnosis (PND) was not uncommon as markers tended to yield higher false positive rates along with increased psychological morbidity.&amp;nbsp; It is the woman’s desire to know more about her baby’s health that triggers PND and unfortunately this can result in unnecessary investigation coupled by the loss of unaffected pregnancies.&amp;nbsp; &lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Given the seriousness of this evidence, the NHS Fetal Anomaly Screening Programme deemed it necessary to review current practice in an attempt to develop a new sustainable policy for future practice and this will be issued as part of the new standards in early 2010. &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;Consent and ultrasound&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;Obstetric ultrasound like all examinations or procedures in pregnancy should be described as an option and not as an inevitable part of antenatal care. If the consent process is to be meaningful, it must be clear that refusal is an option.&amp;nbsp; Individual requirements should be taken into account where possible. Care should be taken to ensure that consent is obtained, even when there is a language or other communication barrier.&lt;SUP&gt;4&lt;/SUP&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;What women may consider being an opportunity to get a scan picture may turn out to be a horrendous experience, if a fetal anomaly is found.&amp;nbsp; Thus, every woman should be informed about the indication, benefits and limitations of screening and allowed sufficient time to make a make a decision which is right for them.&amp;nbsp; &lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="mso-element: footnote-list"&gt;Horizon scanning and future innovations&lt;/H2&gt;
&lt;H2 style="mso-element: footnote-list"&gt;&lt;BR&gt;Nuchal translucency (NT) and cardiac screening&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;In the past screening strategies such as combined testing was only available in the independent sector.&amp;nbsp; However, this is no longer the case since the Model of Best Practice (MoBP) for Down’s Syndrome Screening came into force, advocating the use of first trimester screening.&lt;SUP&gt;5&lt;/SUP&gt; Given that NT is an essential component of combined screening, the Programme Centre has devised a national NT infrastructure to provide sonographers with continual support, training and evaluating their NT performance.&amp;nbsp; &lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;NT is an innovative procedure within NHS hospitals which requires sonographers to undertake additional training.&amp;nbsp; NT requires sonographers to take an ultrasound measurement (in millimetres) of the maximum thickness of the subcutaneous translucency between the fetal skin and the soft tissue overlying the cervical spine.&amp;nbsp; High quality machines and skilled sonographers will be needed in order to obtain reliable measurements.&amp;nbsp; Equally, screening for fetal malformation (including fetal cardiac scanning between 18+0 to 20+6 weeks) requires machines of similar calibre that are capable of improving diagnostic skill.&lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;In recent years there has been an unprecedented emphasis on quality issues in relation to medical care. Recent initiatives are the Darzi report which promotes quality and patient safety.&amp;nbsp; As such, NHS FASP is in collaboration with the NHS Purchasing And Supply Agency (PASA) to produce a ‘buyer’s guide’ which will enable Trusts to purchase equipment in the most cost-effective way. &lt;BR&gt;&lt;/P&gt;
&lt;P style="mso-element: footnote-list"&gt;Major congenital heart defects occur in approximately 3 in 1000 live births. With the advance of better ultrasound equipment and providing specific training, the current four chamber approach will advance and include the outflow tracts.&amp;nbsp; It is hoped that by doing this the detection of cardiac anomalies will improve.&lt;BR&gt;The horizons are open and beckoning and other future considerations include:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Possible introduction of screening modalities (following review of DH policy)&lt;/DIV&gt;&lt;/LI&gt;
&lt;LI&gt;
&lt;DIV style="mso-element: footnote-list"&gt;Possible introduction and development of a first trimester fetal anomaly screening programme&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;/DIV&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;H2 style="mso-element: footnote-list"&gt;&lt;BR&gt;Summary&lt;/H2&gt;
&lt;P style="mso-element: footnote-list"&gt;&lt;BR&gt;From a public health perspective, the identification of anomalies can improve perinatal morbidity and mortality as conditions may be identified early in pregnancy and treated accordingly.&amp;nbsp; From the professional perspective, there are considerable gains if the screening programme were entirely shifted to the first trimester.&amp;nbsp; There would also be benefits to staff in terms of extending the current scope of practice which limits fetal anomaly scanning to just the second trimester.&amp;nbsp; Overall, professional satisfaction would prevail in terms of competence and confidence in clinical practice and in turn, promote a positive pregnancy experience for expectant women.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;References&lt;/H2&gt;
&lt;DIV style="mso-element: footnote-list"&gt;&lt;A style="mso-footnote-id: ftn1" title="" href="#_ftnref1" name=_ftn1&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="mso-special-character: footnote"&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri; FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-US; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"&gt;[1]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt; &lt;?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /&gt;&lt;st1:country-region w:st="on"&gt;&lt;st1:place w:st="on"&gt;UK&lt;/st1:place&gt;&lt;/st1:country-region&gt; National Screening Committee&lt;I style="mso-bidi-font-style: normal"&gt;. Antenatal Ultrasound Screening – Ultrasound Survey of &lt;st1:country-region w:st="on"&gt;&lt;st1:place w:st="on"&gt;England&lt;/st1:place&gt;&lt;/st1:country-region&gt;: 2002.&lt;/I&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp; &lt;/SPAN&gt;2005 NHS &lt;st1:country-region w:st="on"&gt;&lt;st1:place w:st="on"&gt;England&lt;/st1:place&gt;&lt;/st1:country-region&gt;&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/DIV&gt;
&lt;DIV style="mso-element: footnote" id=ftn2&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt" class=MsoFootnoteText&gt;&lt;A style="mso-footnote-id: ftn2" title="" href="#_ftnref2" name=_ftn2&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="mso-special-character: footnote"&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri; FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-US; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"&gt;[2]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt; Royal &lt;st1:place w:st="on"&gt;&lt;st1:PlaceType w:st="on"&gt;College&lt;/st1:PlaceType&gt; of &lt;st1:PlaceName w:st="on"&gt;Obstetricians&lt;/st1:PlaceName&gt;&lt;/st1:place&gt; and Gynaecologists &lt;I style="mso-bidi-font-style: normal"&gt;Routine Ultrasound Screening in Pregnancy: Protocol, Standards and Training &lt;/I&gt;2000 RCOG Press&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/DIV&gt;
&lt;DIV style="mso-element: footnote" id=ftn3&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt" class=MsoFootnoteText&gt;&lt;A style="mso-footnote-id: ftn3" title="" href="#_ftnref3" name=_ftn3&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="mso-special-character: footnote"&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri; FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-US; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"&gt;[3]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt; West Midlands Perinatal Institute &lt;I style="mso-bidi-font-style: normal"&gt;Soft Markers: A guide for professionals&lt;/I&gt; version 2. 2007.&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/DIV&gt;
&lt;DIV style="mso-element: footnote" id=ftn4&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt" class=MsoFootnoteText&gt;&lt;A style="mso-footnote-id: ftn4" title="" href="#_ftnref4" name=_ftn4&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="mso-special-character: footnote"&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri; FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-US; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"&gt;[4]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt; NHS Fetal Anomaly Screening Programme &lt;I style="mso-bidi-font-style: normal"&gt;Consent Standards for Screening Fetal Anomalies During Pregnancy &lt;/I&gt;2007 &lt;st1:country-region w:st="on"&gt;&lt;st1:place w:st="on"&gt;UK&lt;/st1:place&gt;&lt;/st1:country-region&gt; NSC&lt;o:p&gt;&lt;/o:p&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;&lt;/DIV&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt; mso-element: footnote" class=MsoFootnoteText&gt;&lt;A style="mso-footnote-id: ftn5" title="" href="#_ftnref5" name=_ftn5&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="mso-special-character: footnote"&gt;&lt;SPAN class=MsoFootnoteReference&gt;&lt;SPAN style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri; FONT-SIZE: 10pt; mso-fareast-font-family: Calibri; mso-bidi-font-family: 'Times New Roman'; mso-fareast-language: EN-US; mso-ansi-language: EN-GB; mso-bidi-language: AR-SA"&gt;[5]&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/A&gt;&lt;FONT size=2&gt;&lt;FONT face=Calibri&gt; Department of Health &lt;I style="mso-bidi-font-style: normal"&gt;NHS Fetal Anomaly Screening Programme – Screening for Down’s Syndrome: &lt;st1:country-region w:st="on"&gt;&lt;st1:place w:st="on"&gt;UK&lt;/st1:place&gt;&lt;/st1:country-region&gt; NSC Policy Recommendations 2007-2010: Model of Best Practice&lt;/I&gt; 2008&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt; mso-element: footnote" class=MsoFootnoteText&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 10pt; mso-element: footnote" class=MsoFootnoteText&gt;&lt;FONT size=2 face=Calibri&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2 style="MARGIN: 0cm 0cm 10pt; mso-element: footnote" class=MsoFootnoteText&gt;Information to support parents and health professionals once a diagnosis of a congenital abnormality has been confirmed&lt;/H2&gt;&lt;SPAN style="FONT-FAMILY: Arial; mso-fareast-language: EN-US"&gt;&lt;o:p&gt;
&lt;P&gt;The remit and aim of the NHS National Fetal Anomaly Screening Programme is to set standards and oversee the implementation of a screening programme which conforms to an agreed level of quality for all pregnant women in England. The screen is for certain chromosomal and structural abnormalities in their unborn babies. This includes the offer of an ultrasound scan and biochemical testing during the early stages of pregnancy.&lt;/P&gt;
&lt;P&gt;The NHS Fetal Anomaly Screening Programme aims to offer all pregnant women in England a minimum of two ultrasound scans. The first is an early scan, undertaken after 8 weeks gestation and used mainly for dating the pregnancy and confirming viability. The second is undertaken between 18+0 - 20 weeks 6 days of the pregnancy and screens for major structural anomalies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The objectives of the 18&lt;SUP&gt;+0&lt;/SUP&gt; to 20&lt;SUP&gt;+6&lt;/SUP&gt; weeks ultrasound scan is to:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;offer choice to women and their partners about their screening options and pregnancy management&lt;/LI&gt;
&lt;LI&gt;identify abnormalities associated with morbidity incompatible with life at a time when choice can operate about continuation of the pregnancy or termination&lt;/LI&gt;
&lt;LI&gt;identify abnormalities that require early intervention following delivery&lt;/LI&gt;
&lt;LI&gt;identify abnormalities that may benefit from interactive treatment.&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The NHS Fetal Anomaly Screening Programme has agreed that only 11 conditions may be detected by a scan and these have limited detection rates (DR). The detection rates are derived from a number of major reference sources. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Detection Rates: &lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;Anencephaly 98%&lt;/LI&gt;
&lt;LI&gt;Open spina bifida 90%&lt;/LI&gt;
&lt;LI&gt;Cleft lip 75%&lt;/LI&gt;
&lt;LI&gt;Diaphragmatic hernia 60%&lt;/LI&gt;
&lt;LI&gt;Gastroschisis 98%&lt;/LI&gt;
&lt;LI&gt;Exomphalos 80%&lt;/LI&gt;
&lt;LI&gt;Serious cardiac abnormalities 50%&lt;/LI&gt;
&lt;LI&gt;Bilateral renal agenesis 84%&lt;/LI&gt;
&lt;LI&gt;Lethal skeletal dysplasia 60%&lt;/LI&gt;
&lt;LI&gt;Edwards’ syndrome 90%&lt;/LI&gt;
&lt;LI&gt;Patau’s syndrome 90%&lt;/LI&gt;
&lt;LI&gt;Alobar holoprosencephaly 80%&lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The following leaflets have been developed by the NHS Fetal Anomaly Screening Programme to help health professional and parents understand more about the conditions that can be scanned for at the ultrasound stage.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Anencephaly information for parents &lt;/LI&gt;
&lt;LI&gt;Anencephaly information for health professionals &lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Open Spina Bifida information for parents&lt;/LI&gt;
&lt;LI&gt;Open Spina Bifida information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Holoprosencephaly alobar information for parents&lt;/LI&gt;
&lt;LI&gt;Holoprosencephaly alobar information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Diaphramatic Hernia information for parents&lt;/LI&gt;
&lt;LI&gt;Diaphramatic Hernia information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Gastrochisis information for parents&lt;/LI&gt;
&lt;LI&gt;Gastrochisis information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Exomphalos information for parents&lt;/LI&gt;
&lt;LI&gt;Exomphalos information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Bilateral Renal Agenesis information for parents&lt;/LI&gt;
&lt;LI&gt;Bilateral Renal Agenesis information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;Lethal Skeletal Dysplasia information for parents&lt;/LI&gt;
&lt;LI&gt;Lethal Skeletal Dysplasia information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;T13 information for parents&lt;/LI&gt;
&lt;LI&gt;T13 information for health professionals&lt;BR&gt;&lt;BR&gt;&lt;/LI&gt;
&lt;LI&gt;T18 information for parents&lt;/LI&gt;
&lt;LI&gt;T18 information for health professionals&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;These booklets will be printed in limited supply and two copies will be sent to each trust in a binder with the 3 chorionic villus sampling (CVS) and amniocentesis leaflets that the NHS FASP have just developed. The binders will also include an introduction to genetics, a list of support groups and a list of publications available from the NHS FASP. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The idea is that ultrasound departments will be able to photocopy the leaflets for the parents to take home and also point them in the direction of our website if they wish to download them themselves.&amp;nbsp; These binders will be posted to all trusts in the New Year to support the publication of the ultrasound standards. All of the contents of the pack are available on the website at: &lt;A href="http://fetalanomaly.screening.nhs.uk/publication" target="_blank"&gt;http://fetalanomaly.screening.nhs.uk/publication&lt;/A&gt;. Please feel free to download a copy and print it out for your own records.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Serious cardiac heart abnormalities leaflets provided by the British Heart Foundation (BHF).&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;These leaflets have been kindly provided to us by the British Heart Foundation. They form part of a series of booklets about congenital heart diseases. They are meant for parents of children with congenital heart disease and health professionals. It is intended to write 24-30 booklets in total. The estimated date of completion is 2010.&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Hypoplastic left heart (available Winter 2009)&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.bhf.org.uk/publications/view_publication.aspx?ps=1000797" target="_blank"&gt;Aortic stenosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.bhf.org.uk/publications/view_publication.aspx?ps=1000798" target="_blank"&gt;Coarctation of the aorta&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.bhf.org.uk/publications/view_publication.aspx?ps=1000799" target="_blank"&gt;Large ventricular septal defect&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.bhf.org.uk/publications/view_publication.aspx?ps=1000800" target="_blank"&gt;Pulmonary stenosis&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.bhf.org.uk/publications/view_publication.aspx?ps=1000801" target="_blank"&gt;Tetralogy of Fallot&lt;/A&gt;&lt;/LI&gt;
&lt;LI&gt;&lt;A href="http://www.bhf.org.uk/publications/view_publication.aspx?ps=1000802" target="_blank"&gt;Transposition of the great arteries&lt;/A&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;SPAN style="FONT-FAMILY: Arial"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; mso-element: footnote" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;&lt;SPAN style="FONT-FAMILY: Arial"&gt;&lt;o:p&gt;
&lt;P&gt;Additional copies of these leaflets can be ordered from the BHF website at &lt;A href="http://www.bhf.org.uk/" target="_blank"&gt;www.bhf.org.uk&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;These leaflets have been kindly provided to us by the Cleft Lip and Palate Association (CLAPA).&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Antenatal Diagnosis of Cleft Lip and Palate is an 8-page booklet for parents of babies antenatally diagnosed with a cleft. &lt;/LI&gt;
&lt;LI&gt;Cleft Lip and Palate – A guide for sonographers is a 20-page booklet for sonographers, with information on cleft lip and palate, how to diagnose the condition, and how to break the news to parents.&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Illustrated and produced by CLAPA and the Fetal Medicine Unit, St George’s Hospital, London. Additional copies of these leaflets and further information about cleft lip and palate can be obtained from the CLAPA website at &lt;A href="http://www.clapa.com/" target="_blank"&gt;www.clapa.com&lt;/A&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; mso-element: footnote" class=MsoNormal&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt; mso-element: footnote" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial"&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;A href="nelh:325076:0" name=internalLink&gt;Annual evidence update: antenatal screening for neural tube defects&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325075:0" name=internalLink&gt;Annual evidence update: antenatal ultrasound screening for fetal anomalies&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:61078:0" name=internalLink&gt;UK NSC policy on neural tube defects screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:35693:0" name=internalLink&gt;UK NSC policy on fetal anomaly screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/" target="_blank"&gt;NHS Fetal Anomaly Screening Programme website&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/getdata.php?id=11016" target="_blank"&gt;NHS Fetal Anomaly Screening Programme annual report 2006-2008&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information for professionals&lt;/H2&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;National Collaborating Centre for Women’s and Children’s Health. Commissioned by the National Institute for Health and Clinical Excellence. &lt;A href="http://www.nice.org.uk/Guidance/CG62/Guidance/pdf/English" target="_blank"&gt;Antenatal care: routine care for the healthy pregnant woman. CG62: full guidance.&lt;/A&gt; March 2008 (corrected June 2008).&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The NHS Fetal Anomaly Screening Programme has produced a number of pathways which will illustrate the screening process for fetal anomaly and Down's syndrome screening and also the governance responsibilities for health professionals.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://fetalanomaly.screening.nhs.uk/timelines" target="_blank"&gt;NHS Fetal Anomaly Screening Programme Pathways&lt;/A&gt;&lt;/P&gt;
&lt;H2&gt;&lt;BR&gt;&amp;nbsp;&lt;/H2&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>269076</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=269076]]&gt;</url>
    <title>Screening for Fetal Anomalies (National Knowledge Week)</title>
    <publicationDate>2007-09-13T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ 18-20 WEEKS,STAFF USE,SPECIALTIES,NEONATAL,CONGENITAL ABNORMALITIES,FETAL MEDICINE,FETAL ANOMALY,NEURAL TUBE DEFECTS,CHILD HEALTH,SCREENING,SCREENING,ANTENATAL,KNOWLEDGE UPDATES]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Fetal Anomalies (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage13 border=1 name=nelh_tempImage13 alt="pregnant woman having an ultrasound scan" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269076/nelhImp_0007_ultrasound_fetal.jpg" width=174 height=133&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage5 border=1 name=nelh_tempImage5 alt="ultrasound scan of a fetal head" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269076/nelhImp_0008_headprofile.jpg" width=174 height=133&gt;&lt;/TD&gt;
&lt;TD&gt;&amp;nbsp;&lt;IMG id=nelh_tempImage3 border=1 name=nelh_tempImage3 alt="ultrasound scan of a fetal leg" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269076/nelhImp_0009_Fetalleg.jpg" width=174 height=133&gt;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269364" target="_blank"&gt;Evidence Update&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section&lt;SPAN&gt;&lt;EM&gt; has been compiled using text and reports provided by: Pat Ward (Programme Director, National Fetal Anomaly Screening Programme), Lyn &amp;nbsp;Bryant, &amp;nbsp;Adam &amp;nbsp;Fisher &amp;nbsp;&amp;amp; &amp;nbsp;Fiona &amp;nbsp;Vicente (all from the Social Research &amp;nbsp;&amp;amp; &amp;nbsp;Regeneration &amp;nbsp;Unit, University of Plymouth)&lt;/EM&gt;&lt;/SPAN&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Fetal anomaly screening programme&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Screening for fetal anomalies by an ultrasound scan was introduced on an ad hoc basis in many maternity hospitals in the late 1970s, and by 2002 only 3% did not offer a routine 18-20 week ultrasound scan to all women. In 2003, the National Institute for Clinical Excellence (NICE) guideline Antenatal care: Routine care for the healthy pregnant woman&amp;nbsp;[&lt;A href="http://www.nice.org.uk/pdf/CG6_ANC_NICEguideline.pdf" target="_blank"&gt;1&lt;/A&gt;]&amp;nbsp; stated that:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;"&lt;EM&gt;pregnant women should be offered an ultrasound scan to screen for structural anomalies, ideally between 18 to 20 weeks gestation by an appropriately trained sonographer, and with equipment of an appropriate standard&lt;/EM&gt;" (p15)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This has been underpinned by the National Services Framework for Children&amp;nbsp;in 2004 [&lt;A href="http://www.dh.gov.uk/en/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/ChildrenServicesInformation/DH_4089111" target="_blank"&gt;2&lt;/A&gt;].&amp;nbsp;To take this work forward, a funded programme of work has been set in place by the Department of Health [&lt;A href="http://www.screening.nhs.uk/fetalanomaly/fasp_annual_report06.pdf" target="_blank"&gt;3&lt;/A&gt;]. &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;The main aim of the NHS screening programme for Fetal Anomaly is to offer all pregnant women in England a minimum of 2 ultrasound scans. The first is an early scan, undertaken after 8 weeks gestation and used mainly for dating the pregnancy and confirming viability. The second ultrasound scan is undertaken between 18 – 20 weeks of the pregnancy and screens for major structural anomalies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The objectives of the 18 to 20 weeks ultrasound scan are to:-&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;1.&amp;nbsp;offer choice to women and their partners about their screening options and pregnancy management.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;2.&amp;nbsp;identify abnormalities associated with morbidity incompatible with life at a time when choice can operate about continuation of the pregnancy or termination.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;3.&amp;nbsp;identify abnormalities which require early intervention following delivery&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;4.&amp;nbsp;identify abnormalities which may benefit from interactive treatment.&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In 2007, the&amp;nbsp; Social&amp;nbsp; Research&amp;nbsp; &amp;amp;&amp;nbsp; Regeneration&amp;nbsp; Unit&amp;nbsp; at&amp;nbsp; the&amp;nbsp; University&amp;nbsp; of&amp;nbsp; Plymouth&amp;nbsp; was&amp;nbsp; commissioned&amp;nbsp; by&amp;nbsp; the&amp;nbsp; Fetal&amp;nbsp; Anomalies&amp;nbsp; Steering&amp;nbsp; Group&amp;nbsp; to&amp;nbsp; undertake&amp;nbsp; a&amp;nbsp; literature survey related&amp;nbsp; to&amp;nbsp; routine&amp;nbsp; second&amp;nbsp; trimester&amp;nbsp; ultrasound&amp;nbsp; screening. Their search covered the period between January 1996 and 30th April 2007. Detection&amp;nbsp; rates and&amp;nbsp; frequencies&amp;nbsp; for a&amp;nbsp; specified&amp;nbsp; list&amp;nbsp; of&amp;nbsp; anomalies&amp;nbsp; diagnosed&amp;nbsp; at&amp;nbsp; the&amp;nbsp; time window of 18 – 22 weeks gestation from the report are summarised below. For the methods and full details of the results and evidence, see the main report [&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269364" target="_blank"&gt;4&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Central Nervous System (CNS)&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Anencephaly&amp;nbsp; has a&amp;nbsp; high&amp;nbsp; prenatal&amp;nbsp; rate&amp;nbsp; of&amp;nbsp; detection, from 96%-100%.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Encephalocele&amp;nbsp; is&amp;nbsp; reported&amp;nbsp; as&amp;nbsp; having&amp;nbsp; frequency&amp;nbsp; rates&amp;nbsp; in&amp;nbsp; the&amp;nbsp; UK&amp;nbsp; of&amp;nbsp; between&amp;nbsp; 1.2&amp;nbsp; per&amp;nbsp; 10,000&amp;nbsp; and&amp;nbsp; 2.1&amp;nbsp; per&amp;nbsp; 10,000&amp;nbsp; Frequencies&amp;nbsp; of&amp;nbsp; as&amp;nbsp; low&amp;nbsp; as&amp;nbsp; 0.7&amp;nbsp; per&amp;nbsp; 10,000&amp;nbsp; have&amp;nbsp; also&amp;nbsp; been&amp;nbsp; reported. Detection rates vary between 66.6% and 100%.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Spina bifida - increased&amp;nbsp; uptake&amp;nbsp; of&amp;nbsp; folic&amp;nbsp; acid&amp;nbsp; has&amp;nbsp; decreased&amp;nbsp; the&amp;nbsp; incidence&amp;nbsp; of&amp;nbsp; spina&amp;nbsp; bifida&amp;nbsp; and&amp;nbsp; more&amp;nbsp; widesread&amp;nbsp; use&amp;nbsp; could&amp;nbsp; decrease&amp;nbsp; the&amp;nbsp; rates&amp;nbsp; still&amp;nbsp; further. Overall&amp;nbsp; frequency&amp;nbsp; in&amp;nbsp; 16&amp;nbsp; States&amp;nbsp; in&amp;nbsp; the&amp;nbsp; USA&amp;nbsp; was&amp;nbsp; found&amp;nbsp; to&amp;nbsp; be&amp;nbsp; around 4.6&amp;nbsp; cases&amp;nbsp; per&amp;nbsp; 10,000&amp;nbsp; births. &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Hydrocephalus - this&amp;nbsp; condition&amp;nbsp; is&amp;nbsp; frequently&amp;nbsp; found in conjunction&amp;nbsp; with&amp;nbsp; other&amp;nbsp; conditions,&amp;nbsp; and&amp;nbsp; relatively&amp;nbsp; few&amp;nbsp; research&amp;nbsp; papers&amp;nbsp; dealing&amp;nbsp; with&amp;nbsp; isolated&amp;nbsp; hydrocephalus&amp;nbsp; were&amp;nbsp; located.&amp;nbsp;&amp;nbsp; In the UK,&amp;nbsp; frequency&amp;nbsp; rates were&amp;nbsp; from&amp;nbsp; 5.1&amp;nbsp; in&amp;nbsp; 10,000&amp;nbsp; births. Detection&amp;nbsp; rates&amp;nbsp; are&amp;nbsp; variable,&amp;nbsp; from&amp;nbsp; 100%&amp;nbsp; to&amp;nbsp; as&amp;nbsp; low&amp;nbsp; as&amp;nbsp; 33%.&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Holoprosencephaly - the&amp;nbsp; birth&amp;nbsp; prevalence&amp;nbsp; of&amp;nbsp; holoprosencephaly&amp;nbsp; is estimated to&amp;nbsp; be&amp;nbsp; about 1 per&amp;nbsp; 10,000. Ultrasound&amp;nbsp; is&amp;nbsp; seen&amp;nbsp; as&amp;nbsp; being&amp;nbsp; fairly&amp;nbsp; effective&amp;nbsp; in&amp;nbsp; detecting&amp;nbsp; isolated&amp;nbsp; holoprosencephaly,&amp;nbsp; although&amp;nbsp; some&amp;nbsp; claim&amp;nbsp; that&amp;nbsp; MRI&amp;nbsp; imaging&amp;nbsp; may&amp;nbsp; provide&amp;nbsp; better&amp;nbsp; characterisation&amp;nbsp; of&amp;nbsp; the&amp;nbsp; malformations&amp;nbsp; in&amp;nbsp; later&amp;nbsp; pregnancy.&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Dandy Walker malformation (DWM) and Dandy Walker Variant (DWV) - the birth&amp;nbsp; prevalence of&amp;nbsp; Dandy Walker&amp;nbsp; malformation&amp;nbsp; is about&amp;nbsp; 1&amp;nbsp; per&amp;nbsp; 30,000.&amp;nbsp; Both&amp;nbsp; the&amp;nbsp; reported&amp;nbsp; frequencies&amp;nbsp; and&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; show&amp;nbsp; wide&amp;nbsp; variations&amp;nbsp; between&amp;nbsp; research&amp;nbsp; studies,&amp;nbsp; for&amp;nbsp; example a&amp;nbsp; rate&amp;nbsp; of&amp;nbsp; 42% in one study,&amp;nbsp; compared&amp;nbsp; with&amp;nbsp; that&amp;nbsp; of&amp;nbsp; 91.6% in another. &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Cardio Vascular System (CVS): Heart&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Hypoplastic - the&amp;nbsp; majority&amp;nbsp; of&amp;nbsp; cases&amp;nbsp; diagnosed&amp;nbsp; during&amp;nbsp; pregnancy&amp;nbsp; refer&amp;nbsp; specifically&amp;nbsp; to Hypoplastic&amp;nbsp; Left&amp;nbsp; Heart/Ventricle.&amp;nbsp;&amp;nbsp;&amp;nbsp; Varying&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; for&amp;nbsp; this&amp;nbsp; particular&amp;nbsp; anomaly have been shown,&amp;nbsp; ranging&amp;nbsp; from&amp;nbsp; 44.4%&amp;nbsp; to&amp;nbsp; 88%.&amp;nbsp;&amp;nbsp; Varying&amp;nbsp; frequency&amp;nbsp; figures&amp;nbsp; for&amp;nbsp; the&amp;nbsp; anomaly have also been shown,&amp;nbsp; ranging&amp;nbsp; from&amp;nbsp; 1 in 4,856&amp;nbsp; to&amp;nbsp; 7 in 10,000.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;AV&amp;nbsp; Canal – no specific&amp;nbsp; studies&amp;nbsp; on&amp;nbsp; the&amp;nbsp; prenatal&amp;nbsp; detection&amp;nbsp; and&amp;nbsp; diagnosis&amp;nbsp; of&amp;nbsp; the&amp;nbsp; AV&amp;nbsp; canal&amp;nbsp; anomaly&amp;nbsp; through&amp;nbsp; ultrasound&amp;nbsp; scanning&amp;nbsp; during&amp;nbsp; the&amp;nbsp; mid&amp;nbsp; trimester&amp;nbsp; of&amp;nbsp; pregnancy were located.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Transposition – prenatal detection rates of between 50 and 53% in Western Europe.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Fallot - tetralogy&amp;nbsp; of&amp;nbsp; the Fallot&amp;nbsp; condition&amp;nbsp; involves&amp;nbsp; the&amp;nbsp; presence&amp;nbsp; of&amp;nbsp; four&amp;nbsp; heart&amp;nbsp; malformations:&amp;nbsp; ventricular&amp;nbsp; septal&amp;nbsp; defect,&amp;nbsp; pulmonary&amp;nbsp; stenosis,&amp;nbsp; overriding&amp;nbsp; aorta&amp;nbsp; and&amp;nbsp; right&amp;nbsp; ventricular&amp;nbsp; hypertrophy.&amp;nbsp;&amp;nbsp; Studies from Western&amp;nbsp; Europe&amp;nbsp; reveal&amp;nbsp; two&amp;nbsp; varying&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; of&amp;nbsp; 0%&amp;nbsp; and&amp;nbsp; 49%.&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Double&amp;nbsp; Outlets&amp;nbsp;&amp;nbsp; - no studies&amp;nbsp; on&amp;nbsp; the&amp;nbsp; prenatal&amp;nbsp; detection&amp;nbsp; and&amp;nbsp; diagnosis&amp;nbsp; of&amp;nbsp; the&amp;nbsp; Double&amp;nbsp; Outlets&amp;nbsp; anomly&amp;nbsp; through&amp;nbsp; ultrasound&amp;nbsp; scanning&amp;nbsp; during&amp;nbsp; the&amp;nbsp; mid&amp;nbsp; trimester&amp;nbsp; of&amp;nbsp; pregnancy were located.&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp; &lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Valve&amp;nbsp; Atresia&amp;nbsp; - no studies&amp;nbsp; on&amp;nbsp; the&amp;nbsp; prenatal&amp;nbsp; detection&amp;nbsp; and&amp;nbsp; diagnosis&amp;nbsp; of&amp;nbsp; the&amp;nbsp; Valve&amp;nbsp; Atresia&amp;nbsp; anomaly&amp;nbsp; through ultrasound&amp;nbsp; scanning&amp;nbsp; during&amp;nbsp; the&amp;nbsp; mid&amp;nbsp; trimester&amp;nbsp; of&amp;nbsp; pregnancy were located.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Chest&lt;BR&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Cystic&amp;nbsp; Lung&amp;nbsp; Lesions&amp;nbsp; - routine&amp;nbsp; ultrasonograpy&amp;nbsp; has&amp;nbsp; enabled&amp;nbsp; the&amp;nbsp; prenatal&amp;nbsp; detection&amp;nbsp; of&amp;nbsp; “cystic&amp;nbsp; lung&amp;nbsp; disease”.&amp;nbsp; In&amp;nbsp; terms&amp;nbsp; of&amp;nbsp; frequency&amp;nbsp; an&amp;nbsp; incidence&amp;nbsp; of&amp;nbsp; 1&amp;nbsp; in&amp;nbsp; 25,000&amp;nbsp; live&amp;nbsp; births&amp;nbsp; has&amp;nbsp; been&amp;nbsp; suggested&amp;nbsp; in&amp;nbsp; previous&amp;nbsp; studies, and&amp;nbsp; and&amp;nbsp; in&amp;nbsp; Canada&amp;nbsp; an&amp;nbsp; incidence&amp;nbsp; of&amp;nbsp; between&amp;nbsp; 1&amp;nbsp; in&amp;nbsp; 25,000&amp;nbsp; to&amp;nbsp; 1&amp;nbsp; in&amp;nbsp; 35,000&amp;nbsp; pregnancies.&amp;nbsp; The&amp;nbsp; lack&amp;nbsp; of&amp;nbsp; specific&amp;nbsp; accuracy&amp;nbsp; of&amp;nbsp; the&amp;nbsp; diagnoses&amp;nbsp; and&amp;nbsp; the&amp;nbsp; fact&amp;nbsp; that&amp;nbsp; the&amp;nbsp; outcomes&amp;nbsp; may&amp;nbsp; vary&amp;nbsp; widely&amp;nbsp; in&amp;nbsp; different&amp;nbsp; cases&amp;nbsp; has&amp;nbsp; been emphasised&amp;nbsp; in studies.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Diaphragmatic&amp;nbsp; Hernia&amp;nbsp; - congenital&amp;nbsp; diaphragmatic&amp;nbsp; hernia&amp;nbsp; is&amp;nbsp; reported as&amp;nbsp; having&amp;nbsp; an&amp;nbsp; incidence&amp;nbsp; of&amp;nbsp; between 3 to 5 per&amp;nbsp; 10,000&amp;nbsp; live&amp;nbsp; births,&amp;nbsp; and&amp;nbsp; accounts&amp;nbsp; for&amp;nbsp; about&amp;nbsp; 8%&amp;nbsp; of&amp;nbsp; all&amp;nbsp; major&amp;nbsp; congenital&amp;nbsp; abnormalities. &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Abdomen&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Gastroschisis&amp;nbsp; - detection&amp;nbsp; rates&amp;nbsp; reported&amp;nbsp; in&amp;nbsp; the&amp;nbsp; literature&amp;nbsp; tended&amp;nbsp; to&amp;nbsp; be&amp;nbsp; relatively&amp;nbsp; high.&amp;nbsp; In&amp;nbsp; the&amp;nbsp; UK,&amp;nbsp;&amp;nbsp; a&amp;nbsp; six&amp;nbsp; year&amp;nbsp; study&amp;nbsp; of&amp;nbsp; fetal&amp;nbsp; abnormality&amp;nbsp; in&amp;nbsp; six&amp;nbsp; Scottish&amp;nbsp; health&amp;nbsp; boards&amp;nbsp; found&amp;nbsp; that&amp;nbsp; 100%&amp;nbsp; of&amp;nbsp; fetuses&amp;nbsp; with&amp;nbsp; gastroschisis&amp;nbsp; were&amp;nbsp; identified&amp;nbsp; by&amp;nbsp; prenatal&amp;nbsp; ultrasound.&amp;nbsp;&amp;nbsp; Other&amp;nbsp; studies&amp;nbsp; in&amp;nbsp; Western&amp;nbsp; Europe&amp;nbsp; support&amp;nbsp; these&amp;nbsp; findings,&amp;nbsp; and&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; range&amp;nbsp; from&amp;nbsp; 86.6%&amp;nbsp; to&amp;nbsp; 100%.&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Exomphalos&amp;nbsp; - prenatal&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; for&amp;nbsp; exomphalos&amp;nbsp; are relatively&amp;nbsp; high, and range&amp;nbsp; from&amp;nbsp; 67.6%&amp;nbsp; to&amp;nbsp; 100%.&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Oesophageal&amp;nbsp; Atresia&amp;nbsp;&amp;nbsp; - detection&amp;nbsp; rates&amp;nbsp; for&amp;nbsp; oesophageal&amp;nbsp; atresia&amp;nbsp; tend&amp;nbsp; to&amp;nbsp; be&amp;nbsp; low&amp;nbsp; and&amp;nbsp; the sensitivity of detecting it&amp;nbsp; in&amp;nbsp; utero&amp;nbsp; is&amp;nbsp; low. There&amp;nbsp; is&amp;nbsp; a&amp;nbsp; need&amp;nbsp; to&amp;nbsp; undertake&amp;nbsp; scans&amp;nbsp; at&amp;nbsp; &amp;gt;18&amp;nbsp; weeks&amp;nbsp; since&amp;nbsp; low&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; have&amp;nbsp; been&amp;nbsp; reported&amp;nbsp; for&amp;nbsp; this&amp;nbsp; anomaly&amp;nbsp; below&amp;nbsp; 24&amp;nbsp; weeks -&amp;nbsp; the&amp;nbsp; mean&amp;nbsp; time&amp;nbsp; of&amp;nbsp; first&amp;nbsp; detection&amp;nbsp; was&amp;nbsp; at&amp;nbsp; 28.5&amp;nbsp; weeks&amp;nbsp; with&amp;nbsp; a&amp;nbsp; range&amp;nbsp; of&amp;nbsp; 24-35&amp;nbsp; weeks. The few studies that were&amp;nbsp; located&amp;nbsp; gave detection&amp;nbsp; rates from&amp;nbsp; 0%&amp;nbsp; to&amp;nbsp; 50%.&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Renal&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Renal&amp;nbsp; Agenesis&amp;nbsp; -&amp;nbsp; detection rates for the&amp;nbsp; Renal&amp;nbsp; Agenesis&amp;nbsp; anomalies&amp;nbsp; (unilateral&amp;nbsp; and&amp;nbsp; bilateral)&amp;nbsp; ranged&amp;nbsp; from&amp;nbsp; 50%&amp;nbsp; to&amp;nbsp; 100%.&amp;nbsp; &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Bilateral Renal&amp;nbsp; Agenesis&amp;nbsp; is&amp;nbsp; a&amp;nbsp; rare&amp;nbsp; condition&amp;nbsp; which&amp;nbsp; occurs&amp;nbsp; in about&amp;nbsp; 1.8&amp;nbsp; per&amp;nbsp; 10,000&amp;nbsp; live&amp;nbsp; births.&lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Renal&amp;nbsp; Cystic&amp;nbsp; Disease&amp;nbsp; - the&amp;nbsp; accuracy&amp;nbsp; and&amp;nbsp; efficiency&amp;nbsp; of&amp;nbsp; prenatal&amp;nbsp; diagnoses&amp;nbsp; of&amp;nbsp; recessive&amp;nbsp; and&amp;nbsp; dominant&amp;nbsp; polycystic&amp;nbsp; renal&amp;nbsp; disease&amp;nbsp; (ARPKD&amp;nbsp; and&amp;nbsp; ADPKD),&amp;nbsp; and&amp;nbsp; multicystic&amp;nbsp; kidney&amp;nbsp; disease&amp;nbsp; (bilateral&amp;nbsp; and&amp;nbsp; unilateral),&amp;nbsp; by&amp;nbsp; early&amp;nbsp; to&amp;nbsp; mid&amp;nbsp; pregnancy&amp;nbsp; ultrasound&amp;nbsp; screening&amp;nbsp; is&amp;nbsp; debatable.&amp;nbsp; Studies revealed a number&amp;nbsp; of&amp;nbsp; frequencies&amp;nbsp; for&amp;nbsp; renal&amp;nbsp; cystic&amp;nbsp; disease anomalies,&amp;nbsp; but only&amp;nbsp; one&amp;nbsp; detection&amp;nbsp; rate&amp;nbsp; of&amp;nbsp; 52.3%&amp;nbsp; for&amp;nbsp; unilateral&amp;nbsp; multicystic&amp;nbsp; kidney&amp;nbsp; disease&amp;nbsp; (31.1%&amp;nbsp; false&amp;nbsp; positive&amp;nbsp; rate). &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Upper&amp;nbsp; Renal&amp;nbsp; Tract:&amp;nbsp; Hydronephrosis - hydronephrosis&amp;nbsp; has&amp;nbsp; been&amp;nbsp; described&amp;nbsp; as&amp;nbsp; the&amp;nbsp; most&amp;nbsp; common&amp;nbsp; genitourinary&amp;nbsp; tract&amp;nbsp; anomaly&amp;nbsp; identified&amp;nbsp; in&amp;nbsp; prenatal&amp;nbsp; ultrasound&amp;nbsp; studies.&amp;nbsp;&amp;nbsp; The&amp;nbsp; diagnosis&amp;nbsp; levels&amp;nbsp; have been put at&amp;nbsp; between&amp;nbsp; 1%&amp;nbsp; and&amp;nbsp; 5%&amp;nbsp; of&amp;nbsp; all&amp;nbsp; pregnancies. Mild&amp;nbsp; or&amp;nbsp; moderate antenatal&amp;nbsp; hydronephrosis&amp;nbsp; can result&amp;nbsp; in&amp;nbsp; postnatal&amp;nbsp; pathology&amp;nbsp;&amp;nbsp; being&amp;nbsp; relatively&amp;nbsp; low - mild&amp;nbsp; hydronephrosis was shown to improve&amp;nbsp; or&amp;nbsp; disappear&amp;nbsp; spontaneously&amp;nbsp; in&amp;nbsp; 82%&amp;nbsp; of&amp;nbsp; cases.&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Bladder&amp;nbsp; Outflow: Posterior&amp;nbsp; Urethral&amp;nbsp; Valves (PUV) -&amp;nbsp;&amp;nbsp; prenatal&amp;nbsp; detection&amp;nbsp; of&amp;nbsp; PUV&amp;nbsp; is&amp;nbsp;&amp;nbsp; important&amp;nbsp; as&amp;nbsp; surgical&amp;nbsp; correction&amp;nbsp; is&amp;nbsp; required&amp;nbsp; in&amp;nbsp; the&amp;nbsp; early&amp;nbsp; postnatl&amp;nbsp; period&amp;nbsp; to&amp;nbsp; improve&amp;nbsp; survival&amp;nbsp; rates, but most&amp;nbsp; renal&amp;nbsp; valve&amp;nbsp; related&amp;nbsp; anomalies&amp;nbsp; are&amp;nbsp; difficult&amp;nbsp; to&amp;nbsp; diagnose&amp;nbsp; accurately&amp;nbsp; prenatally.&amp;nbsp; Prenatal&amp;nbsp; sonographic&amp;nbsp; findings&amp;nbsp; also vary&amp;nbsp; depending&amp;nbsp; on&amp;nbsp; the&amp;nbsp; gestational&amp;nbsp; age&amp;nbsp; of&amp;nbsp; the&amp;nbsp; fetus&amp;nbsp; and&amp;nbsp; severity&amp;nbsp; of&amp;nbsp; obstruction.&amp;nbsp;&amp;nbsp; Detection&amp;nbsp; rates&amp;nbsp; are relatively&amp;nbsp; high, in France for&amp;nbsp; example,&amp;nbsp; a&amp;nbsp; detection&amp;nbsp; rate&amp;nbsp; of&amp;nbsp; 83.3% was reported. Frequencies&amp;nbsp; have been reported ranging&amp;nbsp; from&amp;nbsp; 1 in 4000&amp;nbsp; to&amp;nbsp; 1 in 25,000.&amp;nbsp;&amp;nbsp;&amp;nbsp; &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Limbs&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Lethal&amp;nbsp; Skeletal&amp;nbsp; Dysplasia&amp;nbsp;&amp;nbsp; - the prevalence of skeletal dysplasias is low, about 3.2 per 10,000 live births. Lethal&amp;nbsp; skeletal&amp;nbsp; dysplasias&amp;nbsp; are described as&amp;nbsp; rare,&amp;nbsp; with&amp;nbsp; an&amp;nbsp; estimated&amp;nbsp; frequency&amp;nbsp; of&amp;nbsp; 1&amp;nbsp; per&amp;nbsp; 10,000&amp;nbsp; live&amp;nbsp; births. Ultrasound&amp;nbsp; is&amp;nbsp; an&amp;nbsp; excellent&amp;nbsp; method&amp;nbsp; for&amp;nbsp; discovering&amp;nbsp; lethal&amp;nbsp; skeletal&amp;nbsp; dysplasias&amp;nbsp; overall,&amp;nbsp; but other&amp;nbsp; methods&amp;nbsp; may&amp;nbsp; be&amp;nbsp; necessary&amp;nbsp; for&amp;nbsp; making&amp;nbsp; specific&amp;nbsp; diagnoses. &lt;BR&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Face&lt;/STRONG&gt;&lt;BR&gt;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Cleft&amp;nbsp; Lip - Cleft&amp;nbsp; lip&amp;nbsp; with&amp;nbsp; or&amp;nbsp; without&amp;nbsp; cleft&amp;nbsp; palate&amp;nbsp; is&amp;nbsp; most&amp;nbsp; likely&amp;nbsp; to&amp;nbsp; occur&amp;nbsp; as&amp;nbsp; an&amp;nbsp; isolated&amp;nbsp; anomaly,&amp;nbsp; with&amp;nbsp; the&amp;nbsp; presence&amp;nbsp; of&amp;nbsp; other&amp;nbsp; congenital&amp;nbsp; anomalies&amp;nbsp; reported&amp;nbsp; as&amp;nbsp; varying&amp;nbsp; between&amp;nbsp; different&amp;nbsp; studies (from&amp;nbsp; 62%&amp;nbsp; to&amp;nbsp; 79%&amp;nbsp; of&amp;nbsp; isolated&amp;nbsp; cleft&amp;nbsp; lip/palate).&amp;nbsp;&amp;nbsp; Detection&amp;nbsp; rates&amp;nbsp; of&amp;nbsp; isolated&amp;nbsp; cleft&amp;nbsp; lip&amp;nbsp; by&amp;nbsp; ultrasound&amp;nbsp; also&amp;nbsp; vary&amp;nbsp;&amp;nbsp; widely&amp;nbsp; and&amp;nbsp; have&amp;nbsp; tended&amp;nbsp; to&amp;nbsp; be relatively&amp;nbsp; low.&amp;nbsp; In&amp;nbsp; the&amp;nbsp; UK a study found that 48%&amp;nbsp; of&amp;nbsp; fetuses&amp;nbsp; with&amp;nbsp; cleft&amp;nbsp; lip,&amp;nbsp; with&amp;nbsp; or&amp;nbsp; without&amp;nbsp; cleft&amp;nbsp; palate,&amp;nbsp; were&amp;nbsp; identified&amp;nbsp; by&amp;nbsp; prenatal&amp;nbsp; ultrasound,&amp;nbsp; with&amp;nbsp; no&amp;nbsp; false&amp;nbsp; positives.&amp;nbsp;&amp;nbsp; Other studies&amp;nbsp; in&amp;nbsp; the&amp;nbsp; USA&amp;nbsp; show detection&amp;nbsp; rates&amp;nbsp; of&amp;nbsp; between&amp;nbsp; 22&amp;nbsp; and&amp;nbsp; 30%&amp;nbsp; by&amp;nbsp; ultrasound&amp;nbsp; carried&amp;nbsp; out&amp;nbsp; prior&amp;nbsp; to&amp;nbsp; 22&amp;nbsp; weeks. The&amp;nbsp; UK&amp;nbsp; studies&amp;nbsp; show&amp;nbsp; detection&amp;nbsp; rates&amp;nbsp; of&amp;nbsp; between&amp;nbsp; 17.5%&amp;nbsp; and&amp;nbsp; 88%.&lt;STRONG&gt;&lt;/STRONG&gt;&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify"&gt;[1] National Institute for Clinical Excellence (&lt;?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /&gt;&lt;st1:stockticker w:st="on"&gt;NICE&lt;/st1:stockticker&gt;). &lt;A href="http://www.nice.org.uk/pdf/CG6_ANC_NICEguideline.pdf" target="_blank"&gt;Antenatal care: Routine care for the healthy pregnant woman&lt;/A&gt;. 2003&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN lang=EN-GB&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN lang=EN-GB&gt;[2] Department of Health. &lt;A href="http://www.dh.gov.uk/en/PolicyAndGuidance/HealthAndSocialCareTopics/ChildrenServices/ChildrenServicesInformation/DH_4089111" target="_blank"&gt;National Service Framework for children, young people and maternity services&lt;/A&gt;. 2004. &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN lang=EN-GB&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN lang=EN-GB&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN lang=EN-GB&gt;[3] National Fetal Anomaly Ultrasound Screening P&lt;/SPAN&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;rogramme for &lt;st1:country-region w:st="on"&gt;England&lt;/st1:country-region&gt;. &lt;A href="http://www.screening.nhs.uk/fetalanomaly/fasp_annual_report06.pdf" target="_blank"&gt;First Annual Report 2005/2006&lt;/A&gt;. &lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;[4]&amp;nbsp; Bryant L, Fisher A &amp;nbsp;and &amp;nbsp;Vicente &amp;nbsp;F. &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269364" target="_blank"&gt;Draft Report. Fetal &amp;nbsp;Anomaly &amp;nbsp;Ultrasound &amp;nbsp;Screening Programme &amp;nbsp;Study: Literature &amp;nbsp;Survey&lt;/A&gt;. June &amp;nbsp;2007&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Annual evidence update on antenatal screening for fetal anomalies&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The Fetal Anomaly Screening Report above [&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269364" target="_blank"&gt;4&lt;/A&gt;] included a literature search from Jan 1996 to 30th April 2007, so an additional evidence update was not conducted by the Screening Specialist Library.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee policy, July 2006&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=35693&amp;amp;tabID=288&amp;amp;catID=2011" target="_blank"&gt;Fetal anomaly screening&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;Antenatal ultrasound surveys - national and regional&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN" lang=EN&gt;&lt;A href="http://www.screening.nhs.uk/fetalanomaly/ultrasound_survey.pdf" target="_blank"&gt;Antenatal ultrasound screening - ultrasound survey of England 2002&lt;/A&gt; &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;B style="mso-bidi-font-weight: normal"&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/B&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/ultrasoundsurvey_east.pdf" target="_blank"&gt;Antenatal Ultrasound Screening: Report of ultrasound service provision in the East of England 2005&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/eastmidlands_USS.pdf" target="_blank"&gt;East Midlands - Review of Antenatal Ultrasound Screening Services 2005&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/ultrasoundsurvey_london05.pdf" target="_blank"&gt;Antenatal Ultrasound Screening: Ultrasound Survey of London 2002&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/NEast_USS.pdf" target="_blank"&gt;Ultrasound Survey: an Evaluation of Service Provision in the North East of England 2004&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/southeast_USS.pdf" target="_blank"&gt;Antenatal Ultrasound Screening: report of ultrasound service provision in the South East region 2004&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/SWest_USS.pdf" target="_blank"&gt;Ultrasound Survey: an Evaluation of Service Provision in the South West of England 2004&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="COLOR: black; mso-ansi-language: EN-US"&gt;&lt;A href="http://www.screening.nhs.uk/downs/WMidlands_USS.pdf" target="_blank"&gt;Antenatal Screening in the West Midlands. Second Report - Ultrasound 2004&lt;/A&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;&lt;/o:p&gt;&lt;/SPAN&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Additional information for health professionals&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;NICE Guidance currently being reviewed: Antenatal Care: routine care for the healthy pregnant woman (Oct 2003). See &lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;review details&lt;/A&gt;. Consultation period: &lt;SPAN class=ip_content_1_join&gt;4 September - 29 October 2007.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;British Medical Association (BMA). &lt;A href="http://www.bma.org.uk/ap.nsf/AttachmentsByTitle/PDFAbortionTimeLimits/$FILE/Abortiontimelimits.pdf" target="_blank"&gt;Abortion time limits: a briefing paper from the BMA. Part 2: diagnosing fetal abnormality&lt;/A&gt;. May 2005.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;Continuous professional development - resources to support the Antenatal and Newborn Screening Programmes:&lt;/SPAN&gt; &lt;A href="http://www.screening.nhs.uk/cpd/fetalanomaly.htm" target="_blank"&gt;Fetal Anomaly&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Economic modelling of antenatal screening and ultrasound scanning programmes for identification of fetal abnormalities. Feb 2006 [&lt;A href="http://www.crd.york.ac.uk/crdweb/ShowRecord.asp?View=Full&amp;amp;ID=22005008266" target="_blank"&gt;NHS EED abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/fetalanomaly/home.htm" target="_blank"&gt;Fetal Anomaly Screening Programme (FaSP)&lt;/A&gt; website&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Down’s Syndrome Screening Programme for England. &lt;A href="http://www.screening.nhs.uk/downs/working_standards.pdf" target="_blank"&gt;Antenatal screening – working standards&lt;/A&gt;. March 2004.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;STRONG&gt;Information to give pregnant&amp;nbsp;women&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Fetal Anomaly Screening Programme. &lt;A href="http://www.screening.nhs.uk/fetalanomaly/ultrasound_leaflet.pdf" target="_blank"&gt;Having a mid-pregnancy ultrasound scan?&lt;/A&gt; May 2007. Booklet providing information about the purpose of the ultrasound scan in mid-pregnancy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Jan 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/" target="_blank"&gt;Screening tests for you and your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;pregnant women and their&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>57338</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band42/b42-4.html]]&gt;</url>
    <title>Screening for Fragile-X Syndrome</title>
    <publicationDate>1997-08-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ FRAGILE X,SCREENING,ANTENATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Screening for Fragile X Syndrome&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/index.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;Bandolier writes: 
&lt;P&gt;"The recommendations made in the report are:- 
&lt;OL type=1&gt;
&lt;LI&gt;Cascade screening (ie in affected families) should be regarded as of proven benefit, but national audit of current practice is needed 
&lt;LI&gt;Paediatric screening - studies are needed to assess current practice 
&lt;LI&gt;Antenatal screening - the practicality, acceptability and cost of routine antenatal screening should be assessed 
&lt;LI&gt;The psychosocial consequences of being identified as a 'carrier' should be studied 
&lt;LI&gt;A central register for all diagnoses should be established. &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;These recommendations reflect the dilemmas faced by almost all new genetic screening programmes. While we now have the technology to undertake sophisticated DNA screening and we know that the incidence of new cases can be reduced, we have little sound information on the human costs of population screening programmes or the real cost/benefits to the NHS. It is critically important that these questions are addressed". 
&lt;H3&gt;Reference:&lt;/H3&gt;
&lt;OL type=1&gt;
&lt;LI&gt;Murray J, Cuckle H, Taylor G, Hewison J. Screening for Fragile X syndrome. Health Technology Assessment 1997; 1(4). &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;&lt;EM&gt;** Note that this review is &amp;gt;&amp;nbsp;10 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>75382</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsherp.htm]]&gt;</url>
    <title>Screening for genital herpes</title>
    <publicationDate>2005-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,GENITAL HERPES,ANTENATAL,SCREENING,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,HERPES,VIRAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for genital herpes, which updates the 1996 recommendations. The USPSTF recommends "against routine serological screening for herpes simplex virus (HSV) in asymptomatic pregnant women at any time during pregnancy to&lt;STRONG&gt; &lt;/STRONG&gt;prevent neonatal HSV infection" and also recommends&amp;nbsp;"against routine serological screening for HSV in asymptomatic adolescents and adults". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/uspstf05/herpes/herpesup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66590</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsgdm.htm]]&gt;</url>
    <title>Screening for gestational diabetes mellitus</title>
    <publicationDate>2008-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ GESTATIONAL DIABETES,CAUSES,NOT ROUTINELY OFFERED,SCREENING,ANTENATAL,DIABETES,DIABETES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational diabetes mellitus. The USPSTF concludes that "the evidence is insufficient to recommend for or against routine screening for gestational diabetes". 
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.chapter.4471" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>71041</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsglau.htm]]&gt;</url>
    <title>Screening for glaucoma</title>
    <publicationDate>2005-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,SCREENING,GLAUCOMA,EYESIGHT,OLD AGE,EYES AND VISION,SCREENING AND SURVEILLANCE,LATER LIFE,GLAUCOMA,ADULT,SCREENING,GLAUCOMA,CONDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for glaucoma. The USPSTF found "insufficient evidence to recommend for or against screening adults for glaucoma." 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/uspstf05/glaucoma/glaucsyn.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63584</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63584]]&gt;</url>
    <title>Screening for Group B Streptococcus - implications for midwifery</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>Royal College of Midwives</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B screening from a NSC workshop</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Group B Streptococcus - implications for midwifery&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;is on the implications of midwifery in antenatal screening for streptococcus B.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>386793</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=71]]&gt;</url>
    <title>Screening for haemochromatosis. A report for the UK National Screening Committee</title>
    <publicationDate>2009-12-01T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HAEMOCHROMATOSIS,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses haemochromatosis against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>377523</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=377523]]&gt;</url>
    <title>Screening for haemochromatosis: a report for the UK National Screening Committee</title>
    <publicationDate>2009-12-01T00:00:00</publicationDate>
    <publisher>Public Health Resource Unit</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HAEMOCHROMATOSIS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for haemochromatosis: a report for the UK National Screening Committee&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report assesses haemochromatosis against the NSC criteria for a screening programme.&lt;/P&gt;
&lt;P&gt;It concludes that general population&amp;nbsp;screening for haemochromatosis in adults should not be offered.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.screening.nhs.uk/policydb_download.php?doc=71" target="_blank"&gt;Read the full text PDF report&lt;/A&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>155373</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspshemoch.htm]]&gt;</url>
    <title>Screening for hemochromatosis</title>
    <publicationDate>2006-08-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ HAEMOCHROMATOSIS,SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hemochromatosis. The USPSTF recommends "against routine genetic screening for hereditary hemochromatosis in the asymptomatic general population".&lt;BR&gt;
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/uspstf06/hemochromatosis/hemochrev.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392489</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=89]]&gt;</url>
    <title>Screening for Hepatitis B and Hepatitis C in ethnic minorities born outside the UK</title>
    <publicationDate>2010-08-03T00:00:00</publicationDate>
    <publisher>Solutions for Public Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HEPATITIS C,NOT ROUTINELY OFFERED,PUBLIC HEALTH,OUTCOMES,MANAGEMENT &amp; INTERVENTIONS,POPULATIONS,GROUPS,LIVER DISORDERS,HEPATITIS,ETHNIC GROUPS,SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,MONTHLY ADDITIONS,NOVEMBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses hepatitis B and hepatitis C in ethnic minorities born outside the UK against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>75380</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspshepb.htm]]&gt;</url>
    <title>Screening for hepatitis B virus infection</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,HEPATITIS B,BEFORE 16 WEEKS,VIRAL,HEPATITIS B,MALE SEXUALLY TRANSMITTED INFECTIONS,MALE UROGENITAL DISORDERS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis B virus infection. The USPSTF strongly recommends "screening for hepatitis B virus (HBV) infection in pregnant women at their first prenatal visit" but recommends against "routinely screening the general asymptomatic population for chronic hepatitis B virus infection". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/hepbscr/hepbup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66408</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspshepc.htm]]&gt;</url>
    <title>Screening for hepatitis C in adults</title>
    <publicationDate>2004-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HEPATITIS C,NOT ROUTINELY OFFERED,GASTROENTEROLOGY &amp; LIVER DISEASES,DISEASE PREVENTION,LIVER,HEPATITIS,HEPATITIS C,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=detail_text&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for hepatitis C virus infection. The USPSFT recommends "against routine screening for hepatitis C virus (HCV) infection in asymptomatic adults who are not at increased risk (general population) for infection" and found "insufficient evidence to recommend for or against routine screening for HCV infection in adults at high risk for infection".&lt;/SPAN&gt; 
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/hepcscr/hepcrev.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212776</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/cgi/reprint/143/7/517.pdf]]&gt;</url>
    <title>Screening for hereditary hemochromatosis: a clinical practice guideline from the American College of Physicians</title>
    <publicationDate>2005-10-01T00:00:00</publicationDate>
    <publisher>American College of Physicians</publisher>
    <publicationType>CARE GUIDELINE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,HAEMOCHROMATOSIS,PRIMARY CARE,NOT ROUTINELY OFFERED,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Practice guideline (USA)</description>
    <body>&lt;![CDATA[ Practice guideline on screening for hereditary haemochromatosis, produced by American College of Physicians.]]&gt;</body>
  </document>
  <document>
    <id>66599</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspshype.htm]]&gt;</url>
    <title>Screening for high blood pressure</title>
    <publicationDate>2007-12-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CORONARY HEART DISEASE,HYPERTENSION,ADULT,CHILD,SCREENING,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for&amp;nbsp;high blood pressure. The USPSTF&amp;nbsp;"recommends&amp;nbsp;screening for high blood pressure in adults aged 18 and older".&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/highbloodsc/hibloodrev.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>98576</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/clinic/uspstf/uspshivi.htm]]&gt;</url>
    <title>Screening for HIV</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ HIV,SCREENING,ADULT,ANTENATAL,NOT ROUTINELY OFFERED,BEFORE 16 WEEKS,MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,HIV,VIRAL,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on&amp;nbsp;screening for Human Immunodeficiency Virus (HIV)&amp;nbsp;infection. The USPSTF recommends that "clinicians screen for HIV all adolescents and adults at increased risk for HIV infection" and that "no recommendation for or against routinely screening for HIV adolescents and adults who are not at increased risk for HIV infection".&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;These recommendations were amended in April 2007. See the &lt;A href="http://www.ahrq.gov/clinic/uspstf/uspshivi.htm" target="_blank"&gt;summary of recommendations and supporting documents&lt;/A&gt; for further details.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392491</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=36]]&gt;</url>
    <title>Screening for hyperbilirubinemia. Report prepared for the UK National Screening Committee</title>
    <publicationDate>2006-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses hyperbilirubinemia against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>75421</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsaisc.htm]]&gt;</url>
    <title>Screening for idiopathic scoliosis in adolescents</title>
    <publicationDate>2004-06-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ CHILD HEALTH,ADOLESCENCE,MUSCULOSKELETAL,CONDITIONS,MAJOR NON-INFLAMMATORY,SPINAL PROBLEMS,MUSCULOSKELETAL,PUBLIC HEALTH,SCREENING,TRAUMA AND ORTHOPAEDICS,SPINE,DISEASE MANAGEMENT,ADOLESCENT SCOLIOSIS,SCREENING,CHILD,SCOLIOSIS,SPECIALTIES,SCOLIOSIS,INVESTIGATION,STAFF USE,NOT ROUTINELY OFFERED,SYSTEMATIC REVIEWS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for idiopathic scoliosis in adolescents. The USPSTF recommends "against the routine screening of asymptomatic adolescents for idiopathic scoliosis". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/scoliosis/scolioup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>78214</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=78214]]&gt;</url>
    <title>Screening for infections in pregnancy; HIV, hepatitis B, rubella and syphilis</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Health Protection Agency</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ HIV,HEPATITIS B,RUBELLA,SYPHILIS,SCREENING,ANTENATAL,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation produced for an antenatal and newborn screening conference</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for infections in pregnancy; HIV, hepatitis B, rubella and syphilis&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN class=detail_text&gt;This is a powerpoint presentation about screening for infections in pregnancy, that was produced for the 2nd North West Regional Antenatal &amp;amp; Newborn Screening Conference held on 31st Jan 2005.&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>325048</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325048]]&gt;</url>
    <title>Screening for infectious diseases in pregnancy (Annual Update 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>Screening specialist collection</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,SCREENING,ANTENATAL,SYPHILIS,HEPATITIS B,HIV,RUBELLA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for infectious diseases in pregnancy (Annual Update 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=center&gt;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="antenatal blood samples in a laboratory" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID267585/nelhImp_0006_blood.jpg" width=200 height=132&gt;&lt;IMG id=nelh_tempImage5 border=1 name=nelh_tempImage5 alt="laboratory analysis" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID267585/nelhImp_0008_image003.jpg" width=200 height=132&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325106:0" name=internalLink&gt;Back to contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Since 2007 the Infectious Diseases in Pregnancy Screening Programme has been working on a range of projects aiming to address issues arising from the implementation of the &lt;A href="nelh:33791:0" name=internalLink&gt;Department of Health’s ‘Standards to support the antenatal screening programme’&lt;/A&gt; (2003).&lt;/P&gt;
&lt;P&gt;This work is summarised in the &lt;A href="nelh:325613:0" name=internalLink&gt;Programme’s annual report&lt;/A&gt; along with data on the uptake of screening and the number of positive test results between 2005 and 2007.&lt;/P&gt;
&lt;P&gt;An important task has been the review and revision of the current programme standards and the development of recommended standards and algorithms for screening laboratories.&amp;nbsp; Consultation on these standards will begin in mid October.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;If you wish to be contacted when the consultation begins please contact John Marshall (&lt;A href="mailto:john.marshall@imperial.nhs.uk" target="_blank"&gt;john.marshall@imperial.nhs.uk&lt;/A&gt;).&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information&amp;nbsp;&lt;/H2&gt;
&lt;P&gt;&lt;A href="nelh:35759:0" name=internalLink&gt;UK NSC policy on Hepatitis B screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:51537:0" name=internalLink&gt;UK NSC policy on HIV screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:51566:0" name=internalLink&gt;UK NSC policy on rubella susceptibility screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:32233:0" name=internalLink&gt;UK NSC policy on syphilis screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://infectiousdiseases.screening.nhs.uk/" target="_blank"&gt;NHS Infectious Diseases in Pregnancy&amp;nbsp;Screening Programme website&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325613:0" name=internalLink&gt;NHS Infectious Diseases in Pregnancy Screening Programme Annual Report 2007-08&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information for professionals&lt;/H2&gt;
&lt;P&gt;National Collaborating Centre for Women’s and Children’s Health. Commissioned by the National Institute for Health and Clinical Excellence. &lt;A href="http://www.nice.org.uk/Guidance/CG62/Guidance/pdf/English" target="_blank"&gt;Antenatal care: routine care for the healthy pregnant woman. CG62: full guidance&lt;/A&gt;. March 2008 (corrected June 2008). &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Hepatitis B&lt;/H2&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;?xml:namespace prefix = o /&gt;&lt;o:p&gt;&lt;A href="http://www.basl.org.uk/media/uploads/BVHGPregnancy.pdf" target="_blank"&gt;BVHG consensus statement - UK guidelines for the management of babies born to women who are HBsAg positive&lt;/A&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;HIV&lt;/H2&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;British HIV Association. &lt;A href="http://www.bhiva.org/cms1221368.asp" target="_blank"&gt;Management of HIV infection in pregnant women&lt;/A&gt;. 2008&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;A href="http://www.bashh.org/documents/91/91.pdf" target="_blank"&gt;2007 UK guidelines for the management of sexual and reproductive health (SRH) of people living with HIV infection&lt;/A&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Syphilis&lt;/H2&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;Kingston et al. &lt;A href="http://www.bashh.org/documents/1879" target="_blank"&gt;UK National Guidelines in the management of syphilis&lt;/A&gt;. International Journal of STD and AIDS 2008; 19:729-40&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Patient information&lt;/H2&gt;
&lt;P&gt;Antenatal and Newborn Screening Programmes. &lt;A href="nelh:239537:0" name=internalLink&gt;Screening tests for you and your baby&lt;/A&gt;. 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>267585</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=267585]]&gt;</url>
    <title>Screening for Infectious Diseases in Pregnancy (National Knowledge Week)</title>
    <publicationDate>2007-09-01T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,OUTCOMES,FEMALE,LIVER DISORDERS,HEPATITIS,GENITOURINARY DISEASES,SEXUALLY TRANSMITTED INFECTIONS,COMMUNICABLE DISEASES,RUBELLA,HIV INFECTION,SCREENING,POPULATION BASED &amp; PREVENTATIVE SERVICES,HIV,HEPATITIS B,SYPHILIS,RUBELLA,ANTENATAL,SCREENING,PUBLIC HEALTH,DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,INDIVIDUAL BEHAVIOUR,SEXUAL HEALTH,SERVICES,GENDER,POPULATIONS]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Infectious Diseases in Pregnancy (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;
&lt;TABLE border=0 width="100%"&gt;
&lt;TBODY&gt;
&lt;TR&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage0 border=1 name=nelh_tempImage0 alt="antenatal blood samples in a laboratory" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID267585/nelhImp_0006_blood.jpg" width=200 height=132&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage9 border=1 name=nelh_tempImage9 alt="GP examining a pregnant woman" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID267585/nelhImp_0007_pregnant.jpg" width=200 height=132&gt;&amp;nbsp;&lt;/TD&gt;
&lt;TD&gt;&lt;IMG id=nelh_tempImage5 border=1 name=nelh_tempImage5 alt="laboratory analysis" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID267585/nelhImp_0008_image003.jpg" width=200 height=132&gt;&amp;nbsp;&lt;/TD&gt;&lt;/TR&gt;&lt;/TBODY&gt;&lt;/TABLE&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;Annual Evidence Updates: &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=155538" target="_blank"&gt;Hepatitis B&lt;/A&gt;, &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269136" target="_blank"&gt;HIV&lt;/A&gt;, &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269134" target="_blank"&gt;Rubella&lt;/A&gt;, &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269135" target="_blank"&gt;Syphilis&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section has been written by Professor Catherine Peckham, Institute of Child Health and John Marshall, Programme Manager, Fetal, Maternal and Child Health Coordinating Group&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Infectious Diseases in Pregnancy Screening Programme is a collaboration between the &lt;A href="http://www.hpa.org.uk/" target="_blank"&gt;Health Protection Agency &lt;/A&gt;(HPA), the UK &lt;A href="http://www.nsc.nhs.uk/" target="_blank"&gt;National Screening Committee&lt;/A&gt; (NSC) and the &lt;A href="http://www.dh.gov.uk/" target="_blank"&gt;Department of Health&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Screening for infectious diseases in pregnancy has been undertaken for many years and the current programme standards were published in 2003 by the Department of Health to consolidate and extend this practice&lt;FONT size=2 face="Times New Roman"&gt; [&lt;A href="http://www.dh.gov.uk/assetRoot/04/06/61/91/04066191.pdf" target="_blank"&gt;1&lt;/A&gt;].&lt;/FONT&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Screening and treatment recommendations are also reflected in the relevant NICE guidance [&lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;2&lt;/A&gt;]. Note that this guidance is currently being reviewed - &lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;see review details&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The standards recommend that all pregnant women should be offered screening, early in each pregnancy, for:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;Hepatitis B&lt;/LI&gt;
&lt;LI&gt;HIV&lt;/LI&gt;
&lt;LI&gt;Rubella&lt;/LI&gt;
&lt;LI&gt;Syphilis&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Screening is offered to help protect the health of both mother and baby.&amp;nbsp; Early screening is recommended for reasons of clinical effectiveness but it should be offered no matter when booking takes place.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In 2004 collaborative work was undertaken by the HPA and NSC to develop tools to support programme implementation and to identify an information standard and data collection process to support programme monitoring.&amp;nbsp; On October 31st 2007, a small workshop will be held to review progress, consider current policies and identify work streams which would help develop the programme further.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Hepatitis B&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Hepatitis B is an infection of the liver caused by a virus which can be transmitted, for example, from mother to child at birth, during unprotected sex with an infected partner or via injections using non-sterile needles.&amp;nbsp; Although 90% of infected adults recover fully from the infection, 10% do become chronic carriers of the virus.&amp;nbsp; However where infection was acquired from mother to child transmission a much higher proportion, sometimes up to 90%, will become chronic carriers.&amp;nbsp; About 25% of these will develop liver problems such as cirrhosis or cancer in later life.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Appropriate treatment, either vaccination or a combination of vaccination and immunoglobulin in cases where there is a higher risk of newborn infection, is very effective in preventing transmission of Hepatitis B.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The purpose of screening for Hepatitis B in pregnancy is to identify carriers of the virus as these are at risk of transmitting the infection and their babies will require an appropriate course of treatment following birth to prevent infection.&amp;nbsp; Identifying mothers with the infection also provides an opportunity for referral for specialist follow up and care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;An &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=155538" target="_blank"&gt;evidence update&lt;/A&gt; has been reviewed and there is no evidence to indicate a change of the current screening policy.&amp;nbsp; Indeed antenatal screening for Hepatitis B is an important element in efforts to reduce the burden of chronic disease in the UK. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;However a significant review of current treatment recommendations was produced by the Cochrane Collaboration in 2006 [&lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004790/frame.html" target="_blank"&gt;3&lt;/A&gt;].&amp;nbsp;This suggests that a combination of vaccination and immunoglobulin may be of value in babies born to all carriers rather than just those in the higher risk categories.&amp;nbsp; The results of the review will be presented at the above mentioned Programme Development Workshop.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Syphilis&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Syphilis is a bacterial infection which can be transmitted from mother to baby, either across the placenta during pregnancy or during birth from contact with lesions in the birth canal.&amp;nbsp; It can also be transmitted during unprotected sex with an infected partner.&amp;nbsp; During pregnancy, infectious syphilis can cause miscarriage or stillbirth and can have serious health consequences for live born children.&amp;nbsp; The risk of mother to baby transmission is linked to the stage of infection with the highest risk associated with primary infection.&amp;nbsp; Risk is also linked to gestation as transmission across the placenta can take place from the 18th week of pregnancy.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The purpose of screening is to identify women who have a syphilis infection, early in pregnancy, and who can be referred to specialist services.&amp;nbsp; Antibiotics are effective in treating maternal infection and, if administered before 18 weeks gestation, are also effective in reducing the risk of transmission to the baby.&amp;nbsp; Babies of women who have a syphilis infection should also be treated with antibiotics following the birth.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;An &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269135" target="_blank"&gt;evidence&amp;nbsp;update&lt;/A&gt; has been reviewed and there is no evidence to indicate a change of the current screening policy.&amp;nbsp; As syphilis facilitates HIV transmission and as surveillance reports have highlighted an increasing number of syphilis cases, both in the general population and in the pregnant population [&lt;A href="http://www.pi.nhs.uk/screening/resources/Infectious_disease_report.pdf" target="_blank"&gt;4]&lt;/A&gt; [&lt;A href="http://www.erpho.org.uk/Download/Public/16316/1/East%20of%20England%20Antenatal%20Annual%20Rpt%202006%20Anonymised%20version.pdf" target="_blank"&gt;4a&lt;/A&gt;] [&lt;A href="http://www.erpho.org.uk/Download/Public/14679/1/East%20of%20England%20Antenatal%20Screening%20Annual%20Rpt%202005.pdf" target="_blank"&gt;5&lt;/A&gt;], the importance of antenatal screening may be enhanced.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Syphilis remains rare in the UK but in the context of a rising rate of infection an important review, published in 2006, highlighted the need to review and monitor local assessment and management practices for syphilis infection in pregnancy [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16595042&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;6&lt;/A&gt;].&amp;nbsp; The need for robust national surveillance was also identified as a priority by the review.&amp;nbsp; The review will be discussed at the above mentioned workshop.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The knowledge update also included a range of references which point to the increasing effectiveness of rapid screening tests for syphilis.&amp;nbsp; These articles mainly refer to poorly resourced contexts but, assuming all four tests could be undertaken in this way, the impact of rapid testing on the patient experience and the cost of screening in the UK could prove valuable to programme’s development.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;HIV&lt;/STRONG&gt; &lt;/P&gt;
&lt;P&gt;Pregnant women are offered screening for HIV infection so that interventions can be given to reduce the risk of mother-to-child transmission of infection as well as to improve the woman’s own health. Antiretroviral therapy, the avoidance of breast feeding and appropriate management of delivery can reduce the risk of mother-to-child transmission from around 25% to less than 2%. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Since the introduction of antenatal screening for HIV there has been a dramatic reduction in paediatric HIV infections among children whose mothers were diagnosed in pregnancy, despite the marked increase in the number of women with HIV infection [&lt;A href="http://www.hpa.org.uk/publications/2006/hiv_sti_2006/" target="_blank"&gt;7&lt;/A&gt;]&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Pregnant women identified in pregnancy are reported to the National Study of HIV in Pregnancy and Childhood (NSHPC), a collaboration between the Institute of Child Health (London) the Health Protection Agency and Health Protection Scotland [&lt;A href="http://www.ucl.ac.uk/paediatric-epidemiology/nshpc/nshpc.html" target="_blank"&gt;8&lt;/A&gt;].&amp;nbsp;&amp;nbsp; The NSHPC is an active and confidential national reporting scheme for pregnancies in HIV-infected women, babies born to HIV-infected women and children with HIV infection. Through the NSHPC it is possible to monitor the prevalence of diagnosed HIV infection in pregnant women and children, evaluate antenatal HIV screening programmes, track changes in the management of HIV in pregnancy and transmission of infection from mother to child and monitor the effects of treatment in pregnancy on children born to HIV-infected women [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17457096&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;9&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16763496&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;10&lt;/A&gt;].&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The NSHPC’s ability to connect information on screening with health outcomes in this way provides a model of best practice for data collection and monitoring of the other three infections within the Infectious Diseases in Pregnancy Screening Programme.&amp;nbsp; The NSHPC’s value in this regard will be discussed at the programme development workshop.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Between 1990 and 2006 about 8000 pregnancies complicated by HIV were reported.&amp;nbsp; The annual number has exceeded 1000 every year since 2003, and was about 1200 in 2005 and 2006. Over 8600 children born to infected women were reported by the end of 2006, of whom about 10% were born abroad, and 1600 are HIV-infected. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;An &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269136" target="_blank"&gt;evidence&amp;nbsp;update&lt;/A&gt; has been reviewed and there is no evidence to indicate a change in the current screening policy. The update highlights the importance of screening pregnant women for HIV infection, achieving high uptake and monitoring the impact of the screening programme.&amp;nbsp; The current programme standards recommend that all women should be counselled on the possibility of acquiring HIV infection in the current pregnancy and the update raises the issue of repeat screening for women at increased risk of infection [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=104%5Bvolume%5D%20AND%201119%5Bpage%5D%20AND%202004%5Bpdat%5D" target="_blank"&gt;11&lt;/A&gt;].&amp;nbsp;&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Several references also point to the importance of rapid tests both for screening women who book late pregnancy or who arrive unscreened in labour and, more generally, as a potential means of improving the screening process [&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7MFB-4F8TW2S-6&amp;amp;_user=10&amp;amp;_coverDate=02%2F01%2F2005&amp;amp;_alid=619245134&amp;amp;_rdoc=1&amp;amp;_fmt=summary&amp;amp;_orig=search&amp;amp;_cdi=23254&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=1&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=54fdd5f1cfe3aa3b9eb0bfbc3f8cb96a" target="_blank"&gt;12&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=82%5Bvolume%5D%20AND%20v1%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;13&lt;/A&gt;] [14] [&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6TBM-48N35NG-B&amp;amp;_user=10&amp;amp;_coverDate=06%2F30%2F2003&amp;amp;_rdoc=10&amp;amp;_fmt=summary&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%235146%232003%23999899996%23432024%23FLA%23display%23Volume)&amp;amp;_cdi=5146&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=13&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=917098bf4b219da8b44ff8fc924841c6" target="_blank"&gt;15&lt;/A&gt;].&amp;nbsp;&amp;nbsp; Research in this latter area may be of benefit to the future development of the Infectious Diseases in Pregnancy Screening Programme.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Rubella&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Rubella is caused by an airborne virus that is passed from person-to-person, for example, by coughs and sneezes. Women who have had rubella or have received the vaccination produce an antibody in the blood that will usually prevent them getting the infection. This protection is called immunity.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Rubella infection is usually mild and often unrecognised but when it occurs during the first three months of pregnancy the baby is at risk of having serious defects, particularly heart defects, vision defects and impaired hearing.&amp;nbsp; Rubella infection, acquired after this stage of pregnancy is unlikely to affect the baby.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The purpose of screening is to identify women who do not have a sufficient amount of antibody to prevent the mother acquiring rubella infection.&amp;nbsp; Women who are, in this way, susceptible to infection are offered MMR vaccine after the birth of the child to protect subsequent pregnancies from complications arising from a rubella infection.&amp;nbsp; A standardised approach to rubella vaccination is required and the recent NICE postnatal care guideline recommended that it should be offered prior to discharge from the maternity unit.&amp;nbsp; Rubella vaccine is contraindicated in pregnancy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Rubella screening in pregnancy supplements the UK childhood immunisation programme in which all children are offered two doses of MMR and as a result of these two approaches congenital rubella is now rare in the UK.&amp;nbsp; Indeed, by the time women reach childbearing age only about 3% overall are found to be susceptible to rubella infection.&amp;nbsp; However, women living in the UK who were born abroad are much more likely to be susceptible to rubella that those born in the UK [&lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-231.asp" target="_blank"&gt;16&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;An &lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269134" target="_blank"&gt;evidence&amp;nbsp;update&lt;/A&gt; has been reviewed and there is no evidence to indicate a change in the current screening policy.&amp;nbsp; The&amp;nbsp;evidence update highlights the importance of surveillance in assessing the success of screening and vaccination programmes [&lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-231.asp" target="_blank"&gt;17&lt;/A&gt;].&amp;nbsp;&amp;nbsp; The UK is fortunate to have a congenital rubella surveillance system organised through the BPSU [&lt;A href="http://bpsu.inopsu.com/studies/congenital_rubella/index.html" target="_blank"&gt;17a&lt;/A&gt;]&amp;nbsp;to which only 13 cases of confirmed congenital rubella were reported between 1997 and 2005.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;However, a combination of demographic change and several years’ sub-optimal uptake of the MMR vaccine emphasises the need to maintain and strengthen the vaccination and screening programmes.&amp;nbsp; Other European&amp;nbsp;[&lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-221.asp" target="_blank"&gt;17b&lt;/A&gt;]&amp;nbsp;countries, such as Italy [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=23%5Bvolume%5D%20AND%2010%5Bissue%5D%20AND%20780%5Bpage%5D%20AND%202004%5Bpdat%5D" target="_blank"&gt;18&lt;/A&gt;]&amp;nbsp;, Romania [&lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-224.asp" target="_blank"&gt;19&lt;/A&gt;]&amp;nbsp; and Holland [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=149%5Bvolume%5D%20AND%2021%5Bissue%5D%20AND%201174%5Bpage%5D%20AND%202005%5Bpdat%5D" target="_blank"&gt;20&lt;/A&gt;]&amp;nbsp;, have reported periodic rubella epidemics and clusters of congenital rubella cases.&amp;nbsp; The possibility of rubella once again starting to circulate in the UK cannot be excluded and this would put pregnant women at risk of acquiring infection.&amp;nbsp; This is particularly the case for women living in the UK who were born abroad.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The&amp;nbsp;evidence update includes references which point to the importance of preconception care in the prevention of congenital rubella syndrome [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16580940&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;21&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=190%5Bvolume%5D%20AND%20713%5Bpage%5D%20AND%20Dreux%5Bauthor%5D" target="_blank"&gt;22&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=143%5Bvolume%5D%20AND%207%5Bissue%5D%20AND%20530%5Bpage%5D%20AND%202004%5Bpdat%5D" target="_blank"&gt;23&lt;/A&gt;]&amp;nbsp; and any future plans to develop these services in the UK might consider the case for including rubella in the panel of issues discussed with women planning a pregnancy.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[1] Department of Health (August 2003).&amp;nbsp;&lt;A href="http://www.dh.gov.uk/assetRoot/04/06/61/91/04066191.pdf" target="_blank"&gt;Screening for infectious diseases in pregnancy&lt;/A&gt;: Standards to support the UK antenatal screening programme.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2]&amp;nbsp;National Institute of Clinical Excellence (NICE) (October 2003).&amp;nbsp;&lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;Antenatal Care: routine care for the pregnant woman&lt;/A&gt;. &lt;A href="http://www.rcog.org.uk/resources/Public/pdf/Antenatal_Care.pdf" target="_blank"&gt;Full guidance document &lt;/A&gt;(304 pages) also available.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[3]&amp;nbsp;Lee C, Gong Y, Brok J, Boxall EH, Gluud C. &lt;A href="http://www.mrw.interscience.wiley.com/cochrane/clsysrev/articles/CD004790/frame.html" target="_blank"&gt;Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers&lt;/A&gt;. &lt;I&gt;Cochrane Database of Systematic Reviews&lt;/I&gt; 2006, Issue 2. Art. No.: CD004790. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[4] Boxall E, Hodgkiss S, Tonks A (May 2007).&amp;nbsp;&lt;A href="http://www.pi.nhs.uk/screening/resources/Infectious_disease_report.pdf" target="_blank"&gt;Antenatal Screening in the West Midlands: Infectious Diseases&lt;/A&gt;, July 2003 – June 2006, Fourth Report.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[4a] Health Protection Agency. &lt;A href="http://www.erpho.org.uk/Download/Public/16316/1/East%20of%20England%20Antenatal%20Annual%20Rpt%202006%20Anonymised%20version.pdf" target="_blank"&gt;Antenatal Screening for Infections in the East of England, Annual Report for Data from 2004 to 2006&lt;/A&gt;. May 2007.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[5] Health Protection Agency (May 2006). &lt;A href="http://www.erpho.org.uk/Download/Public/14679/1/East%20of%20England%20Antenatal%20Screening%20Annual%20Rpt%202005.pdf" target="_blank"&gt;Antenatal Screening for Infections in the East of England,&lt;/A&gt; 2003 to 2005. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[6] Doroshenko A, Sherrard J, Pollard A J. Syphilis in pregnancy and the neonatal period. International Journal of STD &amp;amp; AIDS 2006; 17:221 - 228. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16595042&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[7] Health Protection Agency. The UK Collaborative Group for HIV and STI Surveillance. &lt;A href="http://www.hpa.org.uk/publications/2006/hiv_sti_2006/" target="_blank"&gt;A Complex Picture. HIV and Other Sexually Transmitted Infections in the United Kingdom&lt;/A&gt;: 2006. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[8] Further information can be found at the NSHPC website &lt;A href="http://www.ucl.ac.uk/paediatric-epidemiology/nshpc/nshpc.html" target="_blank"&gt;http://www.ucl.ac.uk/paediatric-epidemiology/nshpc/nshpc.html&lt;/A&gt; or by contacting Pat Tookey at &lt;A href="mailto:nshpc@ich.ucl.ac.uk" target="_blank"&gt;nshpc@ich.ucl.ac.uk&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[9] Townsend C, Cortina-Borja M, Peckham CS, Tookey PA. Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland. AIDS 2007; 21:1019-26 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17457096&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[10] Townsend CL, Tookey PA, Cortina-Borja M, Peckham CS. Antiretroviral therapy and congenital abnormalities in infants born to HIV-1 infected women in the United Kingdom and Ireland, 1990-2003. JAIDS 2006; 42(1): 91-94 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16763496&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[11] ACOG Committee on Obstetric Practice. ACOG committee opinion number 304, November 2004. Prenatal and perinatal human immunodeficiency virus testing: expanded recommendations. Obstetrics &amp;amp; Gynecology 2004, 104(5 Pt 1):1119-24. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=104%5Bvolume%5D%20AND%201119%5Bpage%5D%20AND%202004%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[12] Rapid HIV testing of women during labour delivers fast and accurate results of HIV status. Evidence-based Healthcare &amp;amp; Public Health 2005, 9(1), 30-31 [&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B7MFB-4F8TW2S-6&amp;amp;_user=10&amp;amp;_coverDate=02%2F01%2F2005&amp;amp;_alid=619245134&amp;amp;_rdoc=1&amp;amp;_fmt=summary&amp;amp;_orig=search&amp;amp;_cdi=23254&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=1&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=54fdd5f1cfe3aa3b9eb0bfbc3f8cb96a" target="_blank"&gt;Journal website abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[13] Peeling RW, Holmes KK, Mabey D, Ronald A. Rapid tests for sexually transmitted infections (STIs): The way forward. Sexually Transmitted Infections 2006, 82(SUPPL.5), v1-6 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=82%5Bvolume%5D%20AND%20v1%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[14] Branson BM. Point-of-care rapid tests for HIV antibodies. Laboratoriums Medizin 2003, 27(7-8), 288-295 [no abstract available]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[15] Doughty M, Locksmith GJ. New rapid diagnostic tests for HIV infection. Primary Care Update for Ob/Gyns. 2003, 10(3), 131-134 [&lt;A href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;amp;_udi=B6TBM-48N35NG-B&amp;amp;_user=10&amp;amp;_coverDate=06%2F30%2F2003&amp;amp;_rdoc=10&amp;amp;_fmt=summary&amp;amp;_orig=browse&amp;amp;_srch=doc-info(%23toc%235146%232003%23999899996%23432024%23FLA%23display%23Volume)&amp;amp;_cdi=5146&amp;amp;_sort=d&amp;amp;_docanchor=&amp;amp;view=c&amp;amp;_ct=13&amp;amp;_acct=C000050221&amp;amp;_version=1&amp;amp;_urlVersion=0&amp;amp;_userid=10&amp;amp;md5=917098bf4b219da8b44ff8fc924841c6" target="_blank"&gt;Journal website abstract]&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[16]&amp;nbsp;Tookey P. &lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-231.asp" target="_blank"&gt;Rubella in England, Scotland and Wales&lt;/A&gt;. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles. 2004, 9(4):21-3&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[17] Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GA. &lt;A href="http://epirev.oxfordjournals.org/cgi/content/full/28/1/81" target="_blank"&gt;Prevention of congenital rubella syndrome--what makes sense in 2006&lt;/A&gt;? Epidemiologic Reviews 2006.28:81-7&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[17a] British Paediatric Surveillance Unit (BPSU). &lt;A href="http://bpsu.inopsu.com/studies/congenital_rubella/index.html" target="_blank"&gt;Congenital Rubella&lt;/A&gt;.&amp;nbsp;March 2006.&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[17b] Crowcroft N, Pebody R. &lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-221.asp" target="_blank"&gt;Prevention of congenital rubella infection: a challenge for every country in Europe&lt;/A&gt;. Euro Surveill 2004; 9(4):2-2.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[18]&amp;nbsp;&amp;nbsp; Revello MG, Gorini G, Zavattoni M, Furione M, Gerna G. Congenital rubella infection following rubella outbreak in northern Italy, 2002: need for an effective vaccination programme. European Journal of Clinical Microbiology &amp;amp; Infectious Diseases 2004, 23(10):780-3. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=23%5Bvolume%5D%20AND%2010%5Bissue%5D%20AND%20780%5Bpage%5D%20AND%202004%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[19] Rafila A, Marin M, Pistol A, Nicolaiciuc D, Lupulescu E, Uzicanin A et al. &lt;A href="http://www.eurosurveillance.org/em/v09n04/0904-224.asp" target="_blank"&gt;A large rubella outbreak, Romania--2003&lt;/A&gt;. Euro Surveillance: Bulletin Europeen sur les Maladies Transmissibles 2004, 9(4):7-9.&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[20] Hahne SJ, Abbink F, van Binnendijk RS, Ruijs WL, van Steenbergen JE, de Melker HE. Rubella epidemic in the Netherlands, 2004/'05: awareness of congenital rubella syndrome required. Nederlands Tijdschrift voor Geneeskunde 2005,&amp;nbsp;149(21) : 1174-8 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=149%5Bvolume%5D%20AND%2021%5Bissue%5D%20AND%201174%5Bpage%5D%20AND%202005%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[21] Santis MD, Cavaliere AF, Straface G, Caruso A. Rubella infection in pregnancy. Reproductive Toxicology 2006, 21(4), 390-398 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16580940&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[22] Dreux C,.Crepin G. Protecting the unborn child. Information needed long before pregnancy. Bulletin de Academie Nationale de Medecine 2006,&amp;nbsp;190;713-23 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=190%5Bvolume%5D%20AND%20713%5Bpage%5D%20AND%20Dreux%5Bauthor%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[23] Riskin-Mashiah S. Preconception counseling - for all. Harefuah 2004, 143(7):530-6. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=143%5Bvolume%5D%20AND%207%5Bissue%5D%20AND%20530%5Bpage%5D%20AND%202004%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Annual evidence updates on antenatal screening for infectious diseases&amp;nbsp;2006/07&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Screening Library has identified the&amp;nbsp;new&amp;nbsp;evidence&amp;nbsp;published over the last year, and the results of our search are classified and presented as evidence updates below. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=155538" target="_blank"&gt;Hepatitis B&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269136" target="_blank"&gt;HIV&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269134" target="_blank"&gt;Rubella&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=269135" target="_blank"&gt;Syphilis&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee policies - infectious disease screening&amp;nbsp;for pregnant women,&amp;nbsp;July 2006.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=35759&amp;amp;tabID=288&amp;amp;catID=1996" target="_blank"&gt;Hepatitis B&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:51537:0" name=internalLink&gt;HIV&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:51566:0" name=internalLink&gt;Rubella&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:32233:0" name=internalLink&gt;Syphilis&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:35759:0" name=internalLink&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Guidance/recommendations&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NICE Guidance currently being reviewed: &lt;A href="http://www.nice.org.uk/page.aspx?o=CG006NICEguideline" target="_blank"&gt;Antenatal Care: routine care for the healthy pregnant woman&lt;/A&gt; (Oct 2003). See &lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;review details&lt;/A&gt;. Consultation period: &lt;SPAN class=ip_content_1_join&gt;4 September - 29 October 2007.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NICE (July 2006). &lt;A href="http://guidance.nice.org.uk/CG37/niceguidance/pdf/English/download.dspx" target="_blank"&gt;Postnatal Care: routine postnatal care for women and their babies&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;U.S. Preventive Services Task Force (Feb 2004). &lt;A href="http://www.ahrq.gov/clinic/3rduspstf/hepbscr/hepbrs.pdf" target="_blank"&gt;Screening for Hepatitis B Virus Infection: recommendation statement.&lt;/A&gt; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;U.S. Preventive Services Task Force (July 2004). &lt;A href="http://www.ahrq.gov/clinic/3rduspstf/syphilis/syphilrs.pdf" target="_blank"&gt;Screening for syphilis infection: recommendation statement&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Systematic reviews&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;U.S. Preventive Services Task Force (July 2004). &lt;A href="http://www.ahrq.gov/clinic/3rduspstf/syphilis/syphilup.pdf" target="_blank"&gt;Screening for syphilis: brief update&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;U.S. Preventive Services Task Force (Feb 2004). &lt;A href="http://www.ahrq.gov/clinic/3rduspstf/hepbscr/hepbup.pdf" target="_blank"&gt;Screening for hepatitis B virus infection: a brief evidence update&lt;/A&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;STRONG&gt;Other&amp;nbsp;information for health professionals &lt;/STRONG&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;Continuous professional development - resources to support the Antenatal and Newborn Screening Programmes: &lt;A href="http://www.screening.nhs.uk/cpd/infectious.htm" target="_blank"&gt;Infectious Diseases&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information to give pregnant women&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Jan 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/" target="_blank"&gt;Screening tests for you and your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;pregnant women and their&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Lab tests online - searchable website&amp;nbsp;designed to help consumers&amp;nbsp;understand the many clinical lab tests that are part of routine care. See &lt;A href="http://www.labtestsonline.org.uk/understanding/conditions/pregnancy.html" target="_blank"&gt;pregnancy screening&lt;/A&gt; (Aug 2006).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>155134</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsiron.htm]]&gt;</url>
    <title>Screening for iron deficiency anemia - including iron supplementation for children and pregnant women</title>
    <publicationDate>2006-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,36 WEEKS,ANAEMIA,28 WEEKS,ANAEMIA,BEFORE 16 WEEKS,CHILD,ANTENATAL,SCREENING,IRON DEFICIENCY ANAEMIA,ANAEMIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=detail_text&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for&amp;nbsp;iron deficiency anaemia.&amp;nbsp;The USPSTF concludes that "evidence is insufficient to recommend for or against routine screening for iron deficiency anemia in asymptomatic children aged 6 to 12 months" but recommends "routine screening for iron deficiency anemia in asymptomatic pregnant women".&lt;BR&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;A href="http://www.ahrq.gov/clinic/uspstf06/ironsc/ironscrev.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;&lt;/SPAN&gt;]]&gt;</body>
  </document>
  <document>
    <id>61150</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61150]]&gt;</url>
    <title>Screening for late onset genetic disorders. Breast and Ovarian Cancer</title>
    <publicationDate>2001-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,OVARIAN,CANCER,BREAST CANCER,ADULT,SCREENING,GENETIC CONDITIONS,SYSTEMS &amp; SYMPTOMS,CONDITIONS A-B,FAMILY HISTORY OF CANCER,BREAST &amp; OVARIAN CANCER (FAMILIAL),NOT ROUTINELY OFFERED,GENETIC SCREENING (FOR CONDITIONS),PREGNANCY]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A report on a National Screening Committee workshop</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for late onset genetic disorders. Breast and Ovarian Cancer&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This report is based on a&amp;nbsp;National Screening Committee workshop on screening for late onset genetic disorders (breast cancer and ovarian cancer). 
&lt;P&gt;One of the report's conclusions is&amp;nbsp;that "there is currently no case to offer population screening to identify people at an increased risk of breast or ovarian cancer based on family history".&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>60590</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60590]]&gt;</url>
    <title>Screening for Late Onset Genetic Disorders. Colorectal Cancer</title>
    <publicationDate>2000-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ GENETIC CONDITIONS A-Z,GENETIC CONDITIONS,SCREENING,COLORECTAL (BOWEL) CANCER,ADULT,CONDITIONS A-B,GENETICS - PRACTICE &amp; ISSUES,COLORECTAL CANCER (FAMILIAL) (CRC) (HNPCC) (LYNCH) (FAP) (MUYH),CONDITIONS C,BOWEL CANCER (FAMILIAL),PREGNANCY,GENETIC SCREENING (FOR CONDITIONS)]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A report on colorectal cancer screening, based on papers delivered at a workshop  in Edinburgh.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Late Onset Genetic Disorders. Colorectal Cancer&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;This report on colorectal cancer screening is based on papers delivered at a workshop, organised by the National Screening Committee in Edinburgh on 10th October 2000 in Edinburgh. As part of the report, colorectal cancer&amp;nbsp; is considered against the NSC criteria for appropriateness of a screening programme.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>384920</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/20548246]]&gt;</url>
    <title>Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysisof the baseline findings of randomized controlled trials</title>
    <publicationDate>2010-08-01T00:00:00</publicationDate>
    <publisher>Journal of Thoracic Oncology, Lippincott Williams &amp; Wilkins</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: This systematic review and meta-analysis found insufficient evidence in favour or against screening for lung cancer using low-dose computed tomography.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: The results of a Medline search were evaluated, and studies were selected on the basis of preset criteria for inclusion and exclusion. The data was collected and analysed for statistical significance.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Six RCTs, incorporating 14,000 patients, were&amp;nbsp;included.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Gopal M, Abdullah SE, Grady JJ et al. Screening for lung cancer with low-dose computed tomography: a systematic review and meta-analysisof the baseline findings of randomized controlled trials. &lt;EM&gt;Journal of Thoracic Oncology&lt;/EM&gt; 2010; 5(8):1233-9&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20548246" target="_blank"&gt;PubMed abstract available&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>75435</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/clinic/uspstf/uspsneur.htm]]&gt;</url>
    <title>Screening for neural tube defects</title>
    <publicationDate>1996-01-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ 18-20 WEEKS,NEURAL TUBE DEFECTS,ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for neural tube defects**. 
&lt;P&gt;'Screening for neural tube defects during pregnancy is currently considered part of standard prenatal care.&amp;nbsp; The USPSTF knows of no reason at the present time to update its 1996 recommendation. However, the USPSTF has decided to update its recommendation on folic acid supplementation. This work is in progress.'&amp;nbsp; 
&lt;P align=left&gt;**Please note that this recommendation and the evidence on which it is based is &amp;gt;5 years old&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66409</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsobes.htm]]&gt;</url>
    <title>Screening for obesity in adults</title>
    <publicationDate>2003-12-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,BIOLOGICAL COMPOSITION,OBESITY,ADULTS,GUIDELINES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,ADULT,SCREENING,PUBLIC HEALTH,DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,SERVICES,FRAMES OF REFERENCE,MANAGEMENT &amp; POLICY,POPULATIONS,GROUPS,AGE GROUPS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=detail_text&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for obesity in adults. The USPSTF recommends "that clinicians screen all adult patients for obesity and offer intensive counseling and behavioral interventions to promote sustained weight loss for obese adults" and concludes that "the evidence is insufficient to recommend for or against the use of moderate- or low-intensity counseling together with behavioral interventions to promote sustained weight loss in obese adults" and "the evidence is insufficient to recommend for or against the use of counseling of any intensity and behavioral interventions to promote sustained weight loss in overweight adults".&lt;/SPAN&gt; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64682</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsoral.htm]]&gt;</url>
    <title>Screening for oral cancer</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,ORAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the&amp;nbsp;U.S. Preventive Services Task Force (USPSTF) recommendation on screening for oral cancer. The USPSTF concludes that "the evidence is insufficient to recommend for or against routinely screening adults for oral cancer". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P align=left&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/oralcan/oralcanup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64511</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsoste.htm]]&gt;</url>
    <title>Screening for osteoporosis in postmenopausal women</title>
    <publicationDate>2002-09-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,OSTEOPOROSIS,BONE DISORDERS,CONDITIONS,MUSCULOSKELETAL,ADULT,OSTEOPOROSIS,SCREENING AND SURVEILLANCE,LATER LIFE,NOT ROUTINELY OFFERED,SCREENING,OLD AGE,OSTEOPOROSIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the&amp;nbsp;U.S. Preventive Services Task Force (USPSTF) recommendation on screening for postmenopausal osteoporosis. The USPSTF&amp;nbsp;recommends that "women aged 65 and older be screened routinely for osteoporosis" and that "routine screening begin at age 60 for women at increased risk for osteoporotic fractures". The USPSTF makes "no recommendation for or against routine osteoporosis screening in postmenopausal women who are younger than 60 or in women aged 60-64 who are not at increased risk for osteoporotic fractures". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/osteoporosis/osteosumm.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64685</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsovar.htm]]&gt;</url>
    <title>Screening for ovarian cancer</title>
    <publicationDate>2004-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,OVARIAN,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for ovarian cancer. The USPSTF "recommends against routine screening for ovarian cancer". 
&lt;P&gt;&lt;FONT size=7 face=AGaramond-Bold&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/ovariancan/ovcanup.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64686</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspspanc.htm]]&gt;</url>
    <title>Screening for pancreatic cancer</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the&amp;nbsp;U.S. Preventive Services Task Force (USPSTF) recommendation on screening for pancreatic cancer. The USPSTF "recommends against routine screening for pancreatic cancer in asymptomatic adults using abdominal palpation, ultrasonography, or serologic markers". 
&lt;P&gt;&lt;FONT size=7 face="Times New Roman"&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/pancreatic/pancreup.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/FONT&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>121738</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspspard.htm]]&gt;</url>
    <title>Screening for peripheral arterial disease</title>
    <publicationDate>2005-08-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ OLD AGE,STROKE,CORONARY HEART DISEASE,ADULT,SCREENING,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for&amp;nbsp;peripheral arterial disease. The USPSTF&amp;nbsp;recommends&amp;nbsp;"against routine screening for peripheral arterial disease". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/uspstf05/pad/padup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>77870</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/clinic/uspstf/uspsspku.htm]]&gt;</url>
    <title>Screening for phenylketonuria</title>
    <publicationDate>2008-03-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,PHENYLKETONURIA,BLOODSPOT (&lt;1WK),NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for phenylketonuria. "The USPSTF recommends screening for phenylketonuria (PKU) in newborns." &lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57325</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band37/b37-6.html]]&gt;</url>
    <title>Screening for prostate cancer</title>
    <publicationDate>1997-03-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,PROSTATE,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,PROSTATE CANCER,PROSTATE DISORDERS,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Screening for prostate cancer&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band37/b37-6.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;Bandolier write: 
&lt;P&gt;"Bandolier is impressed with the results of the two [reviews] on prostate cancer. The reviews, while covering similar territory, were done by different teams. Importantly, they reach the same conclusion, that screening for prostate cancer is unproven, and is unlikely to be of any benefit. &lt;BR&gt;
&lt;H3&gt;References:&lt;/H3&gt;
&lt;OL type=1&gt;
&lt;LI&gt;DM Richards, JJ Deeks, TA Sheldon, JL Shaffer. Home parenteral nutrition. Health Technology Assessment 1997 1: no1. 
&lt;LI&gt;S Selley, J Donovan, A Faulkner, J Coast, D Gillatt. Diagnosis, management and screening of early localised prostate cancer. Health Technology Assessment 1997 1: no2. 
&lt;LI&gt;J Chamberlain, J Melia, S Moss, J Brown. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technology Assessment 1997 1: no3. 
&lt;LI&gt;RA Moore. Prostate-Specific Antigen. Kaleidescope 4: 1-55 (1994). &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;** &lt;EM&gt;Note that this review is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57325</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band37/b37-6.html]]&gt;</url>
    <title>Screening for prostate cancer</title>
    <publicationDate>1997-03-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,PROSTATE,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,PROSTATE CANCER,PROSTATE DISORDERS,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Screening for prostate cancer&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band37/b37-6.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;Bandolier write: 
&lt;P&gt;"Bandolier is impressed with the results of the two [reviews] on prostate cancer. The reviews, while covering similar territory, were done by different teams. Importantly, they reach the same conclusion, that screening for prostate cancer is unproven, and is unlikely to be of any benefit. &lt;BR&gt;
&lt;H3&gt;References:&lt;/H3&gt;
&lt;OL type=1&gt;
&lt;LI&gt;DM Richards, JJ Deeks, TA Sheldon, JL Shaffer. Home parenteral nutrition. Health Technology Assessment 1997 1: no1. 
&lt;LI&gt;S Selley, J Donovan, A Faulkner, J Coast, D Gillatt. Diagnosis, management and screening of early localised prostate cancer. Health Technology Assessment 1997 1: no2. 
&lt;LI&gt;J Chamberlain, J Melia, S Moss, J Brown. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. Health Technology Assessment 1997 1: no3. 
&lt;LI&gt;RA Moore. Prostate-Specific Antigen. Kaleidescope 4: 1-55 (1994). &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;** &lt;EM&gt;Note that this review is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64865</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsprca.htm]]&gt;</url>
    <title>Screening for prostate cancer</title>
    <publicationDate>2008-08-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ADULT,CANCER,SCREENING,PROSTATE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,PROSTATE DISORDERS,PROSTATE CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for prostate cancer.&amp;nbsp;The USPSTF concludes that "current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening in men younger than age 75 years." and "recommends against screening for prostate cancer in men age 75 years or older."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64865</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsprca.htm]]&gt;</url>
    <title>Screening for prostate cancer</title>
    <publicationDate>2008-08-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ADULT,CANCER,SCREENING,PROSTATE,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE UROGENITAL DISORDERS,PROSTATE DISORDERS,PROSTATE CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for prostate cancer.&amp;nbsp;The USPSTF concludes that "current evidence is insufficient to assess the balance of benefits and harms of prostate cancer screening in men younger than age 75 years." and "recommends against screening for prostate cancer in men age 75 years or older."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392492</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=78]]&gt;</url>
    <title>Screening for prostate cancer: a review against programme apparaisal criteria for the UK National Screening Committee</title>
    <publicationDate>2010-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,PROSTATE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses prostate cancer against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>387830</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.bmj.com/content/341/bmj.c4543.full]]&gt;</url>
    <title>Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials</title>
    <publicationDate>2010-09-14T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,PROSTATE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Routine screening for prostate cancer with prostate specific antigen (PSA) with or without digital rectal examination is not supported by the existing evidence from randomised controlled trials.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, Embase, CENTRAL , abstract proceedings and reference lists up to July 2010 were searched. Randomised controlled trials comparing screening by PSA with or without digital rectal examination were included.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Six randomised controlled trials (including 387,286 participants) met the inclusion criteria and&amp;nbsp; were analysed.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Djulbegovic M, Beyth RJ, Neuberger MN, &lt;EM&gt;et al&lt;/EM&gt;. Screening for prostate cancer: systematic review and meta-analysis of randomised controlled trials. &lt;EM&gt;BMJ&lt;/EM&gt; 2010; 341:c4543&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.bmj.com/content/341/bmj.c4543.full" target="_blank"&gt;Full text freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>121811</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsdrhi.htm]]&gt;</url>
    <title>Screening for Rh(D) incompatibility</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,BLOOD GROUP &amp; RHD STATUS,BEFORE 16 WEEKS,28 WEEKS,RED-CELL ALLOANTIBODIES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for&amp;nbsp;Rh(D) blood typing.&amp;nbsp;The USPSTF strongly recommends "Rh (D) blood typing and antibody testing for all pregnant women during their first visit for pregnancy-related care". The USPSTF also recommends "repeated Rh (D) antibody testing for all unsensitized Rh (D)-negative women at 24-28 weeks' gestation, unless the biological father is known to be Rh (D)-negative". 
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/rh/rhup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325085</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325085]]&gt;</url>
    <title>Screening for sickle cell and thalassaemia (Annual Evidence Update 2009)</title>
    <publicationDate>2009-09-28T00:00:00</publicationDate>
    <publisher>Screening specialist collection</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ BLOODSPOT (&lt;1WK),NEWBORN,SICKLE CELL DISEASE,ANTENATAL,SCREENING,8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for sickle cell and thalassaemia (Annual Evidence Update 2009)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=center&gt;&lt;IMG id=nelh_tempImage9 border=1 name=nelh_tempImage9 alt="GP examining a pregnant woman" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID267585/nelhImp_0007_pregnant.jpg" width=200 height=132&gt;&lt;IMG id=nelh_tempImage7 border=1 name=nelh_tempImage7 alt="nurse performing heel prick test on newborn baby" src="https://rmsadmin.library.nhs.uk/libraryImages/Screening/contentID269239/nelhImp_0003_heelprick.jpg" width=200 height=132&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325106:0" name=internalLink&gt;Back to contents page&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:325707:0" name=internalLink&gt;Screening for sickle cell and thalassaemia evidence update&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In September 2008, the NHS Sickle cell and Thalassaemia Screening Programme created an &lt;A href="nelh:325295:0" name=internalLink&gt;evidence update and summary&lt;/A&gt; on antenatal screening for sickle cell and thalassaemia and newborn screening for sickle cell.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information&lt;/H2&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[Annual evidence update]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:32452:0" name=internalLink&gt;UK NSC policy on sickle cell and thalassaemia screening in pregnancy&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;A href="nelh:57171:0" name=internalLink&gt;UK NSC policy on sickle cell screening in newborns&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://sct.screening.nhs.uk/" target="_blank"&gt;NHS Sickle Cell and Thalassaemia Screening Programme website&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://sct.screening.nhs.uk/getdata.php?id=10611" target="_blank"&gt;NHS Sickle Cell and Thalassaemia Screening Programme annual report 2007-2008&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Further information for professionals&lt;/H2&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;?xml:namespace prefix = o /&gt;&lt;o:p&gt;National Collaborating Centre for Women’s and Children’s Health. Commissioned by the National Institute for Health and Clinical Excellence. &lt;A href="http://www.nice.org.uk/Guidance/CG62/Guidance/pdf/English" target="_blank"&gt;Antenatal care: routine care for the healthy pregnant woman. CG62: full guidance.&lt;/A&gt; March 2008 (corrected June 2008).&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;A href="http://sct.screening.nhs.uk/professional-resources" target="_blank"&gt;Professional resources&lt;/A&gt; from the NHS Sickle Cell and Thalassaemia Screening Programme&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial; COLOR: black; FONT-SIZE: 10pt; mso-fareast-font-family: 'Times New Roman'; mso-fareast-language: EN-GB; mso-ansi-language: EN" lang=EN&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;H2&gt;Patient information&lt;/H2&gt;
&lt;P&gt;Antenatal and Newborn Screening Programmes. &lt;A href="nelh:239537:0" name=internalLink&gt;Screening tests for you and your baby&lt;/A&gt;. 2007&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://sct.screening.nhs.uk/factsheets" target="_blank"&gt;Factsheets&amp;nbsp;about sickle cell, thalassaemia and&amp;nbsp;screening&lt;/A&gt; from the NHS Sickle Cell and Thalassaemia Screening Programme&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://sct.screening.nhs.uk/cms.php?folder=2418" target="_blank"&gt;Resources for the general public&lt;/A&gt; from the NHS Sickle Cell and Thalassaemia Screening Programme&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>268964</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=268964]]&gt;</url>
    <title>Screening for Sickle Cell and Thalassaemia (National Knowledge Week)</title>
    <publicationDate>2007-09-10T00:00:00</publicationDate>
    <publisher>Screening Specialist Library</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,BLOODSPOT (&lt;1WK),SICKLE CELL DISEASE,ANTENATAL,SCREENING,8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for Sickle Cell and Thalassaemia (National Knowledge Week)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;&lt;A href="nelh:269344:0" name=internalLink&gt;Back to Contents page&lt;/A&gt;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=212461" target="_blank"&gt;Annual Evidence Update&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This section has been written by Dr. Sandra Anglin (Programme Implementation Manager) and Dr. Allison Streetly (Programme Director),&amp;nbsp;NHS Sickle Cell &amp;amp; Thalassaemia Screening Programme, King's College of London, School of Medicine&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;STRONG&gt;Section contents:&lt;A name=section&gt;&lt;/A&gt;&lt;/STRONG&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;A href="#NHS"&gt;NHS Sickle Cell &amp;amp; Thalassaemia Screening Programme&lt;/A&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;A href="#symptoms"&gt;Symptoms and Management of Sickle Cell &amp;amp; Thalassaemia&lt;/A&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;A href="#genetic"&gt;Genetic transmission and prevalence in the UK&lt;/A&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;A href="#newborn"&gt;1. Newborn screening&lt;/A&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;A href="#antenatal"&gt;2. Antenatal screening&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;/SPAN&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&lt;STRONG&gt;NHS Sickle Cell &amp;amp; Thalassaemia Screening Programme&lt;A name=NHS&gt;&lt;/A&gt;&lt;BR&gt;&lt;/STRONG&gt;The NHS Plan&amp;nbsp;[&lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4002960" target="_blank"&gt;1&lt;/A&gt;] made commitments to improve the provision of screening services. The NHS Sickle Cell &amp;amp; Thalassaemia Screening Programme was set up to deliver the following:&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial" lang=EN-GB&gt;&lt;SPAN style="mso-tab-count: 1"&gt;&amp;nbsp;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;•&amp;nbsp;The newborn sickle cell screening programme, to&amp;nbsp;achieve the lowest possible childhood mortality and morbidity rates from sickle cell disease through offering screening for sickle cell disease in newborns. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;•&amp;nbsp;The antenatal sickle cell &amp;amp; thalassaemia screening programme, to offer effective and appropriate sickle cell and thalassaemia screening to all eligible women and couples in a timely manner in pregnancy. &lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Further information about the Programme is available from the following website: &lt;A href="http://www.sct.screening.nhs.uk/" target="_blank"&gt;www.sct.screening.nhs.uk/&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="#section"&gt;Back to section contents&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;Symptoms and Management of Sickle Cell &amp;amp; Thalassaemia&lt;A name=symptoms&gt;&lt;/A&gt;&lt;BR&gt;&lt;/STRONG&gt;Sickle cell disease and thalassaemia are common recessively inherited genetic blood conditions.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;BR&gt;Sickle cell disease changes the biochemistry of haemoglobin in red blood cells and makes the cells sickle-shaped. These blood cells are less able to carry oxygen around the body. The symptoms of sickle cell disease can include:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;severe anaemia&lt;/LI&gt;
&lt;LI&gt;intense pain&lt;/LI&gt;
&lt;LI&gt;damage to major organs&lt;/LI&gt;
&lt;LI&gt;infections&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;Proper management and early detection in newborns can improve quality of life, including enabling parents/guardians&amp;nbsp; to learn to recognise certain risk factors in their child and avoid the factors that can trigger painful ‘crisis’ attacks and giving antibiotics each day to prevent infections. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Thalassaemia major (the most severe form of thalassaemia) reduces the amount of haemoglobin made by the body. Those with the condition require blood transfusions every four to six weeks and can suffer from chronic diseases (such as diabetes), growth or puberty failure. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Because both conditions can restrict a child’s or an adult’s ability to conduct normal daily activities, they can also have profound psychosocial effects on individuals and their families. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="#section"&gt;Back to section contents&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Genetic transmission and prevalence in the UK&lt;A name=genetic&gt;&lt;/A&gt;&lt;BR&gt;&lt;/STRONG&gt;The highest prevalence of these conditions is present in people whose descendants lived in malarial areas. If two healthy carriers of the sickle cell or thalassaemia gene variant have a child, there is a 1 in 4 chance with each pregnancy that the child will have a sickle cell disease or thalassaemia. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In the UK, it is estimated that 240,000 people are healthy carriers of the sickle cell gene variant and over 12,500 people have a sickle cell disease. The highest prevalence of sickle cell disease is found amongst Black Caribbeans, Black Africans and Black British. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Sickle cell disease presently affect more than 1 in every 2400 births in the UK. It is vital to identify babies with the condition as soon as possible. There is a high risk of sudden death in the early years of life and prophylactic treatment must be administered early.&amp;nbsp; All newborn babies are now being offered screening for sickle cell disease.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Thalassaemias are less common. 214,000 people are healthy carriers of the thalassaemia gene variant and over 700 people have thalassaemia. Those with the highest prevalence of thalassaemia are Cypriots, Indians, Pakistanis, Bangladeshis, Chinese, and other Asian groups. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Both gene variants are also (less commonly) found in the northern European population. Modell B et al, 2007 report that with population movement sickle cell and thalassaemia are increasingly common in countries of Northern and Western Europe [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17365984&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;1a&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In general there are a very limited number of high quality trials in the areas of haemoglobinopathies.&amp;nbsp; There is also a lack of accurate information about the size of the population affected, and evidence on the most effective way to manage the disease in the UK, most of which comes from the USA and the Medical Research Council Unit in Jamaica.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The National Institute of Clinical Guidance will be consulting on a revised guideline for all routine care for the pregnant woman from 4 September 2007 to 29 October 2007, including revised guidance on screening for sickle cell and thalassaemia, we therefore urge that you look at this consultation&amp;nbsp;[&lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;2&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="#section"&gt;Back to section contents&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;1. Newborn screening:&lt;A name=newborn&gt;&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Current Policy&lt;BR&gt;&lt;/STRONG&gt;The newborn screening programme for sickle cell disease aim is to offer screening to all infants as an integral part of the newborn bloodspot screening programme identifying all those affected so as to ensure that early treatment reduces mortality and morbidity rates.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;1.1&amp;nbsp;Carrier identification in newborn screening:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The current technology used to screen also identifies those that are genetic carriers of sickle and other haemoglobin variants, but whose health is not affected.&amp;nbsp; The issue for carriers is distinct from the health problems of affected babies as there is no need for treatment and therefore no immediate benefit for health from the screening programme, but there are a variety of possible psychosocial consequences of disclosing carrier status: such as increasing anxiety for families, impacting on parental behaviour towards child, impacting on parental relationship, impacting on reproductive planning, highlighting non paternity etc.&amp;nbsp; Unfortunately there is little evidence and no trials about the impact or effects of disclosing newborn carrier status and/or the best way to inform the parents of those affected.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In the past year the Human Genetic Commission (HGC) has provided a clear view on the issue of newborn carrier identification, which supports the general approach taken by the NSC and the programme. That is, given carriers are identified as a by-product of newborn screening, parents should be informed of these results and they should not be with held.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The HGC recommend that efforts are made to develop methods that will not identify carriers. Information on new technologies under development are covered further on in this review. Finally the HGC suggests an approach to resolution of the unidentified variants issue, which is relevant to both newborn and antenatal screening and about which there is currently no consensus – how this recommendation is actioned is under consideration. Details from letters from the HGC to the UK National Screening Committee and text in their recent report Making Babies [&lt;A href="http://www.hgc.gov.uk/UploadDocs/DocPub/Document/Making%20Babies%20Report%20-%20final%20pdf.pdf" target="_blank"&gt;2b&lt;/A&gt;]&amp;nbsp;are given below:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Human Genetics commission:&lt;/P&gt;
&lt;P&gt;The Making Babies report states that the Commission strongly support sharing information about genetic status from screening (paragraph 3.48).&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;“&lt;EM&gt;The extension of the neonatal screening programme to cystic fibrosis (CF) highlights the issue of detecting carriers for these recessive conditions. Screening for this condition with the current testing technique identifies only a very small proportion of carriers, and they require clinical assessment to ensure that they are not affected by the disease. The numbers of CF carrier infants identified in this way is similar to the number of affected infants likely to benefit from early diagnosis. Whilst some would say this information ought not to be divulged, others, including patient representatives, argue strongly that the result of the tests, once generated, should be given to the parents. We support this latter position and this information should not be withheld from parents who indicate that they wish to have it when agreeing to have their child tested&lt;/EM&gt;. "&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Commission strongly believe that in principle carriers should be notified of their status and the implications of this.&amp;nbsp; However, there may be situations where a medical judgement needs to be made about what genetic information is clinically significant, and should therefore be shared with the patient, and what is not.&amp;nbsp; Such a decision may need to be made about non-sickle haemoglobin variants that are detected that have unknown clinical significance. Exercising such medical judgement is part of normal medical practice.&amp;nbsp; To determine a consistent approach and make an informed policy decision, the National Screening Committee should seek expert opinion on this matter from professionals involved in this specific field.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Also in the Making Babies report at paragraph 3.50, the Commission recommended that efforts be made to develop accurate screening techniques that do not reveal carrier status (where this information is not clinically relevant).&amp;nbsp; Through this recommendation, the Commission would like to see tests developed that reveal the disease phenotype only, as this would enable children to make decisions about whether they should be tested for carrier status when they were able to make this decision for themselves, perhaps before starting a family.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&lt;BR&gt;Further to this the programme would support research in the form of a clinical trial to determine the best way to inform parents of results. Currently research funded by the NHS Health Technology Assessment (HTA) is underway to describe current approaches to information giving, and review the literature [&lt;A href="http://www.hta.nhsweb.nhs.uk/project/1510.asp" target="_blank"&gt;3&lt;/A&gt;].&amp;nbsp; The aim of the study is to describe, explore and synthesise current practice, methods and experience of communicating carrier status information following newborn screening to inform practice and the need for further research.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The study will use postal questionnaires to a sample of relevant stakeholders in the UK to look at current practice and methods for communicating carrier status how and by whom parents are informed, and a qualitative study with parents, using face to face interviews from a sample of parents that have had carrier results.&amp;nbsp; The study aims to report on the challenges and suggest how current practice could be improved.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;1.2&amp;nbsp; New methods&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Two new methods of newborn screening are under development and evaluation. Potentially, both these methods offer more cost-effective methods of screening and would also limit the number of carriers identified.&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P style="MARGIN-RIGHT: 0px" dir=ltr&gt;&lt;STRONG&gt;Tandem mass-spectrometry (MS-MS):&lt;/STRONG&gt;&lt;BR&gt;Earlier work by a group at Guy’s Hospital identified that MS-MS was potentially a useful, cost-effective method for newborn screening [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16098080&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;4&lt;/A&gt;]. Their work demonstrated that consumable costs are minimal and that metabolite and sickle screening can be performed serially on the same MSMS instrument. &lt;/P&gt;
&lt;P style="MARGIN-RIGHT: 0px" dir=ltr&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;More recently this group have had a paper published explaining the use of MSMS to estimate the amount of&amp;nbsp;HbA&lt;SUB&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;2&lt;/SPAN&gt;&lt;/SUB&gt; present in a blood specimen [&lt;A href="http://www.clinchem.org/cgi/content/abstract/clinchem.2007.088682" target="_blank"&gt;5&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The main findings reported are that the delta/beta globin chain ratio, measured using trypsin digestion and electro-spray MSMS, can be used as an alternative to the measurement of HbA&lt;SUB&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;2&lt;/SPAN&gt;&lt;/SUB&gt;. The delta/beta ratio, unlike HbA&lt;SUB&gt;&lt;SPAN style="mso-ansi-language: EN-GB" lang=EN-GB&gt;2&lt;/SPAN&gt;&lt;/SUB&gt;, is stable on blood spots for at least 1 month. The authors suggest that MSMS could be used for both newborn and antenatal haemoglobinopathy screening. As a result of this exciting development, a pilot service evaluation of this method is being undertaken by the Guy’s group in collaboration with Leeds. Results from this work are due in 2008.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Immunoassay method:&lt;BR&gt;&lt;/STRONG&gt;A recent paper from Belgium has evaluated an enzyme linked immunosorbent assay (ELISA) method for sickle cell disease on 27,000 newborn babies [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17007654&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;6&lt;/A&gt;].&amp;nbsp;The method appeared to work well although they report that “..this antibody cross reacts with HbA. Better specificity is achieved if the test is performed not later than day 5”. Given the timing of tests in England of 5-8 days, this may affect the performance of this test unless the timing of the bloodspot was shifted to earlier. Overall 130 samples were positive and there were 17 false positives.&amp;nbsp; A pilot project is due start in London later this summer. &lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;1.3&amp;nbsp;Developments of newborn screening programmes in Europe and North America.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There continue to be reports of pilot projects for newborn screening in other countries which are following the approach adopted in England. As yet Wales, Scotland and Northern Ireland have not made a decision as to their approach to newborn sickle cell screening. The most recent reports in Europe are from Madrid and Catalonia in Spain [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17007654&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;7&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=126%5Bvolume%5D%20AND%208%5Bissue%5D%20AND%20290%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;8&lt;/A&gt;] [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=126%5Bvolume%5D%20AND%208%5Bissue%5D%20AND%20281%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;9&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Programmes also appear to be developing in Canada. The findings of a cord blood testing programme offered to “black” babies demonstrated that such a programme will miss about 10% of affected infants. On the basis of this pilot newborn screening is recommended in Canada. Informally the programme understands that other Canadian States such as British Columbia are now considering the approach to be adopted [&lt;A href="http://www.pulsus.com/Paeds/11_04/robi_ed.htm" target="_blank"&gt;10&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;1.4&amp;nbsp;Evidence of outcomes from newborn screening programmes:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;A report on the outcome of newborn screening from Connecticut in the USA found no deaths in infants identified in the 11 and a half years since the programme was introduced compared to 13 deaths in the preceding 13 years. However they also reported that five affected infants missed since newborn screening were identified at death. This emphasises the importance of adequate failsafe systems being established for the newborn programme in England and effective follow-up and clinical care following identification [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17288099&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;11&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;1.5 Evidence of clinical outcomes and guidance on clinical management:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;The introduction of the new pneumococcal vaccine into the general immunisation schedule in England has been a welcome development. For sickle cell babies there is now evidence from the USA of the significant benefit that will be achieved from this programme where the rate of invasive pneumococcal disease decreased by about 90% in children under 2 years from 3.6 to 0.3 per 1000 person years of follow up. However babies and children with sickle cell disease have a reduced immunity and require extra immunisations as well as penicillin on a continious basis until age 5 as not all infections are prevented by these measures [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=44%5Bvolume%5D%20AND%2011%5Bissue%5D%20AND%201428%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;12&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A key finding since the HTAs&amp;nbsp;[&lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ311.htm" target="_blank"&gt;13&lt;/A&gt;] [&lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ403.htm" target="_blank"&gt;14&lt;/A&gt;]&amp;nbsp;that informed the introduction of newborn screening in England is the potential for stroke prevention as demonstrated in the STOP trial in the USA. This is an additional benefit of early identification of affected infants, especially as the morbidity, mortality and costs associated with stroke in childhood are highly significant. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Sickle cell disease is the commonest cause of stroke in childhood in the UK, with an incidence of 0.6/100 patient years. The peak incidence is between the ages of 2 and 7 years, and by the age of 10 about 6% children have suffered clinical strokes. These are associated with both physical and cognitive problems and generally have a large effect on the quality of life. Children can be screened for narrowing of intracerebral blood vessels from the age of 2 years by transcranial Doppler (TCD) scanning. Children with abnormalities are at increased risk of stroke and the STOP study showed that giving these children regular blood transfusions reduces the risk of stroke by 90%. Stroke is therefore a partly preventable complication making the identification of all children with sickle cell disease more important. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Epidemiological studies from California suggest that the stroke rate is declining following the introduction of TCD scanning, although there is currently limited access to appropriate scans both in the UK and USA - clinical services need to be developed to incorporate these findings. This intervention to prevent stroke should also be incorporated into the stroke strategy (currently &lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_076574" target="_blank"&gt;under consultation&lt;/A&gt;)&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The final results of this trial are now published [&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=16861341" target="_blank"&gt;15&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The findings from this study have been incorporated in Clinical Guidelines produced in this country [&lt;A href="http://www.sickleandthal.org.uk/Documents/DETAILED_CLIN_Oct19.pdf" target="_blank"&gt;16&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Proposals to establish a clinical network to support the ultrasound screening and follow-up required are supported by the Department of Health but not yet developed. The key&amp;nbsp;requirements for stroke prevention are&amp;nbsp;annual quality-assured ultrasound screening for all children from the age of three. Those at high risk of stroke&amp;nbsp;require ongoing transfusion and iron chelation. A new oral iron chelator (Exjade) has recently received a licence. The HTA programme are undertaking a review of this against other iron chelators, including looking at the wider clinical perspective, a report forming part of the HTA monograph series is due to be published early 2008. [&lt;A href="http://www.hta.nhsweb.nhs.uk/project/1632.asp" target="_blank"&gt;17&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A useful review of recent trials in sickle cell is available by Kirkham et al [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=34%5Bvolume%5D%20AND%206%5Bissue%5D%20AND%20450%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;18&lt;/A&gt;]. Interestingly it appears that rates of stroke are as common in children in Cameroon, West Africa as in the Western Countries [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=250%5Bvolume%5D%20AND%201-2%5Bissue%5D%20AND%2079%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;19&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Guidelines from the USA on the prevention of stroke that incorporate recommendations about sickle cell have recently been published and may be useful in the development of relevant guidance in the national stroke strategy [&lt;A href="http://stroke.ahajournals.org/cgi/content/full/37/2/577" target="_blank"&gt;20&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;1.6 Information to support parents&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A useful reference for information on newborn screening from the USA is available [&lt;A href="http://pediatrics.aappublications.org/cgi/content/full/118/3/1304" target="_blank"&gt;21&lt;/A&gt;]. This development is also discussed by Kaye et al in a recent publication [&lt;A href="http://pediatrics.aappublications.org/cgi/content/full/118/3/e934" target="_blank"&gt;22&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The SC and T Programme has produced information for newborn carriers, which is available on the programmes website [&lt;A href="http://www.sickleandthal.org.uk/publications.htm#NBSickleCarrier" target="_blank"&gt;22a&lt;/A&gt;].&amp;nbsp; The leaflets will be&amp;nbsp; ‘market tested’ at a later stage.&amp;nbsp; More detailed information will be produced in 2008.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;A href="#section"&gt;Back to section contents&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2. Antenatal screening:&lt;A name=antenatal&gt;&lt;/A&gt;&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Current Policy&lt;/STRONG&gt;&lt;STRONG&gt;&lt;BR&gt;&lt;/STRONG&gt;The Programme recommends that the offer of screening includes uptake of and reporting of results of pre natal diagnosis and any subsequent action by the end of 12 weeks of pregnancy:&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;In areas of high prevalence (where the fetal prevalence of sickle cell disease is &amp;gt;1.5 per 10,000 births) all women are offered screening for sickle cell including other haemoglobin variants and thalassaemia irrespective of family origins. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;In areas of low prevalence (sickle cell disease prevalence is &amp;lt;1.5 per 10,000 births) women are offered screening for thalassaemia and a family origin questionnaire is used to assess the risk of being a carrier for sickle cell and other haemoglobin variants.&amp;nbsp; If the questionnaire reveals family origins of either the woman or baby’s father in the high risk groups, the woman is offered screening for sickle cell. &lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;UL&gt;
&lt;LI&gt;The Family Origin Questionnaire is&amp;nbsp; available on the Programme website [&lt;A href="http://www.sickleandthal.org.uk/Documents/F_Origin_Questionnaire.pdf" target="_blank"&gt;23&lt;/A&gt;]&lt;/LI&gt;&lt;/UL&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The timing and organisational requirements for the delivery of the main aims and objectives presents a considerable challenge to health care professional, however, there is evidence to support this approach:&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;2. 1. Evidence supporting the antenatal programmes &lt;/STRONG&gt;&lt;STRONG&gt;approach to screening.&lt;/STRONG&gt;&lt;/P&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;2.1.1. Information about professional knowledge and attitudes:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Early screening for sickle cell and thalassaemia in pregnancy or before pregnancy are one of the key aims and objectives of the programme.&amp;nbsp; Practically this means early enough in pregnancy to allow a vacuum suction termination if wished and for decisions on prenatal diagnosis and termination to be made before pregnancy is public knowledge amongst families. Studies have shown that the usual system for antenatal screening for haemoglobinopathies permits termination only after 12 weeks of pregnancy.&amp;nbsp; The study by Wright et al [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=14738652&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;24&lt;/A&gt;] and the study by Thomas et al&amp;nbsp;[&lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=15970065" target="_blank"&gt;25&lt;/A&gt;], shows that primary care based screening programme where pregnant women are screened in general practice (including counselling and follow-up) allows earlier detection of carrier status.&amp;nbsp; The overriding conclusion was that antenatal screening for haemoglobinopathies in general practice lowers the gestational age at which an at-risk pregnancy can be identified.&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A study 'Screening for Haemoglobinopathies In First Trimester ( SHIFT) to assess and compare the feasibility, acceptability, effectiveness and cost-effectiveness of offering antenatal screening for sickle cell and thalassaemia in one of three ways model' is currently underway, due to report in 2008:&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;1.&amp;nbsp;In primary care, when women first report their pregnancies with parallel partner testing&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;2.&amp;nbsp;In primary care, when women first report their pregnancies with sequential partner testing; (i.e. partners of women are only offered screening if the pregnant woman is found to be a carrier)&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;3.&amp;nbsp;In community-based secondary care, when women are booked by midwives with sequential partner testing&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Initial findings show that women generally present early as pregnant irrespective of family or ethnic origin, but there is a considerable delay in referral for the first booking appointment with a midwife.&amp;nbsp; Further information is available on the study website [&lt;A href="http://www.iop.kcl.ac.uk/departments/?locator=862" target="_blank"&gt;26&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;A recent study from the UK suggest that GPs perceive that they lack the confidence to provide basic prenatal genetic advice to women at risk of the commonest recessive disorders, with particularly low confidence where the couple both carry thalassaemia [&lt;A href="http://fampra.oxfordjournals.org/cgi/content/full/23/1/106" target="_blank"&gt;27&lt;/A&gt;]. A significant knowledge gap was demonstrated by the poor awareness of the importance of rapid referral to prenatal diagnostic services. These findings support much anecdotal evidence and emphasise the challenge that raising professional awareness amongst primary care. This area requires action if the screening programme is to achieve its objectives and emphasises the importance of including primary care in antenatal screening education.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;2.1.2 Information about Users Attitudes to screening:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Previous research identified that women are not receiving counselling and testing in time to allow reproductive choice. Women should ideally be offered testing by 10 weeks of pregnancy and as soon as possible after they make first contact with the NHS [&lt;A href="http://www.sickleandthal.org.uk/Documents/ProgrammeSTAN.pdf" target="_blank"&gt;28&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A descriptive qualitative study&amp;nbsp;[&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16475227&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;29&lt;/A&gt;] to explore 43 Pakistani women’s views about antenatal screening for thalassaemia and termination of pregnancy for thalassaemia major concluded that Pakistani women’s attitudes toward prenatal diagnosis and termination of pregnancy are influenced by various factors, and therefore their religion should not be taken as a proxy for their attitudes for or against screening. Women’s responses suggested that the more severe the perception of thalassaemia major, the more likely the woman was to be in favour of antenatal diagnosis and termination of pregnancy. Some women also expressed the view that termination of pregnancy was only acceptable early in pregnancy, although women’s definitions of early ranged from 5-6 weeks to “before people know you are pregnant”.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;One descriptive study aimed to examine the acceptability of pre-natal diagnosis as a means of controlling the number of babies born with sickle cell disease [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=10895231&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;30&lt;/A&gt;].&amp;nbsp; This interview survey was conducted in Nigeria, targeting well-educated, city-dwelling adults (n=433).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The survey respondents were aged 15-50, approximately half of whom were women. 90% of the sample attended school up to secondary and post-secondary level, 67% were in professional occupations (eg. medicine, law and teaching). Two-thirds of the sample knew their Hb phenotype. Most respondents (88%) perceived sickle cell disease as a serious disease, although 19% thought it was curable. Only 4% of those interviewed had received sickle cell counselling, although 15% reported themselves to be sickle cell trait. 78% of respondents felt prenatal sickle cell diagnosis should be available and 45% reported that they would decide to terminate a baby affected with sickle cell disease. Cross-tabulations showed that neither religion nor educational level significantly affected a person’s decision whether or not to terminate an affected pregnancy. &lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;2.1.3. Assessment of Risk for Haemoglobinopathies&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Background&lt;BR&gt;&lt;/STRONG&gt;The SC &amp;amp; T Programme commissioned&amp;nbsp;some work&amp;nbsp;to develop, pilot and evaluate an evidence-based ethnic question to establish its effectiveness as a screening tool to identify individuals at higher risk from specific haemoglobinopathies [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16595318&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;30a&lt;/A&gt;].&amp;nbsp;This paper followed on from earlier research that the programme had commissioned [&lt;A href="http://www.sickleandthal.org.uk/dowloads/Ethnic%20origin%20question/SECONDARY%20REVIEW%20OF%20THE%20ETHNIC%20QUESTION_final%20report.pdf" target="_blank"&gt;31&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;However, the study has had a number of difficulties and conflicts and as a result, there was considerable delay in the publication of the final report, which may have contributed to the lack of directive information in the NICE Antenatal care guideline produced in 2003 [&lt;A href="http://www.rcog.org.uk/resources/Public/pdf/Antenatal_Care.pdf" target="_blank"&gt;32&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The EQUANS study in which this paper has been derived provided limited information in relation to the original intended purpose of informing national policy, and therefore the Programme commissioned a further study as part of the first phase of implementation of antenatal screening in seven maternity units to inform the antenatal policy process.&lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;Integration into Routine Care&lt;/STRONG&gt;&lt;BR&gt;One of the main criticisms of the study led by Simon Dyson is that it did not link well with all staff involved in the programme. In more than&amp;nbsp;one of the sites, they were disappointed and did not think the training delivered by the research team had engaged all key stakeholders, and that offers of help had not been taken up. This makes interpretation of information on uptake of the family origin question in a routine antenatal setting and the offer of the test difficult. This is compounded by the very different results in the four sites suggesting that site specific issues are relevant.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The important point is that the precision of the estimates are reduced.&amp;nbsp; Our findings from the evaluation of the family origin questionnaire from the seven maternity sites involved in the first phase of implementation of antenatal screening, have a considerably higher uptake (completion rates for 6 sites were 97%, as opposed to 25% in this study). We are aware this does not completely invalidate the findings, but does not reflect well and has been superceded by the implementation of the programme.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Analysis of Data&lt;BR&gt;&lt;/STRONG&gt;It is important to clarify the areas of concern overall and their likely importance including the source and type of errors.&amp;nbsp; It is possible (personal correspondence –Aspinall co- applicant) to estimate the rates for each carrier state, for each site, for both question A and B and identify where the problems lie with the question. This has not been done and makes the presentation of the results limited.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Other areas of concern highlighted by the report was the low level of completion of the questionnaire, and the failure to integrate the questionnaire and consequent follow up of it into routine antenatal booking, which may have resulted from issues of training and staff time available rather than the performance of the questions. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;As for the precision of the estimates - there is evidence of between-centre variation in time taken.&amp;nbsp; Under these circumstances, estimates of the average time taken, sensitivity and specificity should have been derived from ‘random effect’ (multi-level) models, and not ruled out.&amp;nbsp; The use of only four centres will result in estimates with much greater uncertainty than is implied by the ‘fixed effect’ model assumed in the analyses reported.&amp;nbsp; As a result of this the Programme is unable to come to the same conclusions, as it is hard to know whether the time taken for questions A and B are realistic. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;With respect to whether the missed cases, the paper reports that 7/122 carriers for question A and 10/103 carriers for question B were not picked up. We learn that of the 7/122 carriers missed; 2 had missing information (would be tested if they consented or counted as refusals but this is not known so probably were not offered screening), 3 were not offered screening, 1 declined and 1 was tested due to findings of routine indices, so was in effect missed by the question but detected by the screening protocol as a whole.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;No information of the types of carriers by these 7/10 cases is given, analysis should have been presented in this report to clarify the missed cases and the types of errors concerned. The analysis should also have described how the question is used in practice in terms of MCH cut-offs to enhance the understanding of how the question works but this is not covered. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;For example as all women have routine blood indices inspected, Beta Thalassaemia carriers should be identified and therefore the key carrier states to be identified by the family origin question are most importantly S C, D &amp;amp; E.&amp;nbsp; The paper gives none of this analysis, which is what is really needed to understand what the likely implications of the findings would be. In&amp;nbsp; addition, there is no comparison of the completeness of missing information rates as a total, refusal rates as a total, or incomplete rates for the two questions simply missing rates for the carrier results.&amp;nbsp; Inclusion of ‘don’t knows’ in the error was misguided as many are not aware of ethnic origins and would be advised to “opt in” to screening.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt; &lt;BR&gt;The main conclusion to be drawn from the study as reported was that ensuring the test was offered is the most important indicator of whether this type of screening tool would work. Due to the limitations described above it is not possible to conclude that the question did not work as there were significant problems in the implementation of the study and engagement of staff.&amp;nbsp; Due to conflicts between the researchers and refusal to share information, as well as the editors of the journal concerned who did not to allow the Programme to write a letter in reply to this article – as the journal does not publish letters-&amp;nbsp; we remain concerned that the true information about these findings are not available. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;In particular of the 7 clinically relevant haemoglobinopathies our impression is that this definition is loose and includes a number of results which the programme would not consider to be “clinically significant” – mainly alpha thalassaemia + results. As far as we are aware only one HbS result was missed.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The sensitivity of question A appears at least as good as the estimates made by&amp;nbsp;Zeuner et al [&lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ311.htm" target="_blank"&gt;13&lt;/A&gt;], but the paper does not report the detail required to comment further.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A useful finding from the paper was that the first question A performed better than the intuitively more attractive question B. This information has been used by the programme in developing the format of the final family origin questionnaire [&lt;A href="http://www.sickleandthal.org.uk/Documents/F_Origin_Questionnaire.pdf" target="_blank"&gt;23&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Our subsequent first phase of implementation using the family origin question adapted from Aspinalls original publication suggest that the study uptake findings are not representative of what can be expected in the NHS service situation which is considerable higher than that reported in the paper published [&lt;A href="http://www.sct.screening.nhs.uk/dowloads/Ethnic%20origin%20question/EQUANS%20Interim%203.pdf" target="_blank"&gt;33&lt;/A&gt;]&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;We have also commissioned an independent study of the family origin questionnaire (FOQ) which gives a huge amount of useful detail, which has since been used in the implementation and used to further modify the FOQ [&lt;A href="http://www.sct.screening.nhs.uk/Documents/Evaluation_FOQ.pdf" target="_blank"&gt;34&lt;/A&gt;]&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;More information about the first phase of implementation in low prevalence areas will be available on the programme website shortly.&lt;/P&gt;&lt;/BLOCKQUOTE&gt;&lt;/BLOCKQUOTE&gt;
&lt;BLOCKQUOTE style="MARGIN-RIGHT: 0px" dir=ltr&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Experience from elsewhere also developing such a questionnaire&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The findings from the study by Lakeman et al supports the SC &amp;amp; T Programme policy for screening in low prevalence areas [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16912581&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;35&lt;/A&gt;]. The questionnaire uses a similar methodology to that adopted in England whereby the couples are asked to report their known origins, although our initial study had ruled out the use of maps as an effective way to identify origins [&lt;A href="http://www.sct.screening.nhs.uk/dowloads/Ethnic%20origin%20question/EQUANS%20Interim%203.pdf" target="_blank"&gt;33&lt;/A&gt;]. &lt;/P&gt;&lt;/BLOCKQUOTE&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;2.2 New technology:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;Daniel et al have described the potential to do antenatal, as well as newborn screening on a dried bloodspot, this would be a useful technique, allowing for further centralisation of antenatal screening, and could potentially reduce the cost of laboratory screening especially in low prevalence areas [&lt;A href="http://www.clinchem.org/cgi/content/abstract/clinchem.2007.088682" target="_blank"&gt;5&lt;/A&gt;].&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&lt;STRONG&gt;2.3 Information for parents:&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;There is a mass of information about haemoglobinopathy screening available of varying quality and accuracy.&amp;nbsp; Involvement of users is a key elelment of the development of policy and implementation of all the screening services including the development of materials for the SC &amp;amp; T Programme.&amp;nbsp; The Programme intends to develop materials for users along the whole care pathway for screening, from pre-conception to antenatal and newborn screening.&amp;nbsp; Some material is already available on the Programme website, and we have also worked with other organisations to develop materials.&amp;nbsp; &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The SC &amp;amp; T Programme commissioned DIPEx to find and post a number of a personal experiences of antenatal screening in text, audio and video formats. These are available on the&amp;nbsp;DipEX website&amp;nbsp;to be used by women and families going through a similar process and / or for training of health care professionals [&lt;A href="http://www.dipex.org/sicklecellandthalassaemia" target="_blank"&gt;37&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="#section"&gt;Back to section contents&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;References&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;[1] Department of Health &lt;A href="http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_4002960" target="_blank"&gt;NHS Plan:&amp;nbsp; plan for investment , a plan for reform&lt;/A&gt; July 2000&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[1a] Modell B, Darlison M, Birgens H, Cario H, Faustino P, Giordano PC et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scandinavian Journal of Clinical &amp;amp; Laboratory Investigation 2007, 67(1):39-69. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17365984&amp;amp;ordinalpos=4&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2] NICE. &lt;A href="http://guidance.nice.org.uk/page.aspx?o=321982" target="_blank"&gt;Clinical guidelines in development&lt;/A&gt; - Antenatal care: routine care for the health pregnant woman. Consultation period: &lt;SPAN class=ip_content_1_join&gt;4 September - 29 October 2007&lt;/SPAN&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[2b] Human Genetics Commission. &lt;A href="http://www.hgc.gov.uk/UploadDocs/DocPub/Document/Making%20Babies%20Report%20-%20final%20pdf.pdf" target="_blank"&gt;Making Babies: &lt;/A&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;A href="http://www.hgc.gov.uk/UploadDocs/DocPub/Document/Making%20Babies%20Report%20-%20final%20pdf.pdf" target="_blank"&gt;&amp;nbsp;reproductive decisions and genetic technologies&lt;/A&gt;. Jan 2006.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[3]&amp;nbsp;Kai, J. &lt;A href="http://www.hta.nhsweb.nhs.uk/project/1510.asp" target="_blank"&gt;Communication of carrier status information following newborn screening: descriptive study of current practice, methods and experience&lt;/A&gt;. Health Technology Assessment (HTA) Project protocol&amp;nbsp; &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[4] Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN. Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry-mass spectrometry. British Journal of Haematology, (2005) 130, 635-643 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16098080&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[5] Daniel YA, Turner C, Haynes RM, Hunt BJ, Dalton RN. &lt;A href="http://www.clinchem.org/cgi/content/abstract/clinchem.2007.088682" target="_blank"&gt;Quantification of Haemoglobin A2 by tandem mass spectrometry&lt;/A&gt;. Clinical Chemistry. (2007) 53, 1448-1454. &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;BR&gt;&lt;/SPAN&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[6] Boemer F, Vanbellinghen J-F, Bours V, Schoos R. Screening for sickle cell disease on dried blood: A new approach evaluated on 27,000 Belgian newborns. Journal of Medical Screening. 2006, 13, 132-136 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17007654&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[7] Cela DJ, et al. Evaluation of systematic neonatal screening for sickle cell diseases in Madrid three years after its introduction.&amp;nbsp;Anales de Pediatria. 2007, 66(4), 382-386 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=66%5Bvolume%5D%20AND%204%5Bissue%5D%20AND%20382%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[8]&amp;nbsp;Joyanes B, et al. Screening of hemoglobinopathies in a cohort of newborns in Madrid. Medicina Clinica. 2006, 126(8):290-2 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=126%5Bvolume%5D%20AND%208%5Bissue%5D%20AND%20290%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[9] Manu-Pereira MM, et al. Neonatal screening of hemoglobinopathies and glucose-6-phosphate dehydrogenase in Catalonia. Pilot study in anonymous not related population. Medicina Clinica. 2006, 126(8):281-5 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=126%5Bvolume%5D%20AND%208%5Bissue%5D%20AND%20281%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[10] Robitaille N, Delvin EE, Hume HA. Newborn screening for sickle cell disease: A 1988-2003 Quebec experience. Paediatrics &amp;amp; Child Health. 2006, 11(4), 223-227. [&lt;A href="http://www.pulsus.com/Paeds/11_04/robi_ed.htm" target="_blank"&gt;Journal website abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[11] Frempong T, Pearson HA. Newborn screening coupled with comprehensive follow-up reduced early mortality of sickle cell disease in Connecticut. Connecticut Medicine. 2007, 71(1):9-12. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=17288099&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[12] Halasa NB, Shankar SM, Talbot TR, Arbogast PG, Mitchel EF, Wang WC et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clinical Infectious Diseases. 2007, 44(11), 1428-1433 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=44%5Bvolume%5D%20AND%2011%5Bissue%5D%20AND%201428%5Bpage%5D%20AND%202007%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[13] Zeuner et al. &lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ311.htm" target="_blank"&gt;Antenatal and neonatal haemoglobinopathy screening in the UK: review and economic analysis&lt;/A&gt;.&amp;nbsp;Health Technology Assessment 1999; Vol. 3: No. 11 &lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[14] Davies et. &lt;A href="http://www.hta.nhsweb.nhs.uk/execsumm/summ403.htm" target="_blank"&gt;Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research&lt;/A&gt;. Health Technology Assessment 2000; Vol. 4: No. 3&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[15] Lee MT, Piomelli S, Granger S, Miller ST, Harkness S, Brambilla DJ et al. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=16861341" target="_blank"&gt;Stroke Prevention Trial in Sickle Cell Anemia (STOP): extended follow-up and final results&lt;/A&gt;. Blood 2006;108:847-52.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[16] NHS Sickle Cell and Thalassaemia screening programme. Sickle cell disease in childhood. &lt;A href="http://www.sickleandthal.org.uk/Documents/DETAILED_CLIN_Oct19.pdf" target="_blank"&gt;Standards and guidelines for clinical care&lt;/A&gt;. Oct 2006.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;&amp;nbsp;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&lt;SPAN style="mso-spacerun: yes"&gt;[&lt;/SPAN&gt;&lt;/SPAN&gt;17] Liverpool Reviews &amp;amp; Implementation Group. &lt;A href="http://www.hta.nhsweb.nhs.uk/project/1632.asp" target="_blank"&gt;Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional hemosiderosis) in patients suffering with chronic anaemia&lt;/A&gt;. Health Technology Assessment (HTA) project in progress.&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;&amp;nbsp;&lt;/P&gt;
&lt;P style="TEXT-ALIGN: justify; MARGIN: 0cm 0cm 0pt" class=MsoNormal&gt;[18] Kirkham FJ, Lerner NB, Noetzel M, DeBaun MR, Datta AK, Rees DC et al. Trials in sickle cell disease. Pediatric Neurology 2006, 34(6):450-8 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=34%5Bvolume%5D%20AND%206%5Bissue%5D%20AND%20450%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[19] Njamnshi AK, Mbong EN, Wonkam A, Ongolo-Zogo P, Djientcheu V, Sunjoh FL et al. The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon. Journal of the Neurological Sciences 2006, 250(1-2), 79-84 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?orig_db=PubMed&amp;amp;db=PubMed&amp;amp;cmd=Search&amp;amp;term=250%5Bvolume%5D%20AND%201-2%5Bissue%5D%20AND%2079%5Bpage%5D%20AND%202006%5Bpdat%5D" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[20] Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K et al. &lt;A href="http://stroke.ahajournals.org/cgi/content/full/37/2/577" target="_blank"&gt;Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack&lt;/A&gt;: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke. Stroke 2006, 37(2):577-617.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[21]&amp;nbsp;Kaye CI. &lt;A href="http://www.pediatrics.org/cgi/content/full/118/3/1304" target="_blank"&gt;Introduction to the Newborn Screening Fact Sheets&lt;/A&gt;. Pediatrics 2006, 118(3), 1304-1312.&amp;nbsp;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[22] Kaye CI, Committee on Genetics, Accurso F, La Franchi S, Lane PA, Hope N et al. &lt;A href="http://pediatrics.aappublications.org/cgi/content/full/118/3/e934" target="_blank"&gt;Newborn screening fact sheets&lt;/A&gt;. Pediatrics 2006, 118(3):e934-63.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[22a] NHS Sickle Cell and Thalassaemia Screening Programme. &lt;A href="http://www.sickleandthal.org.uk/publications.htm#NBSickleCarrier" target="_blank"&gt;Results of Newborn Bloodspot Screening. Carrier of a sickle cell gene - sometimes called trait HbAS&lt;/A&gt;. Sept 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[23] NHS Sickle cell and Thalassaemia Programme. &lt;A href="http://www.sickleandthal.org.uk/Documents/F_Origin_Questionnaire.pdf" target="_blank"&gt;Family Origin Questionnaire&lt;/A&gt;. 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[24] Wright J, Rati N, Kennefick A, et al. A pilot study of ‘fast track’ antenatal screening for haemoglobinopathies. J Med Screen 2003,&amp;nbsp;10(4):169–171 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=14738652&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[25] Thomas P, Oni L, Alli M, St Hilaire J, Smith L, Leavey C, Banarsee R. &lt;A href="http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;amp;pubmedid=15970065" target="_blank"&gt;Antenatal screening for haemoglobinopathies – a whole system participatory action research project&lt;/A&gt;. Br J Gen Pract. 2005; 55, 424-428&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[26] Marteau T et al. &lt;A href="http://www.iop.kcl.ac.uk/shifttrial" target="_blank"&gt;SHIFT: Screening for Haemoglobinopathies in First Trimester&lt;/A&gt;. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[27] Qureshi N, Armstrong S, Modell B. &lt;A href="http://fampra.oxfordjournals.org/cgi/content/full/23/1/106" target="_blank"&gt;GPs' opinions of their role in prenatal genetic services: a cross-sectional survey&lt;/A&gt;. Family Practice 2006, 23(1):106-10.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[28] NHS Sickle Cell and Thalassaemia Screening Programme. &lt;A href="http://www.sickleandthal.org.uk/Documents/ProgrammeSTAN.pdf" target="_blank"&gt;Standards for the linked antenatal and newborn screening programme&lt;/A&gt;. Nov 2006. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[29] Ahmed S, Green JM, Hewison J. Attitudes towards prenatal diagnosis and termination of pregnancy for thalassaemia in pregnant Pakistani women in the North of England. Prenatal Diagnosis 2006,&amp;nbsp;26(3):248-57 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16475227&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[30] Durosinmi MA, Odebiyi AI, Akinola NO et al. Acceptability of prenatal diagnosis of sickle cell anaemia by a sample of the Nigerian population. Afr J Med Med Sci. 1997 Mar-Jun;26(1-2):55-8 [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=10895231&amp;amp;ordinalpos=2&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[30a] Dyson SM, Culley L, Gill C, Hubbard S, Kennefick A, Morris P et al. Ethnicity questions and antenatal screening for sickle cell/thalassaemia [EQUANS] in England: a randomised controlled trial of two questionnaires. Ethnicity &amp;amp; Health 2006, 11(2):169-89. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16595318&amp;amp;ordinalpos=3&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[31] Aspinall P and Dyson S. &lt;A href="http://www.sickleandthal.org.uk/dowloads/Ethnic%20origin%20question/SECONDARY%20REVIEW%20OF%20THE%20ETHNIC%20QUESTION_final%20report.pdf" target="_blank"&gt;Secondary review of existing information in relation to the ethnic question&lt;/A&gt;. 2002. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[32] NICE &lt;A href="http://www.rcog.org.uk/resources/Public/pdf/Antenatal_Care.pdf" target="_blank"&gt;Antenatal care: Routine care for the healthy pregnant woman&lt;/A&gt;. Oct 2003.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[33]&amp;nbsp;&amp;nbsp;ETHOS. EQUANS (Ethnic Question and Antenatal Screening for Sickle Cell/Thalassaemia)&amp;nbsp;Interim Report 3. &lt;A href="http://www.sct.screening.nhs.uk/dowloads/Ethnic%20origin%20question/EQUANS%20Interim%203.pdf" target="_blank"&gt;Use of maps in antenatal screening for SCD/Thalassaemia&lt;/A&gt;. 2002.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[34] ETHNOS. &lt;A href="http://www.sct.screening.nhs.uk/Documents/Evaluation_FOQ.pdf" target="_blank"&gt;Evaluation of the "family origin questionnaire&lt;/A&gt;". March 2006.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[35] Lakeman P, Henneman L, Bezemer PD, Cornel MC, ten Kate LP. Developing and optimizing a decisional instrument using self-reported ancestry for carrier screening in a multi-ethnic society. Genetics in Medicine 2006, 8(8):502-9. [&lt;A href="http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&amp;amp;Cmd=ShowDetailView&amp;amp;TermToSearch=16912581&amp;amp;ordinalpos=1&amp;amp;itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum" target="_blank"&gt;PubMed abstract&lt;/A&gt;]&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;[37] DIPEX. Screening for sickle cell and beta-thalassaemia. &lt;A href="http://www.dipex.org/sicklecellandthalassaemia" target="_blank"&gt;Personal experiences of health and illness – patient information module&lt;/A&gt;. May 2006. &lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Annual evidence updates on antenatal screening for&amp;nbsp;sickle cell and thalassaemia, and newborn screening for sickle cell disease&amp;nbsp;2006/07&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;The Screening Library has identified the&amp;nbsp;new&amp;nbsp;evidence&amp;nbsp;published over the last year, and the results of our search are classified and presented as an evidence update below.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/SpecialistLibrarySearch/Download.aspx?resID=212461" target="_blank"&gt;Sickle cell and thalassaemia&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;National Screening Committee policies, July 2006&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=32452&amp;amp;tabID=288&amp;amp;catID=12458" target="_blank"&gt;Sickle cell and thalassaemia screening (in pregnancy)&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.library.nhs.uk/screening/ViewResource.aspx?resID=57171&amp;amp;tabID=288&amp;amp;catID=2037" target="_blank"&gt;Sickle cell disorders screening (in newborns)&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Other&amp;nbsp;information for health professionals &lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=ip_content_1_join&gt;Continuous professional development - resources to support the Antenatal and Newborn Screening Programmes: &lt;A href="http://www.screening.nhs.uk/cpd/sickle.htm" target="_blank"&gt;Sickle Cell and Thalassaemia&lt;/A&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;&lt;/STRONG&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Information&amp;nbsp;to give&amp;nbsp;pregnant women and parents&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Jan 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/" target="_blank"&gt;Screening tests for you and your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;pregnant women and their&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;National Screening Committee (Sept 2007). &lt;A href="http://www.screening.nhs.uk/anpublications/index.htm" target="_blank"&gt;Screening tests for your baby&lt;/A&gt; - booklet explaining the&amp;nbsp;screening tests&amp;nbsp;offered to&amp;nbsp;newborn babies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Oni L, Dick M, Smalling B and Walters J. &lt;A href="http://www.sickleandthal.org.uk/Documents/ParentsHandbookJune07.pdf" target="_blank"&gt;Care and management of your child with Sickle Cell Disease. A parent's guide&lt;/A&gt;. 2006 (2nd edition).&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;NHS Sickle Cell and Thalassaemia Screening Programme. &lt;A href="http://www.sickleandthal.org.uk/publications.htm#fact" target="_blank"&gt;Factsheets&lt;/A&gt;. Sept 2007.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;Lab tests online - searchable website&amp;nbsp;designed to help consumers&amp;nbsp;understand the many clinical lab tests that are part of routine care. See &lt;A href="http://www.labtestsonline.org.uk/understanding/conditions/pregnancy.html" target="_blank"&gt;pregnancy screening&lt;/A&gt; (Aug 2006).&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;&amp;nbsp;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>388978</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=388978]]&gt;</url>
    <title>Screening for sickle cell and thalassaemia 2010 update</title>
    <publicationDate>2010-10-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,SICKLE CELL DISEASE,NEWBORN,BLOODSPOT (&lt;1WK),8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening for sickle cell and thalassaemia 2010 update&lt;/pageTitle&gt;&lt;pageBody&gt;This document provides an update to the summary produced by the NHS Sickle Cell and Thalassaemia Screening Programme in &lt;A href="nelh:325295:0" name=internalLink&gt;2008&lt;/A&gt;. It reviews the work of the NHS Sickle Cell and Thalassaemia Screening Programme and provides information on antenatal screening for sickle cell and thalassaemia and newborn screening for sickle cell.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>87559</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspshemo.htm]]&gt;</url>
    <title>Screening for sickle cell disease in newborns</title>
    <publicationDate>2007-09-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,SICKLE CELL DISEASE,NEWBORN,BLOODSPOT (&lt;1WK),8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for sickle cell disease in newborns. The USPSTF "recommends screening for sickle cell in newborns"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64885</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/clinic/uspstf/uspsskca.htm]]&gt;</url>
    <title>Screening for skin cancer</title>
    <publicationDate>2009-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ DIAGNOSIS &amp; INVESTIGATION,NOT ROUTINELY OFFERED,SKIN DISORDERS,ADULT,CANCER,SCREENING,DISORDERS,SKIN CANCERS,SCREENING,BASAL CELL CARCINOMA (RODENT ULCER),SQUAMOUS CELL CARCINOMA,SKIN CANCER - GENERAL,MALIGNANT MELANOMA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This document summarises the U.S. Preventive Services Task Force (USPSTF)&amp;nbsp;recommendations on screening for skin cancer.&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ahrq.gov/downloads/pub/prevent/pdfser/skincancer/contents.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>122424</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspschdv.htm]]&gt;</url>
    <title>Screening for speech and language delay in preschool children</title>
    <publicationDate>2006-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CONDITIONS,PRIMARY CARE,MANAGEMENT,LARYNX &amp; PHARYNX DISORDERS,SPEECH &amp; LANGUAGE DELAY,ENT AND AUDIOLOGY,SCREENING,CHILD,SPEECH DISORDERS,SPEECH AND LANGUAGE THERAPY,SPECIALTIES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN class=detail_text&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening&amp;nbsp;for speech and language delay in preschool children.&amp;nbsp;The USPSTF concludes that "the evidence is insufficient to recommend for or against routine use of brief, formal screening instruments in primary care to detect speech and language delay in children up to 5 years of age."&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN class=detail_text&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>386800</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/policydb_download.php?doc=49]]&gt;</url>
    <title>Screening for stomach cancer: a report for the UK National Screening Committee</title>
    <publicationDate>2009-11-02T00:00:00</publicationDate>
    <publisher>Screening Services Public Health Wales</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,STOMACH,BENEFITS &amp; HARMS,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This report assesses stomach cancer against the UK NSC criteria for appraising the viability, effectiveness and appropriateness of a screening programme.]]&gt;</body>
  </document>
  <document>
    <id>66403</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspssuic.htm]]&gt;</url>
    <title>Screening for suicide risk</title>
    <publicationDate>2004-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,MANAGEMENT,NOT ROUTINELY OFFERED,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for suicide risk - the USPSTF concludes that the "evidence is insufficient to recommend for or against routine screening by primary care clinicians to detect suicide risk in the general population".&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/suicide/suicidesum.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>121803</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspssyph.htm]]&gt;</url>
    <title>Screening for syphilis infection</title>
    <publicationDate>2004-07-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,SYPHILIS,BEFORE 16 WEEKS,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,MALE SEXUALLY TRANSMITTED INFECTIONS,BACTERIAL,SYPHILIS,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This&amp;nbsp;is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for syphilis infection. The USPSTF&amp;nbsp;strongly recommends that "clinicians screen persons at increased risk for syphilis infection" and that "clinicians screen all pregnant women for syphilis infection". It recommends against "routine screening of asymptomatic persons who are not at increased risk for syphilis infection". 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>333426</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspssyphpg.htm]]&gt;</url>
    <title>Screening for syphilis infection in pregnancy</title>
    <publicationDate>2009-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BEFORE 16 WEEKS,SCREENING,ANTENATAL,SYPHILIS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This is the USPSTF recommendation on screening for syphilis infection in pregnancy. "The USPSTF recommends that clinicians screen all pregnant women for syphilis infection."&lt;STRONG&gt; &lt;/STRONG&gt;&lt;BR&gt;]]&gt;</body>
  </document>
  <document>
    <id>64886</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.uspreventiveservicestaskforce.org/uspstf/uspstest.htm]]&gt;</url>
    <title>Screening for testicular cancer</title>
    <publicationDate>2004-02-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,TESTICULAR,NOT ROUTINELY OFFERED,KIDNEY DISEASES AND MALE UROGENITAL DISORDERS,TESTICULAR/ SCROTAL DISORDERS,TESTICULAR CANCER,MALE UROGENITAL DISORDERS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This document summarises the U.S. Preventive Services Task Force (USPSTF)&amp;nbsp;recommendations on screening for testicular cancer - the USPSTF recommends "against routine screening for testicular cancer in asymptomatic adolescent and adult males".&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/testicular/testiculup.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>389084</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.annals.org/content/153/6/396.abstract]]&gt;</url>
    <title>Screening for testicular cancer: and evidence review for the US Preventive Services Task Force</title>
    <publicationDate>2010-09-01T00:00:00</publicationDate>
    <publisher>Annals of Internal Medicine, American College of Physicians</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,TESTICULAR,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Author's conclusions&lt;/STRONG&gt;: No new evidence was found that would change the US Preventive Services Task Force's 2004 recommendation against screening for testicular cancer.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: PubMed and the Cochrane Library were searched between 1 January 2001 and 11 November 2009. Randomized controlled trials, meta-analyses, systematic reviews, cohort studies and case-control studies were included to determine benefits. Randomized controlled trials, meta-analyses, systematic reviews, cohort studies, case-control studies and case series of large multisite databases were included to determine harms. Both autors reviewed titles, abstracts and full-text for inclusion and one author carried out data extraction.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Three studies were considered for inclusion.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Lin K and Sharangpani R. Screening for testicular cancer: an evidence review for the US Preventive Services Task Force. Annals of Internal Medicine 2010; 153(6):396-9&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.uspreventiveservicestaskforce.org/uspstf10/testicular/testicup.htm" target="_blank"&gt;Full text also available via the US Preventive Services Task Force website&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64888</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/clinic/uspstf/uspsthca.htm]]&gt;</url>
    <title>Screening for thyroid cancer</title>
    <publicationDate>1996-01-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,CONDITIONS,THYROID &amp; PARATHYROID DISORDERS,MALIGNANT,NEOPLASMS,BENIGN,ENT AND AUDIOLOGY,CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Given the availability of new evidence, the USPSTF has decided to update its 1996 recommendation. This work is currently in progress. The 1996 recommendation may contain information that is out of date.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66401</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsthyr.htm]]&gt;</url>
    <title>Screening for thyroid disease</title>
    <publicationDate>2004-01-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ THYROID DISEASE,SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for thyroid disease - the USPSTF concludes that "the evidence is insufficient to recommend for or against routine screening for thyroid disease in adults".&lt;/P&gt;
&lt;P&gt;
&lt;P align=left&gt;&lt;A href="http://www.ahrq.gov/clinic/3rduspstf/thyroid/thyrsum.pdf" target="_blank"&gt;&lt;/A&gt;&lt;/P&gt;&lt;FONT size=7 face=AGaramond-Bold&gt;&lt;/FONT&gt;&amp;nbsp; 
&lt;P&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66592</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsdiab.htm]]&gt;</url>
    <title>Screening for type 2 diabetes mellitus in adults</title>
    <publicationDate>2008-06-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ VASCULAR RISK,TYPE 2,DIABETES,ADULT,SCREENING,DIABETES,CAUSES,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for type 2 diabetes mellitus in adults. The USPSTF&amp;nbsp;"recommends screening for type 2 diabetes in asymptomatic adults with sustained blood pressure (either treated or untreated) greater than 135/80 mm Hg." but concludes "that the current evidence is insufficient to assess the balance of benefits and harms of screening for type 2 diabetes in asymptomatic adults with blood pressure of 135/80 mm Hg or lower."&lt;BR&gt;&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>93170</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/fullmono/mon1117.pdf]]&gt;</url>
    <title>Screening for Type 2 Diabetes: literature review and economic modelling</title>
    <publicationDate>2007-05-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,OUTCOMES,ENDOCRINE DISORDERS,DIABETES,SCREENING,POPULATION BASED &amp; PREVENTATIVE SERVICES,ADULT,DIABETES,SCREENING,PUBLIC HEALTH,VASCULAR RISK,MANAGEMENT &amp; INTERVENTIONS,SERVICES,2008-NOVEMBER,MONTHLY ADDITIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Screening for Type 2 Diabetes: literature review and economic modelling (Waugh) &lt;EM&gt;Health Technology Assessment&lt;/EM&gt; 2007;&amp;nbsp;Volume 11, number 17.&lt;/P&gt;
&lt;P&gt;This HTA report concluded that:&lt;/P&gt;
&lt;P&gt;"The case for screening for undiagnosed diabetes is probably somewhat stronger than it was at the last review, because of the greater options for reduction of cardiovascular disease, principally through the use of statins, and because of the rising prevalence of overweight and hence type 2 diabetes. However, there is also a good case for screening for IGT, with the aim of preventing some future diabetes and reducing cardiovascular disease."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>318092</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?ID=32009100077]]&gt;</url>
    <title>Screening for visual impairment in children</title>
    <publicationDate>2008-06-02T00:00:00</publicationDate>
    <publisher>Centre for Reviews and Dissemination</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CHILD,VISION,SCHOOL ENTRY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;DIV id=xxx&gt;&lt;STRONG&gt;Bibliographic details of the original research&lt;/STRONG&gt;&lt;/DIV&gt;
&lt;DIV&gt;Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen.&amp;nbsp;Screening for visual impairment in children.&amp;nbsp;Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG).&amp;nbsp;2008&lt;/DIV&gt;
&lt;DIV&gt;&amp;nbsp;&lt;/DIV&gt;
&lt;DIV&gt;The main aim of this review was the benefit assessment (i.e. the assessment of patient-relevant outcomes) of screening for visual impairment (universal vision screening) in children up to the age of 6. By diagnosing and treating amblyopia or amblyogenic risk factors as early as possible, paediatric developmental delay and its potentially lifelong consequences should be prevented, or at least ameliorated.&lt;/DIV&gt;]]&gt;</body>
  </document>
  <document>
    <id>66402</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsvsch.htm]]&gt;</url>
    <title>Screening for visual impairment in children younger than age 5 years</title>
    <publicationDate>2004-05-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ PHYSICAL (6-8 WKS),SCHOOL ENTRY,VISION,NHS CORE CONTENT WITHOUT A CATEGORY,NEWBORN,PHYSICAL (&lt;72HRS),CHILD,SCREENING,EYES,EYES,EYES AND VISION]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for visual impairment in children age 0-5 - the USPSTF recommends "screening to detect amblyopia, strabismus, and defects in visual acuity in children younger than age 5 years".&lt;/P&gt;
&lt;P&gt;&lt;A href="http://www.ahrq.gov/downloads/pub/prevent/pdfser/visual/contents.pdf" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>235586</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?orig_db=PubMed&amp;db=PubMed&amp;cmd=Search&amp;defaultField=Title+Word&amp;term=Screening+hiv-infected+individuals+for+anal+cancer+precursor+lesions%3A+a+systematic+review]]&gt;</url>
    <title>Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review</title>
    <publicationDate>2006-07-01T00:00:00</publicationDate>
    <publisher>University of Chicago Press</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,ANAL,CANCER,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in Clin Infect Dis.</description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America"&gt;Clin Infect Dis.&lt;/SPAN&gt; 2006 Jul 15;43(2):223-33.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;OBJECTIVE:&amp;nbsp;to conduct a&amp;nbsp;systematic review of the indirect evidence in the literature regarding the utility of anal Papanicolau (Pap) smear screening of HIV-infected individuals in the highly active antiretroviral therapy era.&lt;/P&gt;
&lt;P&gt;CONCLUSION: the available evidence demonstrates that HIV-infected individuals have an increased risk for squamous cell cancer of the anus and anal intraepithelial neoplasia.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>239460</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&amp;pubmedid=12958114]]&gt;</url>
    <title>Screening in brief intervention trials targeting excessive drinkers in general practice: systematic review and meta-analysis</title>
    <publicationDate>2003-09-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,PRIMARY CARE,NOT ROUTINELY OFFERED,DETERMINANTS,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,ADULT,ALCOHOL PROBLEMS,SCREENING,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,INDIVIDUAL BEHAVIOUR,ALCOHOL CONSUMPTION,SERVICES,METHODS,ANALYSIS,2008-JULY,MONTHLY ADDITIONS,ANALYSIS &amp; RESEARCH]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in BMJ</description>
    <body>&lt;![CDATA[ &lt;P&gt;BMJ. 2003 September 6; 327(7414): 536–542.&lt;/P&gt;
&lt;P&gt;OBJECTIVE: to determine the effectiveness of programmes of screening in general practice for excessive alcohol use and providing brief interventions&lt;/P&gt;
&lt;P&gt;CONCLUSIONS: Although even brief advice can reduce excessive drinking, screening in general practice does not seem to be an effective precursor to brief interventions targeting excessive alcohol use.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;This reference has been critically appraised by reviewers from the Centre for Reviews and Dissemination (CRD). &lt;A href="nelh:292863:0" name=internalLink&gt;Click here&lt;/A&gt; to read this review.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57641</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=57641]]&gt;</url>
    <title>Screening in England: National Screening Committee (NSC) Programme Director’s Report 2002/2003</title>
    <publicationDate>2003-06-03T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,IMPLEMENTATION,QUALITY ASSURANCE,BENEFITS &amp; HARMS,MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Annual report from the NSC Programme Director</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening in England: National Screening Committee (NSC) Programme Director’s Report 2002/2003&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P align=left&gt;This NSC Annual Report for 2002/2003 outlines the screening policies, standards and quality assurance mechanisms currently in place for England.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>64999</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=64999]]&gt;</url>
    <title>Screening in England: Programme Director’s Annual Report. Summer 2003 – Spring 2004</title>
    <publicationDate>2004-10-15T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ IMPLEMENTATION,SCREENING,MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>2003/4 Annual report from the NSC Programme Director
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening in England: Programme Director’s Annual Report. Summer 2003 – Spring 2004&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This NSC&amp;nbsp;Annual Report (Screening in England Programme Director’s Report Period Summer 2003 – Spring 2004) outlines screening policies and programmes currently in place for England. &lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>389089</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.bjog.org/details/journalArticle/841225/Screening_in_pregnancy_for_fetal_or_neonatal_alloimmune_thrombocytopenia_systema.html]]&gt;</url>
    <title>Screening in pregnancy for fetal or alloimmune thrombocytopenia: systematic review.</title>
    <publicationDate>2010-10-01T00:00:00</publicationDate>
    <publisher>BJOG: An International Journal of Obstetrics &amp; Gynaecology, RCOG</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,THROMBOCYTOPENIA,NEWBORN,NOT ROUTINELY OFFERED,THROMBOCYTOPENIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Author's conclusions: Screening of all pregnancies plus effective antenatal interventions may reduce mortality and morbidity of fetal and neonatal alloimmune thrombocytopenia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, Embase and the Cochrane Library were all searched. Two reviewers independently assessed studies for inclusion and extracted data. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Screening for HPA-1a alloimmunisation detects around two cases in 1000 pregnancies.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Kamphuis M, Paridaans N, Porcelijn L et al. Screening in pregnancy for fetal or alloimmune thrombocytopenia: systematic review. BCOG: An International Journal of Obstetrics &amp;amp; Gynaecology 2010; 117(11):1335-43&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.bjog.org/details/journalArticle/841225/Screening_in_pregnancy_for_fetal_or_neonatal_alloimmune_thrombocytopenia_systema.html" target="_blank"&gt;Abstract freely available&lt;/A&gt;&lt;BR&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>102747</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=102747]]&gt;</url>
    <title>Screening in the United Kingdom: Programme Director's report period summer 2004 - summer 2005</title>
    <publicationDate>2005-07-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ IMPLEMENTATION,SCREENING,MANAGEMENT]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>2004/5 Annual report from the NSC Programme Director</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening in the United Kingdom: Programme Director's report period summer 2004 - summer 2005&lt;/pageTitle&gt;&lt;pageBody&gt;This 2004/5 NSC Annual Report outline screening policies and programmes currently in place in England, Wales, Scotland and Northern Ireland.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>69678</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/publicationspdfs/Updates/screening.pdf]]&gt;</url>
    <title>Screening matters - themed HTA update</title>
    <publicationDate>2004-12-01T00:00:00</publicationDate>
    <publisher>National Coordinating Centre for Health Technology Assessment</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ IMPLEMENTATION,SCREENING,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ The Health Technology Assessment Programme publishes themed updates, concentrating on different health care topics. This update is on screening, and contains a foreword from Dr. JA Muir Gray.]]&gt;</body>
  </document>
  <document>
    <id>69914</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=69914]]&gt;</url>
    <title>Screening men for AAA</title>
    <publicationDate>2010-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This is a powerpoint presentation on screening for aortic aneurysms</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Screening men for AAA&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN class=detail_text&gt;This presentation by the NHS Abdominal Aortic Aneurysm (AAA) Screening Programme provides an overview of the screening programme for primary care audiences.&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>59740</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.crd.york.ac.uk/CRDWeb/ShowRecord.asp?View=Full&amp;ID=12004000037]]&gt;</url>
    <title>Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis</title>
    <publicationDate>2004-02-11T00:00:00</publicationDate>
    <publisher>Centre for Reviews and Dissemination</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Screening performance of first-trimester nuchal translucency for major cardiac defects: a meta-analysis&lt;BR&gt;Makrydimas G, Sotiriadis A, Ioannidis J P A. American Journal of Obstetrics &amp;amp; Gynecology 2003; 189(5): 1330-1335. 
&lt;P&gt;This review has been evaluated by reviewers&amp;nbsp;from the NHS Centre for Reviews and Dissemination (CRD), University of York, as potentially meeting the CRD quality criteria, and a structured abstract is in the process of being written.&lt;/P&gt;
&lt;P&gt;An &lt;A href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;amp;db=pubmed&amp;amp;dopt=Abstract&amp;amp;list_uids=14634564&amp;amp;query_hl=3&amp;amp;itool=pubmed_docsum" target="_blank"&gt;abstract &lt;/A&gt;for this article from&amp;nbsp;American Journal of Obstetrics and Gynecology&amp;nbsp;is available on PubMed&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>182667</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://cpd.screening.nhs.uk/getdata.php?id=10610]]&gt;</url>
    <title>Screening Timeline - optimum times for testing</title>
    <publicationDate>2008-06-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>NSC poster on antenatal screening times</description>
    <body>&lt;![CDATA[ This is an A4 poster showing the optimum times for antenatal and newborn screening tests to take place, produced by the National Screening Committee.]]&gt;</body>
  </document>
  <document>
    <id>112665</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/fullmono/mon1343.pdf]]&gt;</url>
    <title>Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling</title>
    <publicationDate>2009-10-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,PRETERM LABOUR,SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=2 face=Humanist521BT-Roman&gt;&lt;FONT size=2 face=Humanist521BT-Roman&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Honest H, &lt;?xml:namespace prefix = st1 ns = "urn:schemas-microsoft-com:office:smarttags" /&gt;&lt;st1:place w:st="on"&gt;&lt;st1:City w:st="on"&gt;Forbes&lt;/st1:City&gt; &lt;st1:State w:st="on"&gt;CA&lt;/st1:State&gt;&lt;/st1:place&gt;, Durée KH, Norman G, Duffy SB, Tsourapas A, &lt;I&gt;et al&lt;/I&gt;. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. &lt;I&gt;Health Technology Assessment &lt;/I&gt;2009;&lt;B&gt;13&lt;/B&gt;(43).&lt;?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /&gt;&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;&lt;o:p&gt;&amp;nbsp;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Objectives: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;To identify combinations of tests and treatments to predict and prevent spontaneous preterm birth.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Data sources: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Searches were run on the following databases up to September 2005 inclusive: MEDLINE, EMBASE, DARE, the Cochrane Library (CENTRAL and Cochrane Pregnancy and Childbirth Group trials register) and MEDION. We also contacted experts including the Cochrane Pregnancy and Childbirth Group and checked reference lists of review articles and papers that were eligible for inclusion.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Review methods: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Two series of systematic reviews were performed: (1) accuracy of tests for the prediction of spontaneous preterm birth in asymptomatic women in early pregnancy and in women symptomatic with threatened preterm labour in later pregnancy; (2) effectiveness of interventions with potential to reduce cases of spontaneous preterm birth in asymptomatic women in early pregnancy and to reduce spontaneous preterm birth or improve neonatal outcome in women with a viable pregnancy symptomatic of threatened preterm labour. For the health economic evaluation, a model-based analysis incorporated the combined effect of tests and treatments and their cost-effectiveness.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Results: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Of the 22 tests reviewed for accuracy, the quality of studies and accuracy of tests was generally poor. Only a few tests had LR+ &amp;gt; 5. In asymptomatic women these were ultrasonographic cervical length measurement and cervicovaginal prolactin and fetal fibronectin screening for predicting spontaneous preterm birth before 34 weeks. In this group, tests with LR– &amp;lt; 0.2 were detection of uterine contraction by home uterine monitoring and amniotic fluid C-reactive protein (CRP) measurement. In symptomatic women with threatened preterm labour, tests with LR+ &amp;gt; 5 were absence of fetal breathing movements, cervical length and funnelling, amniotic fluid interleukin-6 (IL-6), serum CRP for predicting birth within 2–7 days of testing, and matrix metalloprotease-9, amniotic fluid IL-6, cervicovaginal fetal fibronectin and cervicovaginal human chorionic gonadotrophin (hCG) for predicting birth before 34 or 37 weeks. In this group, tests with LR– &amp;lt; 0.2 included measurement of cervicovaginal IL-8, cervicovaginal hCG, cervical length measurement, absence of fetal breathing movement, amniotic fluid IL-6 and serum CRP, for predicting birth within 2–7 days of testing, and cervicovaginal fetal fibronectin and amniotic fluid IL-6 for predicting birth before 34 or 37 weeks. The overall quality of the trials included in the 40 interventional topics reviewed for effectiveness was also poor. Antibiotic treatment was generally not beneficial but when used to treat bacterial vaginosis in women with intermediate flora it significantly reduced the incidence of spontaneous preterm birth. Smoking cessation programmes, progesterone, periodontal therapy and fish oil appeared promising as preventative interventions in asymptomatic women. Non-steroidal anti-inflammatory agents were the most effective tocolytic agent for reducing spontaneous preterm birth and prolonging pregnancy in symptomatic women. Antenatal corticosteroids had a beneficial effect on the incidence of respiratory distress syndrome and the risk of intraventricular haemorrhage (28–34 weeks), but the effects of repeat courses were unclear. For asymptomatic women, costs ranged from £1.08 for vitamin C to £1219 for cervical cerclage, whereas costs for symptomatic women were more significant and varied little, ranging from £1645 for nitric oxide donors to £2555 for terbutaline; this was because the cost of hospitalisation was included. The best estimate of additional average cost associated with a case of spontaneous preterm birth was approximately £15,688 for up to 34 weeks and £12,104 for up to 37 weeks. Among symptomatic women there was insufficient evidence to draw firm conclusions for preventing birth at 34 weeks. Hydration given to women testing positive for amniotic fluid IL-6 was the most costeffective test–treatment combination. Indomethacin given to all women without any initial testing was the most cost-effective option for preventing birth before 37 weeks among symptomatic women. For a symptomatic woman, the most cost-effective test–treatment combination for postponing delivery by at least 48 h was the cervical length (15 mm) measurement test with treatment with indomethacin for all those testing positive. This combination was also the most&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;cost-effective option for postponing delivery by at least 7 days. Antibiotic treatment for asymptomatic bacteriuria of all women without any initial testing was the most cost-effective option for preventing birth before 37 weeks among asymptomatic women but this does not take into account the potential side effects of antibiotics or issues such as increased resistance.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Conclusions: &lt;/SPAN&gt;&lt;/B&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;For primary prevention, an effective, affordable and safe intervention applied to all mothers without preceding testing is likely to be the most cost-effective approach in asymptomatic women in early pregnancy. For secondary prevention among women at risk of preterm labour in later pregnancy, a management strategy based on the results of testing is likely to be more cost-effective. Implementation of a treat-all strategy with simple interventions, such as fish oils, would be premature for asymptomatic women.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P style="MARGIN: 0cm 0cm 0pt; mso-layout-grid-align: none" class=MsoNormal&gt;&lt;SPAN style="FONT-FAMILY: Arial; FONT-SIZE: 10pt"&gt;Universal provision of high-quality ultrasound machines in labour wards is more strongly indicated for predicting spontaneous preterm birth among symptomatic women than direct management, although staffing issues and the feasibility and acceptability to mothers and health providers of such strategies need to be explored. Further research should include investigations of lowcost and effective tests and treatments to reduce and delay spontaneous preterm birth and reduce the risk of perinatal mortality arising from preterm birth.&lt;o:p&gt;&lt;/o:p&gt;&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>389087</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ijo.sagepub.com/content/54/5/803.abstract]]&gt;</url>
    <title>Screening tools assessing risk of suicide and self-harm in adult offenders: a systematic review.</title>
    <publicationDate>2010-10-01T00:00:00</publicationDate>
    <publisher>International Journal of Offender Therapy &amp; Comparative Criminology</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Author's conclusions&lt;/STRONG&gt;: Standards of reporting were varied. Suicidal Concerns for Offenders in Prison (SCOPE) and Suicide Potential Scale both demonstrated promising levels of sensitivity and specificity. Further research is needed to assess validity of these tools to identify those at risk, particularly those on probation and in the community.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Eleven electronic databases were searched for studies assessing the validity of screening instruments to identify the risk of suicide and self-harm in offenders.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Five studies were included, assessing four screening tools.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Perry AE, Marandos R, Coulton S et al. Screening tools assessing risk of suicide and self-harm in adult offenders: a systematic review. International Journal of Offender Therapy &amp;amp; Comparative Criminology 2010; 54(5):803-28&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://ijo.sagepub.com/content/54/5/803.abstract" target="_blank"&gt;Abstract freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>345774</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.gerimed.co.uk//_downloads/0708.010-clinicalpractice.pdf]]&gt;</url>
    <title>Screening tools for older people at risk of adverse outcomes</title>
    <publicationDate>2007-08-01T00:00:00</publicationDate>
    <publisher>Geriatric Medicine, Ocean Media Group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,NOT ROUTINELY OFFERED,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Standardised screening tools could be used to produce individual risk profiles for older&amp;nbsp;people at high risk for hospital or institutional admission or death.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Systematic search of Medline, Cinahl and Web of Science for short screening tools.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Six screening tools were identified and reviewed&amp;nbsp;as screening instruments that could be incorporated in to a primary care assessment.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Philp I, Hoyle E, O'Brien E, Parker C. Screening tools for older people at risk of adverse outcomes. &lt;EM&gt;Geriatric Medicine &lt;/EM&gt;2007;37(8):10-4. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.gerimed.co.uk//_downloads/0708.010-clinicalpractice.pdf" target="_blank"&gt;Full text freely available&lt;/A&gt;&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This systematic review has not been critically appraised.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57322</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band16/b16-6.html]]&gt;</url>
    <title>Screenwatch - Ovarian Cancer</title>
    <publicationDate>1995-06-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,OVARIAN,ADULT,CANCER,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Ovarian Cancer Screening&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.jr2.ox.ac.uk/bandolier/band16/b16-6.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;Bandolier write: 
&lt;P&gt;"A major drawback is the lack of a randomised controlled trial to show a reduction in mortality from screening. The European Randomised Trial of Ovarian Cancer (ERTOC) is about to start, and should provide evidence in this area. Ovarian cancer is a high profile media issue. This often results in women requesting advice. Thus a decision must be made on what can be identified as best practice based on the available evidence. &lt;BR&gt;&lt;BR&gt;There is no evidence to support screening asymptomatic women in the general population for ovarian cancer. &lt;BR&gt;&lt;BR&gt;Screening asymptomatic women with one affected relative should be confined to recognised research studies [3]. &lt;BR&gt;&lt;BR&gt;Women with two or more first (mother/daughter/sister) or second (grandmother/aunt) degree affected relatives with the disease are at a markedly increased risk. There is no evidence as yet to support actively seeking these women out in the community, as due to the lack of RCT evidence on reduction in mortality, benefit cannot be guaranteed. If a woman with this history presents requesting screening, she should be referred for further advice. This might be to a Gynaecologist or to the UKCCCR Familial Ovarian Cancer Study. Any decision to undergo screening must be based on a fully informed choice. &lt;BR&gt;&lt;BR&gt;The current criterion for the UKCCCR study is two first or second degree relatives living or dead with (epithelial) ovarian cancer. The protocol suggests yearly screening from the age of 25 or 30 with a method such as trans-vaginal or trans-abdominal ultrasound". 
&lt;H3&gt;References&lt;/H3&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;OL&gt;
&lt;LI&gt;HT Lynch, P Watson, C Bewtra, et al. Hereditary ovarian cancer - Heterogeneity in age at diagnosis. Cancer 1991; 67: 1460-6. 
&lt;LI&gt;HT Lynch, W Kimberly, WA Albano, et al, Hereditary nonpolyposis colon cancer (Lynch syndrome I and II). Cancer 1988; 56: 934-8. 
&lt;LI&gt;Non-surgical aspects of ovarian cancer. Report of a meeting of Physicians and Scientists, Institute of Cancer Research and the Royal Marsden Hospital, London. Lancet 1994. 343: 335-40. 
&lt;LI&gt;BAJ Ponder, DF Easton, J Peto. Risk of ovarian cancer associated with a family history. In: Sharp F, Mason W D, Leake R, eds. Ovarian cancer. London: Chapman and Hall, 1990. 3-6. 
&lt;LI&gt;UK Familial Ovarian Cancer Study, Box 238, Addenbrookes' Hospital, Hills Road, Cambridge, CB2 2QQ. &lt;/LI&gt;&lt;/OL&gt;
&lt;P&gt;**&lt;EM&gt;Note that this review is &amp;gt;5 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>59835</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4014560.pdf]]&gt;</url>
    <title>Second Report of the UK National Screening Committee</title>
    <publicationDate>2000-01-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHILD,ADULT,IMPLEMENTATION,BENEFITS &amp; HARMS,QUALITY ASSURANCE,OLD AGE,MANAGEMENT,NEWBORN,VASCULAR,SCREENING,ABDOMINAL AORTIC ANEURYSM,OTHER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This second report from the National Screening Committee outlines the need to be absolutely clear and explicit about the risks and limitations of screening. The report covers policy-making, quality assurance, errors, informed choice, risk reduction and the organisation of screening programmes. 
&lt;P align=left&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>94238</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://jech.bmjjournals.com/cgi/reprint/53/3/179]]&gt;</url>
    <title>Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria</title>
    <publicationDate>1999-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BLOODSPOT (&lt;1WK),NEWBORN,ECONOMICS,SCREENING,PHENYLKETONURIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Journal of&amp;nbsp;Epidemiology and Community Health 1999; 53:179-86**.&lt;/STRONG&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This article is&amp;nbsp;provided in free full text by&amp;nbsp;BMJ publishing from the link given above (requires registration).&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&amp;nbsp;&lt;/STRONG&gt;this systematic literature review aimed to estimate the financial benefit of neonatal screening for phenylketonuria.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions: &lt;/STRONG&gt;this review concluded that the economic literature on&amp;nbsp;phenylketonuria screening is of variable quality.&amp;nbsp;Their analysis of the data&amp;nbsp;showed that neonatal PKU screening is worthwhile in financial terms alone in the UK, and that it justifies the infrastructure for collecting and testing neonatal blood samples.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;** Please note that this article is &amp;gt;5 years old.&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70787</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hqc.sk.ca/download.jsp?PqC9Q/42RnScO7zoxdED+DBIzBf0QfLQkUwK4QBZaJv6asSZVoyNeb6gwaBuNH9X#search]]&gt;</url>
    <title>Selective chest radiography: guidelines review</title>
    <publicationDate>2000-07-01T00:00:00</publicationDate>
    <publisher>Health Services Utilization and Research Commission</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,CANCER,ADULT,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=TimesNewRomanPSMT&gt;
&lt;P align=left&gt;Health Services Utilization and Research Commission (HSURC), Canada is an independent agency that reports on quality of care. 
&lt;P align=left&gt;The HSURC selective chest radiography guideline was released in September 1997. This is an update of the evidence on selective chest radiography, and includes a discussion of new technologies and research that may have implications for the guideline. 
&lt;P align=left&gt;The report concludes that "s&lt;FONT face=TimesNewRomanPSMT&gt;creening for lung cancer continues to be widely debated, with much of the research focus on the use of computed tomography to improve the detection rate of resectable tumours before the presence of symptoms. The HSURC guideline remains current on the use of chest radiography for lung cancer screening".&lt;/FONT&gt;&lt;/FONT&gt; 
&lt;P align=left&gt;See the 1997 HSURC guideline: &lt;A href="http://www.hqc.sk.ca/download.jsp?PqC9Q/42RnScO7zoxdED+DBIzBf0QfLQkUwK4QBZaJtKe/KM7Ao66r6gwaBuNH9X" target="_blank"&gt;Chest Radiography: A Summary of the Evidence Supporting Selective Clinical Practice Guidelines and Recommendation for Implementation&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95753</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/6/6/187?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122644461937_306&amp;stored_search=&amp;FIRSTINDEX=10&amp;journalcode=ebmed]]&gt;</url>
    <title>Short scales were as effective as long scales in screening for depression in older patients</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ ADULT,DEPRESSION,SCREENING,NOT ROUTINELY OFFERED,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Short scales were as effective as long scales in screening for depression in older patients. Evidence-Based Medicine 2001; 6:187.&lt;/P&gt;
&lt;P&gt;&lt;BR&gt;This&amp;nbsp;summary is based on the original article: Pomeroy IM, Clark CR, Philp I. The effectiveness of very short scales for depression screening in elderly medical patients.Int J Geriatr Psychiatr 2001 Mar;16:321–6.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>325505</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.nhs.uk/news/2009/07July/Pages/Cervicalscreening.aspx]]&gt;</url>
    <title>Smear test 'no benefit' in early 20s</title>
    <publicationDate>2009-07-30T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;EM&gt;&lt;STRONG&gt;Behind the headlines&lt;/STRONG&gt; provides an unbiased and evidence-based analysis of health stories that make the news. the service is intended for both the public and health professionals&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;/EM&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;"The &lt;EM&gt;British Medical Journal&lt;/EM&gt; recently published&amp;nbsp;&lt;A href="http://www.bmj.com/cgi/content/abstract/339/jul28_2/b2968" target="_blank"&gt;research&lt;/A&gt; that looked at the effectiveness of smear tests across different age groups of women. This large and well-designed case-control study analysed the impact of cervical screening on the risk of cancer in more than 4,000 diagnosed cases and nearly 8,000 age-matched controls without cancer.&lt;/P&gt;
&lt;P&gt;It found that screening reduced the risk of developing cervical cancer in all age groups except the youngest. As women got older, the more their risk was reduced in the five years after screening. Screening women between the ages of 20 and 24 had no detectable impact on cervical cancer rates at ages 25 to 29. These are important findings, which support the NHS approach of only inviting women for cervical screening once they reach the age of 25."&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>87549</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15003407]]&gt;</url>
    <title>Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review</title>
    <publicationDate>2004-04-01T00:00:00</publicationDate>
    <publisher>Nature Publishing Group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,HIV,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),NEURAL TUBE DEFECTS,INFORMED DECISION-MAKING,11-14 WEEKS,BEFORE 16 WEEKS,18-20 WEEKS,ETHNICITY AND HEALTH,MANAGEMENT AND POLICY,SERVICE DELIVERY,CLINICAL PROFESSIONS,NURSES,SERVICE SECTORS,PRIMARY CARE,CLIENT GROUPS,WOMEN,HEALTH PROMOTION AND PREVENTIVE SERVICES,RACE EQUALITY,8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA,PUBLIC HEALTH,DETERMINANTS,OUTCOMES,SOCIAL DETERMINANTS,MANAGEMENT &amp; INTERVENTIONS,POPULATIONS,GROUPS,ETHNIC GROUPS,WOMEN,SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,MONTHLY ADDITIONS,NOVEMBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Social and ethnic inequalities in the offer and uptake of prenatal screening and diagnosis in the UK: a systematic review. Rowe RE, Garcia J, Davidson LL. &lt;SPAN title="Public health." eventRemoved="AbbrLookUp(this, 'Public Health.');"&gt;Public Health.&lt;/SPAN&gt; 2004 Apr;118(3):177-89.&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;"&lt;STRONG&gt;Objective&lt;/STRONG&gt;: To review studies addressing the question of whether there are social inequalities in either the offer or the uptake of prenatal testing in the UK.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion&lt;/STRONG&gt;: This review provides some evidence of ethnic inequalities in access to prenatal testing. Further research is required to improve our understanding of why testing may not be offered, the reasons for failure to take up testing when offered, and to identify whether there are other social inequalities in access to prenatal testing".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>300992</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://newbornbloodspot.screening.nhs.uk/getdata.php?id=10953]]&gt;</url>
    <title>Standards and guidelines for newborn blood spot screening</title>
    <publicationDate>2008-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ NEONATAL AND INFANT CARE,QUALITY ASSURANCE,BLOODSPOT (&lt;1WK),NEWBORN,SCREENING,WOMEN'S HEALTH,POSTNATAL CARE,NORMAL PREGNANCY,GENERAL EXAMINATION AND SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Standards for blood spot screening in newborn babies</description>
    <body>&lt;![CDATA[ These revised standards aim to drive improvements in&amp;nbsp;performance management, timeliness, population uptake, timely diagnosis, assessment and treatment of screen positive babies.]]&gt;</body>
  </document>
  <document>
    <id>250661</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.mrc.ac.uk/Achievementsimpact/Storiesofimpact/Hearingscreen/index.htm]]&gt;</url>
    <title>Stories of impact: Hearing Screen for Newborns</title>
    <publicationDate>2007-02-01T00:00:00</publicationDate>
    <publisher>Medical Research Council</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ PHYSICAL (&lt;72HRS),NEWBORN,SCREENING,HEARING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>MRC description of the history and impact of its research into newborn hearing screening
</description>
    <body>&lt;![CDATA[ &lt;P&gt;Medical Research Council (MRC) pages on the history and development of newborn hearing screening.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64060</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/NUF83750Report.pdf]]&gt;</url>
    <title>Straight Talking: Communicating Breast Screening Information in Primary Care</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,BREAST CANCER,PRIMARY CARE,MANAGEMENT,INFORMED DECISION-MAKING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=3 face=KorinnaITCbyBT-Regular&gt;
&lt;P align=left&gt;This report looks at&amp;nbsp;the information and communication needs of women and health professionals in primary care, with reference to breast cancer screening.&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>60464</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=60464]]&gt;</url>
    <title>Structured review for the UK National Screening Committee - appraising the viability, effectiveness and appropriateness of an anal cancer screening programme</title>
    <publicationDate>2003-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ NOT ROUTINELY OFFERED,ANAL,CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Assessment of anal cancer screening against NSC criteria.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Structured review for the UK National Screening Committee - appraising the viability, effectiveness and appropriateness of an anal cancer screening programme&lt;/pageTitle&gt;&lt;pageBody&gt;Anal cancer screening&amp;nbsp;is assessed against the National Screening Committee's criteria for appraising the viability, effectiveness and appropriateness of a screening programme.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>325295</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=325295]]&gt;</url>
    <title>Summary update: antenatal screening for sickle cell and thalassaemia and newborn screening for sickle cell (September 2008)</title>
    <publicationDate>2008-09-01T00:00:00</publicationDate>
    <publisher>Screening specialist collection</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,SICKLE CELL DISEASE,NEWBORN,BLOODSPOT (&lt;1WK),8-10 WEEKS,SICKLE CELL &amp; THALASSAEMIA]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Summary update: antenatal screening for sickle cell and thalassaemia and newborn screening for sickle cell (September 2008)&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;A 2008&amp;nbsp;update of the work of the NHS Sickle Cell and Thalassaemia Programme, plus information about screening for sickle cell and thalassaemia.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;A more recent update was produced&amp;nbsp;for&amp;nbsp;October 2010&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>398360</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5909a1.htm?s_cid=ss5909a1_w]]&gt;</url>
    <title>Surveillance of screening-detected cancers (colon and rectum, breast, and cervix - United States, 2004-2006</title>
    <publicationDate>2010-11-26T00:00:00</publicationDate>
    <publisher>Morbidity &amp; Mortality Weekly Report. Surveillance Summaries</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BREAST CANCER,CERVICAL CANCER,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: This report emphasizes the need for ongoing population-based surveillance and reporting to monitor trends in late cancer incidence. Colorectal, cervical and breast cancers are identifiable at earlier and more treatable stages through screening but multiple factors account for why certain populations are underscreened.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Data were obtained from cancer registries affiliated with the Center for Disease Control's National Program of Cancer Registries and the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program. Data on screening were obtained from the Behavioral Risk Factor Surveillance System.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Around half of all colorectal and cervical cancers and one third of breast cancers were diagnosed at a late stage of disease. Incidence rates of late cancers differed by age, race/ethnicity and state, as did the percentage of people who received recommended screening.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Henley SJ, King JB, German RR et al. Surveillance of screening-detected cancers (colon and rectum, breast, and cervix - United States, 2004-2006. Morbidity &amp;amp; Mortality Weekly Report. Surveillance Summaries 2010; 59(9):1-25&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5909a1.htm?s_cid=ss5909a1_w" target="_blank"&gt;Full text freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>144359</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&amp;cmd=Retrieve&amp;dopt=Abstract&amp;list_uids=15545324&amp;query_hl=7&amp;itool=pubmed_docsum]]&gt;</url>
    <title>Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia</title>
    <publicationDate>2004-11-01T00:00:00</publicationDate>
    <publisher>Lippincott Williams and Wilkins</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,OLD AGE,ALZHEIMER'S DISEASE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;SPAN title="American journal of preventive medicine."&gt;Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Dougall NJ, Bruggink S, Ebmeier KP. &lt;SPAN title="The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry."&gt;Am J Geriatr Psychiatry &lt;/SPAN&gt;2004 Nov-Dec;12(6):554-70.&lt;/SPAN&gt;&lt;/P&gt;
&lt;P&gt;&lt;SPAN title="American journal of preventive medicine."&gt;&lt;/SPAN&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;SPAN title="American journal of preventive medicine."&gt;&lt;/SPAN&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;"&lt;STRONG&gt;Objective&lt;/STRONG&gt;: The authors sought to determine the diagnostic accuracy of 99mTc-HMPAO-SPECT in discriminating between Alzheimer disease (AD) and other dementias.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusion&lt;/STRONG&gt;: SPECT may be helpful in the differential diagnosis of AD. Clinical follow-up studies are urgently required to establish its predictive validity with regard to natural history and treatment response."&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>187299</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/nhscsp23.pdf]]&gt;</url>
    <title>Taking samples for cervical screening.</title>
    <publicationDate>2006-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A resource pack for trainers</description>
    <body>&lt;![CDATA[ This resource pack represents best practice for the training of cervical&amp;nbsp;smear sample&amp;nbsp;takers.]]&gt;</body>
  </document>
  <document>
    <id>57336</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band5/b5-1.html]]&gt;</url>
    <title>Testing a Screening Test</title>
    <publicationDate>1994-06-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,BENEFITS &amp; HARMS,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Testing a Screening Test&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band5/b5-1.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;J A Muir Gray writes: 
&lt;P&gt;"When testing a new test against an established diagnostic test or procedure, improvements in sensitivity, specificity and predictive value are sought, as well as cost and patient acceptability. These simple criteria need to be applied to all new screening tests, and to many screening tests presently in use. 
&lt;P&gt;&lt;EM&gt;** Note that this review is &amp;gt; 10 years old&lt;/EM&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>57331</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band3/b3-1.html]]&gt;</url>
    <title>Testing a Test</title>
    <publicationDate>1994-04-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ QUALITY ASSURANCE,BENEFITS &amp; HARMS,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Testing a Test&lt;/STRONG&gt; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band3/b3-1.html" target="_blank"&gt;Bandolier&lt;/A&gt;** 
&lt;P&gt;J A Muir Gray writes: 
&lt;P&gt;"The evaluation of a treatment is often difficult, but at least there is a clear outcome - either the patient gets better or does not. &lt;BR&gt;&lt;BR&gt;When assessing a new diagnostic test, however, the situation may not be so simple. The successful "outcome" for a test may be either a positive or a negative result, depending upon whether a doctor wishes to confirm or exclude a diagnosis. Another possible way of assessing outcome is by whether the test affects the management of the patient: some test results, both positive and negative, will lead to a change in management, whereas in other circumstances a positive or negative result will lead the doctor to continue with the same management plan." 
&lt;P&gt;**&lt;EM&gt;Note that this review is &amp;gt; 10 years old&lt;/EM&gt; 
&lt;P&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63594</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63594]]&gt;</url>
    <title>Tests for group B streptococcus during labour. A Systematic Review</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>Birmingham Women's Hospital</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B screening from a NSC workshop</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Tests for group B streptococcus during labour. A Systematic Review&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;outlines the tests available for group B streptococcus B during labour.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>84767</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cafamily.org.uk/screening.html]]&gt;</url>
    <title>The Contact a Family Directory - Screening</title>
    <publicationDate>2010-03-01T00:00:00</publicationDate>
    <publisher>Contact a Family</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,CHILD,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ Contact a Family is&amp;nbsp;a national charity founded for families with disabled children. Their website&amp;nbsp;has a directory&amp;nbsp;which contains a section on antenatal, neonatal and childhood screening, written for health professionals.]]&gt;</body>
  </document>
  <document>
    <id>95250</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/EJC.38.11.pdf]]&gt;</url>
    <title>The frequency of breast cancer screening: results from the UKCCCR randomised trial</title>
    <publicationDate>2002-01-01T00:00:00</publicationDate>
    <publisher>Elsevier Science Ltd</publisher>
    <publicationType>RESEARCH STUDY</publicationType>
    <topics>&lt;![CDATA[ BREAST CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This randomised trial looked at the frequency of the interval between screening and invitations for the NHS Breast Screening Programme (NHSBSP). It was organised through the United Kingdom Coordinating Committee on Cancer Research, and was supported by the Medical Research Council, Cancer Research UK and the Department of Health&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;publication (European Journal of Cancer 38 (2002) 1458–1464) is provided in full text on the NHS Breast Screening Programme website.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>308881</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=9051]]&gt;</url>
    <title>The handbook for vascular risk assessment, risk reduction and risk management</title>
    <publicationDate>2008-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>NSC Handbook on vascular risk assessment</description>
    <body>&lt;![CDATA[ This handbook, produced by the National Screening Committee and the University of Leicester, brings together in one place information on&amp;nbsp;the current state of knowledge about vascular risk assessment, risk reduction and risk management.]]&gt;</body>
  </document>
  <document>
    <id>95767</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/6/2/57?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122649885708_638&amp;stored_search=&amp;FIRSTINDEX=30&amp;journalcode=ebmed]]&gt;</url>
    <title>The Hopkins Verbal Learning Test had high sensitivity and good specificity for detecting mild dementia in older adults</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Hopkins Verbal Learning Test had high sensitivity and good specificity for detecting mild dementia in older adults. Evidence-Based Medicine 2001;6:57.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;This&amp;nbsp;summary is based on the original article: Frank RM, Byrne GJ.The clinical utility of the Hopkins Verbal Learning Test as a screening test for mild dementia.Int J Geriatr Psychiatry 2000 Apr;15:317–24.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>79059</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=79059]]&gt;</url>
    <title>The importance of infectious disease surveillance in maternity care</title>
    <publicationDate>2005-03-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This is a presentation given at the Antenatal and Newborn Screening conference in London on March 1st 2005</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;The importance of infectious disease surveillance in maternity care&lt;/pageTitle&gt;&lt;pageBody&gt;This is a presentation given by Isabel Oliver, Regional Epidemiologist, at the Antenatal and Newborn Screening conference held in London on March 1st 2005.&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>345776</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/15381343]]&gt;</url>
    <title>The influence of outpatient comprehensive geriatric assessment on survival : a meta-analysis</title>
    <publicationDate>2004-11-01T00:00:00</publicationDate>
    <publisher>Archives of Gerontology &amp; Geriatrics, Elsevier</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,OLD AGE,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Comprehensive Geriatric Assessment (CGA) was not shown to be beneficial&amp;nbsp;to survival of older people.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Meta-analysis of randomized controlled trials.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Nine trials, with 3750 subjects were included in the analysis. Mortality risk ratio between those undergoing CGA and those with usual care.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Kuo H, Scandrett K, Dave J, SL. M. The influence of outpatient comprehensive geriatric assessment on survival: a meta-analysis. &lt;EM&gt;Archives of Gerontology &amp;amp; Geriatrics&lt;/EM&gt; 2004;39(3):245-54&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: Subscription required to access full-text&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;This meta-analysis has not been critically appraised.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95763</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/6/5/159?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122645637319_411&amp;stored_search=&amp;FIRSTINDEX=20&amp;journalcode=ebmed]]&gt;</url>
    <title>The Mini Cog had high sensitivity and specificity for diagnosing dementia in community dwelling older adults</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Mini Cog had high sensitivity and specificity for diagnosing dementia in community dwelling older adults. Evidence-Based Medicine 2001; 6:159.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Scanlan J, Borson S.The mini-cog: receiver operating characteristics with expert and näive raters.Int J Geriatr Psychiatry 2001 Feb;16:216–22.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69664</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=69664]]&gt;</url>
    <title>The natural history of anal intra-epithelial neoplasia</title>
    <publicationDate>2004-12-06T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ CANCER,ANAL,ADULT,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This is a powerpoint presentation produced for a workshop on anal cancer screening</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;The natural history of anal intra-epithelial neoplasia&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;SPAN class=detail_text&gt;&lt;SPAN class=detail_text&gt;A National Screening Committee workshop on anal cancer screening for&amp;nbsp;was held in London on&amp;nbsp;December 6th&amp;nbsp;2004. This powerpoint presentation by Charles Lacy, reader in Infectious Diseases at Hull York Medical School, outlines&amp;nbsp;the natural history of anal intra-epithelial neoplasia.&lt;/SPAN&gt;&lt;/SPAN&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>187335</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/bowel/bowel-ipc-booklet.pdf]]&gt;</url>
    <title>The NHS Bowel Cancer Screening Programme: information for primary care booklet</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ PRIMARY CARE,MANAGEMENT,COLORECTAL (BOWEL) CANCER,ADULT,IMPLEMENTATION,SCREENING,BOWEL CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This booklet produced by the NHS Cancer Screening Programmes provides information about the new bowel cancer screening programme, directed at the primary care team.]]&gt;</body>
  </document>
  <document>
    <id>187339</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/bowel/bowel-ipc-leaflet.pdf]]&gt;</url>
    <title>The NHS Bowel Cancer Screening Programme: information for primary care leaflet</title>
    <publicationDate>2006-01-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER,MANAGEMENT,PRIMARY CARE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Leaflet summarising the bowel cancer screening programme</description>
    <body>&lt;![CDATA[ This 4 page&amp;nbsp;leaflet summarises information on the new NHS bowel cancer screening programme, directed at the primary care team.]]&gt;</body>
  </document>
  <document>
    <id>63592</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=63592]]&gt;</url>
    <title>The prevention of early onset neonatal Group B Streptococcal disease - the RCOG guideline</title>
    <publicationDate>2003-11-01T00:00:00</publicationDate>
    <publisher>Royal College of Obstetricians and Gynaecologists</publisher>
    <publicationType>LEARNING MATERIAL%2FCOURSEWARE</publicationType>
    <topics>&lt;![CDATA[ CHILD HEALTH,SCREENING,SCREENING,ANTENATAL,STREPTOCOCCUS B,SPECIALTIES,NEONATAL,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>Powerpoint presentation on streptococcus B from a NSC workshop
</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;The prevention of early onset neonatal Group B Streptococcal disease - the RCOG guideline&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;The National Screening Committee convened a workshop on antenatal screening for streptococcus B,&amp;nbsp;in November 2003. The policy not to screen was reaffirmed, but issues requiring further work were identified relating to the current level of knowledge of Group B streptococcus. 
&lt;P&gt;This presentation from the workshop&amp;nbsp;looks at the prevention of early onset neonatal group B streptococcal disease in relation to the green-top guideline published by the RCOG.&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>63679</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp55.pdf]]&gt;</url>
    <title>The Right Results. Guide to the Correct Processing and Issuing of Results</title>
    <publicationDate>2003-05-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ ADULT,IMPLEMENTATION,SCREENING,BREAST CANCER,MANAGEMENT,QUALITY ASSURANCE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=justify&gt;This guide aims to help breast screening services to develop local protocols to ensure that the results from breast screening are processed and issued correctly.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>82272</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sogc.org/guidelines/public/135E-CPG-October2003.pdf]]&gt;</url>
    <title>The use of first trimester ultrasound</title>
    <publicationDate>2003-10-01T00:00:00</publicationDate>
    <publisher>Society of Obstetricians and Gynaecologists of Canada</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,ULTRASOUND,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;This guideline aims to review the clinical indications for first trimester ultrasound. The guideline has been&amp;nbsp;approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>95749</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/5/155?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1122642527830_206&amp;stored_search=&amp;FIRSTINDEX=0&amp;journalcode=ebmed]]&gt;</url>
    <title>The WHO-5 Wellbeing index performed the best in screening for depression in primary care</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ MANAGEMENT,NOT ROUTINELY OFFERED,PRIMARY CARE,OUTCOMES,MENTAL &amp; BEHAVIOURAL DISORDERS,DEPRESSION,INTERNATIONAL ORGANISATIONS,PUBLIC HEALTH ORGANISATIONS,PRIMARY CARE SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,SCREENING,ADULT,DEPRESSION,SCREENING,PUBLIC HEALTH,MANAGEMENT &amp; INTERVENTIONS,SERVICES,ORGANISATIONS,POPULATIONS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The WHO-5 Wellbeing index performed the best in screening for depression in primary care. Evidence-Based Medicine 2003; 8:155.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Henkel V, Mergl R, Kohnen R, et al. Identifying depression in primary care: a comparison of different methods in a prospective cohort study.BMJ 2003;326:200–1.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392230</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://informahealthcare.com/doi/abs/10.1080/03009730802579620]]&gt;</url>
    <title>Time-trend of melanoma screening practice by primary care physicians: a meta regression analysis</title>
    <publicationDate>2009-01-01T00:00:00</publicationDate>
    <publisher>Upsala Journal of Medical Sciences</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: The increase in melanoma and other skin malignancies together with the decreased use over time of the full body skin examination (FBSE) to screen for melanoma should be cause for concern.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: Medline, ISI, Cochrane Central Register of Controlled trials were searched and meta-regression analyses of the fifteen included studies was carried out.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Fifteen studies including 10336 physicians were included. 15-82% of physicians surveyed performed FBSE to screen for melanoma. Overall, this proportion decreased each year.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Valachis A, Mauri D, Karampoiki V et al. Time-trend of melanoma screening practice by primary care physicians: a meta-regression analysis. Upsala Journal of Medical Sciences 2009; 114(1):32-40&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://informahealthcare.com/doi/pdf/10.1080/03009730802579620" target="_blank"&gt;Full text pdf&amp;nbsp;freely available &lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>387242</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;ArtikelNr=265942&amp;Ausgabe=253731&amp;ProduktNr=223845]]&gt;</url>
    <title>Timing of group B streptococcus screening in pregnancy: a systematic</title>
    <publicationDate>2010-04-01T00:00:00</publicationDate>
    <publisher>Gynecologic &amp; Obstetric Investigation, S. Karger AG</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,STREPTOCOCCUS B,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Despite the limitations of the screening test for group B streptococcus in pregnancy (where 6% of carriers remain undetected) the results of this review support&amp;nbsp;screening at 35-37 weeks gestation. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: PubMed and Embase were searched from 1966 to February 2009. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: Study features and&amp;nbsp;predictive values of antenatal cultures were abstracted from the nine articles included.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Valkenburg-van den Berg AW.&amp;nbsp; Houtman-Roelofsen RL.&amp;nbsp; Oostvogel PM. et al.&amp;nbsp; Timing of group B streptococcus screening in pregnancy: a systematic review. Gynecologic &amp;amp; Obstetric Investigation 2010; 69(3):174-83&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstract&amp;amp;ArtikelNr=265942&amp;amp;Ausgabe=253731&amp;amp;ProduktNr=223845" target="_blank"&gt;Abstract freely available&lt;/A&gt;.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70629</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.aetmis.gouv.qc.ca/site/download.php?f=30541fecb96a0d9904a3dade8d6d508d]]&gt;</url>
    <title>Transcutaneous bilirubinometry in the context of early postnatal discharge</title>
    <publicationDate>2000-10-01T00:00:00</publicationDate>
    <publisher>Agence d'Evaluation des Technologies et des Modes d'Intervention en Sante</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Agence d’évaluation des technologies et des modes d’intervention en santé (AETMIS) is a government agency in Quebec, Canada. It assesses the introduction, acquisition and use of health technologies. 
&lt;P&gt;This report is based on a review of the scientific literature on transcutaneous bilirubinometry, a noninvasive technology that can provide an estimate of the blood bilirubin level of newborns. The report concludes that "in healthy term newborns, transcutaneous bilirubinometry is an effective technology for screening for cases where a serum bilirubin determination is required".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>66662</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sst.dk/publ/publ2005/CEMTV/diabetes_uk/diabetes_uk.pdf]]&gt;</url>
    <title>Type 2 Diabetes. Health Technology Assessment of screening, diagnosis and treatment</title>
    <publicationDate>2005-01-01T00:00:00</publicationDate>
    <publisher>Copenhagen: National Board of Health</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ VASCULAR RISK,NOT ROUTINELY OFFERED,CAUSES,DIABETES,ADULT,SCREENING,DIABETES,TYPE 2]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT color=#292526 size=2 face=Agenda-Bold&gt;&lt;FONT size=1 face=Agenda-Medium&gt;&lt;FONT size=1 face=Agenda-Medium&gt;Type 2 diabetes. Health Technology Assessment of screening, diagnosis and treatment Danish Health Technology Assessment 2005; 7(1) National Board of Health, Danish Centre for Evaluation and Health Technology Assessment&lt;/P&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/FONT&gt;]]&gt;</body>
  </document>
  <document>
    <id>324401</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=9408]]&gt;</url>
    <title>UK National Screening Committee Annual Report April 2007 - March 2008</title>
    <publicationDate>2009-08-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,QUALITY ASSURANCE,BENEFITS &amp; HARMS,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This UK&amp;nbsp;NSC annual report summarises the progress made between April 2007 and March 2008.]]&gt;</body>
  </document>
  <document>
    <id>113028</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/]]&gt;</url>
    <title>UK Screening Portal</title>
    <publicationDate>2009-04-13T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,CHILD,ADULT,SCREENING,NEWBORN,OLD AGE]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The website of the UK National&amp;nbsp;Screening&amp;nbsp;Committee aims to provide both health professionals and consumers with easy access and links to resources on screening in the UK.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>392218</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.aerzteblatt.de/int/abstract.asp?id=66287]]&gt;</url>
    <title>Ultrasonographic screening for the detection of abdominal aortic aneurysms</title>
    <publicationDate>2010-10-01T00:00:00</publicationDate>
    <publisher>Deutsches Arzteblatt International</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,BENEFITS &amp; HARMS,ABDOMINAL AORTIC ANEURYSM]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Screening for abdominal aortic aneurysm (AAA) using ultrasound is technically simple and associated with a major reduction in AAA-related mortality. Systematic screening for AAA is recommended in all men aged 65 and over and women with a family history. A national screening programme should be introduced in Germany. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: A selective literature review was carried out and four population-based, randomized&amp;nbsp; studies of ultarsonographic screening for the detection of AAA were evaluated. &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: A meta-analysis of four randomized controlled studies showed ultrasonographic screening was associated with a signifcant lowering of AAA-related mortality in men aged 65-80 years. Overall mortality was also lowered significantly after 7-15 years but not after 5 years. The number of elective AAA operations significantly increased and the number of emergency operations reduced by 50% &lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Eckstein HH, Bockler D, Flessenkamper I, &lt;EM&gt;et al&lt;/EM&gt;. Ultrasonographic screening for the detection of abdominal aortic aneurysms. Deutsches Arzteblatt International 2009; 106(41):657-63&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://aerzteblatt.de/v4/archiv/pdf.asp?id=66287" target="_blank"&gt;Full&amp;nbsp;text pdf&amp;nbsp;freely available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>113056</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://bmj.bmjjournals.com/cgi/content/full/330/7505/1413]]&gt;</url>
    <title>Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review</title>
    <publicationDate>2005-06-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,HIPS,NEWBORN,PHYSICAL (&lt;72HRS)]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review. Woolacott N, Puhan M et al. BMJ&amp;nbsp;&amp;nbsp;2005;330:1413&amp;nbsp;(18&amp;nbsp;June).&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;This article is available in &lt;A href="http://bmj.bmjjournals.com/cgi/content/full/330/7505/1413" target="_blank"&gt;free full text&lt;/A&gt; from the BMJ website.&lt;/P&gt;
&lt;P&gt;"&lt;STRONG&gt;Objective&lt;/STRONG&gt;: To assess the accuracy and effectiveness of the screening&lt;SUP&gt; &lt;/SUP&gt;of all newborn infants for developmental dysplasia of the hip&lt;SUP&gt; &lt;/SUP&gt;(DDH) using ultrasound imaging, as is standard practice in some&lt;SUP&gt; &lt;/SUP&gt;European countries but not in the United Kingdom, the United&lt;SUP&gt; &lt;/SUP&gt;States, or Scandinavia.&lt;SUP&gt; &lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions&lt;/STRONG&gt;: Clear evidence is lacking either for or against&lt;SUP&gt; &lt;/SUP&gt;general ultrasound screening of newborn infants for DDH. Studies&lt;SUP&gt; &lt;/SUP&gt;that investigate the natural course of the disorder, the optimal&lt;SUP&gt; &lt;/SUP&gt;treatment for DDH, and the best strategy for ultrasound screening&lt;SUP&gt; &lt;/SUP&gt;are needed.&lt;SUP&gt;"&lt;/SUP&gt;&lt;/P&gt;
&lt;P&gt;This article appears to&amp;nbsp;be based on&amp;nbsp;a Centre for Reviews and Dissemination (CRD) report (no. 28)&amp;nbsp;by the same authors, which was published later:&amp;nbsp;&lt;A href="http://www.york.ac.uk/inst/crd/pdf/report28.pdf" target="_blank"&gt;Systematic review of the clinical and cost effectiveness of ultrasound in screening for developmental dysplasia of the hip in newborns&lt;/A&gt;&amp;nbsp;(Aug 2005).&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>69776</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_ultrasound_cervical_length_for_the_prediction_of_preterm_labor.html]]&gt;</url>
    <title>Ultrasound cervical length for the prediction of preterm labor</title>
    <publicationDate>2003-05-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,NOT ROUTINELY OFFERED,PRETERM LABOUR]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of ultrasound cervical length as a tool in predicting preterm labor. The Technology Assessment Committee summarised by stating that: "ultrasound measurement of cervical length is not recommended as a screening test for preterm labor in the general obstetric population....although cervical length measurement between 28-35 weeks’ gestation may be clinically helpful, its usefulness has not been supported in the literature. Ultrasound measurement of cervical length is not recommended before 14 weeks or after 35 weeks’ gestation".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>79690</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.rcog.org.uk/womens-health/clinical-guidance/ultrasound-screening]]&gt;</url>
    <title>Ultrasound Screening - supplement to Ultrasound Screening for Fetal Abnormalities</title>
    <publicationDate>2000-07-01T00:00:00</publicationDate>
    <publisher>Royal College of Obstetricians and Gynaecologists</publisher>
    <publicationType>SERVICE GUIDANCE</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL PROBLEMS,ANTENATAL CARE,COMPLICATED PREGNANCY,SCREENING,FETAL ANOMALIES,FETAL ASSESSMENT,ULTRASOUND,BEFORE 16 WEEKS]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ This RCOG paper provides recommendations for the two-stage ultrasound scan programme - an initial scan performed at booking and the second at or around 20 weeks' gestation.]]&gt;</body>
  </document>
  <document>
    <id>383898</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://fetalanomaly.screening.nhs.uk/getdata.php?id=11235]]&gt;</url>
    <title>Ultrasound survey of England 2008: Mapping of 1st and 2nd trimester fetal screening services in the NHS</title>
    <publicationDate>2009-12-31T00:00:00</publicationDate>
    <publisher>NHS Fetal Anomaly Screening Programme</publisher>
    <publicationType>REPORT</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,IMPLEMENTATION,DOWN'S SYNDROME (NUCHAL TRANSLUCENCY),FETAL ANOMALY,WOMEN'S HEALTH,NORMAL PREGNANCY,ANTENATAL CARE,SCREENING,ULTRASOUND,QUALITY ASSURANCE,MANAGEMENT,11-14 WEEKS,BEFORE 16 WEEKS,18-20 WEEKS,DOWN'S SYNDROME]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ 'This survey is the second Ultrasound Survey of England conducted on behalf of the UK NSC. The first was commissioned in 2002 and since then policy, recommendations and service provision for fetal anomaly screening have undergone significant changes. Previous published literature and evidence from the &lt;A href="nelh:103161:0" name=internalLink&gt;2002 survey&lt;/A&gt; clearly demonstrate that although routine fetal screening forms a standard part of most antenatal screening packages its application is variable.&lt;BR&gt;The NHS FASP is committed to ensuring all pregnant women in England have access to safe, evidence-based, high-quality, uniform fetal screening services. This study maps local service delivery against current national policy and standards. This will assist in identifying where extra support and guidance is required to improve services to meet the standards.']]&gt;</body>
  </document>
  <document>
    <id>66843</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.sbu.se/en/Published/Alert/Universal-newborn-hearing-screening/]]&gt;</url>
    <title>Universal newborn hearing screening</title>
    <publicationDate>2004-03-31T00:00:00</publicationDate>
    <publisher>Swedish Council on Technology Assessment in Health Care</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,HEARING,ENT AND AUDIOLOGY,CONDITIONS,HEARING DISORDERS/ DEAFNESS,GENERAL EAR &amp; AUDITORY,EAR &amp; AUDITORY SYSTEM DISORDERS,PHYSICAL (&lt;72HRS),NEWBORN,NEONATAL SCREENING,SPECIALTIES,AUDIOLOGY]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Alert is a system for identification and early assessment concerning new methods in health care. The Alert reports are produced by the Swedish Council on Technology Assessment in Health Care, and&amp;nbsp;describe the new methods and their effects. 
&lt;P&gt;This report summarises the methods and effects of universal newborn hearing screening. It concludes that "there is scientific evidence that newborn screening, using either Otoacoustic Emissions (OAEs) or automated Auditory Brainstem Response (aABR), results in earlier detection of congenital hearing impairment and commencement of habilitation".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>63635</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ahrq.gov/CLINIC/uspstf/uspsnbhr.htm]]&gt;</url>
    <title>Universal screening for hearing loss in newborns</title>
    <publicationDate>2008-07-01T00:00:00</publicationDate>
    <publisher>Agency for Health Care Policy and Research, USA</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,PHYSICAL (&lt;72HRS),GENERAL EAR &amp; AUDITORY,EAR &amp; AUDITORY SYSTEM DISORDERS,HEARING DISORDERS/ DEAFNESS,CONDITIONS,HEARING,ENT AND AUDIOLOGY,SCREENING,AUDIOLOGY,SPECIALTIES]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is the U.S. Preventive Services Task Force (USPSTF) recommendation on screening for newborn hearing. The USPSTF recommends screening for hearing loss in all newborn infants. 
&lt;P&gt;&lt;A href="http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat3.chapter.1787" target="_blank"&gt;&lt;/A&gt;&amp;nbsp;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>70115</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cadth.ca/media/pdf/199_bilirubin_cetap_e_.pdf]]&gt;</url>
    <title>Using a spectral reflectance technique to measure transcutaneous bilirubin in neonates: a new device</title>
    <publicationDate>2002-07-01T00:00:00</publicationDate>
    <publisher>Canadian Coordinating Office for Health Technology Assessment</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,NEWBORN]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;The Canadian Coordinating Office&amp;nbsp;for Health Technology Assessment (CCOHTA)&amp;nbsp;publishes Issues in Emerging Health Technologies, a series of bulletins highlighting technologies. 
&lt;P&gt;This bulletin looks at the use of&amp;nbsp;a new spectral reflectance device to meaure bilirubin levels in neonates,&amp;nbsp;and summarises by stating that "as a screening technique for the healthy neonate population, these devices provide instantaneous information, may reduce the need of heel-pricks on neonates, and indicate which neonates will need serum bilirubin measurement".&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>382031</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/pubmed/20004997]]&gt;</url>
    <title>Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis</title>
    <publicationDate>2010-08-01T00:00:00</publicationDate>
    <publisher>Lung Cancer, Elsevier Science Ltd</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CANCER,LUNG,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;Authors' conclusions&lt;/STRONG&gt;: Circulating cell free DNA is not recommended for lung cancer screening alone although its use in combination with conventional markers warrants further investigation.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Method&lt;/STRONG&gt;: A systematic review of English language studies on sensitivity, specificity and othe accuracy measures for the&amp;nbsp;circulating cell free DNA assay in the diagnosis of lung cancer.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Results&lt;/STRONG&gt;: 10 studies were included.&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Citation&lt;/STRONG&gt;: Zhang R, Shao F, Wu X et al. Value of quantitative analysis of circulating cell free DNA as a screening tool for lung cancer: a meta-analysis. Lung Cancer 2010; 69(2):225-31&lt;/P&gt;
&lt;P&gt;&amp;nbsp;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Access&lt;/STRONG&gt;: &lt;A href="http://www.ncbi.nlm.nih.gov/pubmed/20004997" target="_blank"&gt;PubMed&amp;nbsp;abstract available&lt;/A&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>301341</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.screening.nhs.uk/getdata.php?id=8812]]&gt;</url>
    <title>Vasa praevia and placenta praevia screening - review of the evidence for screening against NSC criteria</title>
    <publicationDate>2008-11-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ANTENATAL,SCREENING,36 WEEKS,PLACENTA PRAEVIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>A review of vasa praevia and placenta praevia screening</description>
    <body>&lt;![CDATA[ A review of vasa praevia and placenta praevia screening against NSC criteria.]]&gt;</body>
  </document>
  <document>
    <id>127056</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=127056]]&gt;</url>
    <title>Vascular Risk Management Programme</title>
    <publicationDate>2006-05-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ VASCULAR RISK,STROKE,PREVENTION,MANAGEMENT ISSUES,NHS HEALTH IMPROVEMENT PROGRAMMES,GENERAL / OTHER,HAEMORRHAGIC STROKE,CAUSES / RISK FACTORS,CAUSES / RISK FACTORS,ISCHAEMIC STROKE,PREVENTION,PREVENTION,CAUSES / RISK FACTORS,GENERAL,KIDNEY DISEASE,CORONARY HEART DISEASE,PREVENTION,CAUSES,NOT ROUTINELY OFFERED,DIABETES,ADULT,SCREENING,CARDIOVASCULAR DISEASES,CAUSES AND RISK FACTORS,CORONARY HEART DISEASE,MANAGEMENT ISSUES,CONDITIONS,DIABETES MELLITUS,DISEASE MANAGEMENT,CHRONIC COMPLICATIONS,STROKE,DIABETES,CARDIOVASCULAR]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>This document outlines the need for a vascular disease control programme</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Vascular Risk Management Programme&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;This document outlines a proposal for a&amp;nbsp;co-ordinated Vascular Disease Control Programme covering heart disease, stroke, renal disease, Type 2 diabetes, and peripheral vascular disease.&lt;/SPAN&gt;&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>69707</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.msac.gov.au/internet/msac/publishing.nsf/Content/hs01-1/$FILE/msachs01.pdf]]&gt;</url>
    <title>Virtual colonoscopy</title>
    <publicationDate>2001-12-01T00:00:00</publicationDate>
    <publisher>Medical Services Advisory Committee</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT face=Garamond&gt;
&lt;P align=left&gt;The Medical Services Advisory Committee (MSAC) has undertaken an Horizon Scanning Briefing to provide advice on use of virtualcolonoscopy. This briefing provides an assessment of the current state of development of virtual colonoscopy, its present use, the potential application of the technology and the likely impact on the Australian healthcare system.&lt;/FONT&gt; 
&lt;P align=left&gt;The MSAC concluded that "based on the available evidence, VC appears to be safe when used for diagnosing CRC in individual patients. However, its safety as a population-based screening tool has yet to be evaluated."&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96098</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/9/4/123?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123063357544_119&amp;stored_search=&amp;FIRSTINDEX=30&amp;journalcode=ebmed]]&gt;</url>
    <title>Virtual colonoscopy detected colorectal polyps in asymptomatic patients with average risk of colorectal neoplasia</title>
    <publicationDate>2004-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,COLORECTAL (BOWEL) CANCER]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Virtual colonoscopy detected colorectal polyps in asymptomatic patients with average risk of colorectal neoplasia. Evidence-Based Medicine 2004; 9:123&lt;BR&gt;&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Pickhardt PJ, Choi JR, Hwang I, et al. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med 2003;349:2191–200.&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96099</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/9/4/122?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123063357544_119&amp;stored_search=&amp;FIRSTINDEX=30&amp;journalcode=ebmed]]&gt;</url>
    <title>Virtual colonoscopy performed poorly in detecting colorectal neoplasia</title>
    <publicationDate>2004-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ COLORECTAL (BOWEL) CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Virtual colonoscopy performed poorly in detecting colorectal neoplasia. Evidence-Based Medicine 2004; 9:122.&lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Cotton PB, Durkalski VL, Pineau BC, &lt;I&gt;et al&lt;/I&gt;. Computed tomographic colonography (virtual colonoscopy): a multicenter comparison with standard colonoscopy for detection of colorectal neoplasia. &lt;I&gt;JAMA&lt;/I&gt; 2004;291:1713–9&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>96104</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://ebm.bmjjournals.com/cgi/content/full/8/3/78?maxtoshow=&amp;HITS=10&amp;hits=10&amp;RESULTFORMAT=&amp;fulltext=screening&amp;searchid=1123074664701_428&amp;stored_search=&amp;FIRSTINDEX=40&amp;journalcode=ebmed]]&gt;</url>
    <title>Water soluble gel lubricant on vaginal speculums had no effect on cervical cytology results</title>
    <publicationDate>2003-01-01T00:00:00</publicationDate>
    <publisher>BMJ publishing group</publisher>
    <publicationType>CRITICALLY APPRAISED TOPIC</publicationType>
    <topics>&lt;![CDATA[ CERVICAL CANCER,SCREENING,ADULT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;Water soluble gel lubricant on vaginal speculums had no effect on cervical cytology results. Evidence-Based Medicine 2003; 8:78. &lt;/P&gt;
&lt;P&gt;This&amp;nbsp;summary is based on the original article: Amies AM, Miller L, Lee SK, et al. The effect of vaginal speculum lubrication on the rate of unsatisfactory cervical cytology diagnosis.Obstet Gynecol 2002;100:889–92&lt;/P&gt;
&lt;P&gt;Evidence-Based Medicine is a secondary evidence journal, containing informative abstracts and expert commentaries about the best quality research from primary care medicine.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>112663</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.hta.ac.uk/project/1489.asp]]&gt;</url>
    <title>What are the pros and cons of screening high risk populations for anal cancer? (project)</title>
    <publicationDate>2005-12-01T00:00:00</publicationDate>
    <publisher>Department of Health</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,ANAL,CANCER,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;This is a Health Technology Assessment (HTA) project&amp;nbsp;in progress.&lt;/P&gt;
&lt;P&gt;HTA project abstract: "The evaluation of the likely cost-effectiveness of a screening programme for screening anal cancer will consist of five broad sections. Firstly, a systematic literature review will be undertaken covering the following aspects: the epidemiology and natural history of anal cancer; the effectiveness of LBC as a screening test and alternative screening tests, the acceptability of screening tests in general, and for anal cancer in particular; and estimates of health related quality of life and patient utilities relating to anal cancer and screening; and the clinical and cost effectiveness of alternative treatment options. The data derived from the review will be analysed to formulate prior distributions for unknown parameters. Secondly, following the analysis of the data identified in the literature review, a decision analytic model structure describing the natural history of anal cancer in high risk groups will be develop. This will facilitate the evaluation of alternative forms of screening and treatment options. Thirdly, areas of the developed model for which no useable data are available will be specified and Bayesian methods for eliciting information from experts in these fields will be used to obtain relevant estimates. Finally, a full ‘expected value of information’ (EVI) analysis will be undertaken using a decision analytic framework to estimate the costs of uncertainty associated with the decision to implement screening for anal cancer in high risk groups, as well as to prioritise research by costing the individual (or joint) uncertainty attached to all parameters affecting the cost-effectiveness of screening."&lt;/P&gt;
&lt;P&gt;It is due to be published in&amp;nbsp;October 2010.&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>212712</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?orig_db=PubMed&amp;db=PubMed&amp;cmd=Search&amp;term=118%5Bvolume%5D+AND+1221%5Bissue%5D+AND+U1636%5Bpage%5D+AND+2005%5Bpdat%5D]]&gt;</url>
    <title>What is the most appropriate breast-cancer screening interval for women aged 45 to 49 years in New Zealand?</title>
    <publicationDate>2005-08-01T00:00:00</publicationDate>
    <publisher>New Zealand Medical Association</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ BENEFITS &amp; HARMS,BREAST CANCER,ADULT,SCREENING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Systematic review published in NZ Medical Journal</description>
    <body>&lt;![CDATA[ &lt;P&gt;New Zealand Medical Journal&amp;nbsp;2005; 118(1221): U1636&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;/EM&gt;&lt;EM&gt;specific criteria&lt;/EM&gt;&lt;EM&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed&lt;/EM&gt;&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objective:&lt;/STRONG&gt;&amp;nbsp;to review the international evidence on the benefits and harms of different screening intervals for women aged 45 to 49 years&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions:&lt;/STRONG&gt; there is no robust trial evidence on which to base a decision on the most appropriate breast-cancer screening interval for women aged 45 to 49 years&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>64071</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.retinalscreening.nhs.uk/userFiles/File/NDST%20Factsheet%204%20-%20What%20is%20the%20right%20size%20for%20a%20retinopathy%20screening%20programme,%20May%202004.pdf#search='optimum']]&gt;</url>
    <title>What Is The Right Size For A Diabetic Retinopathy Screening Programme?</title>
    <publicationDate>2004-05-01T00:00:00</publicationDate>
    <publisher>NHS Modernisation Agency</publisher>
    <publicationType>REFERENCE MATERIAL</publicationType>
    <topics>&lt;![CDATA[ CONDITIONS,RETINOPATHY,DIABETIC RETINOPATHY,RETINA,DIABETIC RETINOPATHY,CAUSES,CHRONIC COMPLICATIONS,DIABETIC RETINOPATHY,EYES AND VISION,RETINOPATHY,SCREENING,IMPLEMENTATION,ADULT,DIABETES,EYE DISEASES,MANAGEMENT]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>National Diabetes Support Team Factsheet No. 4</description>
    <body>&lt;![CDATA[ This is a factsheet outlining the importance of deciding what size a diabetic retintopathy screening programme should be - produced by the National Diabetes Support Team.]]&gt;</body>
  </document>
  <document>
    <id>57320</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.medicine.ox.ac.uk/bandolier/band90/b90-7.html]]&gt;</url>
    <title>When to measure bone density</title>
    <publicationDate>2001-08-01T00:00:00</publicationDate>
    <publisher>Bandolier</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ MUSCULOSKELETAL,CONDITIONS,BONE DISORDERS,OSTEOPOROSIS,SCREENING,ADULT,LATER LIFE,SCREENING AND SURVEILLANCE,OSTEOPOROSIS,OSTEOPOROSIS,OLD AGE,SCREENING,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;&lt;STRONG&gt;When to measure bone density.&lt;/STRONG&gt;&amp;nbsp;&amp;nbsp; 
&lt;P&gt;See the review in &lt;A href="http://www.medicine.ox.ac.uk/bandolier/band90/b90-7.html" target="_blank"&gt;Bandolier&lt;/A&gt; 
&lt;P&gt;Bandolier write: 
&lt;P&gt;"It is rare to find an example where a single clinical decision aid has been tested in an independent sample. To find a study that systematically compares all the available decision aids is remarkable. There are several ways in which this information might be used. Many women have bone density measured whatever decision system was used, and some will argue for mass screening. This study is the essential aid to decision making". 
&lt;H3&gt;References:&lt;/H3&gt;
&lt;OL&gt;
&lt;LI&gt;SM Cadarette et al. Evaluation of decision rules for referring women for bone densitometry by dual-energy X-ray absorptiometry. JAMA 2001 286: 57-63.&lt;/LI&gt;&lt;/OL&gt;]]&gt;</body>
  </document>
  <document>
    <id>69784</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.icsi.org/technology_assessment_reports_-_active/ta_whole-body_computed_tomography_as_a_screening_test.html]]&gt;</url>
    <title>Whole-Body Computed Tomography as a Screening Test</title>
    <publicationDate>2003-12-01T00:00:00</publicationDate>
    <publisher>Institute for Clinical Systems Improvement</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ COLORECTAL (BOWEL) CANCER,CORONARY HEART DISEASE,SCREENING,ADULT,VASCULAR RISK]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P align=left&gt;&lt;FONT face=Palatino-Italic&gt;Institute for Clinical Systems Improvement (ICSI) Technology Assessment Reports &lt;/FONT&gt;&lt;FONT face=Palatino-Roman&gt;are designed to provide a scientific assessment, through review and analysis of medical literature, of the safety and efficacy of medical technologies.&lt;/FONT&gt; 
&lt;P align=left&gt;This report looks at the use of whole-body computed tomography (CT)&amp;nbsp;as a screening test for various diseases. The Technology Assessment Committee summarised by stating that "whole-body CT should not be considered as a screening tool at this time. Whole-body CT screening is not specific enough or tailored appropriately to detect coronary artery calcification, lung cancer, or colon polyps or masses"&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>126409</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://hearing.screening.nhs.uk/cms.php?folder=1318]]&gt;</url>
    <title>Why screen all newborns for hearing loss?</title>
    <publicationDate>2008-01-01T00:00:00</publicationDate>
    <publisher>Newborn Hearing Screening Programme</publisher>
    <publicationType>BRIEFING</publicationType>
    <topics>&lt;![CDATA[ NEWBORN,PHYSICAL (&lt;72HRS),SCREENING,HEARING]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description>Document summarising the reasons for having a universal newborn hearing screen
</description>
    <body>&lt;![CDATA[ This document summarises the reasons for&amp;nbsp;having a&amp;nbsp;newborn hearing screen, and includes details about the acceptability of screening, the prevalence of newborn deafness, risk factors for hearing loss and the benefits of early identification.]]&gt;</body>
  </document>
  <document>
    <id>69933</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.cancerscreening.nhs.uk/cervical/publications/womantowoman.pdf]]&gt;</url>
    <title>Woman to Woman: Promoting cervical screening amongst minority ethnic women in primary care</title>
    <publicationDate>2004-04-01T00:00:00</publicationDate>
    <publisher>NHS Cancer Screening Programmes</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ADULT,CERVICAL CANCER,INFORMED DECISION-MAKING,MANAGEMENT,PRIMARY CARE,ETHNICITY AND HEALTH,DISEASES AND CONDITIONS,CANCER,SERVICE DELIVERY,SERVICE SECTORS,PRIMARY CARE,CLIENT GROUPS,WOMEN,PUBLIC HEALTH,OUTCOMES,MANAGEMENT &amp; INTERVENTIONS,POPULATIONS,GROUPS,CANCER,CERVICAL CANCER,ETHNIC GROUPS,WOMEN,SERVICES,POPULATION BASED &amp; PREVENTATIVE SERVICES,PRIMARY CARE SERVICES,SCREENING,MONTHLY ADDITIONS,NOVEMBER 2010]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;FONT size=2 face=GillSans-Light&gt;
&lt;P align=left&gt;This report aimed to explore issues involved in promoting cervical screening amongst minority ethnic women in primary care, to construct a health promotion programme to address issues identified, and to implement the health promotion programme and to evaluate the relative successes and limitations of the programme.&lt;/FONT&gt; 
&lt;P align=left&gt;The report&amp;nbsp;looked at lay and professional views to barriers of screening and found that "there was a divergence in perceptions held by both smear takers and minority ethnic women regarding cervical screening, which contributed to negative experiences on both sides. There is also clear evidence of dysfunctional clinical communication arising from these differing perceptions".&lt;FONT size=2 face=GillSans-Light&gt;&lt;FONT size=2 face=GillSans-Light&gt;&lt;/FONT&gt;&lt;/FONT&gt;&lt;/P&gt;]]&gt;</body>
  </document>
  <document>
    <id>61163</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.library.nhs.uk//screening/ViewResource.aspx?resID=61163]]&gt;</url>
    <title>Workshop on screening for late onset genetic disorders - heritable thrombophila</title>
    <publicationDate>2001-01-01T00:00:00</publicationDate>
    <publisher>National Screening Committee, UK</publisher>
    <publicationType>REVIEW</publicationType>
    <topics>&lt;![CDATA[ ADULT,SCREENING,THROMBOPHILIA,NOT ROUTINELY OFFERED]]&gt;</topics>
    <resourceType>Article</resourceType>
    <description>A report of a National Screening Committee workshop to discuss the likely value of population screening in relation to heritable thrombophilia.</description>
    <body>&lt;![CDATA[ &lt;article&gt;&lt;firstPage&gt;1&lt;/firstPage&gt;&lt;firstPageID&gt;1&lt;/firstPageID&gt;&lt;page&gt;&lt;pageID&gt;1&lt;/pageID&gt;&lt;pageSequence&gt;-1&lt;/pageSequence&gt;&lt;pageTitle&gt;Workshop on screening for late onset genetic disorders - heritable thrombophila&lt;/pageTitle&gt;&lt;pageBody&gt;&lt;P&gt;A report of a National Screening Committee workshop to discuss the likely value of population screening in relation to heritable thrombophilia. 
&lt;P&gt;One of the conclusions of this report was that "it was unanimously agreed that there is no clear benefit from testing for heritable thrombophilia in the individual with venous thrombosis, from the point of view of the clinical management of that individual"&lt;/P&gt;&lt;/pageBody&gt;&lt;/page&gt;&lt;/article&gt;]]&gt;</body>
  </document>
  <document>
    <id>93267</id>
    <name>&lt;![CDATA[ Screening]]&gt;</name>
    <rootDirectory>/screening</rootDirectory>
    <url>&lt;![CDATA[http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=pubmed&amp;dopt=Abstract&amp;list_uids=15572504&amp;query_hl=1]]&gt;</url>
    <title>World Health Organization systematic review of screening tests for preeclampsia</title>
    <publicationDate>2004-12-01T00:00:00</publicationDate>
    <publisher>Obstetrics and Gynecology</publisher>
    <publicationType>SYSTEMATIC REVIEW</publicationType>
    <topics>&lt;![CDATA[ SCREENING,ANTENATAL,PRE-ECLAMPSIA,28 WEEKS,36 WEEKS,PRE-ECLAMPSIA]]&gt;</topics>
    <resourceType>CARDEX</resourceType>
    <description></description>
    <body>&lt;![CDATA[ &lt;P&gt;World Health Organization systematic review of screening tests for preeclampsia. A Conde-Agudelo, J Villar, Lindheimer M. Obstet Gynecol 2004 Dec; 104(6): 1367-91&lt;/P&gt;
&lt;P&gt;&lt;EM&gt;Note: This reference&amp;nbsp;is indexed in Medline, and has&amp;nbsp;been established as&amp;nbsp;a systematic review using &lt;A href="http://libraries.nelh.nhs.uk/cancer/default.asp?page=DCQCINDEX" target="_blank"&gt;specific criteria&lt;/A&gt;. It does not yet appear in any pre-appraised source and so the quality of the&amp;nbsp;research has not been assessed.&lt;/EM&gt;&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Objectives: &lt;/STRONG&gt;This systematic review aims to assess the usefulness of clinical, biophysical and biochemical tests in the prediction of preeclampsia.&lt;/P&gt;
&lt;P&gt;&lt;STRONG&gt;Conclusions: &lt;/STRONG&gt;As of 2004, there is no clinically useful screening test to predict the development of preeclampsia.&lt;/P&gt;]]&gt;</body>
  </document>
</documents>